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Abstract 
Parkinson’s disease patients present with the highest risk of dementia development.  The 
thalamus, integral to several functions and behaviours is involved in the pathophysiology 
of Parkinson’s disease.  The aim of this thesis was to determine if anatomical abnormalities 
in the thalamus are associated with the development of dementia in Parkinson’s disease.   
We examined the thalamus using macro and microstructural techniques and the 
white matter pathways that connect the thalamus with areas of the surrounding cortex 
using diffusion tensor imaging (DTI) based tractography.  T1-weighted magnetic 
resonance and DT images were collected in 56 Parkinson’s disease patients with no 
cognitive impairment, 19 patients with mild cognitive impairment, 17 patients with 
dementia and 25 healthy individuals who acted as control subjects.  An established 
automated segmentation procedure (FIRST FSL) was used to delineate the thalamus and a 
modified k-means clustering algorithm applied to segment the thalamus into clusters 
assumed to represent thalamic nuclei.  Fibre tracts were determined using DTI probabilistic 
tracking methods available in FIRST.  Microstructural integrity was quantified by 
fractional anisotropy and mean diffusivity (MD) DTI measures.   
Results show that microstructural measures of thalamic integrity are more sensitive 
to cognitive dysfunction in PD than macrostructural measures.  For the first time we 
showed a progressive worsening of cellular integrity (MD) in the groups who had greater 
levels of cognitive dysfunction.  Thalamic degeneration was regionally specific and most 
advanced in the limbic thalamic nuclei which influenced executive function and attention, 
areas of cognition that are known to be affected in the earliest stages of PD.  The integrity 
of the fibre tracts corresponding to these thalamic regions was also compromised.  
Degeneration of fibre tracts was most evident in the dementia group, indicating that they 
may be more protected against Lewy pathology than the nuclei of the thalamus.     
Our findings confirm previous histological, animal and lesion studies and provide a 
reliable estimate of cortical degeneration in PD that can be applied non-invasively and in 
vivo.  A longitudinal study is needed to monitor the progression of cognitive decline in PD 
but we have provided the basis for further investigation into the predictive validity of 
thalamic degeneration for cognitive dysfunction.  In the future, the microstructural changes 
of the thalamus could be used as biomarkers for the identification of individuals with a 
higher risk for dementia development and for the longitudinal monitoring of any 
interventions into cognitive decline.    
xvi 
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Chapter 1. RATIONALE AND HYPOTHESES 
1.1 The increasing burden of disease in New Zealand and the cost of 
dementia 
Life expectancy has increased worldwide as we gain better control over infectious diseases 
and cardiovascular disorders.  The additional social and economic cost required to manage 
the increase in people with age-related decline is substantial.  The demand for healthcare 
has significantly increased and society is now facing the reality of costly long-term care 
and increased pressure on disability services (Public Health Intelligence Modelling Stroke: 
A multi-state life table model., 2002).  This is a particular concern in New Zealand as the 
first of the ‘baby boomer’ population (born 1946-1964) reached retirement age last year 
and now number 611,400 (as at 30 June 2012), which is projected to increase to 1.2 million 
in 2036 and 1.5 million in 2061 (Statistics New Zealand, 2008).   
As age is the greatest risk factor for many neurological illnesses there is urgent need 
to address the increasing prevalence of age-related disorders.  The increase in 
neurodegenerative disease is of particular concern as the progressive nature of these 
disorders dictates unavoidable increases in patient resource allocation as patients require 
more assistance (McCrone, Allcock, & Burn, 2007).  Dementia, the most common 
neurodegenerative disorder has now reached pandemic levels (Rockwood, Brown, Merry, 
Sketris, & Fisk, 2002).  Without prevention strategies, the number of new dementia cases 
diagnosed each year in Australia is expected to increase from ~43,000 in 2000 to ~143,000 
in 2050 (Jorm, Dear, & Burgess, 2005) and a proportional increase is also expected in New 
Zealand.   
Dementia is the end stage of many different diseases including Alzheimer’s disease 
(AD), Lewy body dementia, frontotemporal dementia and vascular dementia (Bolla, Filley, 
& Palmer, 2000).  Parkinson’s disease (PD) is one of the most common neurodegenerative 
disorders, second only to Alzheimer’s disease (Bertram & Tanzi, 2005; de Lau & Breteler, 
2006).  While recognised as a motor disorder, diagnosis of dementia follows in up to 80% 
of PD patients (Aarsland, Andersen, Larsen, Lolk, & Kragh -Sorensen, 2003).  The 
prevalence of PD is estimated at 0.08% (76.0 per 100,000) (Caradoc-Davies, Weatherall, 
Dixon, Caradoc-Davies, & Hantz, 1992) and increases steadily with age to 1% of those 
over 60 and up to 3% of those over 80 (Tanner & Goldman, 1996).  By 2030 the 
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prevalence of PD is expected to at least double in all developed countries (Dorsey, et al., 
2007).   
While motor symptoms are the most obvious sign (Hoehn & Yahr, 1967), dementia in PD 
is the most debilitating symptom and the largest contributor to resource expenditure 
(Aarsland, Larsen, Karlsen, Lim, & Tandberg, 1999) due to the requirement for nursing 
home placement as, after age, dementia is the single greatest predictor of nursing home 
admission for PD patients (Aarsland, Tandberg, & Laake, 2000).   
1.2 The need for pre-symptomatic identification of cognitive dysfunction 
If dementia onset could be delayed by even 5 years then dementia prevalence could be 
reduced by 44% (Jorm, et al., 2005).  There are several treatment options for PD and for 
PD dementia (PD-D) which could aid in a worldwide reduction in resource expenditure.  
The only treatment to be approved by the Food and Drug Administration in the United 
States is rivastigmine, which acts to increase cholinergic activity (Maidment, Fox, & 
Boustani, 2010).  This has been shown to improve cognition and aspects of daily living 
(Emre, et al., 2004).  Donepezil, another acetylcholinesterase inhibitor, also shows 
significant promise in treating cognitive dysfunction in Parkinson’s disease dementia.  
After 24 weeks of donepezil treatment, PD-D patients showed improvement on measures 
of executive function and global cognition (Dubois, et al., 2012).  The efficacy of drug 
treatment increases as a function of early recognition of cognitive decline.  Recognising 
cognitive decline as early as possible is therefore paramount in offering the best treatment 
(Seltzer, 2006).   
The urgency of this requirement was outlined by the National Dementia Strategy 
for New Zealand which was launched in 2010.  The report highlights the importance of 
detecting the early stages of Alzheimer’s dementia as earlier diagnosis can also aid in the 
development of interventions that may reduce or delay the need for palliative care (Dorsey, 
Holloway, & Ravina, 2006).  The strategy outlines the problems with current practice and 
recommends the development of new techniques in order to be able to achieve best 
recognition of early symptoms (Alzheimer's New Zealand, 2010).   
Although biomarkers such as changes in the brain, blood and cerebrospinal spinal 
fluid in pre-symptomatic PD patients may facilitate earlier diagnoses of the disease in 
clinical settings, nothing yet exists to aid in discrimination of those patients most at risk for 
PD dementia.  Additional biomarkers are still needed for greater accuracy in diagnosis of 
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the level of cognitive dysfunction (Shi, Bertrand, Hauber., & Zhang, 2009).  Neuroimaging 
advances in recent years have shown that the distribution of pathology in 
neurodegenerative diseases affects the gross structural anatomy of some areas and directly 
contributes to the clinical presentation of disorders (Ashburner, et al., 2003).  Examination 
of brain changes in neurodegenerative disorders therefore, may aid in improving diagnosis 
and monitoring of disease progression and provide a basis to test potential treatment 
options.   
A transitional period of mild cognitive impairment (MCI) which falls between PD-
N and PD-D has been recognised (Litvan, et al., 2011) and cited as a major risk factor for 
dementia in Parkinson’s disease (Janvin, Larsen, Aarsland & Hugdahl, 2006).  Work from 
our institute (Melzer, et al., 2011a) has shown that even in the very early stages of disease - 
in patients who exhibit cognitive function within the normal range (PD-N), there are 
significant cellular changes in the anterior cingulate, midbrain and corticospinal tracts.  In 
PD patients with more impaired cognition (PD-MCI and PD-D) degeneration in these 
regions worsens and, in the anterior regions there is a significant association with cognitive 
status.   
Neurological changes identified in PD-MCI could therefore aid in the future 
prediction of dementia (Aarsland, et al., 2003).  Somewhat surprisingly, despite the early 
evidence for a rapid rate of conversion ~60% from MCI to dementia within four years in 
PD (Janvin, Aarsland, & Larsen 2005), the research strategies into the neurocorrelates of 
PD-MCI remain in their infancy.  Investigation into the neurocorrelates of early stage 
Alzheimer’s disease has been more forthcoming and indicates that imaging subcortical 
structures that are known to be involved in the later stage of disease may also provide 
insight into the pre-cognitive impairment period (Marek & Jennings, 2009).   
1.3 Addressing a gap in the research: the thalamus and the progressive 
brain changes behind cognitive dysfunction 
Although characterising PD-MCI in Parkinson’s disease remains controversial, several 
recommendations have been made for suitable clinical criteria (Aarsland, et al., 2010; 
Dalrymple-Alford, et al., 2011; Jak, et al., 2009; Litvan, et al., 2011; Teng, Tingus, Lu, & 
Cummings, 2009), including recent formal guidelines (Litvan, et al., 2012).  If these 
criteria are used in conjunction with neurological examination a more detailed picture of 
the characteristics of PD-MCI and the likelihood of progression to dementia could emerge.   
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Parkinson’s disease is now recognised as a multi-faceted disorder that affects most 
cortical regions and disrupts multiple levels of cortical connectivity (Braak, Bohl, et al., 
2006).  Monitoring such widespread changes throughout the course of PD is beyond the 
scope of this thesis, but a representative approach was taken whereby the focus on the 
thalamus was examined, as this region reflects the functions of both the cortical mantle and 
the brain stem (Taber, Wen, Khan, & Hurley, 2004).  The justification for this approach is 
clear.  The central location of the thalamus means that all subcortical – cortical 
connectivity passes through this region (Behrens, et al., 2003; Cipolotti, et al., 2008); the 
neural connections of the thalamus are organised in a similar way to the architecture of the 
cortex, with anterior thalamic regions preferentially connecting to anterior regions of the 
cortex and, posterior thalamic regions preferentially connecting to the cerebellum and 
occipital regions (Jones, 2007b).  Also, the thalamus reflects cortical degeneration as the 
level of thalamic atrophy often corresponds to the breakdown in cortical integrity.  In 
patients with a frontal lobe tumours, for example, unilateral removal of the tumour resulted 
in ipsilateral retrograde atrophy of the thalamus in 9 of 12 patients (Hulshoff Pol, et al., 
2000).  More recently, the thalamus has demonstrated a strong relationship with cognition 
in several other neurodegenerative disorders (Byne, Hazlett, Buchsbaum, & Kemether, 
2009; de Jong, et al., 2008; Houtchens, et al., 2007).   
In Parkinson’s disease, atrophy of the thalamus as a single structure is only evident 
in some cases (Lee, et al., 2011a) and the majority of samples show no thalamic changes 
relative to control subjects (McKeown, et al., 2008; Messina, et al., 2011; Peran, et al., 
2010).  Examining only the gross structure of the thalamus with no consideration of its 
components misses an opportunity to partial out the influence of the sub-regions of the 
thalamus on cognitive decline however.  Parkinson’s disease patients exhibit deficits in a 
range of cognitive functions, including attention, executive function, learning and memory 
and visuospatial dysfunction, sometimes in even the early stages before global cognitive 
dysfunction is evident (Janvin, Aarsland, Larsen, & Hughdahl, 2003).  These sub-types of 
cognitive dysfunction have previously been attributed to specific thalamic regions 
(Kopelman, et al., 2001).  Examination of the thalamus in this way could therefore provide 
a biomarker for the earliest identification of cognitive symptoms in PD and may be better 
than that achieved by examination of the thalamus as a single structure.   
In the current thesis, quantative imaging analysis of standard structural and 
comprehensive DT images was employed.  Volumetric changes and DTI were both utilised 
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to enable a multimodal investigation of macro and microscopic measures of local brain 
tissue damage and tructural thalamic disconnection.  A cohort of Parkinson’s disease 
patients who were classified on the basis of detailed cognitive testing was examined to 
establish the relationship between thalamic integrity and cognitive dysfunction.  It was 
anticipated that thalamic volume and microstructural integrity would show a relationship 
with cognition and accurately discriminate between three levels of cognitive status in PD 
(PD-N, PD-MCI and PD-D).  The current investigation is expected to clarify the 
importance of the thalamus in the pathophysiology of PD and PD-D and to provide a 
baseline for further follow up studies using a longitudinal design.  To the best of our 
knowledge this will be the first study to encompass a cross-section of PD patients at 
various levels of cognitive status.     
1.4 Objectives  
1. Review neurological changes in PD (Chapter 2) 
2. Review the relationship between the thalamus and cognition (Chapter 3, Chapter 4) 
3. Investigate if thalamic change in PD is representative of cognitive decline: (Refer 
to individual study chapters outlined below)  
4. Summarise findings (Chapter 10) 
1.5 Hypotheses  
1.5.1 That the thalamus will reflects cognitive dysfunction in Parkinson’s 
disease  
Study One: Structural magnetic resonance imaging  
The primary objective of this study was to examine the influence of thalamic degeneration 
on cognition in Parkinson’s disease using traditional region of interest methods.  The 
thalamus was examined as a single brain region here, in contrast to later investigations 
which isolated sub-components of the thalamus.  For the remainder of this thesis when the 
thalamus is examined as a single structure it will be referred to as an investigation of the 
‘whole thalamus’.  Structural T1 imaging allowed for the examination of the whole 
thalamus and, for the first time, DTI, for the examination of subtler structural changes in 
the thalamus and their potential effect on cognition in PD.   
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The thalamus is involved in cognitive dysfunction in other neurodegenerative 
disorders (Batista, et al., 2012; Byne, et al., 2009; Coscia, et al., 2009; de Jong, et al., 2008; 
Houtchens, et al., 2007; Kassubek, Juengling, Ecker, & Landwehrmeyer, 2005; 
Seidenberg, et al., 2008; Stout, et al., 1999), and, by virtue of group comparisons between 
PD with and without dementia which have identified thalamic changes (Burton, McKeith, 
Burn, Williams, & O'Brien, 2004; Summerfield, et al., 2005), an association between the 
thalamus and cognition in PD has previously been established.  Based on these findings we 
expected that if sensitive methodology was applied we would find that the thalamus was 
degenerated in those patients with dementia.  Few studies (Dalaker, et al., 2011; Melzer, et 
al., 2011b) have included the thalamus for examination in PD-MCI and those that have 
only use whole brain voxel based methods.  Neither of these studies identified thalamic 
degeneration in this group.  Despite this we expected that some level of thalamic atrophy 
would also be evident in this group if stringent criteria were applied to identify this 
intermediate level of dysfunction.  
We expected DTI measures to be more sensitive to cognitive dysfunction in PD as 
DTI allows for inference of cellular, rather than gross anatomical changes (Watts, 2008).  
Microstructural alterations in the absence of atrophy has been identified in the thalamus of 
one PD sample (Peran, et al., 2009) to date.  Although these PD patients did not have 
dementia, they may have been exhibiting cognitive impairment as the cognitive 
examination of this sample was not sensitive to mild forms of impairment.  We expect that 
microstructural alterations will be evident in our PD-MCI patient group and will worsen in 
our PD-D group.   
Methodological and statistical limitations of previous research has not allowed for 
detailed examination of thalamic influence on cognitive dysfunction however.  This is 
primarily due to small sample sizes and restricted neuropsychological testing (Messina, et 
al., 2011; Paviour, Price, Jahanshahi, Lees, & Fox, 2006a; Tinaz, Courtney, & Stern, 
2010).  In addition, in the majority of cases no examination of the cognitive state of the PD 
cohort has been conducted (Lisanby, et al., 1993; McKeown, et al., 2008; Peran, et al., 
2009).  We propose that when extensive neuropsychological testing is applied to a well 
characterised PD cohort and the motor confounds of PD taken into account that we will be 
able to demonstrate thalamic involvement in cognition.   
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Study Two: Voxel based morphometry  
The primary objective of the second study was to examine the thalamus when it is mapped 
to standard space to validate the native space results as previous research has mainly 
applied standard space analysis.  A second objective was to determine which areas within 
the thalamus were most subject to change, an objective that is not possible in native space.   
 We expected the thalamic degeneration identified in native space would also be 
present in standard space analysis.  In line with previous research (Beyer & Aarsland, 
2008; Summerfield, et al., 2005), and that of our own group (Melzer et al., 2011), we 
expect the progressive nature of cognitive decline within Parkinson’s disease to correspond 
to grey matter reduction when the thalamus is isolated, similar to the progression of 
degeneration that is exhibited in the wider cortex (Beyer & Aarsland, 2008).   
 As voxel based morphometry (VBM) allowed for the examination of change within 
individual voxels of the thalamus we expected some regions to show degeneration while 
others did not.  Two previous VBM studies have isolated regions within the thalamus as 
differentially affected in Parkinson’s disease.  Neither of these studies examined the effect 
region specific degeneration had on cognition however, with one focusing on 
neuropsychiatric (Cardoso, et al., 2009) and the other on the movement symptoms 
(Kassubek, Juengling, Hellwig, Spreer, & Lucking, 2002) of PD.  Histological studies in 
Parkinson’s disease do suggest degeneration is worse in some areas than others, especially 
in dorsomedial and ventral regions and that this relates to the level of global impairment 
(Halliday, 2009; Henderson, Carpenter, Cartwright, & Halliday, 2000a).  We expect that 
the region which is most targeted by Lewy pathology (the non-specific 
centromedian/parafascicular region) will show the greatest change in our sample and have 
the strongest influence on Parkinson’s symptoms, including cognitive dysfunction due to 
the connectivity of cortical regions known to be influenced by that nucleus.     
1.5.2 That individual regions of the thalamus will be differentially involved in 
Parkinson’s disease and reflect cognitive dysfunction.   
Study Three: Diffusion tensor imaging investigation 
Our third study employed advanced diffusion techniques (Wiegell, Tuch, Henrik, Larsson, 
& Wedeen, 2003) and examined the structural components of the thalamus and closely 
approximated anatomical guidelines of major thalamic nuclei.  The primary aim of the 
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study was to investigate the association between each thalamic nucleus and cognitive 
dysfunction within the stratified PD cognitive groups (PD-N, PD-MCI and PD-D).  As 
degeneration of the nuclei was hypothesised to be subtle we first had to determine the best 
imaging measure to capture this.  Following investigation into the influence on cognition 
we then wanted to apply diffusion techniques to determine the nuclei which showed the 
greatest changes amongst the PD groups.  One previous study (Li, et al., 2010) has 
investigated the diffusion measures of one thalamic nucleus in PD using a region of 
interest VBM approach of the whole thalamus but this study did not allow for comparison 
with volumetric measures, and was not conducted in regards to cognitive dysfunction.   
In line with what has previously been established by others (Peran, et al., 2009) and 
ourselves (Melzer, et al., 2011a) in the first study we expected microstructural diffusion 
measures of the thalamic nuclei to be more reflective of cognitive diagnosis in PD than the 
volume of these nuclei.  We hypothesised that diffusion measures would be more reflective 
of cognitive dysfunction in the thalamic nuclei than structural atrophy measures as this is 
true for the whole thalamus, and other subcortical structures in PD (Nicoletti, et al., 2006; 
Schocke, et al., 2004), and in other neurodegenerative disorders (Canu, et al., 2010).   
We hypothesised that cellular or structural change in the thalamic nuclei would be 
associated with particular cognitive domains.  Specifically, we hypothesised that the 
cognitive domain most associated with the nuclei’s region of primary cortical connectivity 
would show the strongest relationship with that nucleus.  We expected to see an 
association between the anterior principal (AP) and lateral dorsal (LD) nuclei and memory 
and executive function due to previous findings from lesion (Aggleton & Brown, 1999), 
histology (Byne, et al., 2006) and structural imaging (Gilbert, et al., 2001; Hazlett, et al., 
1999) studies.  We also expected the mediodorsal (MDn) to be implicated in executive 
function and memory due to the connectivity with prefrontal and frontal regions (Van der 
Werf, Witter, Uylings, & Jolles, 2000) and previous findings from Schizophrenia cohorts 
(Byne, et al., 2001).  We expect an association with motor symptoms of PD and the 
centromedian/parafascicular (CM/Pf) complex as regions of the intralaminar nuclei have 
previously been implicated in PD-D (Henderson, Carpenter, Cartwright, & Halliday, 
2000b).  We also expect an association between this region and cognition due to the diffuse 
connectivity of this complex and the influence that the CM/Pf has over aspects of cognitive 
dysfunction in schizophrenia (Kemether, et al., 2003).  We expected a significant 
association between the lateral posterior (LP) and pulvinar (Pu) and the 
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visuospatial/perception cognitive domain due to the previously established involvement of 
these regions in patients with thalamic lesions who exhibit significant visual deficits 
(Ricker & Millis, 1996) and, in regards to the pulvinar nucleus, possible involvement in 
working memory as this has previously shown to occur in other dementia samples 
(Andrews, Wang, Csernansky, Gado, & Barch, 2006; Harms, et al., 2007).  In regards to 
the motor nuclei, ventral anterior (VA) and ventral lateral (VL), and the sensory ventral 
posterior (VP) nucleus we did not expect a relationship with any domain of cognition.   
Due to the prominent connectivity with the regions of the cortex (Behrens, et al., 2003) 
that show the first signs of alterations in PD (Gattellaro, et al., 2009; Karagulle Kendi, 
Lehericy, Luciana, Ugurbil, & Tuite, 2008), we expect that the limbic nuclei will show 
microstructural alterations in the PD groups who have neither PD-D or PD-MCI.  Frontal 
and temporal areas show the most degeneration in PD-D, with the frontal regions 
especially affected as early as PD-MCI (Beyer, Janvin, Larsen, & Aarsland, 2007).  Thus, 
we hypothesise that the nuclei showing primary connectivity with these regions will be the 
first to show degeneration in our sample.  Specifically, we expect the limbic nuclei to 
become implicated in the PD-N group who have no cognitive dysfunction or in the PD-
MCI group who have intermediate cognitive dysfunction and the association (MDn) nuclei 
and possibly also the CM/Pf complex implicated in the PD-MCI group.  The remaining 
nuclei are not expected to show degeneration until PD-D.   
1.5.3 That cortical connectivity will be disrupted between the thalamus and the cortex 
in Parkinson’s disease and contribute to cognitive symptoms  
Study Four: Tractography Investigation  
Our final study extended the diffusion study of the thalamic nuclei and examined the 
integrity of the major cortical connections between each thalamic sub-region and the 
cortex.  Tractography is a new diffusion tensor technique that allows for the quantitative 
examination of the integrity of any major subcortical-cortical connections (Hasan, Kamali, 
& Kramer, 2009).  Previously, the relationship between cognitive or motor symptoms in 
Parkinson’s disease and connectivity impairment has only been able to be hypothesised 
based on other factors such as cell loss or atrophy of subcortical regions. To date, only our 
own group (Melzer, et al., 2011a) has specifically set out to isolate white matter pathways 
in Parkinson’s disease and determine the influence of these on cognition.   
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In line with what we expect from the thalamic nuclei, we also expect the fibre tracts 
originating from the thalamus to have an association with cognitive dysfunction in 
Parkinson’s disease.  The white matter pathways in the mouse model of Parkinson’s 
disease are thought to be the main facilitators of Lewy body distribution (Luk, et al., 2012) 
and thus we expect them to be significantly disrupted.  As Lewy distribution worsens 
alongside cognitive dysfunction (Braak, Rub, & del Tredici, 2006) we expect this to be 
reflected in the fibre tracts.   
1.6 Summary  
There is an urgent need to identify the early stages of cognitive decline in Parkinson’s 
disease due to the rapidly increasing aging population (Statistics New Zealand 2008) and 
the corresponding increase in dementia development that this brings (Janvin, et al., 2006).  
The thalamus is a potential neurocorrelate of cognitive dysfunction in Parkinson’s disease 
due to the influence on several behaviours and processes (Van der Werf, et al., 2000) 
known to be affected in this disorder and also shows a relationship with cognitive decline 
in other neurodegenerative disorders (de Jong, et al., 2008; Houtchens, et al., 2007).  This 
thesis addresses the relationship between thalamic degeneration and cognitive decline in 
Parkinson’s disease across four studies.  We expect the thalamus to have a relationship 
with cognition, for there to be differential involvement of thalamic regions with the limbic 
nuclei to be most affected and, finally for there to be a corresponding decrease in the 
integrity of the thalamic fibre tracts.   
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Chapter 2. THE NEUROLOGICAL CHANGES IN PARKINSON’S 
DISEASE 
2.1 Objectives 
This chapter explores neurological changes in Parkinson’s disease with a particular focus on 
the neurotransmitter and neuropathological correlates of movement, neuropsychiatric and 
cognitive symptoms.  The majority of the neuropathology research has been post-mortem, but 
where applicable in vivo studies are also discussed here, although structural (Chapter 6; 
Chapter 7) and cellular changes (Chapter 8;Chapter 9) are addressed in the relevant study 
chapters.   
2.2 Neurological changes in PD  
Like Alzheimer’s disease, the damage in the PD brain accumulates over time and the 
observable symptoms are the end result of a cumulative pathological process that is not 
identifiable clinically until the disease has reached an advanced stage (Braak, et al., 2000).  
The first symptoms are the result of the degeneration of dopaminergic cells in the substantia 
nigra, which begins before symptoms are present, and at autopsy has cumulated in a cell loss 
of 50-70% (Braak, Bohl, et al., 2006).  The majority of neurological changes in PD directly 
affect, or are mediated by the thalamus.  The thalamus is a component of the extrapyramidal 
system, for example which controls movement (Brooks, et al., 1990), the frontal-striatal 
system which is involved in neuropsychiatric symptoms of PD (Murai, et al., 2001) and the 
limbic system which is significantly affected in PD and correlates with cognitive dysfunction 
(Kaasinen & Rinne, 2002).  Although dopaminergic changes are traditionally considered to be 
the hallmark of PD, the interaction between many different neurochemicals and the 
neuropathology in several cortical regions contributes to the multiple facets of this disorder.   
2.2.1 Lewy pathology  
The main pathological feature of PD is the presence of Lewy bodies (LB) and Lewy neurite 
(LN) inclusions that are formed after the alpha-synuclein (α-sync) protein becomes misfolded 
(Rub, Del Tredici, Schultz, et al., 2002).  Normally the α-sync protein only accounts for 1% 
of the proteins in the brain and plays a role in the modulation of synaptic transmission, 
synaptic vesicle density and neuronal plasticity (Abeliovich, et al., 2000; Murphy, Rueter, 
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Trojanowski, & Lee, 2000).  It has also been suggested that α-sync has a role in neurogenesis 
(Crews, et al., 2008) and cell survival (Yasuda & Mochizuki, 2010).  Although the underlying 
cause is unknown (Braak, Tredici, Rub, de Vos, Jansen Steur & Braak, 2003), when α-sync 
becomes misfolded the aggregations that form, along with other neurofilaments and synaptic 
vesicle proteins generate the characteristic Lewy bodies found in the cytoplasm of neurons in 
PD patients.   
2.2.1.1  The quantification of disease stage  
The spread and degree of Lewy inclusions in the Parkinson’s brain have recently been used to 
develop a scheme of disease stage (Table 2-1).  These inclusions begin developing before 
symptoms are present and spread throughout the cortex in six distinct stages, eventually 
infiltrating all cerebral areas (Figure 2-1).  
 
Figure 2-1:  Braak’s (2004) stages of disease progression 
A: The thalamus is implicated in stage 3, Lewy neurites and bodies are evident in brains of asymptomatic 
patients, once the threshold is exceeded however symptoms worsen with increasing levels of pathology.  B: 
Pathology begins in lower cortical regions and proceeds caudally until all regions of the cortex are affected.   
Lewy body pathology is at first confined to the medulla and moves from here in a 
dorsal direction to the pons, reaching the midbrain in stage three and the mesocortex in stage 
four before finally encompassing the neocortex in the final two stages (Braak, et al., 2003).  
This model of pathology progression is most applicable to those with younger onset PD who 
have a long disease duration as between 6.3 and 43% of cases followed a different pattern of 
Lewy progression, and, when the criteria has been applied to larger samples 49% of cases 
were unable to be classified according to this criteria (Jellinger, 2008).  Only some nuclei of 
the thalamus show Lewy inclusions.  According Braak’s (2002) model of progression the 
motor VA and non-specific intralaminar nuclei are the only regions to show Lewy pathology.  
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Other histological studies in PD that have focussed on the thalamus confirm that Lewy 
inclusions are evident in these areas as well as in the AP and MDn nuclei of the limbic loop, 
and that all regions are similarly affected by neuronal and volume loss.  The mediodorsal and 
ventral anterior nuclei of the thalamus are most affected by Lewy pathology when the limbic 
loop becomes affected (Halliday, Macdonald, & Henderson, 2005).    
Table 2-1: Braak’s stages of disease progression in PD 
Stage Main Areas Affected 
1  Dorsal motor nucleus  
Anterior olfactory structures 
2  Portions of lower Raphe nuclei 
Portions of reticular formation 
Locus coeruleus 
3 Manifestation of motor 
symptoms  
Pars compacta of Substantia Nigra 
Magnocellular nuclei 
Central subnucleus of amygdala 
Cholinergic axons from basal forebrain that pass through external 
capsule 
4  Amygdala 
Ammon’s horn 
Temporal mesocortex (incl. olfactory cortex and hippocampus) 
5 Cognitive decline evident 
when tested with MMSE 
Paling of substantia nigra 
Projections into sensory association areas 
Anterior cingulate cortex 
Prefrontal areas 
6 Correlation between 
degeneration and cognition 
seen in final stages  
First order sensory association 
Premotor areas 
Primary motor field 
Primary sensory association 
Involvement of entire neocortex 
The progression of Lewy body pathology and association with Parkinson disease symptoms as outlined by Braak 
(2006).   
Lewy pathology itself is not detectable using neuroimaging techniques (Vernon, 
Ballard, & Modo) but it is now possible to image amyloid load using contrast agents in MRI 
(Klunk, et al., 2003).  As Lewy pathology precedes neuronal loss (Dickson, Uchikado, 
Fujishiro, & Tsuboi, 2010) and neuronal loss to a large degree is reflected in gross atrophy of 
cortical regions (Halliday, 2009), MRI of atrophy in the neurodegenerative brain could reflect 
clinical symptoms related to Lewy progression.   
Neuropathology at autopsy is the only way to definitively diagnose PD, but the distinct 
early neurological changes suggest pre-symptomatic diagnosis is a future possibility (Olanow 
& Obeso, 2012).  Although the cause of these early neurological changes is not clear, the 
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progression of neurochemical and pathological changes in the PD brain are relatively well 
documented and generally allow for adequate monitoring of clinical symptoms, especially in 
relation to movement dysfunction.   
2.2.2 Neurochemical changes  
The neurotransmitter most involved in PD is dopamine (DA) and the main source of straital 
dopamine is from the pars reticular component of the substantia nigra (SNr).  Although 
theories behind the initial postulation of DA loss are abundant, the only unequivocal risk 
factor for increasing cell loss is advancing age.  Advancing age is a risk factor for Parkinson’s 
disease, but PD does not manifest as part of the normal aging process.  DA neuronal loss in 
PD is severe and involves different subpopulations of the substantia nigra pars compacta 
(SNc) (Bezzard & Gross, 1998).  In normal aging, for example, the dorsal tier of the 
substantia nigra is lost but in PD it is the ventral tier that is most affected (Gibb & Lees, 1991) 
and there remains no clear evidence that PD is an exaggeration of the ageing process (Rakshi, 
et al., 1999).  The degeneration of dopaminergic neurons and their projections may take 
decades to develop and motor signs appear only after 50 - 70% of neurons are lost (Jellinger, 
1999).  The loss of dopamine in extrapyrimidal parts of the motor loop contributes to most of, 
if not all observable symptoms of the disorder.   
2.2.2.1 Movement Symptoms 
Dopaminergic cells normally serve to mediate motor function through the release of 
dopamine into the extrapyramidal system.  The first visible symptom of Parkinson’s disease is 
of movement dysfunction such as tremor at rest, postural instability and difficulty in 
executing movement (Hughes, Daniel, Kilford & Lees, 1992).  In most cases motor 
dysfunction initially affects only one half of the body, gradually progressing to the 
contralateral side.  Bradykinesia, slowness in the execution of movement is a key feature of 
the disorder.  Patients have difficulty dressing, show micrographia, slower walking speed and 
quieter speech.  Patients will also have at least two of the following symptoms.  Resting 
tremor is common and will abate with action or in sleep and almost always appears in the 
distal part of an extremity.  Rigidity in passive movement is characterised by increased 
resistance in muscle tone when moving and may also be associated with the presence of pain.  
The cogwheel phenomenon, when pushing on an arm causes it to move in jerky increments 
instead of smoothly, usually accompanies symptoms of rigidity.  Postural instability, the loss 
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of postural reflexes, is generally a manifestation of the late stages of the disease, occurring 
after onset of other clinical features (Jankovic, 2008).  The neurological changes behind 
movement dysfunction are perhaps the most well researched phenomenon in PD but the 
precise reasons for the origin of symptoms are still beyond our grasp.   
 Dopaminergic cells primarily serve the motor loop which originates in the motor area 
of the cortex and terminates in the striatum portion of the basal ganglia.  The striatum is the 
main region to receive dopaminergic projections from the substantia nigra so DA reduction 
directly disrupts the normal process of the motor loop and other downstream dopaminergic 
processes (Obeso, Rodriguez-Oroz, Rodriguez, DeLong, & Olanow, 2000).  From the 
striatum, neurons project back to the cortex via either the direct or indirect pathway.  The final 
output of the direct pathway is excitatory and stimulates the motor cortex and results in a 
movement increase.  The final output of the indirect pathway is inhibitory which dampens the 
motor cortex and results in a movement decrease.  Figure 2-2 depicts the normal functioning 
of the motor loop (left) and the disrupted loop in Parkinson’s disease (right).  The direct 
pathway causes a net movement increase through inhibition of the SNr-globus pallidus-
internal (GPi) complex.  Because projections from this region normally act to inhibit the 
thalamus, when the action of the SNr-GPi complex is reduced they no longer inhibit thalamic 
activity and the motor nuclei of the thalamus (VA and VL), stimulate the cortex to facilitate 
an increase in movement.  In contrast, the normal function of the indirect pathway is to send 
inhibitory messages to the external portion of the globus pallidus (GPe), eventually causing 
reduced output from the thalamus.  In Parkinson’s disease, the cortico-striatal balance is 
disrupted, leading to reduced activity in the direct circuit and increased activity in the indirect 
circuit and excessive inhibitory output of the GPi/SNr.  The thalamic components of this 
system do not show a large degree of pathology or neuronal loss, instead the intralaminar 
regions, and, to a lesser degree, the limbic regions of the thalamus are implicated in PD 
(Henderson, et al., 2000b).   
 Dopaminergic neuronal death continues after the first appearance of clinical 
symptoms, resulting in significantly decreased dopamine levels throughout the cortex and 
further increase in motor disturbances.  Although dopamine therapy can initially correct 
movement imbalances it leads to a highly unstable system and departure from the normal 
physiological basal-ganglia system (Olanow, Lees, & Obeso, 2008).  Dopamine dysfunction 
in PD therefore has long reaching consequences that are not easily fixed.   
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Figure 2-2: The role of dopamine in the normal and Parkinsonism brain 
Schematic diagram from Smith, Wichmann, Factor & DeLong (2012) shows the direct and indirect pathways of 
the basal ganglia motor circuits in the normal (left) and PD (right) brain.  Red arrows are inhibitory projections 
and blue arrows excitatory.  The thicknesses of the arrows indicate the increase (larger) or decrease (thinner) in 
the activity of connections.  Dashed arrows indicate the partial lesion of that connection in PD.  CM: 
centromedian nucleus; CMA: cingulate motor area; GPe: globus pallidus, external segment; GPi: globus 
pallidus, internal segment; M1: primary motor cortex; PMC: pre-motor cortex; PPN: pedunculopontine nucleus; 
SMA: supplementary motor area; SNc: substantia nigra pars compacta; SNr: substantia nigra pars reticulata; 
STN: subthalamic nucleus; VA/VL: ventral anterior/ventral lateral nucleus.  The motor nuclei of the thalamus 
(VA/VL) are most involved in this loop but the CM/Pf is the region to show the largest degree of Lewy 
degeneration. 
2.2.2.2 Neuropsychiatric Symptoms  
In addition to motor dysfunction there are a number of non-motor complications in PD which 
are also mainly influenced by dopamine dysfunction (Davie, 2008).  In a comprehensive study 
of 150 patients with Parkinson’s’ disease, 16% of patients had one neuropsychiatric symptom 
assessed by the neuropsychiatric inventory (Cummings, et al., 1994), 28% of patients had two 
symptoms and 25% had three or more symptoms.  The most common neuropsychiatric 
symptoms were depression (38% of patients), hallucinations (27%) and anxiety (20%) 
(Aarsland, Larsen, Lim, et al., 1999).  Symptoms mediated by dopamine dysfunction 
increased with more advanced disease and all (delusions, hallucinations and agitation) were 
significantly correlated with Hoehn and Yahr stage and degree of cognitive dysfunction 
(Mancini, et al., 2004).   
 Depression is related to dopamine and noradrenalin levels.  Depressed PD patients 
have lower chemical levels in the locus coeruleus and regions of the limbic system (anterior 
cingulate cortex; thalamus; amygdala and ventral striatum) (Poewe & Luginger, 1999).  
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Depression is more common in those with prominent bradykinesia and gait instability than 
those with tremor-dominant syndromes (Cummings, 1992) and it is not surprising that even 
sub threshold mood fluctuations that are common in advanced stages of the disease are related 
to levels of motor dysfunction (Richard, et al., 2004) and can be alleviated with dopamine 
therapy alongside selective serotonin reuptake inhibitors (Burn, 2002).   
 Psychosis is also mediated by dopamine.  There is severe depletion of dopaminergic 
neurons in the mesolimbic areas in both PD with dementia and dementia with Lewy bodies 
(Naimark, Jackson, Rockwell, & Jeste, 1996).  Visual hallucinations are also mediated by 
dopaminergic and cholinergic systems (Papapetropoulos & Mash, 2005) and functional 
imaging shows several abnormalities in the activity of associative areas in PD patients with 
visual hallucinations.  Increased activation in the superior and inferior fontal gyrus (Stebbins, 
et al., 2004) and hypermetabolism in the frontal gyrus (Nagano-Saito, et al., 2004) are 
common findings and suggest significant disruption in the dopaminergic system.   
2.3 The influence on cognitive dysfunction 
Although James Parkinson noted that the movement disease which was later to be named after 
him left the ‘senses and intellects uninjured’ (Chapter 1, pg.1. Parkinson, 1817) the current 
understanding in PD is that cognitive impairment can occur even in the very early stages of 
diagnosis (Muslimovic, Post, Speelman, & Schmand, 2005) and, for the majority of 
individuals cumulates in dementia in the final years (Aarsland, et al., 2003).  Cognitive 
dysfunction is perhaps now the most widely recognised non-motor complication of 
Parkinson’s disease (Chaudhuri, Healy, & Schapira, 2006).  Mediated by multiple brain 
regions and neurotransmitter symptoms, cognitive decline presents a heterogeneous profile in 
PD patients (Janvin, et al., 2003), especially in the early stages (Muslimovic, et al., 2005).  It 
has long been accepted that dementia is a regular occurrence in Parkinson’s disease.  The 
cumulative prevalence of PD-D is 80% (Aarsland, et al., 2003) and will manifest around 10 
years after Parkinson’s disease is first diagnosed (Hely, Reid, Adena, Halliday, & Morris, 
2008; Hughes, et al., 2000; Williams-Gray, Foltynie, Brayne, Robbins, & Barker, 2007).  In 
more recent years, the prevalence of mild cognitive impairment has also been a prominent 
discussion in Parkinson’s disease research.  Although there is a wide range of applied criteria 
available (Aarsland, et al., 2010; Janvin, et al., 2006; Petersen, et al., 1999), including our 
own (Dalrymple-Alford, et al., 2011) to diagnose MCI in PD it is generally accepted that it is 
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a transitional stage occurring intermediary to no cognitive impairment in early PD and 
dementia in late PD.   
2.3.1  Dementia 
Dementia is characterised by a decline from normal cognitive functioning and is accompanied 
by an inability to retain previously well established social and behavioural skills.  Patients 
display a significant decline in daily functioning and exhibit fluctuating impairment in 
attention, deficits in most aspects of executive functions, visuospatial deficits which are 
disproportionate to the severity of dementia and will also have an impairment in retrieval 
memory, although this is generally mild (Emre, 2010).  The decline to dementia is 
progressive, risk significantly increases as PD advances (Hely, Morris, Reid, & Trafficante, 
2005).   
2.3.2 Mild Cognitive Impairment  
PD patients must experience a transitional period of impairment prior to the onset of 
dementia.  Point - prevalence estimates range from 22-55%, depending on the criteria used for 
diagnosis (Janvin, et al., 2003; Verbaan, et al., 2007).  PD-MCI is characterised by a decline 
in function but without the accompanying difficulty with everyday tasks (Litvan, et al., 2012).  
That is, PD-MCI patients experience memory problems or attention deficits (Aarsland, et al., 
2010) but will continue to engage in activities such as shopping and organising finances 
(Reisberg, et al., 2001).  Areas of cognitive impairment are the same in PD-MCI as those 
affected in PD-dementia, executive function, working memory, visuospatial function and 
attention difficulties, but generally at a lower level than in PD-D (Emre, 2010).  A number of 
cognitive domains can be affected, but any single domain impairment without accompanying 
memory deficit is the most common form of MCI in PD (Litvan, et al., 2011).   
Because not all PD patients develop dementia while others have early onset dementia, 
this suggests there are underlying factors which influence the likelihood of dementia 
development.  Identifying precursors to dementia would aid in recognition of those most at 
risk and could even aid in early intervention for pre-symptomatic patients.  The risk factors 
for early onset dementia include: older age, severity of motor symptoms (Alves, Larsen, 
Emre, Wentzel-Larsen, & Aarsland, 2006; Burn, et al., 2006; Williams-Gray, et al., 2007), 
visual hallucinations (Aarsland, et al., 2003; Aarsland, et al., 2004) and mild cognitive 
impairment (Janvin, et al., 2006).  Mild cognitive impairment, especially when consisting of 
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executive function and memory deficits is the biggest risk factor to the later development of 
dementia (Janvin, et al., 2005).  A better understanding of this transitional phase will enable 
identification of those patients at highest risk for dementia and aid in employing interventions 
to delay or prevent further cognitive decline.  
2.4 Pathology 
The neurological changes in PD include both PD-pathology (Lewy body accumulation) and 
AD-pathology (amyloid deposits and neurofibrillary tangles).  Amyloid pathology has a linear 
relationship with cognition, exhibiting lowest levels in controls and the highest in PD-D with 
the level of pathology in PD patients without dementia at an intermediate level (Compta, et 
al., 2009).  The increasing severity of lesion burden has a direct association with dementia in 
the final three Braak stages (Braak, Rub, et al., 2006).   
The gradual accumulation of Lewy bodies, especially in subcortical structures is 
thought to induce mild cognitive impairment and finally dementia in Braak stages 5-6  of PD 
patients (Braak, Rub, et al., 2006).  Because LB burden in the PD brain is not uniformly 
distributed, the level of burden is not as important as the location, with the pattern of α-
synuclein pathology thought to be more influential over the development of PD symptoms 
than the level of pathology.  Specifically, it is LB pathology in the limbic system that appears 
to have the biggest association with dementia (Kovari, et al., 2003).  Figure 2-3 shows that in 
stage 3, when the limbic system first becomes infiltrated is also the stage where patients 
transition from the cognitive pre-symptomatic to cognitive symptomatic stage (Braak, Bohl, 
et al., 2006) of impairment.  In terms of the thalamus, the anterior and mediodorsal regions 
become involved as early as stages 3 and 4 respectively and are therefore likely to play a 
significant role in the transition to PD dementia.  Although there appears to be an association 
between the locality and degree of degeneration and PD symptoms, the type of clinical 
symptoms that are influenced by this pathology still mostly remains unclear (Emre, 2010).   
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Figure 2-3: The pattern of Lewy pathology burden in PD 
The limbic sites that are crucial to learning and memory become involved at stage 4 and contribute to the 
development of cognitive decline.  The components of the limbic loop are essential to the transfer of information 
from the association cortex to the prefrontal cortex via regions of the basal ganglia and the mediodorsal 
thalamus.  Image from Braak, Bohl, et al., (2006).   
The location of Lewy inclusions appears to be a significant factor in dementia 
development as LB density is greatest in the limbic system (entorhinal cortex and anterior 
cingulate cortex) and has the strongest relationship with cognition in PD (Kovari, et al., 
2003).  Lewy bodies in the frontal gyrus especially have been found to be the most significant 
predictor of cognitive impairment in a PD sample (Mattila, Rinne, Helenius, Dickson, & 
Roytta, 2000).  In Parkinson’s disease with dementia Lewy body distribution was found to be 
highly sensitive (91%) and specific (90%) markers of dementia (Hurtig, et al., 2000).   
Lewy pathology is related to cortical atrophy levels, a greater number of Lewy bodies 
contribute to a larger degree of cortical volume loss.  In PD patients with late onset PD and 
patients with diffuse Lewy body disease for example, there is a significant degree of atrophy 
in the frontal lobes at death.  There was no difference in the level of atrophy in the DLB 
disease patients compared to the late-onset PD patients, indicating that regardless of the 
underlying cause, LB pathology can induce volume loss in neurodegenerative disorders 
(Double, et al., 1996).   
Braak’s (2006) model of disease progression stipulates that pathology begins in the 
brain stem and works steadily upward, increasing the degree and type of symptoms.  This 
model fits with the clinical presentation of cognitive symptoms in PD (Janvin, et al., 2003) 
and has been verified with neuroimaging.  Degeneration occurs in the brainstem regions prior 
to the development of cognitive symptoms (Jubault, et al., 2009), progressing into the limbic 
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regions as cognitive dysfunction becomes apparent (Beyer, Janvin, et al., 2007) and finally 
infiltrating the remaining neocortex in those patients with PD-D.   
Current MRI protocols do not allow for the study of burden in the thalamus but 
volumetric differences and the disruption in cellular architecture within the thalamus can be 
examined using traditional and advanced MR and DT imaging techniques (Wolf, et al., 2003).  
Both of these techniques can be considered to be influenced by lesion burden as the 
accumulation of Lewy bodies in neurons has been shown to cause cell death, atrophy and lead 
to the clinical manifestation of symptoms (Cordato, Halliday, Harding, Hely, & Morris, 
2000).  MR imaging allows for examination of any gross structural abnormalities of the 
thalamus, where volume loss is assumed to represent the cumulative degeneration of neurons 
and supporting cells and the loss of extracellular space (McKeown, et al., 2008).  DT imaging 
allows for more subtle analysis of changes at the microstructural level and is assumed to 
represent the degeneration of axons and damage of cells within a structure (Rose, Janke, & 
Chalk, 2008)   
2.5 Summary 
PD is a neurodegenerative process which affects multiple systems and arises from dopamine 
depletion in the substantia nigra.  Lewy body pathology is the hallmark of Parkinson’s disease 
but this is best identified at autopsy (Braak, Bohl, et al., 2006).  Pathology of this type does 
induce neuronal loss however which manifests as atrophy in some cases and can be detected 
using neuroimaging techniques (Beyer, Larsen, & Aarsland, 2007; Double, et al., 1996; Song, 
et al., 2011).  Although movement dysfunction is the hallmark of Parkinson’s disease, 
pathology has also been shown to relate to neuropsychiatric and cognitive symptoms.  
Changes in thalamic mediated systems underlie these symptoms and in vivo identification of 
thalamic abnormalities in PD could be a useful neurocorrelate of dysfunction.  Cognitive 
dysfunction is especially relevant as the progression to dementia could be monitored or 
predicted through regular neurological examination.  Given the involvement of the thalamus 
in multiple systems which mediate the main symptoms of PD we hope that detailed 
examination of the thalamus will provide an adequate neurocorrelate of dysfunction.   
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Chapter 3. THE THALAMUS  
The thalamus is centrally located and reciprocally connected with multiple areas of the cortex, 
influencing a wide range of functions and behaviours (Taber, et al., 2004).  The location and 
connectivity the thalamus has with the wider cortex means it is grossly affected in 
neurodegenerative disorders and thalamic degeneration has a strong relationship with both the 
clinical and cognitive symptoms of multiple diseases.  In Alzheimer’s disease dementia (AD) 
for example, the volume of the thalamus is significantly reduced (de Jong, et al., 2008), a 
phenomenon that has also been observed in Huntington’s disease (Kassubek, et al., 2005), 
multiple sclerosis (Houtchens, et al., 2007), schizophrenia (Brickman, et al., 2004; Gilbert, et 
al., 2001; Qiu, Zhong, Graham, Chia, & Sim, 2009) and temporal lobe epilepsy (Seidenberg, 
et al., 2008; Stewart, et al., 2009).  In the majority of these disorders the degree to which the 
thalamus is reduced reflects the severity of cognitive dysfunction.   
Thalamic changes have also been identified at the cellular level and the extent of 
microstructural disruption shows a relationship with the severity of symptoms.  In 
Alzheimer’s disease (Rose, McMahon, et al., 2006), the microstructure of the thalamus is 
significantly altered and has a strong relationship with multiple aspects of cognition – 
especially with measures of executive function.  Microstructural changes in this disorder are 
also strongly correlated with the level of volume loss.  The identification of microstructural 
changes is especially useful as, prior to meeting criteria for AD the majority of patients will 
first enter a transitional phase of mild cognitive impairment (Apostolova, et al., 2006).  In 
patients at the MCI stage, a disruption in cellular integrity was identified and had a 
relationship with cognitive dysfunction despite thalamic volume being maintained (Cherubini, 
et al., 2010).   
In Parkinson’s disease (PD), research on thalamic involvement is limited and has 
mainly been conducted using neuro-histology methods (Halliday, 2009; Henderson, et al., 
2000a).  Where MR methods have been applied, the transitional PD-MCI stage has generally 
been ignored (McKeown, et al., 2008) or the thalamus has only been examined using a 
standard template (Beyer, Janvin, et al., 2007), a practice known to warp the true nature of 
degeneration, especially in a sample of older participants (Mechelli, Price, Friston, & 
Ashburner, 2005).   
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3.1 Objectives  
The aim of this review chapter is to first provide a background on the normal function of the 
thalamus in order to be able to understand subsequent chapters where thalamic degeneration 
in Parkinson’s disease is explored.  In order to comprehend how thalamic changes may affect 
normal processes, the effect of thalamic degeneration in other neurodegenerative disorders is 
also discussed.  The thalamic changes that occur in Parkinson’s disease will be explored in 
subsequent chapters that employ the same methodology as these previous studies.  The 
methodology that has been used to investigate the thalamus in PD thus far includes structural 
imaging in both native (McKeown, et al., 2008) and standard space (Beyer, Janvin, et al., 
2007) as well as diffusion tensor imaging (Cherubini, et al., 2010) and thalamic changes in 
PD that have been identified using these techniques will be reviewed in chapters Chapter 6, 
Chapter 7, and Chapter 9 respectively.   
3.2 The role of the thalamus in cognition  
Although the thalamus has traditionally been considered a ‘relay system,’ which receives 
messages from the sensory system and relays them to the appropriate cortical area, there is 
now significant evidence which suggests that the thalamus is also independently involved in 
multiple aspects of functioning (Sherman, 2007).  Information gained from individuals who 
have suffered localised thalamic strokes, or other forms of brain lesions, for example provides 
strong evidence that the thalamus contributes, rather than merely facilitates cognitive function 
(Carrera & Bogousslavsky, 2006; Van der Werf, et al., 2003; Van der Werf, et al., 2002).  In 
order to understand the significance of thalamic damage however we must first examine the 
normally functioning thalamus.   
3.2.1 Location and composition  
The thalamus is a large aggregation of nuclei that is situated in the diencephalon – one of the 
major subdivisions of the brain that lies between the forebrain and midbrain (Jones, 2007a).  
As the largest component of the limbic system, the thalamus is easily identifiable in MR 
images.  Although it is surrounded by the other grey matter structures of the basal ganglia, the 
immediate borders of the thalamus include the white matter of the external capsule and, 
medially, the third ventricle which provide a great contrast in MR images (Figure 3-1).   
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Figure 3-1: FIRST segmentation of the basal ganglia 
Horizontal (top) sections at the a) dorsal (Z = 100) and b) ventral (Z = 92) level show the thalamus surrounded 
by the components of the basal ganglia.  The thalamus is easily identifiable in MR images due to being 
surrounded by the lateral (c: saggital section, X = 118) and third (d: coronal section Y = 22) ventricles.  Co-
ordinates are in MNI space.   
3.2.2 Connectivity 
Nearly all incoming sensory information is relayed through the thalamus before being 
transmitted to wider cortical areas – a system which underlies many cognitive, behavioural 
and motor functions (Sherman & Guillery, 2004).  Information is relayed through a series of 
fibre connections, each beginning, and ending in a specific location of the cortex (Figure 3-2).   
a) 
 
b) 
 
 c) 
 
Figure 3-2: Thalamic connectivity 
a) Horizontal Z = 58, b) coronal Y = 66 and c) saggital Z = 29 sections of the thalamic fibre tracts that originate 
in left (red) and right (green) thalamus.   
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There are three main areas of the thalamus which receive and send fibre connections 
to specific areas of the cortex: relay nuclei; intrinsic nuclei and the midline & intralaminar 
nuclei.  The relay nuclei receive input from the basal ganglia, limbic system, cerebellum, 
brain stem and spinal cord and transfer information to the motor and limbic regions of the 
cortex – influencing movement and cognition.  The intrinsic nuclei receive projections from 
within the thalamus and project to the association areas of the cortex, regions within the 
occipital, parietal and motor cortices and serve to mediate functions such as vision, hearing, 
touch, temperature, and the interpretation of pain and taste.  The midline and intralaminar 
nuclei receive input from multiple lower sources including the brain stem, spinal cord and the 
cerebellum and project fibres to the basal ganglia, and to a lesser degree also to the 
somatosensory, motor and premotor cortices which influences multiple movement and 
cognitive processes (Aglioti, 1997).  These three functional groups of thalamic nuclei can be 
further subdivided into individual nuclei, each of which project to smaller areas within the 
cortex and the differential connectivity of which will be explored in the subsequent chapter 
(Chapter 4).   
3.2.3 Function  
The thalamus is a crucial component for multiple functions, including cognition and 
movement (Jones, 2007a), with the only function not mediated by the thalamus thought to be 
olfactory processing (Wilson & Mainen, 2006).  The fibre networks that enable these 
processes to be carried out depend on the intact structure of the thalamus, as nearly all of 
these fibres traverse at least one thalamic region (Behrens, et al., 2003).  The fibres are 
preferential, with those that mediate each processes only passing through a specific thalamic 
region.  Each region within the thalamus therefore mainly contains neurons that preferentially 
connect to only one or two cortical areas.  In the case of motor function, for example, the 
motor nuclei of the thalamus will mainly consist of motor projection neurons which primarily 
terminate in the motor cortex (Jones, 2007a).   
There are two functionally distinct types of thalamic nuclei.  First order relay nuclei 
carry messages from the lower brain to the neocortex and include the: anterior thalamic 
nucleus; the ventral anterior; ventral lateral; and the ventral posterior thalamic nuclei.  Higher 
order relay nuclei receive incoming messages from the cortex itself and relay these messages 
from one cortical area to another.  Nuclei included in this division are the: mediodorsal 
nucleus which links one part of the frontal cortex to another; the laterodorsal nucleus which 
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links two areas of the cingulate cortex together; the pulvinar complex and the lateral posterior 
nuclei, both of which link areas of the occipital and temporal lobes together; and the 
intralaminar nuclei which span both first order and higher order relay nuclei divisions – 
linking lower brain regions with the neocortex while also linking areas of the motor cortex to 
the striatum (Sherman & Guillery, 2004).  The communication between these areas is possible 
due to the chemical transmission of signals between the cells, or neurons in each area.  Each 
neuron (Figure 3-3), although there are several different types, consists of a cell body, 
dendrites, an axon and axon terminals (Stufflebeam, 2008). 
 
Figure 3-3: The structure of a typical neuron 
There are several different types of neurons, but regardless of their function or location all neurons consist of 
dendrites, a call body, an axon and axonal terminals which through the transmission of neurotransmitters allow 
for communication between neurons.  Image from Stufflebeam (2008).   
A message is received in a neuron when chemicals - or neurotransmitters enter the 
neurons dendrites.  Once in the dendrites, the signal flows through a series of changes in the 
neurotransmitter through to the cell body and down the axon.  The neurotransmitters are then 
released from the axon terminals to the dendrites of the next neuron (Stufflebeam, 2008) and 
the signal continues.   
There are several different types of neurons but the majority of neurons are either 
projection neurons or interneurons.  Projection neurons only communicate with other 
projection neurons and are far reaching, their axons project to the cortical regions of the brain 
and to the spinal cord.  Projection neurons can be either motor or sensory in nature.  As their 
names suggest, motor neurons convey motor information while sensory neurons convey 
sensory information throughout the nervous system.  Interneurons interconnect with all other 
neurons and cover only a small distance within the brain (Stufflebeam, 2008).   
In Parkinson’s disease it is the far reaching projection neurons that are especially 
vulnerable to Lewy body pathology – particularly those which have disproportionally long 
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and thin axons in relation to the size of the cell soma.  An exception to this is those projection 
neurons which maintain a well-developed myelin sheath, as this serves as a neuro-protective 
feature against the formation of Lewy pathologies.  Projection neurons with short axons are 
less affected by Lewy neurites and Lewy bodies (Braak, Bohl, et al., 2006). 
Each thalamic nucleus contains both projection and interneurons.  Thalamic regions 
that are targeted by LB pathology may therefore show differential levels of degeneration 
depending on the quantity of projection neurons in each area.  The majority of neurons in the 
ventral anterior nucleus (Hani, Al-Haidari, & Saboba, 2007), for example, are projection 
neurons with the remainder of the nucleus consisting of interneurons – suggesting that this 
region may show higher neuronal loss than some other regions.  In contrast, the ventral lateral 
and ventral posterior regions of the thalamus may not be as affected by LB pathology as there 
are a smaller number of projection neurons than interneurons in these regions (al-Hussain, 
1992).  The opposite is true for the remaining thalamic regions (Armstrong, 1990; Steriade, 
Jones, & McGormick, 1997) however, so in the majority of thalamic nuclei LB pathology 
may be a strong influence on neuronal death.   
3.2.4 The information processing model  
A disruption to any part of the communication system that the thalamus is part of will result 
in functional deficits.  This is because the structures of the brain do not contribute to 
behaviour and cognition independently but instead have several connections, many of them 
reciprocal between each other and the wider cortex.  A breakdown in a substantial number of 
these connections leads to deficits in cognitive, and other behavioural functions (Rub, Del 
Tredici, Schultz, et al., 2002).  The general association between cortical areas and certain 
cognitive processes is well established.  For example, damage to the frontal cortex has long 
been associated with attention deficits (Heilman & Valenstein, 1972) and damage to the 
temporal lobe with memory deficits (Alvarez & Squire, 1994).  These broad associations can 
be further narrowed to the smaller subcortical structures within these areas.  Within the 
temporal lobe, for example, the progressive relationship between degeneration in the 
subcortical hippocampal structure and the decline in semantic memory in Alzheimer’s disease 
can predict conversion from MCI to AD (Apostolova, et al., 2006).   
In regards to the thalamus – the primary connections that each thalamic region has 
with specific areas within the neocortex is considered to be influential over those processes 
that are supported by that region.  Additionally, the connectivity that a thalamic region has 
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with other subcortical structures before the fibre connections reach the neocortex is also 
influential over those processes mediated by that structure.  A breakdown in the connectivity 
between the thalamus and the hippocampus, for example, would impact on memory function 
– even if the hippocampus itself remained intact.   
An influential model which presents the theory of dysfunction as arising from the 
disruption in connectivity in PD is the information processing model (Figure 3-4), proposed 
by Rub et al., (2002).  They theorised that Lewy body pathology in subcortical regions alone 
cannot cause the myriad of symptoms in PD and instead, it is the disruption in communication 
between key areas that is thought to be a stronger contributor to PD symptoms.   
In the itnralaminar regions of the thalamus for example, the degree of LB burden is 
heavy.  Neuropathology here could cause neuronal death in this region which would, in turn, 
affect the axonal connectivity the itnralaminar region has with the surrounding hippocampal 
region and the anterior cingulate and prefrontal cortex.  This axonal disruption prevents the 
normal communication process and is related to the frontal symptoms  of PD (Beyer, Janvin, 
et al., 2007).   
The idea of LB pathology affecting neuronal degeneration is also supported by 
histological studies conducted by Henderson, et al., (2000a).  Although this group identified a 
great degree of neuronal loss in subregions of the thalamus in their PD sample, LB’s were 
only present in a small proportion of the remaining neurons.  They suggested that this high 
degree of cell loss with relatively low level LB’s showed that LB’s caused neuronal death.  
LB infiltration in the neuron was thought to lead to the death of that neuron, resulting in the 
reabsorption of both neuron and LB debris, leaving no neuron and no trace of LB remaining 
in the thalamus.  This outcome suggests that neuronal loss could be a better marker of disease 
progression than level of LB’s as the LB level may change depending on whether neuronal 
death has occurred.   
In regards to the breakdown in connectivity, LB pathology alone may not cause the 
axonal degeneration of affected neurons, but when the cell body of the neuron dies, so too 
does the axon arising from that cell body.  This has been established to occur in patients with 
frontal lobe tumours (Hulshoff Pol, et al., 2000).  After removal of the tumour, axonal density 
in the affected area was also severely reduced.  As a consequence, the areas the axons 
projected to also had significant cell loss.  Thus, neuronal loss in the thalamus could restrict 
subcortical-cortical connectivity as axons degenerate and the communication between key 
areas is reduced.   
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Figure 3-4: The information processing model in Parkinson’s disease  
Lewy pathology throughout the subcortical and cortical structures in Parkinson’s disease causes a system wide 
disruption in cortical communication.  The nuclei of the thalamus are key components of the striatal, cerebellar 
and limbic loops – contributing to the autonomic, emotional and cognitive symptoms of PD respectively.  Image 
from Rub, Del Tredici, Schultz, et al., (2002).  The degree of LB burden is indicated using a progressive shading 
scale where white is no LB burden and black is heavy burden.   
3.3 The influence on cognitive dysfunction  
Given the location and connectivity of the thalamus, it is not surprising that damage to this 
area results in a myriad of symptoms.  Primary evidence for the thalamic contribution to 
cognitive decline comes from individuals who had suffered thalamic infarction after a stroke 
but who are otherwise neurologically intact.  Severe memory loss has been reported as a 
consequence of thalamic damage in the majority of these individuals, with the anterior and 
medial portions of the thalamus most involved in this aspect of cognitive dysfunction.  The 
anterior nuclei are the strongest contributors to amnesia and anterograde amnesia is normally 
only seen in patients where thalamic damage is concentrated to areas of the anterior thalamic 
nuclei or in the mammillo-thalamic tract (Carrera & Bogousslavsky, 2006).  Mammillo-
thalamic tract damage is of particular interest because it is this white matter bundle that 
projects from the anterior thalamus to the cingulate gyrus, hippocampus and the orbitofrontal 
and prefrontal cortices, mediating both memory and executive function processes (Mori & 
Hashimoto, 2001).   
Memory deficits after thalamic infarct has also been reported in another cohort (van 
der Werf, et al., 2003) of individuals with thalamic lesions.  The exact location of the lesion 
site was able to be verified using MRI, and in the cases where the lesion site was restricted to 
a specific sub region of the thalamus - any cognitive or functional changes of the patient could 
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be attributed to that individual region.  Within this cohort, those who had thalamic lesions but 
no other cortical damage were isolated.  It was found that although damage to the mamillo-
thalamic tract predicted memory deficits, no single area in the thalamus accounted for 
memory impairment.  If there was damage to several areas within the thalamus such as within 
the anterior and the medial regions however, this significantly contributed to amnesic 
symptoms.  Conversely, lesions within the posterior and lateral thalamus could be present 
without any memory deficits arising.  Although the executive functioning and attention of the 
patients was also examined, impairment on these tasks could not be attributed to any single 
region of the thalamus (van der Werf, et al., 2003).  Evidence from this study supports the 
idea that thalamic regions are functionally specific and although each will primarily be 
involved in separate areas of function, the combined influence of thalamic nuclei is greater 
than the sum of its parts due to the extensive connectivity each thalamic region has with other 
subcortical structures.   
An additional study (Carrera & Bogousslavsky, 2006) conducted on patients with 
post-stroke thalamic infarcts also supports the idea that thalamic damage in isolated regions 
results in the varied presentation of cognitive deficits between patients.  Infarcts in the 
anterior thalamus, for example are well established to result in amnesic syndrome and patients 
with MRI proven anterior infarcts in this cohort also suffered from intrusions of unrelated 
topics, distorted memories, short-term amnesia and executive dysfunction.  Anterograde 
amnesia, with recognition preservation was also a common result of an anterior thalamic 
infarct in these individuals, with symptoms continuing to persist several years after the stroke.  
Hemisphere of the affected thalamus is also relevant as visuospatial deficits (Graff-Radford, 
Eslinger, Damasio, & Yamada, 1984) have been reported in patients with infarcts restricted to 
the right thalamus and verbal impairment (Clarke, et al., 1994) reported in those with 
predominately left thalamic damage.   
The dorsomedial regions have also been implicated without anterior involvement in 
memory impairment in other samples.  Infarcts that span both the combined dorsomedial and 
centromedian regions of the thalamus show a relationship with amnesia (Castaigne, et al., 
1981) and memory/attention impairment (Gentilini, De Renzi, & Crisi, 1987).  Disinhibition 
and other behavioural changes are also widely reported after infarcts in these areas 
(Bogousslavsky, et al., 1988).  The effect of the dorsomedial and centromedian regions are 
also able to be further dissociated, as patients with pure centromedian involvement present 
with discrete amnesia but also severe distractibility (Mennemeier, Fennell, Valenstein, & 
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Heilman, 1992), suggesting that attention deficits may be underlying the presentation of 
memory deficits here.  Patients with lesions in only the dorsomedial area, on the other hand, 
present with amnesia less severe than those in the anterior thalamic region but nevertheless 
also show symptoms of executive dysfunction, anterograde amnesia and – for those patients 
with left sided lesions, aphasia (Carrera, Michel, & Bogousslavsky, 2004).   
 The difference in patient presentation of lesions located to the dorsomedial and 
anterior thalamic regions can be easily attributed to their primary connectivity with separate 
regions of the cortex.  Both involved in the limbic loop (Figure 3-4), the mediodorsal 
thalamus has direct connectivity with prefrontal association areas, mediating attention and 
executive function processes while the anterior thalamus is primarily connected with the 
hippocampus and mediates memory processes.   
In addition to this, infarcts in the ventral lateral regions of the thalamus have also been 
reported to affect executive function – a process that spans both attention and working 
memory.  Patients with lesions in these regions showed impairment on tests of verbal and 
figure fluency and performance of the Stroop attention and processing task (Annoni, et al., 
2003).  As these cognitive changes have also been reported after cerebellum lesions 
(Schmahmann & Sherman, 1998) these deficits are thought to mainly arise due to impairment 
in the connectivity of the ventral lateral regions with the cerebellum.   
3.4 Thalamic changes in other neurodegenerative disorders  
Changes in the macro structure of the thalamus have been identified in other 
neurodegenerative disorders such as multiple sclerosis (MS: Houtchens, et al., 2007), 
Huntington’s disease (Kassubek, et al., 2005), and Alzheimer’s disease (de Jong, et al., 2008), 
with microstructural changes also evident in AD (Cherubini, et al., 2010).  Despite the 
variation in the clinical presentation of these disorders, they all show some degree of 
cognitive dysfunction - although the type and degree of this varies.  In Huntington’s disease 
for example, the main area of cognitive impairment is in the domain of executive function 
while in multiple sclerosis cognitive deficits are mainly of attention and episodic memory 
(Deloire, et al., 2005).  In AD-MCI cognitive impairment manifests as a decline in memory 
function with all other areas of cognition preserved.  Once these patients progress to 
dementia, all areas of cognition become progressively worsened, especially in the language 
and visuospatial domains (Lambon Ralph, Patterson, Graham, Dawson, & Hodges, 2003). 
The thalamus, having been implicated in all the above areas of cognition (van der Werf, et al., 
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2003) is the underlying common factor in all these disorders, suggesting that the type and 
severity of cognitive function in neurodegenerative disorders may reflect the extent, location 
and degree of cell loss in the thalamus.   
3.4.1 Volume  
Cell loss can be measured at autopsy (Halliday, 2009) with an in vivo representation of cell 
loss also able to be visualised using MR imaging.  Atrophy of the thalamus for example is 
assumed to represent the destruction of neurons and axons (Houtchens, et al., 2007) and can 
be measured using either manual (Houtchens, et al., 2007), or automatic (de Jong, et al., 2008) 
methods from structural (T1) MRI images in either native subject (Houtchens, et al., 2007) or 
standardised (Kassubek, et al., 2005) space.   
3.4.1.1 Huntington’s disease  
In Huntington’s disease, standardised voxel based morphometry methods have typically been 
applied.  This involves the image from each subject being mapped to the same stereological 
space with the average thalamic volume of the disease group then able to be compared to the 
average of the control group.  Results show that, on average, the thalamus has markedly 
decreased grey matter density compared to that of the control subjects in this cohort 
(Kassubek, et al., 2005).  Loss was concentrated in large areas of the dorsomedial, 
ventrolateral and centromedian regions of the bilateral thalamus, occurred independently of 
normal aging and had a significant association with performance on tasks of executive 
function.   
3.4.1.2 Multiple sclerosis  
In the multiple sclerosis sample (Houtchens, et al., 2007) the thalamus was measured using 
manual tracing methods in subject native space.  A 16.8% reduction in thalamic volume was 
reported in the MS group relative to control subjects after normalisation for intracranial 
volume (ICV).  Thalamic volume reduction was associated with impairment on cognitive tests 
of processing speed/working memory and visuospatial memory in the MS group.  Thalamic 
volume in this sample predicted cognitive function better than other MRI measures of third 
ventricle width, lesion volume and whole brain atrophy.  In another MS sample slowed 
cognitive processing has also been independently associated with thalamic atrophy (Batista, et 
al., 2012).  After controlling for the influence of neocortical and basal ganglia volume, 
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thalamic volume was found to be significantly independently associated with multiple 
measures of information processing and speed performance in the patient sample.  
3.4.1.3 Temporal lobe epilepsy  
Thalamic degeneration and the association with cognitive dysfunction has also been 
implicated in those with temporal lobe epilepsy (TLE), a disorder which mainly causes 
memory deficits due to the reoccurrence of seizures that induce alterations in neural circuits 
(Pitkanen & Sutula, 2002).  Using manual tracing methods to delineate the thalamus and 
hippocampus of patients, Seidenberg et al., (2008) showed reduced thalamic volume in the 
patient group relative to healthy controls.  Furthermore, this study indicated differential 
involvement of the thalamus depending on the hemisphere it was located in.  The left 
thalamus was the best predictor variable of verbal IQ in patients with right TLE and the right 
thalamus the best predictor of verbal IQ and performance IQ in those with left side TLE.  In a 
different sample of TLE patients (Stewart, et al., 2009) thalamic volume was compared with a 
healthy control group, and although volume loss was only evident at trend level, there was a 
significant association between volume and a test of memory recall.  The volume of the 
thalamus continued to be an independent predictor of this score even after controlling for 
hippocampal volume.   
3.4.1.4 Schizophrenia  
Several studies have examined thalamic volume in Schizophrenia due to the reciprocal 
connectivity the thalamus shows with the cortical regions that are implicated in the disorder.  
The prefrontal cortex, for example has a strong association with some of the negative 
symptoms of Schizophrenia such as deficits in emotional responses and other thought 
processes which present as apathy, blunted affect or a lack of motivation (Martino, Bucay, 
Butman, & Allegri, 2007) and is also reciprocally connected with the anterior and medial 
regions of the thalamus (Jones, 2007b 2007a).  Nearly all Schizophrenia samples point to a 
significant bilateral (Brickman, et al., 2004; Gilbert, et al., 2001) or left (Qiu, Zhong, et al., 
2009) thalamic reduction in patients relative to control subjects which survives correction for 
ICV in all but one (Csernansky, et al., 2004) sample.  Only some studies have gone further 
and examined the relationship between reduced thalamic volume and impaired cognition in 
schizophrenia, finding a positive association with executive function measures (Batista, et al., 
2012) and executive function and language (Coscia, et al., 2009).  In one of these samples, 
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(Qiu, Zhong, et al., 2009), although the shape of the thalamus was significantly correlated 
with measures of spatial memory and executive function, the volume of the thalamus did not 
have a relationship with any measure – suggesting perhaps that the memory and executive 
function deficits in this sample were influenced by regional thalamic changes rather than 
gross thalamic atrophy.   
3.4.1.5 Alzheimer’s disease 
In contrast, when thalamic volume has been examined in Alzheimer’s disease samples there is 
a consistent deficit in volume loss which has a strong relationship with cognition.  Thalamic 
involvement in AD is of particular interest as, traditionally it is the hippocampus that is 
considered to be the main biomarker of cognitive impairment (Apostolova, et al., 2006; Jack, 
et al., 1999) as AD mainly presents as memory dysfunction (Bronnick, Emre, Lane, Tekin, & 
Aarsland, 2007).  Given that AD is not a disorder of ‘pure’ memory deficit however it is not 
surprising there is also some degree of thalamic involvement in cognitive symptoms.  
Thalamic volume has been reported to be significantly reduced in a sample (Stout, et al., 
1999) of AD patients and has a strong relationship with cognition.  Thalamic volume loss in 
this sample was measured after segmentation of images into grey and white matter and the 
subcortical structures were manually delineated from the grey matter maps.  Thalamic atrophy 
had an independent association with the learning, delayed recall and recognition trials of the 
California Verbal Learning Test.  Learning of the CVLT word list was found to be more 
impaired when damage to the thalamus or surrounding medial temporal cortex was more 
severe than damage in the neocortex, indicating that thalamic damage in this case is a stronger 
contributor to learning and memory than damage to the grey matter of the wider cortex and 
perhaps occurs first.   
Some AD samples show significant thalamic volume loss, but no association with 
cognition.  In a different sample of AD patients (Callen, Black, Gao, Caldwell, & Szalai, 
2001), the thalamus showed a significant volume loss compared to healthy control subjects.  
This study was somewhat unique in that it measured all structures of the limbic system (basal 
forebrain, cingulate, hippocampus, mammillary bodies, orbitofrontal cortex, parahippocampal 
cortex, septal area and thalamus) rather than just concentrating on the hippocampus.  
Although all regions except the anterior cingulate showed a significant degree of volume loss 
in AD, the degree to which a particular structure was involved varied.  The hippocampus for 
example, showed the greatest volume loss of 28.30% and was also the only subcortical 
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structure which, alone, could discriminate between the patient and control group with a 
significant degree (85%) of accuracy.  The thalamus was not an independent predictor of 
cognition and did not appear to contribute to cognitive dysfunction.  Although there was a 
significant volume reduction of 12.7% this measure could not accurately discriminate 
between the patient and control groups, even when examined in the same model as other 
subcortical structures.   
Unfortunately only the Mini Mental Status Exam (MMSE) and the Dementia Rating 
Scale were applied as cognitive measures in this sample so it is difficult to determine exactly 
the neuropsychological profile of this cohort.  Given that a progressive memory deficit is 
required for the diagnosis of AD and is generally the first symptom a patient will report 
(Aarsland, Cummings, & Larsen, 2001) it is likely that only the hippocampus was mainly 
involved at this stage of the disorder as patients may not have yet been exhibiting large 
deficits in any wider areas of cognition.   
 In support of this idea, several studies have shown that thalamic volume appears to 
only be reduced when memory deficits are severe, which could explain the inconsistency 
between results in the Callen, et al., (2001) and Stout, et al., (1999) samples.  In a study of 
those that self reported memory deficits (de Jong, et al., 2008), for example, thalamic volume 
was not found to be significantly reduced despite the fact patients felt they had memory 
impairment.  Conversely, in the same study, the thalamus showed a significant volume 
reduction in those with diagnosed AD.  The self report group was classed as ‘memory 
complainers’ rather than healthy controls in this case as they presented with self reports rather 
than objective measures of memory impairment.  Deficits were at a sub-clinical level however 
as no decline was evident when the group was tested using objective memory measures.  
Deficit was examined using both the MMSE and the Cambridge Cognitive Examination-
Revised (CAMCOG-R: Roth, Huppert, Mountjoy, & Tym, 1999).  The insensitivity of the 
MMSE to mild forms of cognitive impairment in PD (Zadikoff, et al., 2007) has already been 
discussed and may have also missed MCI in this sample, classifying patients as exhibiting 
normal cognition when, in fact they were not.   
 There are also some reports that suggest the CAMCOG-R faces this problem, showing 
low accuracy in discriminating between MCI and control subjects, although it can 
discriminate between MCI and dementia with more success (Nunes, et al., 2008).  Another 
difficulty in interpreting this study comes from the lack of healthy control group.  The 
memory complainers group may, in fact, have been exhibiting volume loss that was 
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intermediate to that of normal controls and the AD group.  Regardless of whether the 
subtleties of mild cognitive impairment was missed in the ‘memory complainers’ or if they 
were in fact of a normal cognitive status, these results merely confirm that the thalamus shows 
gross atrophy if cognitive impairment is severe.  If these participants were in fact in the early 
stages of AD it only adds to the conclusion that the thalamus is significantly degenerated in 
dementia, over and above what may be expected as a consequence of normal aging.  Even 
after adjustment for age, gender and ICV in this sample, bilateral thalamus was reduced in the 
AD group relative to the comparison group.  Furthermore, in the AD group, volume reduction 
in the left was correlated with poor executive functioning scores while volume reduction in 
both left and right thalamus was correlated with poor scores of global cognition.   
3.4.1.6 In Mild Cognitive Impairment  
Thalamic volume has been examined in other cohorts exhibiting MCI but inconsistent results 
are reported, further suggesting that thalamic volume loss is only evident when cognitive 
dysfunction is severe, or that the volume varies according to the criteria that is used to 
diagnose MCI.  In one sample (Karas, et al., 2004), for example the idea that the thalamus 
shows significant levels of degeneration in the early stages of AD was confirmed.  From a 
whole brain voxel based analysis, the thalamus was identified as the region most affected in 
MCI compared to healthy control subjects.  MCI was diagnosed according to Petersen criteria 
(Petersen, et al., 1999) which states MCI is present if there is an impairment of memory (1.5 
SD below age adjusted means of normative data adjusted for age) but general cognitive 
function is normal.  Between MCI and AD, although the greater temporal lobe showed 
significant degeneration in this study there was no further thalamic degeneration, suggesting 
that the greatest disruption of the thalamus occurs early in the AD process.  Further 
degeneration may progress in an outward pattern from here and manifest as further cognitive 
impairment as additional regions become involved (Braak & Braak, 1996).   
In a similar MCI cohort (Pennanen, et al., 2005) volume loss was identified using 
voxel based analysis in regions of the thalamus, along with the hippocampus, amygdala, 
anterior cingulate and parietal and temporal lobes compared to healthy control subjects.  The 
authors of this study did not examine the relationship between volume of the ROI’s and 
cognition but, as MCI was diagnosed according to criteria proposed by the Mayo Clinic 
Alzheimer’s Disease Research Centre (Petersen, et al., 1995) as impairment in one memory or 
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any one other cognitive domain it is safe to assume that cognitive dysfunction was influenced 
by volumetric degeneration in subcortical structures and was not an artefact of normal aging.   
In line with this, a recent AD sample (Roh, et al., 2011) that did not differentiate 
between MCI and AD but included patients across the whole spectrum of cognitive 
dysfunction (CDR range 0.5-2) found thalamic volume was reduced as a function of disease 
severity but that this only reached statistically significant levels when severity was 1 on the 
CDR scale.  Thalamic volume did have a strong positive relationship with all areas of 
cognition (attention, language, visuospatial function, memory, frontal executive function) 
both independently and as an aggregate measure in this sample.  A further AD sample also 
showed that thalamic degeneration was only identifiable once cognitive impairment was 
extreme, with significant atrophy evident in the AD group relative to controls but not in the 
MCI group (Cherubini, et al., 2010).  This last sample also diagnosed MCI according to the 
criteria of (Petersen, et al., 1999) but thalamic volume was measured using an automated 
procedure individually for each subject – perhaps suggesting that the previous results are 
spurious and mainly the result of the standardisation procedure.   
Arguably the most informative methodology for thalamic involvement in the 
progression of MCI to AD is that that is gained from longitudinal studies.  Studies of this kind 
first examine the thalamus in a MCI cohort and then that same cohort is followed up some 
time later and differences between those who have developed AD are compared to those that 
have not.  One such study (Chetelat, et al., 2005) uses voxel based methods and provides 
strong evidence for the involvement of the thalamus in those with MCI who later convert to 
Alzheimer’s disease.  Eighteen patients with amnesic MCI were followed for 18 months to 
determine if any neurological differences between those who developed Alzheimer’s disease 
in this time period existed compared to those who did not.  Although the MCI group were not 
initially compared to a control group, at follow up, six of the eighteen patients who had 
initially been diagnosed with MCI had converted to AD.  Over time, the areas of greatest grey 
matter loss in the combined converters and non converters group included prominent areas 
within the temporal, frontal and parietal lobes.  The only subcortical structure implicated was 
the left thalamus.  In converters compared to non converters, there was accelerated grey 
matter loss concentrated in the inferior and middle temporal neocortex, indicating that 
although the atrophy process is similar in both groups it occurs faster in the converters.   
A similar longitudinal study (Fischl, et al., 2002) that did include a control group 
supports these results.  Delineation of the thalamic structure was achieved with an automated 
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segmentation procedure which allowed for simultaneous examination of ventricles and the 
hippocampus alongside the thalamus.  Patients were initially categorised as those with AD 
and those with questionable AD at baseline based on the clinical dementia rating scale.  Those 
with questionable AD were further subdivided into either converters or non-converters at 
three year follow up examination.  Converters were those that progressed from questionable 
AD at baseline to the National Institute of Neurological and Communicative Disorders and 
Stroke/Alzheimer’s Disease and Related Disorders Association criteria for probable AD.  
Thalamic volume (defined at initial examination) was then compared cross-sectionally across 
the converters, probable AD and control subjects.  The thalamic volume of the converters and 
the AD patients was significantly reduced compared to control subjects.  Subcortical volumes 
were not re-examined at follow up.  The fact that the thalamus was showing significant 
volume reduction before AD was diagnosed indicates that thalamic disruptions occur prior to 
the appearance of clinical symptoms.  The third and lateral ventricles also showed significant 
increases in the converters and the AD patients relative to the control subjects, indicating that 
thalamic degeneration is accompanied by ventricular enlargement in this case.   
3.4.2 Cellular microstructure  
Although, it is perhaps now evident that the thalamus shows some degree of degeneration 
prior to the onset of dementia, inconsistent methodology and criteria for MCI renders these 
results questionable.  MR technology has significantly advanced in recent years however and 
now, alongside gross structural abnormalities the subtle changes at the cellular level are also 
able to be examined.  As subtle changes in thalamic tissue composition may not necessarily 
result in gross structural volume loss examination of the thalamus at the cyto-archetecture 
level is invaluable.   
The MR technique of diffusion tensor imaging (DTI) is able to provide evidence of 
tissue disruption where conventional measures of atrophy may fail to detect size differences.  
This has been demonstrated in Schizophrenia (Agarwal, et al., 2008; Rose, Chalk, et al., 
2006) and in AD-MCI (Cherubini, et al., 2010; Rose, McMahon, et al., 2006).   
3.4.2.1 Schizophrenia  
In one of the schizophrenia samples (Agarwal, et al., 2008) there were subtle cellular 
abnormalities in the thalamus even though overall thalamic volume was maintained.  This 
cohort consisted of 71 patients with schizophrenia and 75 control subjects.  The diffusion 
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measure was the apparent diffusion coefficient (ADC) which provides a measure of the 
average rate and degree of diffusion through specific regions of the brain and takes into 
account barriers to the normal movement of water such as cellular structures.  The ADC can 
also be referred to as mean diffusivity, the two terms are interchangeable (ADC = MD).  In 
the schizophrenia patients, the rate of diffusion through the thalamus was significantly higher 
than it was through the thalamus of the control subjects.  The volume of the thalamus on the 
other hand, only showed a trend for volume loss – and only in the left thalamus.  Neither 
measure showed a relationship with the clinical symptoms of Schizophrenia, although both 
diffusion and volume was correlated with the age of the participants.   
A second schizophrenia sample (Rose, Chalk, et al., 2006) also reported significantly 
elevated diffusion within the thalamus.  In this sample, diffusion increases (MD) were 
concentrated to anterior and medial thalamic regions.  No analyses in relation to the 
association this may have had with any aspects of function were reported.   
Results are still somewhat controversial in schizophrenia, as in patients with first 
episode schizophrenia, the opposite effect is present (Qiu, Zhong, et al., 2009).  Significant 
volume loss, but no changes in MD has been reported in one patient sample relative to control 
subjects.  This study also examined the fractional anisotropy (FA) measure of diffusion – a 
measure of the direction of diffusion which infers the integrity of the underlying cell 
structures.  A higher FA value indicates that diffusion is occurring in one main direction and 
shows that the cell structures are mostly intact.  As the water follows the direction of cellular 
structures, if they were damaged the water would be free to move about in any direction, and 
give a lower measure of directionality (R.  Watts, 2008).  There were no differences in FA 
values in the thalamus of the Schizophrenic group compared to the normal control subjects 
although the level of FA in this cohort was associated with deficits in spatial working 
memory.  The authors suggest this result, which is in contrast to both previous studies which 
have examined diffusivity parameters in Schizophrenia is due to the fact their cohort was 
comprised of first episode patients.  These patients had not yet undergone any significant 
pharmacological alterations that may have occurred due to antipsychotic medications.  
Caution then needs to be undertaken when interpreting results of cohorts that may be subject 
to intense intervention.   
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3.4.2.2 Alzheimer’s disease 
Results are more consistent in Alzheimer’s disease.  In AD the integrity of the thalamus is 
shown to be significantly disrupted at the first signs of cognitive dysfunction, before 
degeneration has reached the cortex.  In patients with amnesic MCI for example, several 
subcortical structures, including the right thalamus showed significantly reduced FA while 
most of wider cortices showed no changes (Rose, McMahon, et al., 2006).  In the sample of 
MCI patients already mentioned in the volumetric section above (Cherubini, et al., 2010), 
although significant levels of thalamic atrophy were not detected until AD, prior to this, the 
thalamus of the MCI group showed significant microstructural degeneration.  There was also 
a significant increase in MD in AD relative to the MCI group, suggesting microstructural 
changes of this nature could be followed throughout the course of the disease as a 
neurocorrelate of cognitive dysfunction.   
There is one study (Kantarci, et al., 2001) that has reported contrasting results to this 
in pre AD MCI however.  This study did not use standard criteria to quantify MCI so patients 
with MCI were diagnosed as having subjective MCI if they 1) had a memory complaint (not 
measured); 2) exhibited global cognition within the normal range, 3) had normal activities of 
daily living and were not demented.  In this cohort of MCI patients compared to healthy 
control subjects, increased diffusivity was only evident in the hippocampus, with thalamic 
diffusivity increases evident at trend level only.  Once AD had developed, however, increased 
diffusivity was evident in several further cortical regions (parietal, occipital, temporal cortices 
and anterior and posterior cingulate) but the level of cellular disruption remained the same in 
both the thalamus and in the frontal lobes.  Given that AD can be considered to be more of a 
temporal rather than frontal disorder (Apostolova, et al., 2006), this perhaps just indicates that 
thalamus contributes to some of the deficits in AD but cannot be considered to be an 
independent factor in the progression of the disorder.  Had more detailed neuropsychological 
information for any of the above samples been available, maybe some relationship between 
those samples who do exhibit thalamic disruption and those who do not and their cognitive 
profiles could have been established.   
3.5 Summary 
As the thalamus is centrally located and connected to most cortical regions this subcortical 
structure plays some role in most cognitive functions (Taber, et al., 2004).  The neurons of the 
thalamus, especially the projection neurons are targeted by LB pathology in Parkinson’s 
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disease which causes significant levels of cell loss in some thalamic regions (Halliday, 2009; 
Henderson, et al., 2000a, 2000b).  Neuronal loss in the thalamus not only causes significant 
thalamic disruption but has a follow on effect where multiple cortical and subcortical 
processes are also affected as the connectivity between the thalamus and the cortex breaks 
down (Hu, et al., 2001).  In other neurodegenerative disorders where similar cognitive deficits 
are present the thalamus shows a significant degree of volume disruption, associated with 
cognitive dysfunction (de Jong, et al., 2008; Hazlett, et al., 1999; Houtchens, et al., 2007).  
Prior to volume loss, the cellular integrity of the thalamus is also disrupted and has a 
relationship with even subtle levels of cognitive dysfunction in the early stages of some 
disorders (Rose, McMahon, et al., 2006).      
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Chapter 4. THE THALAMIC NUCLEI  
4.1 Objectives 
This review will first examine the anatomy and function of thalamic nuclei.  Evidence of 
changes in pathology, structure and cellular integrity in both thalamic nuclei and their 
associated projection sites obtained from post-mortem and neuroimaging studies will be 
discussed.  The relationship between thalamic nuclei and behaviour will be explored using 
evidence from multiple neurodegenerative and neuropsychiatric diseases as well as from case 
studies where localised brain injury or lesion has occurred.  Where possible, studies for 
review have been restricted to those with structural, and diffusion methodology only.  As such 
a small amount of these have been conducted in cohort of PD participants however, any 
studies that have addressed changes in thalamic nuclei in PD have been included.  Information 
presented here will aid understanding of Chapter 6 which address the gross anatomical, 
cellular and integrity changes of thalamic nuclei and Chapter 9 which addresses the changes 
in the integrity of axonal connectivity between thalamic nuclei and projection sites in the 
cortex.  In conjunction, the two studies provide a unique opportunity to investigate the 
relationship between the thalamus, it’s axonal connectivity and the predictive validity this 
provides for cognition and motor dysfunction in PD.   
4.2 Thalamic organisation 
The thalamus is organised according to the cyto-architecture of neuronal cell bodies and 
axonal cortical connectivity and reflects the organisation of the cerebral cortex (Figure 4-1).  
The substructures that comprise the thalamus preferentially connect to one area of the cortex 
and each primarily serve a specific area of function (Sherman & Guillery, 2004).  Nearly all 
incoming information is routed through one or more groups of the thalamic nuclei before 
terminating in cortical areas, a highly regimented and organised form of communication 
which relies on the integrity of not only the thalamic nucleus involved, but also on the 
integrity of the axons that connect it with other thalamic, subcortical and cortical regions 
(Jones, 2007a).  The majority of the thalamic nuclei are specific, preferentially projecting to 
independent and separate regions of the cortex which in turn control motor, limbic, 
association and sensory functions.  The motor regions of the thalamus have afferent and 
efferent connectivity with the primary, supplementary, premotor and cingulate motor areas of 
the cortex, influencing all the different aspects of motor control (Picard & Strick, 2001).  The 
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limbic regions of the thalamus are reciprocally connected with the sensory association and 
prefrontal regions of the cortex, primarily influencing memory, specifically episodic memory 
and the ability to learn (Braak & Braak, 2000).  The prefrontal association areas are involved 
in attention and executive function (Lewis, Dove, Robbins, Barker, & Owen, 2003).  The 
medial and posterior regions of the thalamus which encompass the association nuclei have 
primary connectivity with the auditory association area in the temporal lobes, the 
somatosensory association area in the parietal lobes and the visual association area in the 
occipital lobes (Hendry & Barbas, 2003)  and mediate the interpretation of sound, touch and 
visual stimuli (Nieuwenhuys, Voogd, & van Huijzen, 2008b).  In the centre of the thalamus, 
lies the intralaminar complex which encompasses the centromedian and parafascicular nuclei.  
These nuclei are non-specific, axons from this area project around several other nuclei before 
continuing to multiple areas of the wider cortex and influence multiple processes and 
behaviours.   
a) 
 
b) 
 
 c) 
 
Figure 4-1: The organisation of thalamic components 
a) Primary axonal connectivity between thalamic nuclei and the cerebral cortex, image from Nieuwenhuys, 
Voogd, & van Huijzen, (2008a).  b) Cortical regions associated with thalamic regions c), image from Behrens, et 
al., (2003).  The thalamus is comprised of several sub regions.  The organisation of thalamic sub regions reflects 
the organisation of the cerebral cortex with each region preferentially projecting to specific regions and 
influencing specific aspects of behaviour.   
4.3 Motor Relay Nuclei 
The motor nuclei are perhaps the most widely studied of the thalamic nuclei in Parkinson’s 
disease due to their reciprocal connections with the motor and pre-motor cortex 
(Nieuwenhuys, et al., 2008b), key areas of functional and structural alterations in PD which 
result in significant and deliberating motor symptoms.  Further subdivided by functionality, 
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the motor nuclei consist of the ventral anterior (VA) and ventral lateral (VL) nucleus.  The 
VA is principally involved in the execution of movement and the regulation of self-generated 
voluntary movement while the VL nucleus influences involuntary or automatic movement.   
a) 
 
b) 
 
Horizontal Z: 45 (53-40) Saggital X: 73 (30-96) 
    
Coronal Y: 64 (71-54) Saggital X: 76 (56-83) Coronal Y: 64 (104-18) Horizontal Z 28 (45-16) 
Figure 4-2: Motor thalamic nuclei 
Anatomical location (a) and connectivity (b) of the VA (green) and VL (red) nuclei.  In each case the section 
giving the best view of the regions and their connectivity is presented on the top with views in corresponding 
slices given underneath.  X, Y and Z gives co-ordinates in standard (MNI) space and parenthesis the co-ordinates 
of the first and final slices where the thalamus is visible.  MRIcron images in a) are resliced when opened and 
are thus displayed using neurological convention, the left side of the image corresponds to the left side of the 
brain.  Images in b) are displayed using radiological convention, the left side of the image corresponds to the 
right side of the brain.    
4.3.1 Ventral Anterior Nucleus (VA) 
4.3.1.1 Anatomy, location and connectivity 
The VA nucleus is the smallest of the motor nuclei and located in the most anterior position 
of the ventral thalamus (Figure 4-2a).  Afferent and efferent connectivity between the VA and 
cortex occurs by way of the striatal loop (Figure 4-3).  Originating in the prefrontal cortex, 
the straital loop passes through the dorsal striatum, an area heavily influenced by the 
substantia nigra, continues through the pallidum, subthalamic nucleus and VA before 
terminating in the premotor cortex (Braak, et al., 2000), the area which assums primary 
responsibility for the generation of movement.   
4.3.1.2 Function  
The normal function of the straital loop is to initiate self-generated movement through 
communication with the pre-motor area of the cerebral cortex (Jenkins, Jahanshahi, Jueptner, 
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Passingham, & Brooks, 2000).  Self-generated movement is the preparation for and ability to 
produce intentional behaviour.  This form of movement is internally cued, the individual must 
decide to perform an action such as reaching for an object or raising an arm, engage in the 
necessary preparatory procedures for action initiation and then execute it.  In contrast, 
externally cued movement is elicited automatically in response to a stimulus, negating the 
decision making process (Siegert, Harper, Cameron, & Abernethy, 2002).   
While the striatal loop will mediate all forms of self-generated movement the VA 
nucleus itself appears to be primarily involved in complex movements which have a cognitive 
aspect, rather than simple repetitive movements.  fMRI shows that when healthy control 
subjects are required to correctly execute a series of finger tapping tasks which were either of 
a complex nature, requiring several movements which had to be remembered or of a simple 
nature, requiring only single movements, the VA showed more activation in the complex 
sequence compared to the simple one (Lehericy, et al., 2006).  Although both the VA and the 
VL project to the motor cortices, the VA directly targets the rostal areas while the VL 
terminates more caudally.  It is this connectivity with the rostal area that appears to be 
responsible for the mediation for motor tasks with cognitive requirements, as during a 
complex task the rostal area of the motor cortex shows significantly greater activation than 
any other region (Haber & Mcfarland, 2001).   
4.3.1.3 Motor deficits in PD associated with nuclei dysfunction  
In Parkinson’s disease there is a significant deficit in self-initiated movement compared to 
externally cued movement.  If a fire alarm was to sound for example, a patient, even if 
suffering from significant movement dysfunction would get up and walk away much easier 
than if the movement was internally decided (Siegert, et al., 2002).  This deficiency in self-
generated movement presents as bradykinesia, one of the cardinal symptoms of PD.  
Clinically, patients with bradykinesia will experience fatigue, difficulty in initiating 
movement, completing actions, shifting between motor tasks and will also show an overall 
reduction in their range of movement (Fahn, 2003).   
4.3.1.4 Associated areas of PD pathology and degeneration  
Deficit in self-generated movement is associated with reduced activation in the pre-motor 
regions of the cerebral cortex in PD patients.  Compared to healthy controls, reduced brain 
activity in this area in PD is event, most likely due to a disruption in communication within 
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the straital loop, as no other regions showed activation during this task.  In contrast, during an 
externally cued task the brain regions of patients were no different to those of control subjects 
(Jahanshahi, et al., 1995).  Intact functioning of the components within the striatal loop and 
the pre-motor regions of the cortex, therefore, are primarily responsible for self-generated 
movement and have little influence on externally cued movement.   
The VA nucleus only suffers from slight Lewy pathology (Henderson, et al., 2000b) 
all other subcortical components of the striatal loop - except the substantia nigra are relatively 
spared until infiltratio of the motor cortex in the final stages of PD.  Although the substantia 
nigra is heavily infiltrated prior to the development of motor symptoms (Braak & Braak, 
2000) there is no reduction in the density or distribution of neurons in either the striatum or 
the globus pallidus (internal and external components) of the straital loop of PD or PD-D 
patients (Goto, Hirano, & Matsumoto, 1990).  
The structures within the straital loop appear to be relatively intact, disrupted 
connectivity between these regions and the cortex is therefore the most likely the reason for 
impairment in self-generated movement in PD.  Evidence from a fMRI study conducted on 
PD patients in a resting state supports the theory for disrupted connectivity.  Wu et al., (2009) 
examined a sample of PD patients and healthy control subjects at rest to determine the degree 
of disruption in the motor circuit.  Hypothesising that motor deficits arise from interactions in 
the motor network rather than from disruption in a singular area they chose to examine 
subjects at rest instead of during a specific motor task.  This allowed for greater interpretation 
of the whole motor network as, by it’s nature, examination of fMRI responses during 
performance of a single motor task limits interpretation to only those regions involved in that 
specific task.  Compared to control subjects, functional connectivity within the entire motor 
network was significantly reduced in patients, affecting connections to the supplementary 
motor area, prefrontal cortex and left putamen.  Degeneration in dopaminergic neurons 
appeared to be the primary cause of disruption,  when L-dopa was administered, the pattern of 
function in patients returned to that of the normal control subjects.  The degree of disruption 
related to the severity of motor impairment, implicating the straital loop rather than only the 
VA in the observable motor deficits in PD.   
Further evidence for both disrupted structure of the VA and disrupted connectivity 
confirms the above results.  During the performance of pre-learned but self generated motor 
tasks in an fMRI study, the VA nucleus along with premotor, parietal and motor cortices all 
showed increased activation in control participants.  In PD patients, although similar areas 
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were activated during the same task there was a significant decrease in activation of the 
striatum and ventral lateral thalamic nuclei.  Decreased activation corresponded to the level of 
motor impairment as measured by the UPDRS (Mallol, et al., 2007). 
4.3.2 Ventral Lateral Nucleus (VL) 
4.3.2.1 Anatomy, location and connectivity 
The ventral lateral nucleus is the largest of the ventral nuclei and is located directly posterior 
to the VA (Figure 4-2) and anterior to the ventral posterior nucleus (VP).  The VL is a 
primary component of the cerebellar loop (Figure 4-3), connecting the pre-motor field to the 
primary motor field via several regions including the magnocellular nucleus, the pontine grey 
nucleus and cerebellum (Braak, et al., 2000).   
 
Figure 4-3: The motor nuclei in the striatal and cerebella loops  
Diagram modified from Braak & Braak, (2000), the ventral anterior nucleus is a primary component of the 
straital loop – influencing the initiation of movement while the ventral lateral nucleus is involved in the 
cerebellar loop, influencing voluntary movement.   
4.3.2.2 Function  
Normally, the function of the cerebellar loop, especially the ventral lateral component is to 
modulate the activity of the motor cortex in order to ensure the smooth generation of 
movement.  The intact functioning of the motor cortex enables the appropriate movement to 
be performed as a response to outside stimuli and is also moderated by mechanisms of bio-
feedback, with movement ceasing when the desired outcome is achieved (Blandini, Nappi, 
Tassorelli, & Martignoni, 2000).   
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4.3.2.3 Motor deficits in PD associated with nuclei dysfunction  
Tremor, a symptom seen in the majority of PD patients is the result of disruption within the 
cerebellar circuitry.  Disruption in any of these components results in less inhibitory signals 
reaching the cortex and the overproduction of movement.  Tremor is the involuntary 
movement of an affected body part when it is at rest and is commonly the first symptom a 
patient will present with, although it is not always necessary for diagnosis.  Rest tremor is 
intermittent in the earlier stages of PD, initially only appearing in stressful situations.  With 
the progressive increase of nigrostriatal dopamine loss however, symptoms worsen steadily 
over time and eventually tremor will occur frequently, continuing to worsen with stress or 
excitement (Fahn, 2003).   
4.3.2.4 Associated areas of PD pathology and degeneration  
In this case, it appears the reduction in function of the VL nucleus itself is the primary cause 
of disruption in the cerebellar circuit.  Although Lewy pathology is largely absent from any of 
the structures within the cerebellar loop (Braak & Braak, 2000), including the VL (Halliday, 
2009), the results of lesion studies still suggest that components of the VL are the strongest 
contributor to involuntary movement in PD.  The VL region was the original target for deep 
brain stimulation in the treatment of tremor, for example.  The ventral intermediate nucleus, a 
region within the VL is the lesion target as damage to this region results in reduction of the 
frequency and amplitude of tremor in PD.  This occurs through the reduction of excitatory 
signals and the restoration of normal cerebellar communication (Pollak, et al., 2002; Temel & 
Visser-Vandewalle, 2006).  Lesions of the VL significantly decrease tremor but has no effect 
on bradykinesia, confirming the functional dissociation between these motor nuclei in regards 
to PD symptoms.  Using MRI Duval et al., (2006) conducted a similar experiment, lesioning 
the ventral intermediate nucleus in PD but with the added advantage of examination of the 
lesion site both pre and post operatively, a technique that is not normally available until 
autopsy.  Tremor amplitude was significantly decreased in all cases.  The imaging showed 
that although the lesions were comparatively large in this case, encompassing all regions of 
the ventral lateral nucleus as well as a small region between the VL and VLp nucleus, the VA 
nucleus was completely unharmed.  
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4.3.2.5 Summary of the motor nuclei  
The motor nuclei are able to be distinguished by their primary function.  The VA is involved 
in the self-generation of movement – the deficit of which results in bradykinesia.  In contrast, 
the VL influences the level of tremor symptoms in PD.  The VA is a component of the straital 
loop, and although showing limited pathology itself, disruption in the connectivity between 
the straital loop and the pre-motor cortex appears to influence the PD symptom of 
bradykinesia.  Decreased activation of both motor cortices and the VA nucleus is evident in 
patients compared to controls during movement tasks.  The VL also shows limited pathology 
and neuronal loss, but as lesioning of the intermediate nucleus - a subcomponent of the VL 
results in the reduction of tremor symptoms of PD, it is degeneration of this region that is 
thought to be the primary influence on this form of movement dysfunction.   
4.4 Limbic Nuclei 
Not widely studied in PD, these nuclei nevertheless have important implications in the 
cognitive aspects of this disorder due to their connectivity with the frontal and prefrontal 
cortex (Aggleton & Brown, 1999).  The prefrontal and frontal regions mediate executive 
function and learning and memory in healthy subjects, both areas of cognition that PD 
patients present with early in the disorder (Janvin, et al., 2003) and the biggest predictor of 
later dementia (Piccirilli, D'Alessandro, Finali, & Piccinin, 1997).  With essentially the same 
regions of connectivity, the limbic nuclei can be differentiated by their cellular make up more 
easily than their functionality and are divided into the anterior principal nuclear complex (AP) 
and the lateral dorsal nucleus (LD), both of which project to the prefrontal cortex, cingulate 
gyrus and enthorinal cortices and subiculum of the limbic system (Nieuwenhuys, et al., 
2008b).   
 
 
 
 
The Thalamic Nuclei 
Chapter 4 | 67 
a) 
 
b) 
 
Horizontal Z:51 (53-40) Coronal Y:51 
    
Coronal Y:69 (71-54) Saggital X:62 (56-83) Horizontal Z:30 Saggital X:66 
Figure 4-4: Limbic thalamic nuclei 
Anatomical location (a) and connectivity (b) of the AP (green) and LD (yellow) nuclei.  In each case the section 
giving the best view of the regions and their connectivity is presented on the top with views in corresponding 
slices given underneath.  X, Y and Z gives co-ordinates in standard (MNI) brain space and parenthesis the co-
ordinates of the first and final slices where the thalamus is visible.  MRIcron images in a) are resliced when 
opened and are thus displayed using neurological convention, the left side of the image corresponds to the left 
side of the brain.  Images in b) are displayed using radiological convention, the left side of the image 
corresponds to the right side of the brain.    
4.4.1 Anterior Nuclear Complex (AP) 
4.4.1.1 Anatomy, location and connectivity  
The anterior group is made up of the anterior dorsal, anterior medial and ventral anterior 
nuclei (Aggleton & Brown, 1999).  For the purpose of this study the anterior medial and 
anterior dorsal nuclei will be combined and considered as the ‘anterior principal nuclei’ as the 
anterior dorsal nucleus only makes up a small portion of thalamus volume, curving around the 
anterior ventral nucleus (Zarei, et al., 2009) and is thus difficult to identify on MR images.  In 
addition, there is little observable difference between the cellular makeup of the anterior 
dorsal nucleus and anterior medial nucleus as both consist of medium sized cells distributed at 
a moderate density (Jones, 2007b), resulting in similar diffusion parameters and making the 
segmentation of nuclei difficult.  The ventral anterior nuclei will be considered separately.  
Evidence from animal studies suggests that in order for the full role of the anterior nuclei to 
be seen, all three of these nuclei must be involved.  For example, in rats, lesions restricted to 
individual nuclei will produce some degree of deficit on a spatial memory task.  It is not until 
these lesions are combined that the full effect of this deficit is seen however (Aggleton, Hunt, 
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Nagle, & Neave, 1996) so consideration of the anterior medial and anterior dorsal nucleus 
together will establish the total degree of memory deficit in patients.   
The AP nucleus is primarily involved in the limbic loop and connects the sensory 
association areas with the prefrontal association areas of the frontal cortex.  This loop 
mediates learning ability and memory functions (Braak & Braak, 2000).  The 
mammillothalamic tract, bridging the mammillary bodies and the AP complex is the main 
input (Van, Saunders, & Aggleton, 2007) while efferent connections from the AP primarily 
target the anterior cingulate via the retrosplenial region (Figure 4-5).   
 
Figure 4-5: Episodic memory 
Crucial to episodic memory function, the direct and indirect projections from the hippocampus to the anterior 
thalamic nuclei via the fornix and mammillothalamic tract respectively comprise the limbic loop.  Image from 
Aggleton & Brown (2008).   
4.4.2 Lateral Dorsal Nucleus (LD) 
4.4.2.1 Anatomy, location and connectivity 
The lateral dorsal nucleus shares similar connectivity with the cortex as the anterior nucleus, 
the only difference is with the projections received from the mammillary bodies.  As with the 
anterior nucleus, there are reciprocal connections between the LD and the limbic cortex of the 
cingulate gyrus, retrosplenial area and the subiculum (Nieuwenhuys, et al., 2008b).  Due to 
the anterodorsal location and afferent connectivity from the fornix it is appropriate to consider 
the LD nucleus, along with the AP as part of the extended hippocampal pathway which 
mediates the recall memory process (Edelstyn, Hunter, & Ellis, 2006).  Our study addresses 
the AP and LD nuclei separately but as they share similar functionality, deficits in PD 
associated with these nuclei will be considered together here.  
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4.4.3 Combined AP and LD Nuclei  
4.4.3.1 Function 
Intact function of the limbic circuitry primarily serves episodic memory (Aggleton, 
Desimone, & Mishkin, 1986) with damage to any part of this system resulting in antrograde 
amnesia (Aggleton & Brown, 1999).  There is also evidence of memory and learning 
associated with the AP being mediated by temporal connectivity as stimulation of the AP 
results in a reduction of temporal lobe seizures in epileptic patients, indicating connectivity in 
the temporal lobe alongside the frontal lobes (Fisher, et al., 2010).  In line with this, the 
connective properties of the AP appear to influence the cognitive and behavioural symptoms 
of schizophrenia, a disorder known for its temporal and frontal disruption (Davidson & 
Heinrichs, 2003).  Histology of the AP in schizophrenic patients reveals there is a significant 
reduction in neurons compared to control subjects (Byne, et al., 2006; Young, Manaye, Liang, 
Hicks, & German, 2000).  MRI shape analysis has also revealed volume loss in the wider 
anterior regions of the thalamus (Hazlett, et al., 1999), and the segmentation of nuclei from 
MRI has identified volume loss in the anterior regions (Gilbert, et al., 2001).  Schizophrenic 
patients in the Hazlett sample had significantly reduced neuropsychiatric scores on executive 
function and memory measures and in patients it was only the MDn nucleus which correlated 
with behavioural symptoms, highlighting that the AP was primarily mediating cognitive 
function in this sample.  In addition, the cohort of Gilbert et al., (2001) was drug-naive, first 
episode patients, indicating that AP volume reduction occurs independently of potentially 
confounding treatment or duration of illness effects.   
 The AP has also been implicated in progressive supranuclear palsy (PSP) – a 
parkinsonian syndrome with motor symptoms similar to Parkinson’s disease (Nath & Burn, 
2000).  Patients showed areas of reduced grey matter within the AP compared to control 
subjects suggesting that atrophy of this region could also be involved in motor dysfunction.  
AP degeneration did not exist in isolation in this sample however.  The pulvinar and 
dorsomedial nuclei were also reduced along with other subcortical regions outside the 
thalamus, suggesting an interaction between areas of degeneration and the clinical 
presentation of symptoms.   
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4.4.3.2 Cognitive deficits in PD associated with nuclei dysfunction  
Episodic Memory 
In Parkinson’s disease, episodic memory, specifically the ability to recall word items 
(Bohlhalter, Abela, Weniger, & Weder, 2009) is one of the earliest cognitive symptoms, 
appearing well before dementia (Muslimovic, et al., 2005).  In the early stages of PD the 
neuropsychological profile varies between patients so a memory deficit is not always present 
or necessary for the diagnosis of dementia (Emre, Dubois, et al., 2007; 2007).  Patients will 
always demonstrate some form of fontal syndrome however as, for those who have intact 
memory, executive function is likely to be impaired (Janvin, et al., 2003).  Executive 
dysfunction is one of the biggest predictors for the development of dementia, indicating that 
the limbic circuitry is one of the first systems to be affected to a great degree in PD.  Patients 
exhibit deficits on both short term and long term recall of words when asked to recall them 
freely but markedly less deficit when asked to recall all the items they can remember from a 
specific subset, e.g.: patients are more likely to recall the presented item of ‘apple’ when 
asked to list all pieces of fruit they were presented with rather than when they are asked to list 
all items regardless of category.  Outside of the clinic, recall of day to day events will become 
impaired but recognition, of family members for example will remain intact (Breen, 1993).   
 While familiarity of an object appears to be mediated by the MDn, recollection is 
mediated by the anterior thalamic nucleus and supported by the LD nucleus (Aggleton & 
Brown, 1999).  This influential model of memory dysfunction in relation to the thalamus has 
recently been investigated using diffusion tensor imaging in patients who have thalamic 
infarctions (Cipolotti, et al., 2008).  Two patients who had localised lesions within the 
thalamus as a result of stroke were investigated.  Both had left MDn nucleus and anterior 
nucleus and mammillothalamic tract involvement and exhibited deficits on familiarity and 
recall when examined verbally.  Non verbal examination was not in line with the model 
however, most likely due to cellular disruption in the MTT which was localised to the left 
hemisphere. In the patient with lesions which encompassed the right MTT, for example, the 
MDn was spared, dictating that familiarity should have been preserved.  The patient, however, 
exhibited significant deficits when asked if she recognised faces from the Recognition 
Memory Test.  In the patient with damage to the right MDn, the AP and MTT were spared, 
indicating recollection should have been intact.  This patient showed significant deficits when 
asked to recall both verbal and visual information across all tests including the recognition 
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memory test and the Rey Complex Figure test.  The disrupted the fibre connectivity within the 
thalamus appears to have a significant influence over cognition and influences, in this case, 
both recall and recognition.   
The dissociation between recall and recognition in PD is most likely influenced by all 
regions and the connections of the anterior thalamic system.  In severe alcoholics with 
amnesia, damage in the AP alone appears to induce the same cognitive profile that is observed 
in PD.  These patients show amnesic syndrome similar to the memory dysfunction in PD 
which doesn’t appear to be due to the influence of alcoholism.  MRI analysis of showed 
damage was restricted to the AP in amnesic alcoholics compared to alcoholics without 
amnesia (Harding, Halliday, Caine, & Kril, 2000).  The lateral dorsal nucleus also influences 
symptoms.  In a patient with severe bilateral LD lesions which were able to be identified on 
MRI only recall memory was impaired, leaving recognition intact.  The mammillary bodies 
and fornix were intact and the lesion site completely spared the AP and the main connections 
to the AP nucleus (only slightly encroaching on left MDn) (Edelstyn, et al., 2006).  The LD, is 
therefore an independent influence on memory, and deficits in this region may be a strong 
contributing factor to early cognitive impairment in PD.   
Executive Function  
Executive function deficits are the inability to correctly plan, initiate, monitor behaviour, 
apply problem solving skills and the flexibility to change behaviour when presented with new 
information (Leh, Petrides, & Strafella, 2009).  Components of the Wechsler Adult 
Intelligence Scale – IV (Wechsler, 2001) such as letter, action and category fluency or 
category switching tasks for example are sensitive to executive dysfunction in Parkinson’s 
disease.  Clinically, patients with executive dysfunction will have difficulty generating the 
names of objects within a subset (e.g.: animals) or beginning with a certain letter (e.g.: words 
beginning with F).  Category switching, the ability to rapidly complete a task which 
intermittently requires the use of different processes or abilities is also an area which shows 
clinical decline.  Measured using trail making tests, where patients are required to link 
sequential sets of numbers interrupted by an opposing sequential set of letters (e.g. A-1, B-2 
etc), patients show significantly more difficulty than healthy control subjects.  In daily life, 
the initiation of behaviour, planning and multi-tasking in patients with PD are the tasks most 
affected by executive dysfunction.  Whereas healthy participants can perform two tasks 
simultaneously, PD patients tend to focus only on the first task, spending less time and 
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performing worse on the second in order to adequately achieve the first.  This is commonly 
seen when patients are asked to carry a conversation whilst walking (Koerts, Van Beilen, 
Tucha, Leenders, & Brouwer).   
4.4.3.3 Associated areas of PD pathology and degeneration  
There is strong evidence to suggest that disruption in limbic circuitry rather than the AP 
nucleus itself mediates these frontal cognitive deficits in PD.  Although several other 
structures within the limbic loop succumb to Lewy pathology, the anterior dorsal component 
of the AP is spared (Braak & Braak, 2000), showing neither volume nor neuronal loss at 
autopsy (Halliday, 2009).  Despite this, there is compelling evidence for AP involvement in 
the early stages of PD.  Episodic memory deficit is a likely result of disruption in the circuitry 
of the limbic loop.  Episodic memory scores in non demented PD patients show a significant 
positive correlation with blood flow in the bilateral prefrontal cortex (Santens, et al., 2003), 
the region where the limbic loop terminates.  Similarly, executive function deficits have an 
association with reduced ventrolateral and dorsolateral prefontal activity in PD patients when 
examined using fRMI during a working memory task.  Those without executive function 
syndrome demonstrated activation similar to that of control subjects.  As patients were 
grouped according to those with executive function deficits and those without but matched in 
all other neuropsychological tests this suggests preferential involvement of the AP nucleus in 
executive function (Lewis, Cools, et al., 2003).  The anterior thalamic radiation – the white 
matter bundle connecting the anterior thalamus with the prefrontal cortex has been implicated 
in cognitive dysfunction in schizophrenia (Mamah, et al., 2010) and also supports the 
influence of this fibre tract on cognition.   
4.4.3.4 Summary of the limbic nuclei  
The limbic nuclei share similar regions of primary connectivity and perform similar functions.  
Primarily involved in executive function and memory, the AP has been investigated 
previously in relation to amnesia and is a crucial component of an influential model of 
information processing (Aggleton & Brown, 1999).  The LD has not previously been widely 
investigated, but due to its projections with the hippocampus the LD can be considered part of 
the extended hippocampal system mediating memory.  The AP appears to be spared by LB 
pathology, and has not been included in histology studies of PD to date, heavily suggesting 
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disruption in the frontal circuitry of the limbic loop results in the executive function and 
memory deficits observed in PD rather than disruption to the nucleus itself.   
4.5 Association Nuclei 
The association nuclei and the centromedian nuclei are easily visible on MR images and are 
the most investigated in neurodegenerative disorders.  In healthy subjects, examination of the 
correlations between these nuclei and the cortex have been carried out in one sample to date.  
Volumetric and metabolic parameters of each nucleus and associated areas of the cortex were 
obtained and the relationship between them established.  Findings followed the known 
patterns of anatomical connectivity, the mediodorsal nucleus correlated with all cortical 
regions except the cingulate and occipital areas, the centromedian with temporal, parietal, 
occipital, dorsolateral and orbital frontal regions and with selected cingulate regions.  The 
pulvinar showed an association with retrosplenial areas, the primary auditory area in the 
temporal lobe and with selected occipital and parietal areas (Mitelman, et al., 2006).   
The association nuclei include the mediodorsal nucleus (MDn) which has strong 
connectivity with the prefrontal cortex and is involved in attention and executive function 
processes and the lateral posterior nucleus (LP) and pulivnar (Pu), which share similar 
reciprocal connectivity with the sensory, motor and visual association areas of the cortex 
(Nieuwenhuys, et al., 2008b). 
a) 
 
b) 
 
Saggital X:60 (56-83) Horizontal Z:27 
    
Coronal Y:56 (71-54) Horizontal Z:48 (53-40) Saggital X:76 Coronal Y:65 
Figure 4-6: Association thalamic nuclei 
Anatomical location (a) and connectivity (b) of the MDn (red), LP (green) and Pu (yellow) nuclei.  In each case 
the section giving the best view of the regions and their connectivity is presented on the top with views in 
corresponding slices given underneath.  X, Y and Z gives co-ordinates in standard (MNI) brain space and 
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parenthesis the co-ordinates of the first and final slices where the thalamus is visible.  MRIcron images in a) are 
resliced when opened and are thus displayed using neurological convention, the left side of the image 
corresponds to the left side of the brain.  Images in b) are displayed using radiological convention, the left side of 
the image corresponds to the right side of the brain.    
4.5.1 Mediodorsal Nucleus (MDn) 
4.5.1.1 Anatomy, location and connectivity 
The mediodorsal is one of the largest thalamic nuclei, spanning two thirds of the length of the 
thalamus.  Located posterior to the AP and anterior to the LP nuclei, the primary target of this 
nucleus is the prefrontal cortex, with afferent connectivity terminating in the anterior 
cingulate cortex, medial precentral areas and the ventral lateral orbital areas.  The MDn is 
comprised of several smaller nuclei which are easily identified based on their distinct cellular 
distribution and their independent connectivity with the prefrontal cortex.  The magno-cellular 
division (MDmc) is in the anterior portion of MDn and is made up of large, widely dispersed 
cell bodies, the axons of which terminate in the dorsolateral regions of the prefrontal cortex.  
The paravocellular division (MDpc) is located in the lateral regions of MDn and is made up of 
smaller, more tightly packed cells than the MDmc, and it’s axons primarily terminate in the 
orbitofrontal regions of the cortex (Jones, 2007b).  As a whole, the MDn also receives afferent 
fibres from olfactory areas of the cortex, the lateral orbital cortex and the ventral agranular 
insular area, regions that, along with the amygdala, comprise the olfactory loop connecting 
the olfactory cortex, thalamus and neorcortex.   
4.5.1.2 Function  
The MDn is primarily involved in executive function and working memory processes due to 
the extensive connectivity with the prefrontal regions and, to a lesser degree, with the 
temporal, parietal and occipital regions (Buchsbaum et al., 2006).  The function of the MDn is 
mediated by the AP.  In patients with thalamic infarctions, when the lesion site included the 
medial dorsal, midline and/or the intralaminar nuclei, for example, accompanying deficits in 
executive function were observed.  In every case except one there was also significant 
memory impairment which was worse than the level of executive function impairment.  In 
patients who had both MDn and AP lesions, memory impairment was significantly worse than 
those who had lesions only in the MDn.  Executive function impairment remained 
approximately the same (van der Werf, et al., 2003) suggesting that while both the MDn and 
AP play a role in memory and executive function the MDn is an equal contributor to both 
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domains.  When working memory is specifically examined in healthy subjects, reduced 
working memory performance is directly associated with increased cellular degeneration 
(measured using mean diffusivity) in the MDn (Piras, Caltagirone, & Spalletta, 2010).  The 
MDn is thought to be primarily involved in the recognition aspects of memory (Aggleton & 
Brown, 2008) but there is also some evidence to suggest that the MDn is involved in 
recollection.  In otherwise healthy subjects with MDn lesions for example, word recall is 
significantly impaired alongside executive function deficits despite word recognition 
remaining intact.  This effect was only evident in those with lesions isolated to the lateral 
MDn (Zoppelt, Koch, Schwarz, & Daum, 2003) which suggests functional dissociation within 
the MDn.   
When both executive function and working memory are examined in conjunction 
using fMRI the entire MDn region shows a significant increase in activation.  In this case 
MDn segmentation was achieved by isolating all voxels within the thalamus that had strong 
connectivity with the prefrontal cortex.  This method of nuclei identification relies on 
thalamic-cortico connectivity, suggesting connectivity as well as intact structural integrity of 
the MDn is essential for correct cognitive processing (Johansen-Berg, et al., 2005).  Both sub-
regions of the MDn were implicated in the correct execution of executive function tasks, with 
a strong correlation between the size of MDn sub-regions (medial and lateral) and 
performance on executive function tasks in healthy subjects (Jakab, Blanc, & Berenyi, 2012).   
This has also been demonstrated in Huntington’s disease.  The regions of the thalamus 
which had the most connectivity with the prefrontal areas and striatum were the regions that 
displayed the greatest volume loss.  The mediodorsal region was particularly affected and 
showed the strongest association with executive function and attention measures (Kassubek, 
et al., 2005).   
As attention and executive function deficits are characteristic of Schizophrenia 
(Lindenmayer, Harvey, Khan, & Kirkpatrick, 2007) the MDn and associated regions of 
connectivity have been extensively investigated as a neural substrate of this disorder.  This 
has lead to an abundance of imaging research which mostly supports the role of MDn in 
executive dysfunction.  Structural imaging of Schizophrenic patients relative to healthy 
control subjects has revealed bilateral volume reduction of the MDn independent of any other 
thalamic regions (Gur, et al., 1998), MDn reduction in conjunction with atrophy of the 
pulvinar and CM/Pf (Kemether, et al., 2003), volume loss after correction for total thalamic 
volume (Shimizu, et al., 2008) and volume loss independent of medication levels 
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(Pakkenberg, 1992).  Some studies have also reported volume reduction in the total 
association nuclei (MDn and Pu) but not in the MDn independently (Byne, et al., 2001).  
Shape analysis of the whole thalamus has revealed a significant alteration of thalamic shape in 
Schizophrenia compared to control subjects, postulated to be due to degeneration in the 
medial-dorsal regions of the thalamus and occurring independently of total volume loss (Qiu, 
Zhong, et al., 2009).   
More recently DTI has been applied to MDn and associated cortical regions in 
Schizophrenia with results indicating large areas of increased cellular disruption localised to 
the MDn and prefrontal cortex.  Smaller regions of increased diffusivity are also evident in 
the temporal and parietal lobes (Rose, Chalk, et al., 2006) and diminished anisotropy evident 
in the white matter of the frontal lobes (Buchsbaum, Buchsbaum, et al., 2006).  The frontal 
and temporal regions of the cortex are the areas to show the fastest rate of degeneration 
(Mathalon, Sullivan, Lim, & Pfefferbaum, 2001), and have a strong correlation with memory 
and executive function in this cohort (Baare, et al., 1999).  Cortical degeneration in these 
areas also results in disrupted connectivity and the subsequent cellular degeneration of the 
MDn.  Gross structural changes show the same result, volume reduction in the prefrontal and 
orbito-frontal cortex is correlated with the level of volume reduction in the mediodorsal 
regions of the thalamus (Kim, et al., 2007).   
These changes in associated subcortical and cortical regions suggest a deficit in the 
thalamic-prefrontal circuitry must also be present.  In one of the few studies to investigate this 
in Schizophrenia, Kito et al., (2009) used diffusion tensor imaging to examine the structural 
integrity of the anterio thalamic peduncle – the neuronal tract which runs from the MDn to the 
dorsolateral prefrontal cortex via the anterior limb of the internal capsule.  There was a 
significant reduction in cross-sectional area of the tract, suggesting some disruption to the 
frontal-striatal-thalamic pathway.  When this same tract was investigated in a similar study, 
tract integrity was also found to be significantly disrupted and overall length of the tract was 
shorter in schizophrenia patients compared to healthy control subjects, (Buchsbaum et al., 
2006).   
Interpretation of the association between degeneration and cognition is limited by 
studies that have carried out cognitive and behavioral analysis.  Only two of the above studies 
examined neuropsychiatric symptoms, with one showing no association between structure and 
function (Kito, et al., 2009) and the other reporting a high correlation between MDn regions 
and both negative symptoms and antipsychotic medication dose  in Schizophrenia (Kim, et 
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al., 2007).  Qiu et al., (2009) was the only study to report an association between the thalamus 
and cognition, showing that their cohort of Schizophrenic patients had poorer performance on 
executive function and spatial working memory tasks compared to the control subjects and a 
significant correlation between both cognitive measures and the compressed shape of the 
thalamus in the medial dorsal region.   
The MDn region also shows an association with executive function in an Alzheimer’s 
disease sample, exhibiting significantly reduced volume in patients relative to control 
subjects.  The observed volume reduction was thought to be primarily due to degeneration of 
the medial-dorsal regions based on the fact it is these regions most targeted by LB pathology 
(de Jong, et al., 2008).  More robust analysis of the thalamic shape in AD also supports this 
result, showing that atrophy in the medial-dorsal regions of the thalamus correspond to 
decreases in the cellular integrity of the MDn region (Zarei, et al., 2009).  MDn shape changes 
are possibly only evident when cognitive decline is advanced however.  When both dementia 
and pre-AD mild cognitive impairment patients were examined, the medial thalamus of the 
MCI group was not any different to that of the control group and only showed a significant 
shape change in the AD group (Qiu, Fennema-Notestine, et al., 2009).   
4.5.1.3 Cognitive deficits in PD associated with nuclei dysfunction  
Clinically, PD patients show a range of attention, executive function and memory deficits 
(Janvin, et al., 2003).  Cognitive deficits, especially those in the executive function domain 
are associated with changes in frontal lobes and fronto-striatal circuitry (Lewis, Dove, et al., 
2003), indicating a mediation role for the MDn and its associated connectivity.  In an fMRI 
paradigm using a motor task for example, performance was significantly worse in the task 
which required the patients to pay attention in order to successfully complete it.  Patients were 
either required to pay attention in order to perform the task or had previously over learned the 
task so it was automatic.   Furthermore, although associated with activation of prefrontal and 
supplementary motor areas of the cortex in controls, patients failed to show the expected 
increase in prefrontal activation during the attention task (Rowe, et al., 2002).   
The neurocorrelates of executive function are similarly affected, Parkinson’s patients 
with and without executive function impairments who were well matched on all other areas of 
cognitive function were examined using a working memory task which was designed to 
assess dorsolateral and ventrolateral executive systems.  In the subgroup with executive 
function deficits, task performance was significantly associated with reduced activity in the 
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prefrontal regions while prefrontal activity remained normal in the group without executive 
impairment (Lewis, Cools, et al., 2003).   
4.5.1.4 Associated areas of PD pathology and degeneration  
Surprisingly, the MDn itself has rarely been examined in PD, with only a handful of autopsy 
studies and one imaging study isolating this nucleus.  Autopsy studies have shown low levels 
of LB pathology (Braak & Braak, 2000; Rub, Del Tredici, Del Turco, & Braak, 2002) but no 
neuronal (Halliday, 2009) or volume (Henderson, et al., 2000b) loss in the MDn.  As none of 
the patients in any of these studies had cognitive impairment however, this could just reiterate 
that the MDn is not a big factor in motor dysfunction in PD.  Only one imaging study to date 
(Li, et al., 2010) specifically isolated the thalamus and identified the MDn as showing change 
in PD using voxel based morphometry.  A small group of PD patients with and without 
depression were recruited and the whole thalamus identified a priori as a region of interest 
which could potentially be implicated in depressed PD patients.  Although there were no 
changes in mean diffusivity in any regions of the thalamus, FA measures did show a 
significant decrease in the medial-dorsal region of the depressed PD group compared to the 
non-depressed group.  All patients were in early to mid-stage of disease and although in depth 
cognitive analysis was not conducted, their MMSE scores indicate relatively intact cognition 
(MMSE ~ 29.3).  The authors, of course conclude that the MDn is a neurocorrelate of 
depression, which is possible but it should also be noted that when depression is screened for 
and specifically excluded as is done in our own cohort (Melzer, et al., 2011b) atrophy in the 
medial thalamic region remains a significant predictor of global cognitive measures in PD.   
4.5.2 Pulvinar Nucleus (Pu) 
4.5.2.1 Anatomy, location and connectivity 
The pulvinar is the largest thalamic nucleus and makes up one quarter of the thalamus (Letinic 
& Kostovic, 1997).  The pulvinar is comprised of four distinct components, the anterior 
pulvinar (Jones, 2007b) which has projections to the somatosensory cortex in the parietal lobe 
(Hirsch, 2000), the inferior pulvinar which has primary connectivity with the visual cortex, 
the medial pulvinar, linked to the temporal and parietal lobes and the lateral pulvinar which 
has afferent terminations in visual, temporal and parietal cortices (Highley, Walker, Crow, 
Esiri, & Harrison, 2003).  The cellular make up of these regions is distinct and the 
subdivisions easily identified.  The medial division has small and widely dispersed cells, the 
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lateral, cells of a similar size, broken up by the fibres of the corticotectal tract that runs 
through this region.  The inferior nucleus has densely packed cells, with most cells relatively 
small but some large cells also scattered throughout.  The anterior division has the smallest 
and most widely dispersed cells of all those in the pulvinar.  For the purpose of this research 
all components of the pulvinar were combined into one nucleus.  The main input to the 
pulvinar is from the visuomotor regions of the brain, specifically the pretectum and the 
superior colliculus.  Corticothalamic fibers are also received from the striate and extrastriate 
cortex, terminating in all regions of the pulvinar (Jones, 2007b).  In addition, the pulvinar is 
interconnected with several subcortical structures including the superior colliculus, other 
thalamic nuclei and caudate nucleus along with the primary and secondary visual areas, visual 
inferotemporal areas, parietal association areas and prefrontal areas which mediate visual 
information processing and visual spatial attention (Leh, Chakravarty, & Ptito, 2008).   
4.5.1 Lateral Posterior Nucleus (LP) 
4.5.1.1 Anatomy, location and connectivity 
The lateral posterior nucleus (LP) is comprised of a cluster of densely packed medium sized 
cells.  Located dorsally adjacent to the pulvinar, the projections of the LP terminate in the 
same cortical areas as the Pu, with the projections of the LP rostal to those of the anterior 
pulvinar (Nieuwenhuys, et al., 2008b).  Although definition of the subdivision between the LP 
and Pu has not always been consistent (Jones, 2007b) and MRI studies often combine the two 
nuclei (Nieuwenhuys, et al., 2008b) we have considered the LP and Pu separately in this 
study, with each segmented from the whole thalamus independently.  As they essentially 
influence the same functions however, their functionality will be reviewed together.   
4.5.2 Combined LP-Pu Complex 
4.5.2.1 Function 
The pulvinar is most recognised for its visual influence (Jones, 2007b).  Specifically, the 
interpretation of visual stimuli and visuospatial attention is served by the pulvinar.  Given all 
the objects present in the human visual field at any one time, the goal of the visuospatial 
system is to only use the information from the target object and ignore all other irrelevant 
stimuli.  Several fMRI studies conducted on healthy control subjects have further expanded 
our understanding of the Pu.  The Pu shows increased activation when participants are 
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required to attend to a target compared to a non target stimuli during a fMRI procedure 
(Buchsbaum et al., 2006).  The Pu connectivity with the extrastriate cortex, a region of the 
occipital lobe adjacent to the primary visual field appears to be primarily responsible for the 
detection of visual stimuli.  Hierarchically organised, specific areas of this cortex are 
associated with the perception of colour, movement, shape, faces and spatial locations.  
Spatial location of objects appears to be the main function of this region of the occipital lobe 
as increased activation is evident in this region during tasks requiring detection of location 
rather than face matching in healthy control subjects (Hazxby, et al., 1994).   
This response is not elicited just from the presentation of visual stimuli, as the Pu only 
shows activation (Kastner, et al., 2004) or increased glucose uptake (a measure of increased 
activation) (LaBerge & Buchsbaum, 1990) if the participant is instructed to pay attention to 
the stimulus.  No activation is evident under passive conditions when the subject is instructed 
to remain fixated on a central point whilst stimuli are presented.  Attending to visuospatial 
information proves impossible when the Pu is lesioned.  Significant visuospatial hemineglect 
is evident in lesion patients as they are unable to direct attention to the visual hemifield 
contralateral to the lesion site (Karnath, Himmelbach, & Rorden, 2002).   
Similar to the mediodorsal nucleus, the pulvinar has also been implicated in 
Schizophrenia.  Structural MRI analysis has shown the Pu to be significantly reduced in 
patients relative to control subjects (Byne, et al., 2001), even after correction for total brain 
volume (Kemether, et al., 2003) and, in both cases in the absence of wider thalamic 
degeneration.  Shape analysis also revealed inward deformation of the posterior region of the 
thalamus in schizophrenic subjects relative to controls (Harms, et al., 2007).   
The combined function of the LP and Pu, examined together as ‘posterior thalamic 
nuclei’ have a significant effect on visual spatial function and perception.  In patients with 
lesions restricted to the posterior region of the thalamus a significant deficit in several spatial 
and perception tasks is evident.  Visual discrimination, especially, was lower in those with 
posterior thalamic regions compared to those with lesions in frontal or straital regions, 
suggesting the LP and Pu are strong components of intact visual/spatial function.  There was 
no association between visuospatial function and measures of executive function in this 
cohort.  The posterior nuclei do not appear to be mediated by executive function process when 
contributing to intact visual spatial function (Ricker & Millis, 1996).   
The pulvinar could also mediate memory function as significant volume reduction of 
the temporal lobe, one of the main regions of connectivity with the pulvinar is evident in 
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schizophrenic patients.  Volume reduction of the temporal lobe is consistently reported, of 51 
cohorts, 61% showed volume reduction, (see Shenton, Dickey, Frumin & McCarley, (2001) 
for review).  The same review also reports that of MRI studies that examined the parietal lobe, 
60% found a reduction in volume.  Studies regarding the occipital lobe are not as clear 
however as only 44% report occipital volume differences in Schizophrenia, and this from a 
sample size of only 9 studies that have examined the occipital lobe.  
In regards to the influence on cognitive function, structural MR studies tend to report 
no association between cognition and the temporal or occipital lobes (Seidman, et al., 1994), 
with a recent fMRI meta-analysis also reporting no difference in activation of the temporal 
lobes during a cognitive processing task between controls and Schizophrenic patients 
(Davidson & Heinrichs, 2003).   
The pulvinar nucleus itself shows a strong association with cognition however and 
may be more involved in cognitive dysfunction than the connectivity of associated cortical 
regions.  In patients with a form of dementia called subcortical ischemic dementia (SVD) that 
primarily exhibits deficits in executive function and memory (Erkinjuntti, 2003), blood flow 
in the pulvinar is significantly reduced compared to controls.  Blood flow was significantly 
associated with cognitive score (MMSE) in the left frontal region, suggesting connectivity 
disruption between the pulvinar and frontal cortex (Kato, et al., 2008).  The pulvinar is also 
associated with more general measures of cognition, Coscia (2009) reports significant shape 
changes in the pulvinar region of the thalamus which are associated with global measures of 
cognition and language, motor and executive functions.  Shape change of the pulvinar is also 
associated with memory, Harms, et al., (2007) showed a weak correlation between shape 
change in the thalamus that was thought to correspond to pulvinar degeneration and working 
memory, while Andrews, et al., (2006) reports pulvinar activation during a working memory 
task in Schizophrenia.  
4.5.2.2 Cognitive deficits in PD associated with nuclei dysfunction  
Clinically, PD patients exhibit a significant degree of visuospatial deficits (Cronin-Golomb & 
Braun, 1997; Owen, et al., 1993), even in the early stages in some cases (Janvin, et al., 2003).  
Manifesting as an array of visual perceptual deficits or visual spatial deficits, visual 
impairment heavily impacts on patient daily function and caregiver burden.  Visual perceptual 
deficits include: detection of colour, motion and deficits in facial scanning – leading to 
problems with the recognition of emotion.  Visual spatial deficits arise from difficulty in 
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perceiving the spatial relationship among stimuli, presenting as difficulity in tasks such as 
judging the relationship between a coffee cup and table when trying to place the cup down, or 
between a moving vehicle and one that is stationary at a red light up ahead when preparing to 
stop (Seichepine, et al., 2011).  A range of neuropsychological tests can measure the degree to 
which patients are affected.  The fragmented letter subtests derived from the visual Object 
Space and Perception (VOSP) battery can be used to assess visuoperception deficits in 
patients while the Judgement of Line orientation (JLO) can be used to assess visuospatial 
deficits.   
4.5.2.3 Areas of pathology and degeneration in PD associated with the LP and Pu 
Neither the LP or Pu exhibit extensive pathology in PD, the pulvinar nucleus exhibits isolated 
LB’s in the anterior and medial subregions with slightly higher LB or LN infiltration evident 
in the LP (Rub, Del Tredici, Schultz, et al., 2002).  Despite this, the pulvinar nucleus has 
shown a significant degree of grey matter loss in PD-D relative to PD after inclusion of 
clinical movement characteristics in our cohort (Melzer, et al., 2011b), suggesting a 
significant role in cognitive dysfunction in PD.   
4.5.2.4 Summary of the association nuclei  
The association nuclei are easily identifiable on MR images, and are frequently examined in 
neurodegenerative disease, most commonly in Schizophrenia (Byne, et al., 2001; Kemether, 
et al., 2003).  Although several studies report volume reduction of these nuclei, normally in 
the absence of wider thalamic reduction – very few have carried out any investigation into the 
effect that this has on cognition.  Primarily connected to temporal and parietal lobes (Highley, 
et al., 2003), with the MDn also projecting to frontal regions (Buchsbaum, Schoenknecht, et 
al., 2006), these nuclei could be involved in memory, attention, executive function and visual 
perception in PD.  The LP and Pu do not exhibit extensive pathology at autopsy (Rub, Del 
Tredici, Schultz, et al., 2002), but regions of primary connectivity such as the temporal 
(Summerfield, et al., 2005) and frontal lobes (Karagulle Kendi, et al., 2008), do show 
significant change in PD subjects.  Disruption in the thalamic-cortico, especially the frontal 
circuitry could therefore be a factor in cognitive dysfunction in PD.  
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4.6 Sensory Relay Nuclei 
The sensory relay nuclei have projections which ascend to the primary sensory fields of the 
neocortex (Nieuwenhuys, et al., 2008b) and are involved in somatosensory information such 
as touch, vision and auditory function.  New evidence suggests that it is the interaction 
between our different senses, occurring in the higher association areas of the neocortex that 
mainly aids our interpretation of the environment (Kayser & Logothetis, 2007).  A deficit in 
any of the association cortices could therefore cause a myriad of symptoms which affect 
cognitive processing and function.  The sensory relay nuclei include the medial (MGN) and 
lateral (LGN) geniculate nuclei and the ventral posterior nucleus (VP).  The medial and lateral 
geniculate nuclei are involved in auditory and visual processing.  Reciprocal connections from 
these regions preferentially terminate in respective association areas of the temporal and 
occipital cortex (Nieuwenhuys, et al., 2008b).  Although intact visual and auditory 
functioning will moderate cognition in PD, due to the similar connectivity of these nuclei to 
the pulvinar and the limited influence over other aspects of function, they will not be included 
for examination in this cohort.  Located ventral and either medial or lateral to the main dorsal 
thalamus, the MGN and LGN are automatically excluded from the dorsal thalamus during the 
automatic segmentation procedure we have applied here (Patenaude, 2007).   
a) 
 
b) 
 
Horizontal Z:45 (53-40) Horizontal Z:27 
    
Coronal Y:59 (71-54) Saggital X:62 (56-83) Saggital X:76 Coronal Y:65 
Figure 4-7: Sensory thalamic nucleus 
Anatomical location (a) and connectivity (b) of LP nuclei.  In each case the section giving the best view of the 
regions and their connectivity is presented on the top with views in corresponding slices given underneath.  X, Y 
and Z gives co-ordinates in standard (MNI) brain space and parenthesis the co-ordinates of the first and final 
slices where the thalamus is visible.  MRIcron images in a) are resliced when opened and are thus displayed 
using neurological convention, the left side of the image corresponds to the left side of the brain.  Images in b) 
are displayed using radiological convention, the left side of the image corresponds to the right side of the brain.    
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4.6.1 Ventral Posterior Nucleus (VP) 
4.6.1.1 Anatomy, location and connectivity 
The main projections of the ventral posterior nucleus are to the somatosensory cortex, 
terminations primarily end in the primary sensory cortex and, to a lesser degree in the 
secondary sensory cortex.  There are two main inputs to the VP, which work to convey 
sensation and communicate information relating to pain, temperature and touch of the body 
(Bhatnagar, 2002).  The first input is from the trigeminal lemniscus which communicates 
information from the head, trunk and oral structures and terminates in the medial region of the 
ventral posterior nucleus (VPM).  The dorsal columns-lemnisal pathway receives input from 
the contralateral limbs and trunk and terminates in the lateral region of the ventral posterior 
nucleus (VP).  The two nuclei divisions are easily distinguishable, separated by the white 
matter of the arcuate lamella and are also easily identified by their cellular make up.  The 
VPM is composed of a high density of small closely packed neurons whilst the VP is an 
arrangement of larger cell clusters (Jones, 2007b).  Here we have combined the ventral lateral 
and medial components of the ventral posterior nucleus and considered them as one ventral 
posterior complex.   
4.6.1.2 Function 
The VP primarily appears to be involved in pain.  The VP is involved in patients with central 
pain syndrome, a disease of the central nervous system involving neuronal systems which 
communicate the sensation of touch in the somatomotor system.  Symptoms include pain, 
abnormal regulation of blood flow, increased fluid in the skin and movement dysfunction in 
the absence of any other neurological conditions (Janig & Baron, 2002).  The VP shows 
increased neuronal firing in the areas of the VP which represent the body part where the 
patient experiences pain (Lenz, 1992).  Evidence for the role of the sensory nuclei also comes 
from lesion studies in dystonia – a neurological condition which presents as twisting and 
repetitive movements or abnormal postures of the body (Fahn, 1988).  Lesions of the ventral 
posterior nucleus are found to cause dystonic symptoms which can be differentiated by the 
region of the VP that is affected.  Lesions in the lateral VP for example cause dystonic spasms 
- sustained muscle contraction causing prolonged spasm, while lesions encompassing both the 
medial as well as lateral VP result in myoclonic dystonia – rapid jerking movements (See 
Deleu, Lagopoulos, & Louon, (2000) for review).   
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4.6.1.3 Sensory deficits in PD associated with nuclei dysfunction  
Not surprisingly, pain is significantly associated with symptoms of dystonia in PD.  
Compared to healthy controls, patients with PD report significantly greater levels of pain, 
associated with the degree of dystonic symptoms (Defazio, et al., 2008).  Sensory complaints 
that are unrelated to motor symptoms have also been described in PD patients and include 
aching, numbness, tingling, burning and vibrating sensations in an extremity (Snider, Fahn, 
Isgreen, & Cote, 1976).   
4.6.1.4 PD Pathology 
There is some evidence to suggest that disruption within the somatosensory cortex causes the 
experience of painful sensations in PD patients.  One controlled PET study has been carried 
out using PD patients and control subjects to examine differences in cerebral activity during 
simulation of pain receptors.  Neither group were experiencing pain symptoms before the 
study, enabling the same level of pain stimuli to be administered during the scanning 
procedure.  Pain threshold was lower in patients than controls and corresponded to higher 
activation of somatosensory cortex pathways.  Pain threshold returned to normal ranges after 
administration of levodopa in the patients but did had not effect on the pain symptoms in 
controls, suggesting a primary role for the degeneration of dopaminergic neurons in the 
increased perception of pain in PD patients (Brefel-Courbon, et al., 2005).  In previous studies 
which have examined pathology of thalamic nuclei (Halliday, 2009; Henderson, et al., 2000a), 
the VP region was not included so it is difficult to determine the level of degeneration that 
occurs in this region and the consequent effect this has on the sensory deficits seen in PD.   
4.6.1.5 Summary of the sensory nucleus 
The VP nucleus is primarily involved in pain perception (Lenz, 1992), with some evidence 
also suggesting an influence over the movement symptom of dystonia (Defazio, et al., 2008).  
The VP has not been previously examined for level of LB infiltration in PD, making it 
difficult to gauge the level of degeneration that occurs in this region.  A single imaging study 
has shown the somatosensory cortex – the region of primary association with the VP to be 
significantly affected during the perception of pain in PD patients (Brefel-Courbon, et al., 
2005) however, suggesting degeneration of connectivity between this thalamic region and the 
cortex underlies sensory disruption in PD.   
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4.7 Intralaminar Nuclei 
The intralaminar nuclei have traditionally been considered non-specific nuclei, nuclei that 
have such diffuse cortical projections that they influence multiple behaviours.  Modern 
anatomical tracing techniques have recently revealed the CM/Pf complex projects 
preferentially to particular cortical areas however, with only slight overlap in the projection 
fields of adjacent nuclei (Groenewegen & Berendse, 1994).  Similar to the function of the 
pulvinar, there is also evidence to suggest CM/Pf involvement in attention tasks in healthy 
subjects.   The CM/Pf region was the only thalamic region to show an increase in blood flow 
during an attention task compared to resting state in healthy control subjects (Kinomura, 
Larsson, Gulyas, & Roland, 1996).   
a) 
 
b) 
 
Horizontal X: 73 (56-83) Horizontal Z: 27  
    
Coronal Y 62 (71-54) Saggital Z: 43 (53-40) Saggital X:76 Coronal Y:65 
Figure 4-8: Non-Specific thalamic nucleus 
Anatomical location (a) and connectivity (b) of the CM/Pf nucleus.  In each case the section presenting the best 
view of the regions and their connectivity is presented on the top with views in corresponding slices presented 
underneath.  X, Y and Z give coordinates in standard (MNI) brain space and parenthesis the co-ordinates of the 
first and final slices where the thalamus is visible.  MRIcron images in a) are resliced when opened and are thus 
displayed using neurological convention, the left side of the image corresponds to the left side of the brain.  
Images in b) are displayed using radiological convention, the left side of the image corresponds to the right side 
of the brain.    
4.7.1 Centromedian – Parafascicular Complex (CM/Pf) 
4.7.1.1 Anatomy, location and connectivity 
For the purpose of this research the centromedian (CM) and parafascicular (Pf) nuclei were 
combined and analysed together.  These nuclei are found within the posterior region of the 
internal medullary lamina and are easily differentiated by their cellular distributions as the 
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parafascicular nucleus is made up of dense cells in the posterior region of the internal 
medullary lamina while the centre median nucleus extends laterally from the parafascicular 
nucleus and is comprised of small, closely packed cells.  There are widespread connections 
from the intralaminar nuclei throughout the cortex, and although a few intralaminar cells 
project to every cortical area, the main projections of the CM/Pf complex are to the striatum.  
In regards to cortical connectivity, the majority of CM cells project to medial and basal areas 
of the cortex while a smaller number project to the primary motor cortex.  The Pf projects to 
deeply placed areas around the rhinal sulcus and to the cingulate gyrus.  In its entirety, the 
complex receives afferent fibres from the basal ganglia, midbrain, cerebellum and spinal cord 
with the CM alone receiving projections from the globus pallidus, motor cortex and limbic 
cortex (Jones, 2007b).   
4.7.1.2 Function 
To date, two studies have specifically set out to examine the CM/Pf complex, both of which 
isolated both the CM/Pf and the association nuclei in Schizophrenia.  Contrasting results are 
reported, Byne et al., (2002) shows volume and neuronal reduction in the MDn and Pu nuclei, 
but not in the CM/Pf, and Kemether, et al., (2003) shows volume loss all three thalamic 
nuclei.  Both the centromedian and parafascicular nuclei do also independently show 
reduction in those classified as ‘severely disabled’ after a traumatic brain injury when 
compared to control participants (Maxwell, MacKinnon, Smith, McIntosh, & Graham, 2006).  
This could indicate that volume loss is related to degeneration of cortico-thalamic pathways. 
Significant damage to the cerebral cortex could result in neuronal loss in fibre pathways that 
connect to subcortical regions, for example, an idea that appears to be supported by this data.  
The parafascicular complex showed the highest reduction, suggesting that this region has 
weaker connections to the cortex than the centromedian nuclei.   
4.7.1.3 Cognitive deficits in PD associated with nuclei dysfunction  
Deficits in executive function, attention and memory in PD associated with the association 
nuclei have already been reported above.  These cognitive domains could also be influenced 
by the CM/Pf due to the association between this aspect of cognition and the anterior 
cingulate and dorsolateral prefrontal areas (Mitelman, et al., 2006).   
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4.7.1.4 PD Pathology 
Lewy pathology heavily infiltrates the CM, and to a lesser degree the Pf nucleus in PD (Rub, 
Del Tredici, Del Turco, et al., 2002), pathology is at a level only slightly below that of the 
components of the limbic loop (Halliday, 2009).  Both regions also show a heavy degree of 
neuronal loss, and evidence of atrophy in the Pf nucleus (Henderson, et al., 2000a).  The 
CM/Pf complex has also been implicated in PD patients without cognitive impairment.  In an 
imaging study which simultaneously examined volume and shape of the thalamus, differential 
reduction of the CM/Pf complex was reported.  There was a significant change in thalamic 
shape, thought to be due to CM/Pf degeneration without an overall reduction in volume of the 
whole thalamus (McKeown, et al., 2008).  There is also some evidence to suggest that 
degeneration in the intralaminar areas contributes to PD dementia, there is an association 
between the central lateral (CL) nucleus and PD-D.  The CL is a small intralaminar nucleus 
located adjacent to the CM.  Volume loss in this region is more acute in PD-D than in PD 
without dementia (Brooks & Halliday, 2009).  As the CL shares similar reciprocal 
connectivity as the main CM/Pf complex, it is likely that this region will be included with the 
wider CM/Pf nuclei when the thalamus is segmented and may influence the relationship 
between CM/Pf and cognition in our sample.   
4.7.1.5 Summary of the intralaminar complex  
Although the intralaminar region has traditionally been considered a ‘non-specific’ nucleus 
(Jones, 2007b) evidence from schizophrenia samples (Kemether, et al., 2003) suggests this 
region has influence on some behavioural and cognitive functions.  There is extensive 
pathology in the intralaminar nuclei in PD (Brooks & Halliday, 2009; Rub, Del Tredici, Del 
Turco, et al., 2002) and degeneration in this region could influence the cognitive symptoms of 
Parkinson’s disease.   
4.8 Summary 
In other neurodegenerative disorders such as Alzheimer’s disease and Schizophrenia there is 
some evidence to suggest that neuronal integrity (Buchsbaum, Buchsbaum, et al., 2006; Rose, 
Chalk, et al., 2006; Zarei, et al., 2009), neuronal loss (Byne, et al., 2006; Young, et al., 2000) 
or gross volume reduction (de Jong, et al., 2008; Gilbert, et al., 2001; Gur, et al., 1998; 
Hazlett, et al., 1999; Kemether, et al., 2003; Pakkenberg, 1992; Shimizu, et al., 2008) in 
individual thalamic regions has an association with cognition.  In PD, histology studies have 
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reported differential infiltration of Lewy pathology in thalamic nuclei (Halliday, 2009; 
Henderson, et al., 2000b), in some cases also reporting significant neuronal and volume loss 
which corresponds to the degree of LB burden (Henderson, et al., 2000a).   
Our group has previously provided significant justification for the current thesis as, 
using robust methodology and advanced neuropsychological testing we have shown a strong 
association between specific domains of cognitive dysfunction and grey matter loss in the 
pulvinar nuclei and significant grey matter loss in cortical areas known to be reciprocally 
connected with thalamic nuclei (Melzer, et al., 2011b).  We have also shown disruption in the 
connectivity between anterior thalamic regions and the neocortex (Melzer, et al., 2011a).  The 
individual components of the thalamus have not yet been isolated a priori and examined in 
relation to cognition however.  Given the extensive connectiviety between the thalamus and 
the neocortex, and thalamic involvement in cognitive symptoms, this suggests there still 
remains a significant gap in the research.  The thalamic nuclei are hypothesised to be a good 
indicator of current cognitive dysfunction in PD, and a tool for the monitoring of disease 
progression in the future.   
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Chapter 5. METHODOLOGY 
5.1 Objectives 
The participants in this thesis are a convenience sample obtained from a wider group of 
participants who are involved in ongoing research at the New Zealand Brain Research 
Institute, (NZBRI: formally the Van der Veer Institute) Christchurch.  This chapter describes 
the methodology surrounding the recruitment and examination of the participants in the wider 
research.  A brief background surrounding the relevant aspects of MR and DT imaging and 
the wider image acquisition procedure is also described.  This thesis employed several 
imaging techniques, and as such, the elimination of some subjects from aspects of the study 
was necessary.  This was primarily due to image artefacts or other abnormalities that were 
identified during the scanning procedure.  Further methodological details for each of these 
subsets will thus be described in the relevant subsequent chapters.   
5.2 Participants 
A sample of one hundred and forty two patients who were part of an ongoing longitudinal 
study at the NZBRI who had undergone neuropsychological testing on or before 25 March 
2010 were included in the initial cohort.  Parkinson’s disease had previously been diagnosed 
in these individuals based on the UK Parkinson’s disease society’s criteria for idiopathic PD 
(Hughes, et al. 1992) by an experienced clinician (T.A).  Participants were excluded from the 
study if they showed any of the following disorders: atypical Parkinson disorder; other central 
nervous system disorder; a prior learning disability; a major psychiatric or medical illness in 
the previous 6 months or a previous history of neurological conditions including: moderate-
severe head injury; stroke and vascular dementia.  All patients were tested in an “ON” state 
where most patients were receiving an anticholinergic agent or L-dopa in addition to another 
dopamine agonist.   
From this initial sample, further exclusion criteria specific to this thesis was necessary 
and is outlined in Figure 5-1.  Patients who had not yet undergone or had not completed the 
entire DT and MR scanning procedure on or before 13 March 2010 (scanning began for this 
sample on the 26 May 2007) were not able to be included in the study.  Patients with 
movement artefacts or other brain abnormalities were also excluded.  Control subjects were 
mainly excluded due to cognitive dysfunction or abnormal image artefacts.   
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The healthy control group consisted of thirty eight individuals who were part of the 
volunteer database held at the NZBRI.  The participants on this database are recruited through 
community advertising and matched to the patient group on mean age, sex ratio and education 
level after recruitment by a trained examiner (L.L.) and are only contacted for those studies 
where their characteristics match the age, sex and education levels of the participant group of 
that study.  Participants were required to meet the same inclusion criteria as the patients and 
were additionally excluded if they met NZBRI criteria for mild cognitive impairment (Section 
5.2.2), or had a MoCA score below 26, the recommended cutoff for cognitive impairment 
based on normative data (Nasreddine, et al., 2005).  Some control participants were also 
excluded after the MR imaging procedure revealed brain abnormalities such as cysts or 
lesions.  Informed consent was obtained for all participants after they had read through an 
overview of the research and understood what it was they were required to do in order to be 
included in the study.  Where additional consent was required, informed consent was provided 
by the patients’ significant other.  Volunteers were compensated for their time and travel 
requirements with vouchers of $30 for each neuropsychological testing session and $20 for 
the MRI scan.  Ethics approval was obtained by the local Ethics Committee, New Zealand 
Ministry of Health.   
5.2.1 Recruitment Procedure  
Parkinson’s disease patients are recruited from the specialist movement disorders clinic at the 
New Zealand Brain Research Institute.  The eligibility of the patient for any upcoming 
research is assessed and an information sheet and outline of the study they are most eligible 
for is posted to the patient.  Should they wish to participate, patients are asked to phone the 
institute.  For this thesis the patient sample was obtained from two ongoing studies, the PD 
study and the biomarkers study.  For both of these wider studies the recruitment procedure 
was the same.  It was desirable that the patients completed all components of the study within 
one month, so they were generally booked in for all appointments simultaneously.  Two 
neuropsychological test sessions, one eye movement examination and one MRI scan were 
required.  During the eye movement appointment the patient was also required to make sure 
the individual acting as their significant other was available for a separate interview.  Eye 
movements were assessed by another examiner (C.G. or T.P.).  This enabled the 
psychometrician that examines the patient to be also able to see the patients’ significant other, 
maximising the opportunity to gain detailed information about the patient.   
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For the studies within this thesis, all patients from the PD study and the biomarkers 
study were initially included and systematically excluded if they had not completed all 
components of the research at the end of the first year or did not meet the individual 
requirements for this thesis.  All cognitive, demographic, clinical and behavioural data was 
initially obtained from patient files along with the information from the significant other.  Eye 
movement information was not included.  
All healthy controls that were part of the wider PD study were included in this 
research.  The final sample was 92 PD patients (PD-D = 17; PD-MCI = 19, PD-N = 56) and 
25 control subjects. 
Figure 5-1: Subjects that were excluded from the initial sample.   
The number of subjects excluded at each step, the final sample was 92 PD patients (PD-D = 17; PD-MCI = 19, 
PD-N = 56) and 25 control subjects.   
5.3 Neuropsychological testing  
Cognitive examination was completed in two sessions of up to two hours each.  The first 
Neuropsychological Inventory 1 (NP1) was administered in the first session and the second 
Neuropsychological Inventory 2 (NP2) in the third session.  Both NP inventories consisted of 
a series of cognitive tests which, in their entirety examined all cognitive domains 
recommended by the Movement Disorder Society task force in the diagnosis of mild 
cognitive impairment and dementia (Emre, et al., Dubois, et al., 2007; 2007) in Parkinson’s 
disease: learning and memory; executive function; language; visuospatial function and 
attention.  
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5.3.1 Demographic and Clinical Information collected for all participants 
Demographic information was collected from database information and medical files for each 
participant and included age, sex, handedness and years of education.  Handedness was 
defined as the hand an individual wrote with, not the hand that is used predominately in 
everyday tasks.  Education was defined as the number of years in a formative institution, 
including primary school.   
5.3.1.1 Older Person’s Mood Scale: Brief 15-item version 
For the control participants, the level of depressive symptoms was the only clinical 
information collected and was measured using the brief 15-item version of the Geriatric 
Depression Scale (GDS: Yesavage, et al., 1982).  As major depression had already been 
excluded in this cohort the administration of the GDS was applied only to give an indication 
of sub-threshold depressive symptoms and did not result in a diagnosis of depression.  The 
GDS was completed during session 1 and initially asked the participant 4 questions about 
their life for which they are to respond either ‘yes’ or ‘no’.  The questions include items such 
as ‘are you basically satisfied with your life?’ and ‘do you prefer to stay at home rather than 
going out to do new things?’  If the participant answers ‘yes’ to any of the first four questions 
this indicates depression is present and the rest of the scale is administered to gain more 
insight into the level of depressive symptoms.  Items 5-15 are also ‘yes’ or ‘no’ questions and 
include items such as ‘do you often feel helpless?’ and ‘do you feel that life is empty?’  
Participants are assigned one point for every ‘yes’ answer and given a score out of 15.  The 
GDS has been validated against both the Hamilton Rating Scale for Depression (HRS-D: 
Hamilton, 1960) and the Zung Self-Rating Depression Scale (SDS: Zung, 1965) and found to 
be a reliable and valid self-rating screening scale for the elderly (Yesavage, et al., 1982).   
5.3.2 Clinical Information collected for patients only  
The same demographic information was collected for the patient group.  In addition, the 
clinical information pertaining to disease duration, disease severity and disease stage was 
collected from patient files and The Unified Parkinson’s Disease Rating Scale (UPDRS: 
Fahn, Elton, & Committee., 1987).  Disease duration was defined as the time from diagnosis, 
not the number of years that symptoms had been present.  Disease severity was measured 
using Part III – motor examination of the UPDRS and disease stage with the Hoehn and Yahr 
(Hoehn & Yahr, 1967) which forms part V of the UPDRS.   
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5.3.2.1 The Unified Parkinson’s Disease Rating Scale  
The UPDRS is administered during session two.  For the purposes of this thesis only the 
scores for Part III and Part V were collected from patient files.  In its entirety the UPDRS 
allows for examination of the patient by a trained examiner across several different functions 
and also includes a historical report of mental function and activities of daily living based on 
patient self-report.  Parts I, II and III contain 44 questions which are each measured on a 5 
point scale (0-4).  Part I measures mentation, behaviour and mood through the examination of 
intellectual impairment, thought disorder, motivation and depression.  Part II measures the 
patients’ level of activities of daily living including their speech, swallowing, handwriting, 
dressing and hygiene.  Part III is described below and examines motor function.  Part IV 
consists of 11 questions about any complications the patient may be experiencing due to 
therapy such as dyskinesia-duration, dyskinesia-pain and nausea or vomiting using a 
subjective rating scale which ranges from 0 to 23.  Part V is the modified version of the 
Hoehn and Yahr exam.  For each subsection the patient is assigned a total score based on the 
rating of severity (where a higher score indicates more severity) and a total UPDRS score 
(range 0 – 176) is the combined sum of parts I – IV.  Although the UPDRS is a subjective 
rating scale, the inter-rater reliability is high, and test-retest results have not been found to be 
statistically different (Metman, et al., 2004).   
Part III – motor examination  
The motor subsection consists of 14 questions which ask the patient to perform tasks such as 
opening and closing their hand in rapid succession, the movement of major joints and 
initiation of movement such as arising from their chair.  The severity of symptoms is assessed 
by the examiner for all questions.  For some questions, such as facial expression the examiner 
rates the patient’s severity of symptoms without the patient being required to participate.  The 
score for each question is added and the patient is given a total between 0 – 56 where a higher 
score indicates more severe impairment.   
 
Part V – Hoehn and Yahr Stage  
The Hoehn and Yahr exam requires the examiner to subjectively define the patents stage of 
disease.  Stages range from stage 0 to stage 5 where stage 0 is assigned if the patient shows no 
sign of disease and stage 5 if the patient is wheelchair bound or bedridden unless aided.  The 
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examiner asks the patient to perform a series of tasks or movements, assigning them a score 
for each task.  Tremor at rest is also examined during this procedure without the patient being 
required to participate.  Scores are added to give an overall total for each component which 
translates to the Hoehn and Yahr stage.   
5.3.2.2 Significant Other Interview 
The significant other interview is completed with L.L. in the second session and includes: the 
Adaptive Behaviour Assessment System – second edition (ABAS: Harrison & Oakland, 
2003); the Neuropsychiatric Inventory (Cummings, et al., 1994); the One Day Fluctuation 
Assessment Scale (Walker, et al., 2000) and the Activities of Daily Living – International 
Scale (ADL: Reisberg, et al., 2001).  For each questionnaire the examiner reads out the 
questions to the significant other and they are asked to rate the level of patient symptoms 
using different Likert scales.  The entire procedure is completed within an hour.   
For the healthy control participants the procedure is slightly different.  At the first 
session they are asked to take home a booklet for their significant other to complete.  The 
booklet includes detailed instructions on how to answer each questionnaire and includes the 
ABAS and the ADL.  The clinical dementia rating scale (CDR: Morris, 1993) is also included 
as a measure of cognition and includes tests of memory, awareness, judgement and problem 
solving abilities.   
The Adaptive Behaviour Assessment System – second edition 
The ABAS consists of several subscales which measure the patient’s abilities across several 
settings.  Each subscale consists of 20-27 questions which examine: levels of communication; 
ability to use the community; functional academics; home living; health and safety; leisure; 
self care; self direction and work.  The significant other is required to answer each question 
using a Likert scale of 0 = ‘is not able,’ to 3 = ‘always or almost always when needed.’  The 
participant is given a total score for each subscale by adding the number given for each 
question.  Provision is made for those questions that the significant other needs to guess or 
does not know the answer to.   
The Neuropsychiatric Inventory 
The Neuropsychiatric Inventory measures 10 behavioural disturbances that commonly occur 
in dementia patients including delusions, hallucinations, aggression, depression and anxiety.  
Within each subsection a screening question is first asked to ascertain if the behavioural 
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disturbance is present.  This is a simple question to which the significant other either responds 
‘yes’ or ‘no’  If the answer is ‘no’ the examiner moves to the next section.  If the answer is 
‘yes’ the significant other is asked to rate the severity and frequency of the behaviour using 
the below scale.   
For each sub-question, the informant is asked to rate the:   
 frequency: 1 = ‘occasionally, less than once per week,’ to 4 = ‘very frequently 
– essentially continuously present’ 
 severity: 1 = ‘mild, symptom is distressing but usually responds to redirection 
or reassurance,’ to 3 =’ marked – symptom is very distressing and a major 
source of suffering for the patient’ and  
 distress: 0 = ‘not at all’ to 5 = ‘very severely or extremely.’   
For each subsection the significant other is also asked to rate their own distress that is 
associated with the patients behaviour before moving on to subsequent sections.   
The One Day Fluctuation Assessment Scale  
This scale gives a measure of the patient’s behaviour over the previous 24 hours and includes 
several subsections which measure areas of confusional behaviour (falls, fluctuations in 
cognitive functioning, drowsiness, attention, disorganised thinking, altered level of 
consciousness and communication) with specific questions such as ‘has (the patient) fallen in 
the last 24 hours’ and ‘did (the patient) have difficulty focusing attention throughout the day?’  
The scale for subsections 1-3 begin with a dichotomous ‘yes/no’ question relating to the 
presence of the behaviour.  If the answer is yes the significant other is asked to state how 
many times the behaviour occurred or how much of the day (25%, 25-75% or 75%+) the 
behaviour was present for.  Items 4-5 only require the dichotomous answer and item 7 asks 
how well the patient understands communication using the scale of 1 – ‘understands almost 
everything you communicate’ to 3 – ‘understands almost nothing of what you communicate.’  
The scores for each subsection are summed to provide a severity score for fluctuating 
confusion ranging from 0 to 21.   
Activities of Daily Living – International Scale  
The ADL is a 40 item questionnaire which measures the global and cognitive process of 
dementia.  Questions include ‘does the patient have difficulty putting household items in the 
right places?’ and ‘does the patient have problems remembering important dates and events?’  
The significant other is asked to rate the severity of difficulty using a 4 point Likert scale (0 = 
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‘never’ - 3 = ‘always’).  The score for each question is then added to give a total severity 
score out of 160.   
Clinical Dementia Rating Scale  
The CDR is only given to the significant other of the control participants.  This rating scale 
consists of several subsections which address memory, orientation, judgement and problem 
solving, community, social and home and hobbies of the participant.  Within each subsection 
the significant other rates the severity of symptoms using the options of: usually; sometimes; 
rarely or don’t know.  Some questions also require a brief explanation about the behaviour.   
5.3.3 Measures of Global Functioning and Pre-Morbid Ability 
From the initial NP1 and NP2 batteries, test scores from the following neuropsychological 
exams were also included in this thesis.  Measures of global function were assessed by the 
Mini Mental State Examination (MMSE: Folstein, Folstein, & McHugh, 1975), the Montreal 
Cognitive Assessment (MoCA: Nasreddine, et al., 2005) and the Alzheimer’s Disease Rating 
Scale (ADS: Rosen, Mohs, & Davis, 1984).  The Wechsler Test of Adult Reading (WTAR: 
Wechsler, 2001) was also included to give a measure of pre morbid functioning.  There were 
no deviations from the normal administration instructions for any of the tests.   
5.3.3.1 The Mini Mental State Examination 
The MMSE is a brief screening instrument for dementia, used to give an overview of global 
function.  The test consists of 30 questions which cover a small set of verbal functions, 
memory and construction abilities simply and quickly.  The verbal functions consist of an 
orientation task where the participant is asked the year, season, month, date and day and a 
language test where they are asked to name a series of objects, repeat a phrase and follow 
separate written and verbal commands.  The construction task is a combination of following 
the verbal command to fold a paper in half and copying an interlocking pentagon design.  For 
the attention task there are two options.  In this case the total score for MMSE is based on the 
inclusion of the ‘serial sevens’ task in which the participant is asked to deduct 7 from a series 
of numbers, beginning at 100.  This replaces the ‘WORLD’ task in which the participant is 
asked to spell ‘world’ backwards, as serial sevens is considered to be more challenging and is 
used in the diagnosis of dementia for Parkinson’s disease (Dubois, et al., 2007).  The outcome 
measure for the MMSE is the number of correct answers, where the participant is awarded 
one point for each answer out of a possible 30.  For this study, age and education adjusted 
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scores were then calculated based on normative data.  There is no time restriction on the 
MMSE but in its entirety it is expected to take between 5-10 minutes.   
5.3.3.2 The Montreal Cognitive Assessment 
As the MMSE is not as sensitive to the milder forms of cognitive impairment evident in 
Parkinson’s disease and is prone to ceiling effects (Zadikoff, et al., 2007), the MoCA was 
administered as an additional measure of global function.  The MoCA is also a brief screening 
tool but was developed specifically for the detection of mild cognitive impairment in patients 
who normally perform within the normal range on the MMSE (Nasreddine, et al., 2005).  The 
test is the same size as the MMSE, consisting of 30 questions which cover: short term 
memory recall; visuospatial abilities; executive function; attention and working memory; 
language and orientation to time and place.  The stimuli for the short term memory task are 
two learning trials of five nouns, and delayed recall is measured after 5 minutes.  Visuospatial 
ability is measured from a clock-drawing task and a cube copy task.  Executive function is 
measured using a smaller section of the Trail Making Test (TMT) - B task, a verbal fluency 
task and a verbal abstraction task.  Attention and working memory are measured together 
using a test of sustained attention where the participant is required to detect a target letter 
from a series of stimuli letters; a serial subtraction task and the digits forward and backwards 
task (abridged to 5 forwards and 3 backwards stimuli).  Language is measured through a 
naming task where participants are required to name three animals they are unlikely to be 
familiar with and the repetition of complex sentences.  Orientation to time and place is also 
evaluated through questioning of the date, month, year, day, place and city.  One point is 
awarded for each correct answer and age and education adjusted score then gained from the 
normative data.  The MoCA is expected to take a maximum of 10 minutes.   
5.3.3.3 The Wechsler Test of Adult Reading 
The Wechsler Test of Adult Reading is used as a measure of premorbid function because, 
unlike other cognitive abilities, reading recognition is relatively stable in a diseased or ageing 
brain (Strauss, Sherman, & Spreen, 2006).  The test stimuli are 50 words with irregular 
pronunciation that the participant has to read out to the examiner.  Irregular pronunciation is 
used so that the participant cannot apply currently known pronunciation rules and has to rely 
solely on the word having been previously learned.  The participant is awarded one point for 
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every correct answer which can then be converted into a WTAR standard score based on 
normative tables.  There is no time constraint for this examination.   
5.3.4 Movement Disorder Society Task Force Recommended Cognitive Domains 
Following the recommendations of the Movement Disorder Society Task Force (MDS: Emre, 
et al., 2007), the cognitive profile of participants was examined in four key areas of function: 
attention; memory; executive function and visuospatial function.  Several different tests were 
used for each cognitive domain.  For each cognitive test the patients score was converted to a 
standard score based on age and education adjusted normative data.  These standard scores 
were then averaged for each cognitive domain and an overall Z score created from each 
average domain score.  The purpose, procedure and outcome measure for each test are 
outlined within their relevant domain below with the order of administration is given in Table 
5-1.   
5.3.4.1 Attention/working memory/processing speed 
Attention/working memory/processing speed was primarily examined using components of 
the Weschler Adult Intelligence Scale (WAIS-IV: Wechsler, 2001), the Delis-Kaplan stroop 
task (Delis, Kaplan, & Krammer, 2001) and the trail making task from the Army Individual 
Test battery (Army Individual Test Battery: Manual of directions and scoring, 1944).   
Digit Span Forwards and Backwards  
Digit span modality tests are used as a measure of the working memory component of verbal 
IQ (Strauss, et al., 2006).  Both the digit span forwards and digit span backwards tasks are 
recommended by the MDS to measure short term and working memory (Dubois, et al., 2007).  
The digit span test has been shown to be sensitive to the development of PD dementia (Woods 
& Troster, 2003a).  This sample consisted of patients who initially presented as non-demented 
but who were diagnosed with PD-D at one year follow up.  The baseline scores on the digits 
backwards subset exhibited diagnostic accuracy in predicting PD-D at follow up.  The stimuli 
for the digits tests are verbal, a series of non sequential numbers are read to the participant at a 
rate of one per second.  Each subset is presented twice using different digits.  Part 1 measures 
forwards digit span using stimuli subsets of 2-9 numbers and Part 2 measures backwards digit 
span using stimuli subsets of 2-8 numbers.  Once the entire sequence has been presented the 
participant is instructed to repeat the sequence of digits back to the examiner in the order they 
were given (Digit span forwards) or in reverse order (Digit span backwards) without any 
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constraint on time.  Scoring is contingent on the participant correctly repeating all numbers in 
the trial for which they gain one point.   
Digit Ordering Test  
The digit ordering test is sensitive to working memory deficits in PD without dementia 
(Hoppe, Muller, Werheid, Thone, & von Cramon, 2000) and is recommended by the MDS to 
measure working memory deficits in PD (Dubois, et al., 2007).  Similar to the digit span 
modality tests, the digit ordering test consists of stimuli subsets of 3-8 numbers which are 
presented to the participant in two trials of independent stimuli.  After presentation of the 
digits the participant is required to repeat the numbers back to the examiner in ascending 
numerical order, gaining one point for the completion of each trial.   
Map Search  
The map search task is a test of everyday memory and attention (Robertson, Ward, Ridgeway, 
& Nimmo-Smith, 1996) that requires the participant to ignore all distracter stimuli and 
identify the target stimuli – a measure of focussed attention.  The map search has been applied 
in one of our own PD samples (Dalrymple-Alford, et al., 2011) as part of the proposed 
diagnostic criteria for PD-MCI and shows adequate discrimination between PD-MCI and PD-
N and between PD-D and PD-MCI.  The map search also has a 63-72% sensitivity in 
discriminating between MCI and dementia of the Alzheimer’s type (De Jager, Hogervorst, 
Combrinck, & Budge, 2003).  The apparatus in this case is a large laminated street map and 
the target stimuli are restaurant symbols.  The participant is required to use a whiteboard 
marker to circle all the target stimuli.  This task is time constrained to two minutes.  The 
outcome measure is the number of correct (hits) and incorrect responses which are recorded 
separately in two, one minute intervals.  The total number of hits and incorrect responses is 
also calculated as an outcome measure.   
Stroop Task  
The Stroop task measures selective attention failures and is recommended by the MDS in the 
diagnosis of PD dementia (Dubois, et al., 2007).  The Stroop consists of three main trials: the 
colour trial, word trial and the stroop task proper.  The colour trial requires the participants to 
merely interpret patches of block colour and state the name of it.  Similarly, the word trial 
requires them only to read a printed word.  Participants are first required to complete the 
colour trial and the word trial to ensure competency for the completion of the Stroop task 
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proper.  The stoop task proper is hampered by a combination of the previous trials and 
incongruent conditions whereby the printed word of the colour is written in ink of a different 
colour such as the word ‘RED’ written in green ink.  All three trials have a good 
discrimination between PD-N and PD-MCI (AUC = 68-81) and between PD-MCI and PD-D 
(AUC = 83-85) when examined in one of our own PD samples (Dalrymple-Alford, et al., 
2011).   
Colour Trial  
The Stroop colour trial measures the participants visual ability.  The stimuli for this trial is 
several rows of colour patches.  Colours are restricted to primary colours (red, blue, yellow 
and green).  Operating in left to right, top to bottom sequential order the participant is 
required to name the colour patches.  The outcome measure is the number of correct 
responses with one point awarded for each correct response.  This trial is limited to 90 
seconds.   
Word Reading Trial 
The Stroop word reading trial measures the participants reading competency which is 
essential for the completion of the Stroop task proper.  For this trial the stimuli is several rows 
of colour words ‘RED, GREEN, BLUE’ printed in black ink.  Similar to the colour trial the 
participant is required to read each of the words and given one point for each correct response.  
This trial is also limited to a total of 90 seconds.   
Trail Making Test – Part A 
The trail making test is a measure of scanning and visuomotor tracking and is sensitive to 
cognitive changes in mid stage Parkinson’s disease patients (Hietanen & Teravainen, 1986).  
The TMT is divided into two parts and it is one of the tests recommended by the MDS to 
measure abilities of set activation, set shifting and set maintenance (Dubois, et al., 2007).  The 
stimuli for both parts is the same, the participants are presented with an A4 sheet of paper on 
which is printed a series of randomly positioned sequential numbers (1-25), each encased in 
small circles.  Part A requires participants to link the numbers together in numerical ascending 
order using a pencil.  Participants are instructed to complete the task ‘as fast as you can’ with 
the outcome measure the total time to completion.   
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5.3.4.2 Executive function 
The test that is primarily used for executive function measures is the Delis-Kaplin Executive 
Function System (Delis, et al., 2001) which is nine independent tests that are designed to 
measure the fluency and cognitive flexibility aspects of executive function.  The following 
subsets of this examination were administered independently in this study, only the category 
fluency and category switching test were given consecutively.   
Letter Fluency (Version A) 
It is recommended that verbal fluency tests are used in the criteria to diagnose PD dementia 
(Dubois, et al., 2007) as they are a relatively pure measure of executive function and 
performance is significantly reduced in patients with Parkinson’s disease dementia (Pillon, 
Dubois, & Agid, 1991).  Together with verbal memory measures, verbal fluency performance 
is also reduced in those PD patients with cognitive impairment without dementia (Jacobs, et 
al., 1995; Levy, et al., 2002).  The letter fluency task consists of three trials and requires the 
participant to draw on skills of processing speed, task initiation and simultaneous processing 
abilities.  The participant is required to list as many words as they can think of beginning with 
the letters ‘F,’ ‘A,’ and ‘S.’  Words are not allowed to be proper nouns and each trial is 
restricted to a maximum of 60 seconds.  The outcome measure of interest is the number of 
correct words that are able to be generated.   
Action Fluency 
Not specifically recommended by the MDS (Dubois, et al., 2007), action fluency is 
nevertheless sensitive to the cognitive changes between PD-N and PD-MCI and between PD-
MCI and PD-D in our own sample (Dalrymple-Alford, et al., 2011).  Similar to the letter 
fluency task, the participant is required to list as many verbs (explained as ‘things that people 
do’) as they can in a 60 second time frame.  The outcome measure is the number of correct 
words that are able to be generated.   
Category Fluency 
Category fluency is a verbal fluency task that is recommended to aid in the diagnosis of 
dementia (Dubois, et al., 2007).  Category fluency uses the same processing and retrieval 
skills as the letter fluency task but requires that the participant follow the additional rule of 
semantic category.  The D-KEFS categories stipulates that the participant must list as many 
animals as they can think of in Trial 1, followed immediately by as many boys names in Trial 
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2, requiring the participant to employ a selection and discounting process for each generated 
word.  Each trial is restricted to a time of 60 seconds and the outcome measure is the number 
of correctly generated words.  
Category Switching 
The category switching task occurs immediately subsequent to the category fluency trails and 
requires participants to rapidly generate both fruits and furniture (switching between 
categories for each word).  Significantly impaired in both PD-D and PD-MCI (Dalrymple-
Alford, et al., 2011), category switching is considered a measure of cognitive flexibility.  This 
test consists of one trial lasting 60 seconds where the outcome measure is the number of 
correct words in the category switches.   
Trail Making Test – Part B 
Adding to the requirements of Part A of the TMT, Part B is a measure of divided attention 
and cognitive flexibility.  The stimuli for this test are similar but the numbered circles from 
the original test are interspersed with circled letters.  Participants are required to connect 
sequential numbers and letters, alternating between each (for example, 1-A, 2-B, 3-C).  The 
outcome measure is total time to completion.   
Stroop Total 
The total Stroop task measures selective attention.  The stimuli in this task are conflicting and 
presented in either a congruent or incongruent manner.  In the congruent set, the word is 
written in the colour it stands for (i.e.: the word ‘RED’ is written in red ink), in the 
incongruent set, the word is written in an opposing colour (i.e.: the word ‘RED’ is written in 
green ink).  For both sets the participant is required to name the colour the word is printed in 
and ignore what the word says.  Findings suggest that patients who struggle on the 
incongruent trials have difficulty concentrating and ignoring distractions (Strauss, et al., 
2006).  The outcome measure is the total score where one point is given for each correct 
response.  This trial is time constrained to 180 seconds.   
5.3.4.3 Visuoperceptual/Visuospatial function 
This domain encompasses measures of spatial awareness and stimuli perception.  It is difficult 
to gain a ‘pure’ measure of spatial awareness or stimuli perception as there is a great degree of 
overlap between the two functions.  The Judgement of Line test (JOL: Benton, Varney, & 
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Hamsher, 1978) mainly requires spatial awareness while the fragmented letters test from the 
Visual Object and Space Perception Battery (VOSP: Warrington & James, 1991) mainly 
measures stimuli perception.  The copy subset of the Rey Complex Figure Test (Meyers & 
Meyers, 1995) encompasses both spatial awareness and perception skills.   
Judgement of Line Orientation 
The JOL was applied as a measure of visuospatial ability.  This test is sensitive to pure 
visuospatial deficits in Parkinson’s disease as the high failure rate on this measure is 
independent of cognitive ability, disease severity or PD duration (Montse, Pere, Carme, 
Francesc, & Eduardo, 2001).  The JOL stimuli can be any two lines which vary in angle from 
0 – 180 degrees and a separate picture where all possible line angles are presented together.  
There are 11 possible angle options.  The participant is presented with the line pairs and asked 
to match them to the test picture.  There are 30 test stimuli which are presented and the 
participant gains one point only if they correctly identify the angle of both lines in the pair.   
Fragmented letters 
The fragmented letters subset of the VOSP is a measure of visual perception and is one of the 
tests recommended by the MDS in the diagnosis of dementia (Dubois, et al., 2007).  The 
participant is presented with 20 large alphabet cards that have each been altered until only 
30% of the original shape remains.  The participant gains one point for each correctly 
identified shape and is given up to 10 seconds per card before being told to ‘guess if you are 
not sure.’  The outcome measure is the number of correctly identified letters.   
Rey Complex Figure – Copy Trial 
The RCF stimulus  is a complicated diagram comprised of several different shapes and lines 
of varying angle and size.  The figure is placed in front of the participant in a horizontal 
direction and they are required to copy the figure exactly as they see it without moving or 
rotating the test stimulus.  The copy trial measures both visual perception, when the 
participant is required to interpret the stimulus; and perceptual organisation/spatial abilities 
when the participant is required to re-draw the shape.  To score the participants performance 
on this task the examiner copies what the participant draws as they draw it, changing the 
colour of the pen used in order to note the sequence in which the figure is completed.  For this 
study the pen colour was changed at an interval of 60 seconds.  The participant is given an 
unlimited amount of time to copy the diagram but time to completion is recorded.  The 
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scoring system is based on the participants’ placement of the stimulus, the size of the 
components and accuracy of the drawing.  The figure is divided into 18 scorable units which 
are individual areas or details of the figure.  A correctly placed and proportional copy of each 
unit earns 2 points so the maximum score for the total figure is 36 points.   
5.3.4.4 Learning and Memory 
Learning and memory was measured using both verbal and visual stimuli as both functions 
are impaired in early PD and have been shown to be independent of medication effects (Singh 
& Behari, 2006).  Verbal memory was examined using the California Verbal Learning Test 
(CVLT: Delis, Kramer, Kaplan, & Ober, 1987) which has been shown to be sensitive to 
memory dysfunction in early PD (Taylor, Saint-Cyr, & Lang, 1990).  Visual memory was 
examined using the Rey Complex Figure Test (RCFT: Meyers & Meyers, 1995) which is 
sensitive to cognitive dysfunction in PD without dementia (Uc, et al., 2005).  Although 
recognition memory appears to be intact in early PD, evidence is starting to suggest this is not 
the case in PD-D (Whittington, Podd, & Kan, 2000).  The aim of this study was to measure 
cognitive dysfunction in the early and mild cognitive impairment stages of PD as well as in 
the PD-D stage.  Therefore, in accordance with recommendations made by the movement 
disorder society task force (Emre, et al., 2007), the recognition trials of the CVLT and RCFT 
were not included in this thesis, although they were administered for the wider PD and 
biomarker studies.   
California Verbal Learning Test – Acquisition trials 
The CVLT is designed to examine the use of semantic association as a strategy for word 
learning.  The stimuli for each CVLT list is 16 words which each belong to one of four 
categories.  The lists used for this study were List A, which categorised the words into 
vegetables, animals, ways of travelling and furniture and List B, which, in addition to the 
vegetables and animals category from List A also categorised words into musical instruments 
and parts of furniture.  For the acquisition trial the entire list is read to the participant at a 
slow, even pace so that the list takes 12-14 seconds to read.  The participant is given four 
trials to list all the words they remember, with the list read to them again at the beginning of 
each trial.  The total number of correct words are recorded along with the total number of 
repetitions and total number of words that were not on the list but were given as being 
remembered from the list (intrusions).   
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California Verbal Learning Test – short delay (30sec) free recall trial 
The short delay free recall trial occurs after a 30 second distractor task.  In this case the 
distractor task required the participant to count backwards from 100.  The participant has not 
previously been forewarned that they will be required to remember the CVLT word list but is 
then required to list as many of the words as they can remember.  Scoring is conducted in the 
same way as for the acquisition trials.   
California Verbal Learning Test – long delay (10 min) free recall trial 
The long delay free recall trial occurs after a delay of 10 minutes from the short delay free 
recall trial.  Again, the participant has not been told that they will be tested on the words a 
second time.  The participant is given one trial to recall as many words as possible, with 
scoring occurring in the same manner as in previous trials.   
Rey Complex Figure Test – short delay (3 min) free recall trial 
The short delay free recall trial of the RCFT was administered after an interval of 
approximately 3 minutes.  The participant had not been previously warned that they would be 
recreating the figure from memory.  The participant was given a sheet of paper and instructed 
to draw the complex figure from memory with scoring occurring in the same manner as for 
the copy trial.   
Rey Complex Figure Test – long delay free recall trial  
The long delay free recall trial is administered 30 minutes after the stimulus is first presented 
in the copy trial, considered to be a length of time that is sufficient for retention to have 
occurred.  The procedure and scoring did not vary from that which was conducted in the 
previous trials.   
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Table 5-1: Study procedure  
Recruitment procedure for the ongoing work at 
NZBRI 
 Neuropsychological testing procedure  Recruitment procedure for this 
thesis  
   Session 1  Session 2    
Patients  
 Identified from 
specialist clinic 
attendance  
 Recruitment begins by 
mail contact 
 Patient expresses 
interest  
 Patient is contacted by 
phone and 
appointments are 
arranged in a way that 
ensures they are all 
completed within a 
month 
 
Healthy control subjects 
 Recruited through 
community advertising  
 Added to the database 
held at the NZBRI 
research clinics 
 Control subjects are 
only contacted if they 
meet the eligibility 
criteria for a specific 
study  
MRI procedure  
The participant 
undergoes a complex 
scanning procedure 
where T1, T2, and DT 
images are obtained.  
 
Significant other 
interview 
Patients 
The patient is required to 
bring a significant other 
to the second session.  
This person will then 
complete the interview in 
a separate room to the 
patient.   
 
Healthy control subjects 
The significant other of 
the healthy control 
participants is posted the 
questionnaire and is able 
to complete it at home 
prior to the first session.   
 1. Consent form  
2. Health checklist and 
background for PD  
3. MMSE 
4. GDS 
5. WTAR 
6. CVLT-II Short Form – 
free recall trial 
7. VOSP – shape detection 
and incomplete letters 
8. Digit span – forwards 
9. Digit span – backwards 
10. Digit ordering  
11. CVLT-II Short Form – 
long delay free recall 
12. Letter fluency 
13. JOL Orientation – Form 
H 
14. Category Fluency and 
Category Switching 
15. Trail Making – Part A 
16. Trail Making – Part B 
17. WASI – Matrix 
Reasoning  
18. Boston Naming Test 
1. Parkinson’s disease 
questionnaire 
2. RCFT – copy trial 
3. RCFT – immediate 
recall trial 
4. MoCA 
5. RCFT – delayed recall 
trial – short delay 
6. Stroop task – colour 
trial 
7. Stroop task – word trial 
8. Stroop task – test trial 
9. RCFT – delayed recall 
trial – long delay 
10. RCFT – recognition 
trial 
11. DRS-2 
12. TEA map search 
13. ADAS-cog 
14. SCOPA-Cog delayed 
recall  
15. ADAS-cog continued 
 
 Patients  
1. Data from all patients that 
had completed NP testing by 
25 March 2010 was collected 
2. Images for each patient were 
collected.  Those patients for 
who the scanning procedure 
had not been completed by 13 
March 2010 were discounted.  
3. Exclusion criteria specific to 
this thesis was applied to all 
remaining participants.   
 
Healthy control subjects 
1. Data from all healthy control 
subjects was collected from 
the database. 
2. Images for each participant 
were collected, those subjects 
for whom imaging had not 
yet been completed were 
discounted 
3. Exclusion criteria for this 
thesis was applied to all 
remaining participants 
MMSE: Mini mental state examination; GDS: geriatric depression scale; WTAR: Weschler test of adult reading; CVLT: California verbal learning test; VOSP: the visual object and space 
perception battery; JOL: judgement of line orientation; WASI: Wechsler abbreviated scale of intelligence; RCFT: Rey complex figure test; MoCA: Montreal cognitive assessment; DRS: 
dementia rating scale; TEA: test of everyday attention; SCOPA: Scales for outcomes in Parkinson disease; ADAS: Alzheimer’s disease assessment scale   
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5.1 Clinical diagnosis of Parkinson’s disease  
Diagnosis of Parkinson’s disease was made following the UK Parkinson’s disease brain 
bank criteria (Hughes, et al., 1992) by a qualified neurologist (T.A) prior to this study 
being conducted.  This criteria (Figure 5-2) outlines three steps in the diagnosis of 
Parkinson’s disease: the diagnosis of Parkinsonian syndrome; any criteria which would 
exclude Parkinson’s disease cannot be met and there must be supportive positive criteria 
for Parkinson’s disease.   
 
Figure 5-2: Parkinson’s disease criteria  
UK Parkinson’s Disease Society Brain Bank clinical diagnostic criteria (Hughes, et al., 1992) used for the 
diagnosis of PD.   
UK Parkinson's Disease Society Brain Bank clinical diagnostic criteria 
 
Step 1 Diagnosis of Parkinsonian syndrome 
 Bradykinesia (slowness of initiation of voluntary movement with progressive reduction in speed 
and amplitude of repetitive actions) 
 And at least one of the following: 
 muscular rigidity 
 4-6 Hz rest tremor 
 postural instability not caused by primary visual, vestibular, cerebellar, or 
 proprioceptive dysfunction. 
 
Step 2 Exclusion criteria for Parkinson's disease 
 History of repeated strokes with stepwise progression of parkinsonian features 
 History of repeated head injury 
 History of definite encephalitis 
 Oculogyric crises 
 Neuroleptic treatment at onset of symptoms 
 More than one affected relative 
 Sustained remission 
 Strictly unilateral features after 3 years 
 Supranuclear gaze palsy 
 Cerebellar signs 
 Early severe autonomic involvement 
 Early severe dementia with disturbances of memory, language, and praxis 
 Babinski sign 
 Presence of cerebral tumor or communicating hydrocephalus on CT scan 
 Negative response to large doses of levodopa (if malabsorption excluded) 
 MPTP exposure 
 
Step 3 Supportive prospective positive criteria for Parkinson's disease 
(Three or more required for diagnosis of definite Parkinson's disease) 
 Unilateral onset 
 Rest tremor present 
 Progressive disorder 
 Persistent asymmetry affecting side of onset most 
 Excellent response (70-100%) to levodopa 
 Severe levodopa-induced chorea 
 Levodopa response for 5 years or more 
 Clinical course of 10 years or more 
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5.2 Diagnosis of Cognitive Impairment 
5.2.1 Parkinson’s disease with dementia  
Parkinson’s disease dementia was diagnosed based on the Movement Disorders Task Force 
criteria (Dubois, et al., 2007; Emre, et al., 2007).  The criteria for a diagnosis of probable 
PD-D stipulates that the patient must have: 1) a diagnosis of PD – made according to the 
Queen Square Brain Bank criteria; and 2) a dementia syndrome of insidious onset and slow 
progression that has developed within the context of established PD.  The patient must also 
show at least three associated clinical features, two of which are cognitive and one of 
which is behavioural.  Cognitive features include impairment in the MDS recommended 
cognitive domains of attention, executive functions, visuo-spatial function, memory and 
language.  Behavioural features include apathy, personality changes, hallucinations, 
delusions and excessive daytime sleepiness.  Features such as the co-existence of any other 
abnormality which may cause cognitive impairment (vascular disease or an unknown time 
between the development of motor and cognitive symptoms) make the PD-D diagnosis 
uncertain and cannot be present.  Features that suggest another condition also may not be 
present and include: cognitive and behavioural symptoms appearing only within other 
conditions such as a systemic disease or drug intoxication; major depression according to 
DSM-IV criteria; or any features that are compatible with probable vascular dementia 
criteria.  Following the criteria of Emre, et al., (2007) the patients’ symptoms must be 
severe enough to impact on their activities of daily living and cannot be attributed to their 
motor impairment.   
5.2.2 Mild cognitive impairment  
A diagnosis of mild cognitive impairment was made according to New Zealand Brain 
Research Institute criteria.  This criteria has been examined relative to other methods of 
MCI diagnosis and found to be a valid and reliable measure of cognitive impairment which 
optimises the trade off between identifying cases with poor cognition and avoiding those 
with relatively good cognition (Dalrymple-Alford, et al., 2011).  Aspects of this criteria, 
namely those requiring that impairment is present in at least one test in each of two or 
more separate cognitive domains have also recently been included in MDS task force 
guidelines for diagnostic criteria for mild cognitive impairment (Litvan, et al., 2012).  The 
full criteria requires that participants have unimpaired activities of daily living (verified in 
a structured interview with the patients’ significant other) but exhibit cognitive decline, 
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defined as test scores of at least 1.5 standard deviations below that of normative data on at 
least two measures within the four MDS cognitive domains (executive function, working 
memory, attention and visuospatial functions).  This criteria was used to identify MCI in 
both the healthy control group and the Parkinson’s disease group for both the PD and 
biomarkers studies.   
5.2.3 Parkinson’s disease with no cognitive impairment  
Parkinson’s disease patients were considered to be unimpaired if they did not meet the 
criteria for MCI.   
5.3 MR and DT Imaging  
During the scanning procedure several scanning sequences were utilised in order to 
maximise the time and staff resources that were allocated to the wider study.  
Consequently, although the sequences required for this study were short, the total scanning 
time was around an hour for each participant.  In total, those sequences which gave rise to 
a structural T1, clinical T2, T2 flair and T2*, a 4D brain, arterial spin labelling (ASL) and 
single voxel spectroscopy in the posterior cingulate and striatum were applied.  For the 
purpose of this study only those files needed to form the structural T1, T2 and the diffusion 
4D, FA and MD images were imported for analysis.   
5.3.1 The MRI machine  
More advanced and less dangerous than X ray, the MRI machine enables visualisation of 
soft tissues without exposing the patient to harmful rays (Pooley, 2005).  The New Zealand 
Brain Research Institute was the first place in New Zealand to install a General Electric 3 
Tesla MRI machine (Figure 5-3a).  The 3T scanner enables scans to be performed faster, 
at a higher resolution and with better contrast than the previously available 1.5T scanners 
and is especially valuable for research.  The MRI scanner itself is large structure which 
essentially enables the patient to be slid into a strong magnetic field and operates according 
to the properties of magnetisation and the principals of diffusion.   
A human cell is made up of 60-90% water.  The properties of diffusion stipulate 
that this water moves slowest through barriers such as cell membranes and faster when 
movement is unrestricted.  In the brain for example, the bodies of the neurons are more 
densely packed than the axons so water distributes more freely around the axons.  Due to 
the inherently magnetic properties of the water molecule, the MRI machine is able to 
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detect the speed and direction the water molecules move in.  This in turn gives rise to the 
MR signal which is then able to be detected in the MRI machine.  The magnetic field 
within the MRI machine is able to be systematically altered which allows for visualisation 
of water movement in multiple directions and areas of the brain.   
The strength of the magnetic field depends on the number and strength of each type 
of MRI magnet.  The MRI scanner has three main magnet types.  The permanent magnet is 
the largest and is always charged – requiring no electricity to generate the magnetic field.  
Gradient magnets are wound around a cylinder within the scanner and only create a 
magnetic field when electricity runs through them.  By selecting a gradient magnet 
(denoted Gx, Gy and Gz) for the current to run through, the MR signal for a certain 
direction can be mapped.  The gradient magnets operate in three main directions.  The X 
gradient magnet allows the scanner to image the brain in coronal sections, the Y gradient in 
sagittal sections and the Z gradient in axial or horizontal sections (Pooley, 2005).   
5.3.2 Image acquisition 
All imaging was performed using the General Electric (GE) 3 Tesla HDx MRI scanner 
using an eight channel head coil.  Structural MR images were acquired with a T1 weighted, 
three dimensional spoiled gradient recalled (SPGR) echo acquisition (TE/TR = 2.8/6.6ms, 
TI = 400ms, flip angle = 15 deg, acquisition matrix = 256 x 256 x 170, slice thickness = 
1mm (no gaps), FOV = 250 x 250mm
2
 reconstruction matrix = 512 x 512 x 170, 
reconstructed voxel size 0.5 x 0.5 x 1
 
mm
3
), scan time = 5min 6sec.   
Diffusion weighted images were acquired with a 2D diffusion-weighted, spin echo, 
echo planar imaging sequence, with diffusion weighting in 28 uniformly distributed 
directions (b = 1000s/mm²) and 4 acquisitions without diffusion weighting (b = 0s/mm
2
): 
TE/TR = 86.4/13000 ms, flip angle = 90 deg, acquisition matrix = 128 x 128 x 48, slice 
thickness = 3mm (no gaps), (FOV = 240mm), voxel size = 1.88x1.88x3mm
3
 scan time = 
7min 9sec.   
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a) 
 
b) 
 
Figure 5-3: The GE 3T MRI machine  
a) The 3T MRI machine housed at the New Zealand Brain Research Institute, b) the configuration of the 
gradient magnets within the MRI machine that determine the direction that the MR signal is mapped in.  
Image b from Coyne (2012).   
5.3.3 Image creation  
An MR image is essentially a snapshot of the distribution of the MR signal (Buxton, 2002).  
Individual spatial locations within the patient are able to be localised by combining 
radiofrequency pulses - which serve to excite the water molecules, and magnetic field 
gradients which orientate and move the water molecules in the desired direction (Busherg, 
Seibert, Leidholdt, & Boone, 2002).  A temporary matrix comprising several 3D cubes 
(voxels) is created and each cube within the matrix is able to be filled with the MR signal 
by altering the gradient of the magnetic field and filling in every row and column for each 
brain slice.  Once in the matrix, mathematical transformations are applied to each row and 
column of voxels.  This results in an image where the horizontal and vertical axis 
correspond to the horizontal and vertical spatial frequencies of the original matrix (Hoa, 
2009).    
5.3.3.1 The MR Signal 
The MR signal is created when the water molecules within the human body move in 
response to being placed in the main magnetic field of the MRI machine.  Two hydrogen 
atoms and one oxygen atom form to make a water molecule (H2O).  The protons of the 
hydrogen atom are inherently positively charged (magnetic moment) and can be detected 
by the MRI’s receivers.  When first placed in an MRI scanner the proton orientates to the 
direction of the main magnetic field (B0), Figure 5-4.  The movement of the proton creates 
an MR signal, the strength of which varies according to the density of the protons and the 
time it takes for magnetised protons to return to their normal state parallel or perpendicular 
to the main magnetic field.   
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a) 
 
b) 
 
Figure 5-4: The creation of the MR signal  
a) The precession of the proton atom within the water molecule that allows for the creation of the MR signal.  
Image from Mori & Zhang, (2006), b) schematic diagram of the direction of the magnetic field.  Image from 
Pooley (2005).   
The main magnetic field is always in the Z direction and proton movement is 
around this axis.  The force of the magnetic field causes the proton to ‘precess,’ that is to 
wobble about its’ axis whilst trying to maintain the original orientation.  The precession of 
the protons occurs at a speed proportional to the strength of the magnetic field (Larmor 
frequency) and results in a voltage which can be read in the receiver coil of the machine.  
The voltage shows the direction the proton is orientated to.  In the absence of the magnetic 
field, the spin of the protons will naturally relax and settle back into a stable state over 
time.  The time taken to return to stable state varies and is affected by processes that reduce 
magnetisation.  It is the measurement of this loss of signal that gives rise to the brain 
images.  The image is created when energy is first introduced into the stable state by 
applying an electromagnetic wave at the same frequency as the Larmor frequency.  This 
radiofrequency energy (RF) is generated by rapidly changing magnetic and electric fields 
within the scanner.  The RF energy is transmitted for a short period of time (RF pulse) and 
excites the spin system of the protons from the stable state.  The effect of this 
electromagnetic wave is to induce an alternating voltage of the same frequency as the 
Larmor frequency in the receiver coil which is interpreted as the MR signal.   
This signal fades due to one of two processes which reduce magnetisation in the 
transverse plane.  Spin-lattice interaction (T1 Relaxation) is the primary source of contrast 
in the T1 images while spin-spin interaction (T2 Relaxation) is the source of contrast in the 
T2 images.   
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5.3.4 Structural T1 Image: Longitudinal relaxation 
The longitudinal magnetization (Z) (Figure 5-4) can be rotated exactly into the transverse 
plane (XY) by a radiofrequency pulse which is strong enough and long enough to tip the 
magnetisation exactly 90⁰ (RF 90⁰).  After a RF 90⁰ pulse the protons are aligned with the 
transverse plane and the longitudinal plane is zero.  As the transverse magnetization (Mxy) 
decays, the magnetic moments of the protons realign with the Z axis of the magnetic field 
(longitudinal relaxation).  The relaxation rate varies for protons associated with different 
tissues.   
For the T1 image, relaxation occurs through the transfer of energy from the protons 
to the lattice field.  The lattice field is the complex magnetic field that groups of nuclei 
create to distribute energy.  The lattice field is created when a nucleus in a low energy state 
interacts with a nucleus in a high energy state.  This contact causes the energy to be evenly 
distributed between the two nuclei.  When the radiofrequency pulse is applied, more 
energy is gained by the nuclei and again distributed throughout the lattice.  The spin-lattice 
relaxation refers to the time it takes for the spins to give the energy obtained by the RF 
pulse back to the surrounding lattice.  The transfer of energy restores the protons to their 
equilibrium state (Mori & Zhang, 2006).  As different tissues have inherently different T1 
values, this is one basis of introducing tissue contrast into the MR image.  Myelin causes 
white matter to have a shorter T1 than grey matter (Gowland & Stevenson, 2003) for 
example, so the T1 tissue relaxation time for magnetic strength of 1.5T of cerebral grey 
matter is 900ms while the tissue relaxation time for cerebral white matter is 780ms (Webb, 
2003). 
a) 
 
b) 
 
Figure 5-5: The T1 image 
a) The loss of magnetisation over time in the longitudinal direction (Pooley, 2005), b) Horizontal section of 
whole brain, the T1 image provides good contrast between grey and white matter but a high level of detail is 
not visible.  The T1 image is created using a scanning sequence with a short echo time (TE) and short 
relaxation time (TR) and is governed by the spin-lattice relaxation time.   
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5.3.5 Structural T2 Image: Transverse Relaxation 
The decay of transverse magnetisation occurs as the spinning protons transfer their energy 
to each other, instead of to a surrounding lattice field.  The spins are associated with small 
magnetic fields that randomly interact with each other.  The movement of protons within 
an electromagnetic field can be described by their phase.  The phase of the proton is its 
position on the precessional path which is expressed as an angle.  For example, if proton A 
and B were precessing at the same speed but B was ahead of A by 10⁰ then B is said to 
have a phase of 10⁰ relative to A.  After excitation, the spins precess together (phase = 0⁰).  
This is referred to as phase coherence.  All protons still rotate about the Z axis but phases 
differ by angles.  Phase coherence is gradually lost, some spins advance while others fall 
behind the precessional path.  When this happens, individual magnetisation vectors begin 
to cancel each other out instead of adding together.  The vector sum of the transverse 
magnetization becomes smaller and smaller and finally disappears which results in 
disappearance of the MR signal (Weishaupt, Kochli, & Marincek, 2008).  When the 
transverse magnetisation is completely in phase, the measured MR signal is at a maximum.  
When this magnetisation begins to diphase, the measured MR signal begins to decrease 
until the magnetisation is completely dephased and the MR signal is zero (Pooley, 2005). 
a) 
 
b) 
 
Figure 5-6: The T2 image 
a) The loss of magnetisation over time in the transverse plane (Pooley, 2005), b) T2 horizontal section, the 
T2 image is governed by a spin-spin relaxation time and has a long echo time (TE) and long relaxation time 
(TR), where TE is the time from the application of the radiofrequency pulse to the peak of the signal induced 
in the coil and TR is the time from the application of one RF pulse to another RF pulse.   
The T1 and T2 images are independent of each other but occur at the same time.  
The decrease in MR signal due to T2 relaxation occurs within the first 100-300ms of the 
scanning sequence and finishes before there has been complete recovery of longitudinal 
relaxation due to T1 relaxation (0.5 – 5 sec) (Weishaupt, et al., 2008). 
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5.3.6 Diffusion tensor images  
The same properties relating to the detection of proton movement apply in the diffusion 
weighted (DW) sequences, except in this sequence there is an additional encoding process 
where a short, high-amplitude gradient pulse is applied that excites the spin population 
between the initial 90° RF and the 180° refocusing RF pulses.  This additional gradient 
pulse accelerates the precession of some of the proton spins (dependent on their spatial 
location).  If the gradient is applied in the Z direction for example, those protons with high 
Z coordinates will precces faster than those with low Z coordinates.  Spins are therefore 
precessing (and giving rise to the MR signal) at different rates.  The second step is to apply 
a gradient pulse of equal amplitude and duration as the first one.  This causes those spins 
with high Z coordinates to again precess faster but since they are now orientated to the 
opposite direction, the spins will rephase.  If the individual spins remain at exactly the 
same spatial coordinates during both gradient pulses the rephasing will be exact and there 
will be no loss of signal in the spin echo.  If the protons become displaced between the 
pulses however then rephasing will be incomplete and there will be a loss of signal in the 
spin echo.   
Gradients additional to the traditional X, Y and Z direction are added during the 
DW sequence.  To measure diffusion in multiple different directions, the axes on which the 
diffusion weighting gradient is applied are varied, changing the motion of the water 
molecules.  Computerised mathematics is then applied to calculate the diffusion tensor at 
every voxel within the image, taking into account the strength of the signal and the noise in 
each measurement.  The combination of the increased signal and additional directions 
allows for an image much more sensitive to changes at the micro level than the T1 and T2 
images.   
The additional directions results in the creation of 1536 files, compared to the 
normal 170 files that are created during the T1 or T2 sequences.  The DW files allow for 
visualisation of 48 brain slices in 32 different directions.  Each direction is then combined 
across the total brain, forming 32 directional volume files.  From here, the files are used to 
create one 4D image which contains the normal 3D image (X, Y, Z direction) and the level 
of diffusion weighting (b = 1000 or b = 0) for each direction.   
The following preprocessing steps were completed in FSL, a comprehensive library 
of analysis tools used for MRI and DTI data created by the FMRIB analysis group (Smith, 
et al., 2004).  The 4D image undergoes an eddy current correction to correct for movement 
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artifacts and is fitted to the diffusion tensor using the DTI fit function in FSL.  The fit of 
the diffusion tensor model to the data allows for interpretation of the data in a way that 
incorporates all the directional information.  The properties of diffusion (speed and degree 
of proton movement) for each voxel are then calculated and transformed mathematically to 
form the fractional anisotropy and mean diffusivity maps.  These diffusion maps allow for 
cellular structure and density to be inferred from the image.  The diffusion images used in 
this study are complied of 1.88 x 1.88 x 3 mm
3 
sized voxels.  Within this area, multiple 
bundles of axons, myelin sheaths, astrocytes and extracellular spaces will be present (Mori 
& Zhang, 2006) and the density of these structures is reflected in diffusion parameters.   
The FA map is one of the most widely used measures of diffusion anisotropy and 
shows the principal direction of diffusion within a voxel.  Each voxel on this map gives a 
numerical value representing the proportion of the diffusion tensor (D) which is due to 
diffusion in one direction (Wheeler-Kingshott, Barker, Steens, & van Buchem, 2003).  The 
direction of diffusion is scaled from 0 (isotropic) to 1 (anisotropic) where isotropic 
diffusion indicates that proton movement is unrestricted and anisotropic diffusion means 
that proton movement is occurring only along one axis and is fully restricted in all other 
directions (Mori & Zhang, 2006).  The FA of each voxel is calculated by taking the 
average of the diffusion tensor for that voxel using the Eig X, Y and Z files which 
correspond to the direction of diffusion along the lengths of the longest, middle and 
shortest axis of the ellipsoid (eigenvalues λ1, λ2 and λ3) respectively.   Eig X is the right – 
left direction, Eig Y is the anterior-posterior direction and Eig Z is the superior-inferior 
direction.   
 
where λ1 = Eig X, λ2 = Eig Y and λ3 = Eig Z. 
The FA map is easy to interpret as there is a great contrast between grey matter and 
white matter (Figure 5-7), which makes it ideal for defining regions of interest.  The Eig 
X,Y and Z files can also be colour coded to the direction of the main eigenvector so that 
fibers orientated to the X direction are coded as red, fibers in the Y direction are coded as 
green and fibers in the Z direction are coded as blue.  This step was completed in 
MATLAB version 7 ("MATLAB," 2008) which resulted in the creation of three new files 
(RED, GREEN, BLUE) which were then able to be overlayed onto any other image to help 
with defining the boundaries of the region of interest.   
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Interpretation of the FA map allows for inferences about the directionality of fibre 
tracts and the integrity of surrounding cellular structures.  It is assumed that an FA value 
close to 1 represents diffusion in an almost uniform direction – a phenomenon typical to 
axonal fibre tracts.  FA reduction in neurodegenerative disease has been attributed to a 
number of factors including demyelination, gliosis and inflammation (Assaf & Pasternak, 
2008).  The relationship between FA and cell density still remains controversial however, 
with reports of FA both increasing (Kinoshita, et al., 2008) and decreasing in densely 
packed areas (Stadlbauer, et al., 2006).   
a) 
 
b) 
 
c) 
 
Figure 5-7: Colour Maps 
a) FA map, each voxel gives a value which is the proportion of the diffusion tensor that is due to anisotropic  
diffusion, b) Eig X, Y and Z files can be overlayed onto the FA map to show directional dependence, c) The 
directions of the axis of the ellipsoid (top) correspond to the eigenvalues λ1, λ2 and λ3 and each eigenvalue is 
represented by a different colour. Image from Mori & Zhang (2006). 
The mean diffusivity map (Figure 5-8) shows the average speed and direction of 
movement through a voxel and can also be calculated from the eigenvector X, Y and Z 
files by averaging diffusivity along the principal axis (axial diffusivity) and each of the two 
minor axes (radial diffusivity) using the following formula:  
 
where MD is mean diffusivity, λ1 is diffusivity in the X direction, λ2 is diffusivity in the Y direction and λ3 
is diffusivity in the Z direction. 
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a) 
 
b) 
 
Figure 5-8: Diffusion weighted image 
a) Image with diffusion weighting that is used to calculate mean diffusivity, b) diffusion (represented by an 
ellipsoid) can be measured by averaging diffusion in each direction.  λ1 is the principal direction of diffusion 
with λ2 and λ3 diffusion in the minor axes.  Each axes corresponds to the eigenvalues of the diffusion tensor 
(Watts, 2008).   
In areas of greater diffusion (such as the ventricles), the pixels of the image are 
darker because as the signal is lost the molecule is free to move about.  A higher diffusion 
value means the molecule has travelled far without interruption and it has taken the signal 
with it.  Interpretation of MD values allows for inference about the integrity and density of 
cellular structures.  A high MD value indicates that water movement is mostly unrestricted, 
inferring that cells are damaged in some way.  A low MD value indicates cellular 
structures are mostly intact.  Inferences about cell density can also be obtained from the 
MD values.  MD is lower when cells are densely packed as there are more barriers against 
diffusion which results in a slower diffusion rate (Kinoshita, et al., 2008).   
5.4 Summary 
A convenience sample of PD patients and healthy control participants was collected from 
data held for ongoing research at the New Zealand Brain Research Institute, Christchurch.  
Several scanning sequences were performed on each individual which were incorporated 
into structural, clinical, blood flow and diffusion images.  Patients and healthy control 
participants underwent a detailed neuropsychological examination that covered the four 
cognitive domains recommended by the Movement Disorder Society Task force (attention, 
executive function, learning and memory and visuospatial function).  Patients received a 
cognitive diagnosis of either Parkinson’s disease with dementia, Parkinson’s disease with 
mild cognitive impairment or Parkinson’s disease with no cognitive impairment.  In order 
to include only healthy controls for comparison, those participants who met criteria for 
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MCI were also excluded.  The final sample included 92 PD patients (PD-D = 17; PD-MCI 
= 19, PD-N = 56) and 25 control subjects. 
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Chapter 6. Study One: THE THALAMUS IN NATIVE SPACE  
6.1 Objectives  
The main objective of this chapter was to perform a novel investigation into the thalamic 
integrity of Parkinson’s disease patients.  A second objective was to determine if thalamic 
degeneration was primarily contributing to the cognitive, rather than the motor symptoms 
that characterise this disorder.  This chapter was the first study conducted for this thesis 
and examines the thalamus in native subject space.  Thalamic volume changes are 
investigated using structural T1 and thalamic microstructure using structural MD and FA 
images.  Cross-sectional analysis was used to compare the three Parkinson’s disease 
groups who were stratified by cognitive status and the healthy control group.  The 
Parkinson’s disease groups were PD with no cognitive impairment (PD-N), PD with mild 
cognitive impairment (PD-MCI) and PD with dementia (PD-D) (Section 5.2).  It is 
assumed that any changes identified in those groups with worse cognitive dysfunction 
represent the progression of dementia development.  Similarly, the comparison between 
PD-N and the healthy group is assumed to represent the changes that are primarily 
representative of Parkinson’s symptoms and not cognitive dysfunction as this group 
exhibited neuropsychological test scores that were not consistently different from the 
control group.  This chapter begins with a literature review of thalamic changes that have 
already been investigated in PD in native space.  The characteristics of previous studies are 
outlined in Table 6-1 and briefly discussed.  Wider cortical changes identified in native 
subject space are also examined here as all cortical regions have strong connectivity with 
the thalamus and are likely to play a part in the degeneration of this region in PD (Kendi, 
Lehericy, Luciana, Ugurbil, & Tuite, 2008; Nagano-Saito, et al., 2005b).   
6.2 Structural alterations in Parkinson’s disease 
Neuroimaging is a valuable tool used to measure the progression of disease related decline 
in PD by examining alterations in blood flow, glucose, oxygen and the metabolism of 
dopamine (Brooks, 2004; Monchi, Martinu, & Strafella, 2010).  Lewy pathology and 
neuronal loss are not easily detected from neuroimages as degeneration must be substantial 
in order to be reflected in structural images (Stoessl, 2011).  Structural examination is still 
valuable however, particularly in native subject space as it allows for the measurement of 
changes in individual patients and for a priori hypotheses to be made about areas that are 
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likely to be affected.  Automated methods of segmentation are also available which 
reduces user bias, are more accurate and significantly faster than manual segmentation 
(Morey, et al., 2009).  Structural imaging may also allow for pre-clinical identification of 
Parkinson’s disease.  Atrophy in the pons and medulla, identified using T1 imaging 
techniques (Jubault, et al., 2009), confirms the progression of degeneration as outlined in 
Braak’s (Braak, Bohl, et al., 2006) model.  Significant alterations are evident in these 
regions in patients who are in the very early stages (Hoehn and Yahr stage I and II) of 
disease.  As the progression of disease correlates with cognition (Braak, Rub, et al., 2006) 
we can expect that other structural changes identified in vivo may also be reflective of 
cognitive impairment in PD.    
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Table 6-1: Previous literature which has addressed thalamic changes in PD in native subject space  
Author Cohort Areas examined Method of examination Areas of volume loss 
     
Volume changes  
 
In PD without dementia  
Bruck, Kurki, 
Kaasinen, 
Vahlberg, & 
Rinne, 2004 
20 non-demented PD, 22 
healthy age matched 
controls  
prefrontal cortex (axial images), 
hippocampus (coronal images)  
visual rating scale 0-4 bilateral prefrontal cortex, bilateral 
hippocampus PD < controls 
Hu, et al., 2001 8 non-demented PD, 10 
age matched controls  
total brain, ventricles registration of scans, visual rating 
scale, subtraction of follow up images 
from baseline images   
total brain (visually identified to be worst in 
frontal, temporal and parietal regions), 
ventricles, PD < controls 
Tinaz, et al., 
2010 
15 PD, 15 age matched 
controls 
total brain, frontal, parietal, 
middle temporal, temporal pole, 
hippocampus, amygdala, 
thalamus, caudate, putamen, 
pallidum, accumbens 
automated surface reconstruction and 
segmentation 
Bilateral frontal gyrus, left sulcus.  Bilateral 
putamen ratio PD < controls 
Geng, Li, & 
Zee, 2006  
16 early stage, 8 advanced 
stage PD, 8 normal 
controls  
caudate, globus pallidus and 
substantia nigra 
manual segmentation, completed twice 
and measurements averaged  
putamen: PD < controls 
Lisanby, et al., 
1993 
18 PD, 36 controls  thalamus, putamen, caudate  manual tracing from T2 images thalamus, putamen, caudate: PD < controls  
  6 month, 1 year, 2 year follow up  thalamus, putamen, caudate: PD < controls  
Lee, et al., 2011 15 non-demented PD, 15 
controls  
thalamus, putamen and caudate 
nucleus 
manual segmentation of ROI ‘ thalamus, putamen and caudate nucleus PD < 
controls 
McKeown, et 
al., 2008 
9 PD, 10 healthy, age-
matched controls 
thalamus manual tracing and automated 
reconstruction 
no volume change but areas of change within 
the thalamus thought to be the CM/Pf region PD 
< controls  
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Table 6-1 Continued 
Peran, et al., 
2010 
30 early stage PD, 22 age, 
sex and education matched 
controls 
thalamus, basal ganglia, 
substantia nigra  
automated segmentation (FSL) no change  
Messina, et al., 
2011 
72 PD, 32 PSP, 15 MSA-
P, 46 healthy, age matched 
controls  
basal ganglia, limbic system  automated segmentation (FreeSurfer) no change  
Paviour, Price, 
Jahanshahi, 
Lees, & Fox, 
2006b  
18 PSP, 9 MSA-P, 9 PD, 
18 healthy controls 
frontal, midbrain, regions of the 
brainstem (pons, peduncles, 
cerebellum) and the lateral 
ventricles  
semi-automated region of interest 
analysis 
no areas of change 
Paviour, et al., 
2006a  
17 PSP, 9 MSA-P, 9 PD, 
18 healthy controls  
 12 month follow up no areas of change 
     
In PD with dementia  
Junque´, et al., 
2005 
16 PD, 16 PD-D, 16 age 
and education matched 
controls  
hippocampus, amygdala manual tracing, corrected for total 
brain volume  
hippocampus, amygdala PD-D < controls 
Camicioli, et 
al., 2011 
23 non-demented PD, 10 
PD-D, 39 controls  
lateral, third ventricles 
(combined to give total 
ventricular volume)  
manual segmentation of ROI ‘ total ventricular volume PD-D > PD 
   36 month follow up  rate of change PD-D > PD 
In PD with mild cognitive impairment  
Dalaker, et al., 
2011 
45 PD, 42 controls  thalamus, ventricles, caudate 
nucleus, pallidum, nucleus 
accumbens, hippocampus, 
amygdala, cerebellum 
manual tracing from T1 image left inferior lateral, third and fourth ventricles 
PD-MCI > C; third and left inferior lateral PD-
MCI > PD.   
Apostolova, et 
al., 2010 
12 non-demented PD, 8 
PD-MCI, 15 PD-D, 20 
controls  
ventricles, hippocampus, 
caudate nucleus  
manual tracing from T1 image, 
converted into 3D average models  
no change  
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Table 6-1 Continued 
Cellular changes  
 
In PD without dementia  
Peran, et al., 
2010 
same as above  same as above  same as above  thalamus mean diffusivity: PD > controls; 
thalamus fractional ainsotropy: PD < controls; 
substantia nigra mean diffusivity PD > controls.   
Nicoletti, et al., 
2006 
16 PD, 16 MSA-P, 16 
PSP, 15 controls 
bilateral caudate, putamen, 
pallidus, thalamus, prefrontal 
and precentral white matter and 
middle cerebral peduncles  
regions within ROI manually 
segmented  
components of basal ganglia: no change; 
prefrontal and frontal white matter ADC: PD > 
controls  
Schocke, et al., 
2004 
17 PD, 11 MSA-P, 10 
healthy controls 
basal ganglia (putamen, globus 
pallidus and caudate nucleus) 
manual segmentation of ROI globus pallidus rADC: PD > controls  
Rizzo, et al., 
2008 
13 PD, 7 CBS, 10 RS, 9 
controls  
cerebral cortex, corpus 
callosum, putamen, midbrain, 
third ventricle, thalamus 
manual segmentation of ROI no change  
Gattellaro, et 
al., 2009 
10 non-demented PD, 10 
age matched controls 
substantia nigra, corticospinal 
tract, corticospinal tract in 
internal capsule, head of caudate 
nucleus, thalamus, globus 
pallidus, putamen, genu and 
splenium of corpus callosum, 
superior longitudinal fasciculus, 
cingulum 
small regions within ROI manually 
defined  
thalamus mean diffusivity: no change; 
substantia nigra mean diffusivity PD > controls.  
thalamus fractional ainsotropy: no change; 
superior longitudinal fasciculus, genu PD < 
controls.   
Chan, et al., 
2007 
73 PD, 78 age and sex 
matched control subjects 
thalamus, basal ganglia (caudate 
nucleus, globus pallidus, 
putamen, substantia nigra) 
manual segmentation of ROI ‘s thalamus FA and ADC: no change  
FA values of substantia nigra and putamen:PD 
< controls  
Li, et al., 2010 14 depressed PD, 18 non 
depressed PD 
thalamus manual segmentation of thalamus FA values of bilateral thalamus (mediodorsal 
region) PD depression < PD non depression; 
MD: no change  
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6.2.1 In Parkinson’s disease without dementia  
Focal volumetric reduction is mainly concentrated to regions within the frontal and 
temporal cortices in non-demented Parkinson’s patients.  Visual rating of cortical areas 
indicates reduction in the prefrontal (Bruck, Kurki, Kaasinen, Vahlberg, & Rinne, 2004) 
and frontal, temporal and parietal cortices (Hu, et al., 2001).  Within the frontal lobe, 
segmentation of the frontal gyrus and sulcus after 3D reconstruction of the cortex also 
shows volume loss, without any change in total brain volume (Tinaz, et al., 2010).  
Subcortically, the bilateral hippocampus (Bruck, et al., 2004) and regions within the basal 
ganglia are the only regions to show significant volume reduction in non-dementing PD.  
The putamen and caudate nucleus, regions heavily involved in the motor loop (Braak & del 
Tredici, 2008) show significant atrophy when manually segmented from structural images 
in PD (Lee, et al., 2011a; Lisanby, et al., 1993).  The putamen also exhibits significant 
levels of atrophy when it is examined independently from the rest of the basal ganglia 
using both automated (Tinaz, et al., 2010) and manual (Geng, Li, & Zee, 2006) 
segmentation methods.  
In contrast, other studies that have applied semi automated and automated 
segmentation techniques have not detected any structural abnormalities in PD.  Paviour, 
(2006b) isolated the frontal lobes, midbrain, lateral ventricles and regions of the brain stem 
(pons, peduncles, cerebellum) using semi-automated region of interest analysis and 
reported no volumetric reduction of any region.  At 12 month follow up (Paviour, et al., 
2006a) the PD patients continued to show normal regional volumes.  Peran (2010) applied 
the same automatic segmentation technique we have used in this study and also report no 
atrophy of any regions within the basal ganglia or substantia nigra.   
6.2.1.1 Thalamic changes in Parkinson’s disease without dementia  
The thalamus was included, or specifically targeted as a region of interest in some of the 
above studies.  The level of thalamic involvement in non-dementing Parkinson’s disease 
patients is controversial.  Lisanby (1993) was the first to specifically target the thalamus as 
a region of interest in PD after recognising that the changes in the substantia nigra may 
lead to a breakdown in communication with connected subcortical nuclei.  Thalamic 
volume was significantly reduced, and despite showing no correlation with disease 
duration continued to show reduction of 39.4%, 37.1%, and 35.9% in subsets of patients 
who had repeat MRI’s at 6 months, 1 year or 2 years after their baseline assessment 
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respectively.  Lee (2011a) later confirmed thalamic atrophy in PD, reporting significant 
atrophy in the thalamus and some basal ganglia regions compared to control subjects.  
Automatic segmentation of the basal ganglia and thalamus (Messina, et al., 2011; Peran, et 
al., 2009) gives conflicting results however.  Both studies show no thalamic reduction, or 
reduction in any component of the basal ganglia in PD.  A final study (McKeown, et al., 
2008) which specifically targeted the thalamus may aid in understanding the discrepancy 
between these results as the authors report differential degeneration of a small area within 
the thalamus, but no overall volume loss.  Alongside overall volume, the shape of the 
thalamus was also examined and a significant change was identified in the ventral region, 
thought to correspond to degeneration of the centromedian/parafascicular nucleus.  
Histology of this region has previously revealed significant Lewy body pathology, 
neuronal, and volumetric reduction which is concentrated to this area (Halliday, 2009).  
Examination of thalamic components, rather than the whole thalamus may therefore be 
more sensitive to PD dysfunction.   
6.2.2 In Parkinson’s disease with mild cognitive impairment  
Structural changes in PD-MCI are not robust.  To date, only two studies have quantified 
atrophy from T1 images in PD-MCI patients and report contrasting results in relation to 
ventricular dilation.  One (Dalaker, et al., 2011) examined components of the limbic 
system, basal ganglia and the ventricles.  Compared to control subjects, the left inferior 
lateral, third and fourth ventricles were all increased in PD-MCI.  Within PD, the third and 
the left inferior lateral ventricle was increased in PD-MCI relative to PD.  In contrast, 
Apostolova, et al., (2010) reported no ventricular changes in PD-MCI and changes only at 
trend level in other subcortical structures.  Similar methodology was applied in both 
studies; the ventricles were manually segmented from T1 images in both cases but 
Apostolova and colleagues then converted these images into 3D group average models.  In 
addition to the ventricles, this group also examined the hippocampus and caudate nucleus 
in this way.  Although the hippocampus initially showed significant reduction in the PD-
MCI group compared to the PD group, this effect disappeared after controlling for age.   
6.2.2.1 Thalamic Changes in Parkinson’s disease with mild cognitive impairment 
Dalaker, et al., (2011) is the only study so far to include the thalamus for examination in 
PD-MCI in native space.  Although the authors report changes in the ventricles 
surrounding the thalamus; the thalamus did not reflect increased levels of cognitive 
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impairment in this group.  There was no atrophy in PD-MCI relative to controls or to PD 
without cognitive impairment.   
6.2.3 In Parkinson’s disease with dementia  
In Parkinson’s disease with dementia the focus has been on subcortical changes.  Manual 
tracing methods have shown atrophy of the hippocampus and amygdala ratios (corrected 
for total brain volume) in PD-D relative to control subjects (Junque´, et al., 2005) and an 
increase in total ventricular volume in PD-D relative to non-dementing PD (Camicioli, et 
al., 2011).  In the Camicioli, et al study, at 36 month follow up the rate of change was also 
significantly greater in PD-D compared to PD patients.  Ventricular enlargement is 
particularly relevant as the ventricles surround grey matter structures and are directly 
affected by putamen and thalamic atrophy (Gaser, Nenadic, Buchsbaum, Hazlett, & 
Buchsbaum, 2004).   
 
  
 
Figure 6-1: The third and lateral ventricles of the brain  
Image is a T1 structural image of a Parkinson’s disease patient with dementia who is a 61 year old male with 
7 years of disease duration.   
6.2.4 The relationship between cortical changes and cognitive dysfunction 
In PD without dementia, atrophy is mainly evident in regions that correlate with movement 
dysfunction such as the basal ganglia or substantia nigra.  Degeneration of the frontal and 
temporal regions, particularly in the hippocampus could be representative of cognitive 
dysfunction however.  In the Hu, et al., (2001) sample, for example, volume reduction of 
the whole brain was associated with estimated reductions in performance IQ (estimated by 
subtracting IQ at follow up from IQ at baseline as measured by the National Adult Reading 
Test-Revised).  At two year follow up these patients had lost further brain volume at a rate 
that was significantly greater than the control subjects.  The level of atrophy was directly 
related to declining cognition as at follow up, patients were further impaired on tests of 
vocabulary, visuospatial ability, memory and general cognition and there was a strong 
Third ventricle 
Anterior horn of the 
lateral ventricle  
Posterior horn of the 
lateral ventricle  
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correlation with the percentage of brain loss.  This study is particularly relevant as findings 
remained even after accounting for motor symptoms.  In the only other study to examine 
the influence of atrophy on cognitive dysfunction in non-dementing PD, Bruck (2004) 
performed correlation analysis between level of atrophy and cognition.  The left 
hippocampus was correlated with verbal memory and prefrontal atrophy correlated with 
attention impairment.  The association between the level of atrophy and cognition may be 
particularly relevant in this early stage of Parkinson’s disease as attention and memory 
dysfunction are some of the key deficits identified in early stage PD patients who later go 
on to develop dementia (Janvin, et al., 2006).   
The hippocampus was also implicated in Parkinson’s disease with dementia 
(Junque´, et al., 2005), indicating degeneration in this region is likely to be progressive and 
worsen in accordance with cognitive dysfunction.  There was a significant association with 
both the amygdala and hippocmapus with global cognition in this sample and with the 
hippocampus and delayed recall.  Ventricular enlargement is also reflective of cognitive 
dysfunction in Parkinson’s disease dementia, showing a significant association with 
Dementia Rating Scale Scores and the Mini Mental State Exam but not the UPDRS score 
in PD-D (Camicioli, et al., 2011).   
In PD-MCI, only the fourth ventricle, located in the brainstem has an association 
with cognition and shows a high correlation with memory performance (Dalaker, et al., 
2011).  This finding could reflect Braak’s (2006) model of disease progression as the lower 
levels of the brainstem regions are infiltrated first.  Ventricle association with memory 
impairment here could therefore be reflective of the greater cell loss in surrounding brain 
stem regions that has not yet occurred in higher regions.  The ventricles were also the only 
regions implicated in relation to cognitive dysfunction in the Apostolova, (2010) study and 
were significantly correlated with the MMSE, despite not showing significant levels of 
enlargement in the PD group.  More sensitive examination of the regions surrounding the 
ventricles could therefore reveal significant alterations and a strong association with early 
stages of cognitive decline in Parkinson’s disease.   
6.2.5 Cellular changes  
Neuronal loss must be severe to induce atrophy in subcortical regions (Halliday, 2009) and 
atrophy is not easily detected from structural MR images (Brooks, 2010).  Diffusion tensor 
imaging (DTI), on the other hand may allow for visualisation of neuronal degeneration or 
integrity disruption before gross atrophy is visible.  One sample (Peran, et al., 2009) to date 
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has shown cellular changes in the thalamus, reflected in altered DTI measures but in the 
absence of atrophy in Parkinson’s disease.  Despite no evidence of volumetric changes, the 
thalamus showed significantly higher mean diffusivity and lower fractional anisotropy in 
the PD group compared to the control group.  Although the basal ganglia was also 
examined, the only other region to show cellular changes was the substantia nigra which 
showed reduced FA in the PD group.  Combined with the parameters of the substantia 
nigra, the diffusion measures of the thalamus showed a good sensitivity (100%) and 
specificity (80%) for the classification of Parkinson’s disease patients.   
Other studies (Nicoletti, et al., 2006; Rizzo, et al., 2008; Schocke, et al., 2004) have 
also applied DTI measures in the thalamus.  This technique has mainly been used to 
investigate the validity of using cellular changes as a tool for differential diagnosis of other 
parkinsonism disorders which have a similar presentation of motor symptoms.  Although 
Nicoletti, et al., reports increased diffusivity in the prefrontal cortex and Schocke, et al., 
reports increased diffusivity in the globus pallidus of PD subjects all three studies show no 
diffusivity changes in the thalamus relative to control subjects.  Two other studies (Chan, 
et al., 2007; Gattellaro, et al., 2009) have also examined the thalamus in early stage PD 
using DTI techniques with both reporting no cellular abnormalities although there was 
increased MD (Gattellaro, et al., 2009) and reduced FA (Chan, et al., 2007) in the 
substantia nigra.  The only other study (Li, et al., 2010) to examine the thalamus in PD 
reports reduced FA in the mediodorsal region of the thalamus of PD patients with co-
morbid depression relative to PD patients without depression.  None of the above diffusion 
studies examined cellular abnormalities in relation to cognitive dysfunction which leaves 
significant questions surrounding the influence of the thalamus on the cognitive symptoms 
of PD.   
6.3 Overcoming the limitations of previous work 
Cognition was only explicitly examined in a few of the above studies (Gattellaro, et al., 
2009; Li, et al., 2010; Nicoletti, et al., 2006; Peran, et al., 2010).  The majority limited 
testing to the MMSE only (Li, et al., 2010; Nicoletti, et al., 2006; Peran, et al., 2010) or 
diagnosed PD-D based on the MMSE and DSM criteria for dementia which is not specific 
to Parkinson’s disease dementia (Gattellaro, et al., 2009).  It is difficult to quantify the 
relationship between the thalamus and cognition in Parkinson’s disease from what has been 
conducted so far.   
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Very few studies have examined the thalamus in Parkinson’s disease.  From those 
that have, there are several limitations.  The main limitation is that few neuropsychological 
evaluations have been carried out in all previous studies that have included the thalamus as 
a region of interest in PD cohorts.  In many cases cognitive dysfunction is present even in 
the early stages of PD (Janvin, Larsen, Aarsland & Hugdahl, 2006) and may be evident at 
subthreshold levels in these samples.   
Methodology is also another limiting factor as only two studies (Li, et al., 2010; 
McKeown, et al., 2008) identified the thalamus as a region of interest a pirori, problematic 
when there is no provision made for multiple comparisons.  There is also the issue of 
sample size: in two cases (McKeown, et al., 2008; Nicoletti, et al., 2006), the sample size 
was less than 20.  Small sample size greatly reduces the power of a study and increases 
Type II error, a phenomenon where the effect exists, but is not detected in statistical 
analysis (Howell, 2007).   
To overcome these common problems this research used a large sample size, 
participants received extensive neuropsychological testing and confounding effects such as 
age and clinical symptoms such as motor dysfunction were controlled for in statistical 
analyses.  In addition, all PD patients were diagnosed as either PD with dementia, PD with 
mild cognitive impairment, or PD with no detected cognitive impairment.  This provided a 
cross section of cognitive function within PD and enabled in depth examination of 
thalamic degeneration at various disease stages.   
6.4 Summary 
The structural changes in areas that are connected to, or are adjacent to the thalamus such 
as the frontal and temporal lobes (Hu, et al., 2001) and the structures of the basal ganglia 
(Geng, et al., 2006), limbic system (Junque´, et al., 2005) and ventricles (Camicioli, et al., 
2011) which show a relationship with cognition suggest that the thalamus will also be 
reflective of cognitive dysfunction in PD.  The ventricles are particularly relevant as 
ventricular enlargement is the only region to date that shows a significant change between 
PD with and without MCI (Dalaker, et al., 2011).  Thalamic change therefore could also be 
a marker of disease progression and aid in identifying PD-MCI and separating these 
patients from those without impairment.   
To date, thalamic changes have been identified in some PD cohorts.  Volumetric 
analysis has shown a trend for decreased volume in PD (McKeown, et al., 2008), while the 
diffusion measure of mean diffusivity shows a trend for higher values in patients (Nicoletti, 
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et al., 2006; Rizzo, et al., 2008).  In a PD patient sample with intact cognition (Li, et al., 
2010), there was no difference in MD values of the thalamus.  Microstructural changes 
appear to be more sensitive to symptoms in the earliest stages of PD as both a reduction in 
FA and increase in MD in the thalamus of a PD group has been identified in the absence of 
volume reduction (Peran, et al., 2010).   
6.5 Hypothesis 
 That the whole thalamus will be reflective of cognitive dysfunction in Parkinson’s 
disease 
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6.6 Method 
6.6.1 Participants 
The thalamus was able to be automatically segmented from all images so all participants 
(Section 5.2) were included in this initial study.  The final sample of participants for which 
the thalamus was defined included 56 PD-N, 19 PD-MCI, 17 PD-D patients and 25 healthy 
control participants.   
6.6.2 Image Preparation 
Before image analysis could be conducted, the raw structural images had to undergo a 
number of different prepatory procedures.  The following steps were all completed using 
the Statistical Parametric Mapping 5 (SPM 5) programme (Friston, 2005).   
6.6.2.1 Reslicing the T1 image  
The T1 image was resliced to fit the FA image (rT1) so that the voxels of the T1 image 
were the same size as the voxels in the FA image (1.88 x 1.88 x 3mm
3
).  This is a 
necessary step to ensure the FA image can be overlayed onto the T1 image which aids in 
the manual definition of thalamus boundaries.  The ‘realign: reslice’ option was used and 
the FA image was entered first as the reference image and the T1 second as the image to be 
resliced.  Images were resliced using the 2.n option, which only reslices the second image 
in the list, leaving the first intact.  Interpolation for writing the T1 image to the FA space 
was defined as nearest neighbour as this was the most suitable for our images.  Images 
were not wrapped to fit the defined space and were left in standard subject (native) space.   
6.6.2.2 Orientation to the Anterior Commissure 
Images were orientated to the Anterior Commissure (AC) in order for all the images 
created from one individual to have the same MNI co-ordinates.  SPM allows for the 
structural T1 image to be displayed in all three planes (X, Y, Z) simultaneously (Figure 
6-2), enabling the manual realingment of the image by the user (N.B).  This is done using 
the pitch (X axis), roll (Y axis) and yaw (Z axis) function which are defined on a trial and 
error basis until the image is alinged upright and straight in all three views.  When the 
image is aligned to a satisfactory degree, the anterior commissure (AC) is isolated and set 
at position 0,0,0.  All other scans are then registered to the same position using T1 as the 
template using SPMs ‘coreg: estimate’ option, ensuring that the X,Y, Z co-ordinates of one 
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image correspond to the same place in the brain of the X,Y,Z co-ordinates on all other 
images.   
a) 
 
b) 
 
c) 
 
d) 
 
Figure 6-2: Orientation to the anterior commissure  
The location of the anterior commissure is presented on the whole brain saggital (a) view and corresponding 
4x magnified coronal (b), saggital (c) and horizontal (d) views.  The SPM 5 programme is employed to 
orientate all scans to the anterior commissure   
6.6.2.3  Masking 
For 8 participants (seven patients and one control subject) assistance was needed to keep 
the head still during the scanning procedure.  For these individuals only, a styrofoam gel 
pad was placed in the scanner and aided in the correct positioning of the patients head.  
Because the FIRST programme uses a probability map based on voxel intensity to define 
the thalamus and the gel pad appears as a solid white mass on the images, the presence of 
the gel pad prevents accurate definition of the thalamus in these cases.  The gel pad was 
removed from each image by the manual creation of a brain mask.  A pen tablet was used 
to enable the user (N.B) to manually trace onto the image, and all white voxels 
corresponding to the gel pad were isolated.  The tracing defined a region of interest that 
could then be excluded from the image using the ‘mask’ function of MRIcron’s draw tools.  
The new T1 image was saved and used for all future processing.   
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6.6.3  Image Analysis 
The algorithm FIRST (v 1.2) was applied to separately estimate left and right volume of 
the thalamus from the T1 image in native space.  FIRST is part of FMRIB’s Software 
library (FSL: Patenaude, 2007) and performs both the registration and segmentation of the 
thalamus, transforming the image to MNI standard space (Figure 6-5).  Following 
recommendations of de Jong et al.,(2008) a boundary correction of a Z-value of 3 was 
used, corresponding to 99.98% certainty that voxels belonged to the thalamus.  Accuracy 
was confirmed by visual inspection of all MR images and comparison to anatomical 
guidelines (Duvernoy, 1991; Nolte & Angevine, 2007).  In addition, a sub set (n = 7) was 
manually traced for comparison purposes.  The manual and automated methods were 
compared using a t test for dependent samples.  The different methods did not result in a 
difference between thalamus size for either the left [t(6) =-0.78, p = 0.47] or right, [t(6) = -
0.94, p = 0.38] thalamus.   
6.6.3.1 Manual Tracing – The Gold Standard 
The thalamus was manually segmented based on the guidelines of Portas, et al., (1998) 
who defined boundaries according to the anatomical guidelines of (Duvernoy, 1991).  For 
reference another more detailed anatomical atlas was also used (Nolte & Angevine, 2007).  
Manual tracing of the thalamus was achieved using the MRICRON programme which 
allows the user to view the image in coronal, saggital and axial planes simultaneously and 
use the pen tablet.  The boundaries of the thalamus are, for the most part, easily visualised 
due to the high contrast between grey matter and the cerebral spinal fluid which fills the 
ventricles.  All borders were manually traced onto the resliced T1 image (rT1) image as 
this provided the highest level of contrast (Figure 6-3).  The FA maps, coloured to show 
directional dependence are used to define the internal capsule which forms the lateral 
boundary.  When the ‘BLUE’ file (superior-inferior direction) is overlayed onto the rT1 
image the internal capsule appears as a solid blue line, allowing for easy identification of 
this border.  This is best seen on the axial image although it is useful to simultaneously 
check segmentation on the coronal image. The medial boundary is defined by the third 
ventricle and the dorsal boundary by the main body of the lateral ventricle.  The inferior 
boundary is not as easily defined as it must be segmented from the brainstem.  This is best 
done on the saggital image as there is sharp contrast between white matter of the brainstem 
and grey matter of the thalamus in this image. 
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a) 
 
b) 
 
The diffusion sequence gives an FA map 
which colours the principal direction of 
diffusion.  The BLUE FA map is the 
superior-inferior direction. 
The internal capsule is clearly visible as a 
solid blue line and represents the lateral 
boundary of the thalamus. 
 
 
The medial boundary is defined by the 
lateral ventricle, clearly visible on the rT1 
image. 
The dorsal boundary is also drawn on this 
image, defined by the third ventricle. 
 
 
 
The inferior border is the brainstem, 
clearly visible in the saggital section due 
to contrast between thalamus and white 
matter of the brainstem. 
 
c) 
 
d) 
 
e) 
 
Figure 6-3: Thalamus Boundaries 
The boundaries used for the manual definition of the thalamus are easily visualised after application of the 
directional ‘BLUE’ image (a, b) while the dorsal (c) and medial (d) boundaries are easily visualised on the 
rT1 image due to the contrast with ventricles.  Definition of the ventral boundary is more difficult due to 
merging with the brain stem, but the saggital image (e) provides the best view and contrast between the grey 
matter of the thalamus and white matter of the brain stem.   
Intracranial volume was measured from the T1 image by one observer (N.B.) 
following the method of (Eritaia, et al., 2000).  The intracranial cavity of each 10
th
 saggital 
slice was manually traced using the dura matter as a border.  The first slice was randomly 
selected within the first 10 slices that the cortex became visible.  In the absence of dura 
matter the cerebral contour is outlined.  Other landmarks include the undersurface of the 
frontal lobe in which pixels deemed to be cerebral cortex are rendered until a white line is 
visible, this is the dorsum sellae.  This line is then employed as a guide to the cilvus, which 
appears as a solid white dot.  The intracranial cavity includes the CSF to the left of this 
landmark and rendering excludes any white pixels.  When the base of the brain is reached, 
a horizontal line must be drawn between the anterior and posterior arch of the first cervical 
vertebra (C1) to segment the cortex from the brainstem.  The last saggital slice occurs 
within the last 10 slices that cortex is visible.  ICV is then calculated using MATLAB 
which multiplies the total of all slices by 10 to give overall volume.   For each subject the 
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ROI is then able to be divided by that persons intracranial volume, giving an accurate ratio 
of the region of interest relative to total cranial size.   
 
 
1. The outer table of the skull.   
2. Cerebral contour.   
3. The dorsum sellae.   
4. Clivus.   
5. Anterior arch of C1.   
6. Posterior arch of C1.   
7. Dura matter, visible as a white line.   
 
Figure 6-4: Boundaries for the manual segmentation of intracranial volume 
The red line indicates the region of interest, manually outlined in the MRIcron programme.  Also note that 
although the cerebral cortex shows signs of atrophy this does not affect the location of the dura matter.  
6.6.3.2 Automatic Segmentation 
The FSL programme provides comprehensive tools that can be used with fMRI, MRI and 
DTI imaging data.  For the purposes of this research the FSL FIRST v 1.2 tool was used to 
define the left and right thalamus of each individual.  The FIRST tool is FMRIB’s 
integration and segmentation tool which segments subcortical brain structures using 
Bayesian shape and appearance models (Patenaude, Smith, Kennedy, & Jenkinson, 2011).   
a) 
 
b) 
 
c) 
 
Figure 6-5: Automatic Segmentation of the Thalamus 
a) Saggital X = 57, b) Coronal Y = 58 and c) Horizontal Z = 27 sections of FIRST segmentation of left (red) 
and right (green) thalamus overlayed on the rT1 image.   
The individual T1 image data to be analysed is uploaded and converted to native 
space.  The thalamus was then determined based on a large database of hand-segmented 
images provided by Centre for Morphometric Analysis (CMA), MGH, Boston.  FIRST 
searches through linear combinations of shape modes for the most probable shape given 
the intensities of the T1 image and then renders the voxels that are determined to be a part 
of that structure.  The entire sequence takes approximately 25 minutes per scan and gives 
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the user individual images for each subcortical structure.  Once thalamus is defined the 
image file is created and can be read by MATLAB to give total volume.  
6.6.4 Diffusion Weighted (MD and FA) Imaging 
The diffusion variables are calculated from the mean diffusivity and fractional ainsotropy 
maps.  The whole image file is imported into MATLAB and values read for each voxel of 
the image.  In order to limit values to thalamus only, the automatically defined thalamus is 
then imported into Matlab and only those values which fall within these voxels are read.  
An average value FA and MD value is calculated for each thalamus.   
6.6.5 Statistical Analysis 
Between group differences were examined using a between and within groups analysis of 
variance (ANOVA) where the dependent variable in each model was the integrity measure 
of the thalamus (volume, FA or MD) and the independent variable the subject group 
(healthy control, PD-N, PD-MCI and PD-D).  The post hoc Newman-Keuls analysis was 
applied in the case of a significant group effect.  In the case of a significant group by 
hemisphere interaction, a one way ANOVA was conducted independently for each 
hemisphere if there was significant lateralisation of the group effect.  Where required, 
Kruskal-Wallis ANOVA was employed for non parametric data.  Analysis of covariance 
was used to test the effects of the covariates: age; education and depression.  Separate 
models were used in which control participants were excluded and the additional 
continuous predictors (disease duration and UPDRS) included as co-variates to test the 
effects of clinical covariates specific to PD.   
The relationship between the thalamus and cognition was tested by a series of 
Pearson correlations in the first instance.  In the case of a significant relationship, multiple 
regression analysis was employed to test the effect while accounting for covariates.  In the 
first regression model the thalamic variables MD, FA and volume were entered as 
independent variables along with the demographic (age, sex, education, depression) and 
clinical (disease duration) variables to examine the relationship with global Z score.  
Additional multiple regressions were applied in the same way in order to predict score in 
the other four domains: attention/working memory/processing speed; executive function; 
visuospatial/visuopercetption and learning and memory. 
Receiver operating characteristics (RoC) analysis was used to distinguish the 
cognitively impaired groups from those not impaired, and in some cases those less 
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impaired using the thalamic variables (e.g.: the following pairwise comparisons could be 
examined: C>PD-N>PD-MCI>PD-D).  
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6.7 Results 
6.7.1 Participant information 
Demographic and clinical characteristics for all participants are reported in Table 6-2.  
Adjacent group wise comparisons show that the PD-MCI (p = 0.04) and PD-D (p < 0.01) 
groups are older and have lower levels of premorbid IQ than the PD-N group.  The PD-N 
group did not differ from the healthy control group on any measures.  As expected, there 
was progressive worsening of clinical function and length of disease duration from PD-N 
to PD-MCI (Hoehn and Yahr p < 0.01; UPDRS III p = 0.03; disease duration p < 0.001) 
and from PD-MCI to PD-D (Hoehn and Yahr p < 0.001; UPDRS III p < 0.001; disease 
duration p = 0.03).   
Measures of global cognition, cognitive domain scores and individual 
neuropsychological test scores are reported in Table 6-3.  The PD-N group was comparable 
to the control group, only exhibiting lower performance on the map search, category 
switching, trails, the Stroop interference task, CVLT and RCFT measured delayed memory 
and aggregate Z scores of executive function, learning and memory and general cognition.  
The PD-D group was significantly worse on all tasks compared to the PD-N group and the 
PD-MCI group performed at a level consistently better than that of the PD-D group and 
lower than that of the PD-N group.   
 
The Thalamus in Native Space 
Chapter 6 | 143 
Table 6-2:  Mean (std dev) of demographic and clinical data for all participants  
 Control  
(n = 25) 
PD-N  
(n = 56) 
PD-MCI 
(n = 19) 
PD-D  
(n = 17) 
Statistic  p  Adjacent pair-wise 
comparisons 
Demographic        
Age 67.2 (9.6) 64.7 (8.4) 70.8 (8.5) 73.4 (6.8) F=5.78 <0.01 C=N<MCI=D 
Education 13.8 (2.8) 13.5 (3.0) 12.2 (3.3) 12.4 (2.3) F=1.40 0.25 C=N=MCI=D 
Depression (GDS) [median (range)] 0.00 (0-1) 0.0 (0-9) 0 (0-11) 4 (0-8) H=15.58  <0.01 C=N=MCI=D 
Sex 17/8 37/19 13/6 15/2 χ2=3.18 0.36  
Handedness 20/4 56/2 19/3 16/1 χ2=5.19 0.16  
Premorbid IQ (WTAR)  117.8 (1.0) 114.4 (8.5) 107.2 (12.5) 106.1 (11.5) H=17.38 <0.01 C=N>MCI=D 
Clinical        
Hoehn + Yahr [median (range )]  2.0 (1-3) 2.5 (1.5-4) 4 (2-4) F=28.74 <0.01 N<MCI<D 
UPDRS III (max=88)  24.9 (13.6) 34.7 (16.4) 52.9 (20.1) F=25.85  <0.01 N<MCI<D 
Disease Duration  3.9 (3.3) 7.5 (5.3) 12.9 (8.5) H=21.91 <0.01 N<MCI<D 
GDS: Geriatric depression scale; WTAR: Weschler test of adult reading; UPDRS III: Unified Parkinson’s disease rating scale.  All participants completed all tests unless 
otherwise indicated by n value.   
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Table 6-3:  Mean (std dev) of neuropsychological test scores for all participants 
 Control 
 (n = 25) 
PD-N  
(n = 56) 
PD-MCI  
(n = 19) 
PD-D  
(n = 17) 
Statistic  p  Adjacent pair-wise 
comparisons 
Global Cognitive         
MMSE (max=30) 28.6 (1.5) 28.5 (1.4) 26.1 (2.4) 22.9 (3.2) H=28.2 <0.01 C=N>MCI>D 
MoCA (max=30) 27.8 (1.5) 26.7 (2.1) 22.6 (2.3) 16.4 (3.9) H=38.2 <0.01 C=N=MCI>D 
Attention and working memory
+
 0.4 (0.5) -0.0 (0.4) -0.9 (0.5) -2.0 (0.6) F=98.7 <.001 C>N>MCI>D 
Digits Forward/Backwards 1.0 (1.2) 0.4 (0.8) 0.0 (0.9) -0.8 (1.0) F=13.4 <.001 C=N>MCI>D 
Digit Ordering -0.4 (0.9) -0.5 (1.0) -1.7 (0.7) -2.2 (0.6) F=24.8 <.001 C=N>MCI>D 
Map Search 0.7 (1.0) -0.2 (0.9) -1.7 (0.7) -2.3 (0.8) F=50.5 <.001 C>N>MCI>D 
Stroop Colour Trial 0.2 (0.8) -0.0 (0.9) -0.6 (0.8) -2.0 (1.0) F=29.0 <.001 C=N>MCI>D 
Stroop Word Trial 0.3 (0.6) 0.1 (0.6) -0.5 (0.8) -1.7 (1.2) H=36.5 <.001 C=N>MCI>D 
Trail Making Test A 0.3 (0.9) 0.0 (0.7) -0.8 (1.0) -2.7 (0.5) F=65.0 >.001 C=N>MCI>D 
ExecutiveFunction
+
 0.9 (0.5) 0.4 (0.6) -0.7 (0.7) -2.1 (0.5) F=101.6 >.001 C>N>MCI>D 
Letter Fluency 1.1 (1.2) 0.8 (1.1) -0.2 (1.1) -1.5 (1.0) F=22.6 >.001 C=N>MCI>D 
Action Fluency 0.7 (1.0) 0.2 (1.3) -0.9 (1.0) -1.7 (0.7) F=21.7 >.001 C=N>MCI>D 
Category Fluency 1.2 (1.0) 0.9 (1.2) -0.4 (1.0) -2.1 (0.9) F=32.7 >.001 C=N>MCI>D 
Category Switching 1.1 (0.9) 0.3 (0.9) -0.7 (0.8) -2.1 (0.9) F=55.4 >.001 C>N>MCI>D 
Trail Making Test B 0.7 (0.5) 0.0(0.9) -0.9 (1.2) -2.9 (0.3) H=55.8 >.001 C>N>MCI>D 
Stroop Interference 0.6 (0.5) 0.4 (0.7) -1.2 (1.5) -2.5 (0.8) H=56.1 >.001 C=N>MCI>D 
Learning and memory
+
 0.9 (0.8) 0.4 (0.8) -0.7 (0.5) -1.7 (0.7) F=55.6 >.001 C>N>MCI>D 
CVLT Free Recall 0.9 (0.9) 0.5 (0.8) -0.9 (0.9) -2.0 (1.0) F=48.3 >.001 C=N>MCI>D 
CVLT Short Delay (30s) 1.1 (1.2) 0.4 (1.1) -0.7 (1.0) -1.8 (0.8) H=50.3 >.001 C>N>MCI>D 
CVLT Long Delay (10min) 0.8 (0.8) 0.4 (0.8) -0.5 (0.8) -1.0 (0.7) F=23.3 >.001 C=N>MCI>D 
RCFT Immediate (3 min) 1.0 (1.3) 0.3 (1.4) -0.5 (1.4) -1.8 (0.8) F=17.1 >.001 C=N>MCI>D 
RCFT Delayed (30 min) 0.8 (1.5) -0.3 (1.5) -1.2 (1.2) -1.9 (1.1) F=13.5 >.001 C>N=MCI=D 
Visuospatial/Perception function
+
 0.6 (0.5) 0.5 (0.4) -0.4 (0.6) -1.3 (0.8) H=46.1 >.001 C=N>MCI>D 
RCFT Copy 0.3 (0.9) 0.1 (0.8) -0.9 (1.3) -2.0 (1.3) F=25.7 >.001 C=N>MCI>D 
JOL 0.7 (0.6) 0.6 (0.6) -0.1 (0.9) -0.8 (1.0) F=23.0 >.001 C=N>MCI>D 
VOSP Fragmented Letters 0.8 (0.8) 0.7 (0.5) -0.0 (1.1) -1.0 (1.1) F=24.8 >.001 C=N>MCI>D 
Global Z
+
 0.7 (0.4) 0.3 (0.4) -0.7 (0.4) -1.7 (0.5) F=165.5 >.001 C>N>MCI>D 
+age adjusted Z score. Global Z score is an aggregate score of the mean value in each cognitive domain.  MMSE: Mini mental state examination; MoCA: Montreal cognitive 
assessment.  CVLT: California verbal learning test; RCFT: Rey complex figure test; JOL: Judgement of line orientation; VOSP: Visual object space perception battery.  All 
participants completed all tests unless otherwise indicated by n value.  Three participants (PD-N) were not tested on the MoCA; there was no other missing data 
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6.7.2 Thalamic volume  
The thalamus volume was examined as an absolute value and as a ratio, relative to the 
individuals intracranial volume (thalamus divided by ICV for each subject).  Between – 
within ANOVA examined group differences and the co-variates age, education and 
depression added in ANCOVA model.  A subsequent ANCOVA model which excluded 
the control subjects and additionally included disease duration and UPDRS III examined 
the group effect of thalamic degeneration after accounting for clinical co-variates.  The 
assumption of normality was tested using the Shapiro-Wilk test, and held for all thalamic 
variables in all four groups.  Intracranial volume in the dementia group deviated slightly 
from normal (SW-W = 0.87, p = 0.02) due to a slight positive skew (skew = 1.48).  
Homogeneity of variance, examined using the Levene’s Test held for all variables.  The 
assumption of independence was upheld by using the left/right thalamic variables in 
separate analysis to the weighted average or total thalamic variables and correcting for 
multiple comparisons as necessary.  As the deviations from normality were slight and all 
other assumptions held, statistical analysis continued as normal and non parametric testing 
was not needed.  In regards to the ANCOVA models, the additional assumption of linearity 
- that the relationship between Y and each co-variate is linear was also necessary.  This 
assumption held for all groups.   
Mean values of all thalamic measures are shown in Table 6-4 with adjacent group 
comparisons after accounting for co-variates presented in Figure 6-7.  For absolute 
thalamic volumes and ICV there were no group differences.  The left hemisphere was 
larger than the right [F (1,113) = 79.50, p < 0.01] but this did not result in a group by 
hemisphere interaction [F(3,113) = 1.45, p = 0.23].  Adding demographic covariates to the 
model did not result in a group effect [F(3,110) = 1.03, p = 0.38] but the effect of 
hemisphere was no longer significant [F(1,110) = 2.55, p = 0.11].  Excluding the control 
subjects in the second model and adding clinical covariates did not change results [F(2,84) 
= 0.54, p = 0.58].   
Correcting for intracranial volume changed results; the PD groups were sensitive to 
thalamic degeneration.  Thalamic volume was significantly reduced in the dementia group 
relative to the control subjects (p = 0.03).  As with the absolute values, the hemisphere 
effect remained [F(1,113) = 80.25, p < 0.01] but this was a consistent effect across all 
groups and there was no interaction [F(3,113) = 1.00, p = 0.40].  When demographic 
covariates were added to the model the volume in the dementia group was significantly 
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lower than all other groups (Figure 6-6) and the hemisphere effect was no longer 
significant [F(3,110) = 1.10, p = 0.35].  Adding clinical covariates in the second model did 
not change results [PD-N p = 0.03; PD-MCI p = 0.01].    
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Table 6-4: Comparison of thalamic integrity measures between PD groups (stratified by cognitive status) and control subjects 
 C 
(n = 25) 
PD-N 
(n = 56) 
PD-MCI 
(n = 19) 
PD-D 
(n = 17) 
 Group Effect 
      F p Newman-Keulis 
Volume (mm
3
)     
Absolute  6721.80 (637.4) 7030.12 (760.21) 6666.52 (682.1) 6794.57 (962.7)  1.45 0.23 C=N=MCI=D 
Left 6824.82 (674.7) 7168.16 (790.95) 6752.81 (643.1) 6960.8 (1012.2)  1.93 0.13 C=N=MCI=D 
Right 6618.78 (626.7) 6892.09 (753.8) 6580.24 (743.4) 6628.35 (927.8)  1.38 0.25 C=N=MCI=D 
     
Relative x 10
-3
 4.52 (0.4) 4.53 (0.4) 4.53 (0.4) 4.27 (0.4)  2.23 0.09 C>D 
Left 4.59 (0.4) 4.62 (0.4) 4.59 (0.4) 4.37 (0.4)  1.76 0.16 C=N=MCI=D 
Right 4.45 (0.4) 4.45 (0.4) 4.47 (0.4) 4.17 (0.4)  2.61 0.05 C=N=MCI>D 
         
ICV (cm
3
) 1492.1 (149.0) 1557.4 (181.1) 1472.8 (100.0) 1593.0 (177.5)  2.56 0.06 C=N=MCI=D 
         
Fractional Ainsotropy (range 0-1)     
Left 0.32 (0.02) 0.32 (0.03) 0.32 (0.03) 0.32 (0.02)  0.04 0.99 C=N=MCI=D 
Right 0.31 (0.02) 0.31 (0.03) 0.30 (0.02) 0.31 (0.02)  0.37 0.77 C=N=MCI=D 
Weighted 
average  
0.31 (0.02) 0.31 (0.02) 0.31 (0.02) 0.31 (0.01)  0.16 0.92 C=N=MCI=D 
         
Mean Diffusivity (mm
2
 per sec x 10
-3
)     
Left 0.88 (0.05) 0.88 (0.05) 0.91 (0.06) 0.95 (0.06)  8.84 0.00 C=N<MCI<D 
Right 0.88 (0.05) 0.89 (0.05) 0.92 (0.06) 0.95 (0.05)  8.23 0.00 C=N<MCI<D 
Weighted 
average 
0.88 (0.04) 0.88 (0.05) 0.92 (0.06) 0.95 (0.05)  9.66 0.00 C=N<MCI<D 
Absolute and relative (thal/ICV) thalamic volume, fractional anisotropy and mean diffusivity measures are reported mean (SD).  Repeated measures ANOVA was used to 
examine the group effect where left and right thalamic variables served as the within factor.  There was no group x hemisphere interaction for any of the thalamic variables. 
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6.7.3 Fractional Anisotropy  
Diffusion values were computed for bilateral thalamus using the following formula for 
weighted average:  
a  
where l = left thalamus, r = right thalamus, v = thalamic volume and x = the diffusion 
variable of interest e.g.: FA or MD.  Fractional anisotropy was skewed in both hemispheres 
(Left: SW-W = 0.95, p = 0.02; Right: 0.95, p = 0.02) but this was only slight and there 
were no other assumption violations so analysis continued as normal.  Fractional 
anisotropy measures did not reflect cognition.  Adding demographic (Figure 6-6) and 
clinical [F(2,84) = 0.25, p = 0.78] covariates did not change results.   
6.7.4 Mean Diffusivity  
Mean diffusivity values were computed using the weighted average formula and although 
the mean values for the left hemisphere (SW-W = 0.91, p < 0.01) were slightly skewed 
analysis continued as normal as all other assumptions held.  Mean diffusivity was the 
integrity measure that was most sensitive to cognition.  Relative to control subjects, 
cellular disruption was evident in PD-MCI (p = 0.02) with a further increase in PD-D 
relative to PD-MCI (p = 0.04).  Mean values were higher in both the PD-MCI (p = 0.02) 
and the PD-D (p < 0.001) group, indicating the result was not only due to PD motor 
symptoms.  In contrast to volume and fractional anisotropy results, mean diffusivity was 
the only thalamic variable which did not have an effect of hemisphere [F(1,113) = 3.47, p 
= 0.06].  The right hemisphere was slightly more affected in the control group, but this gap 
closed as cognition worsened and did not result in a group by hemisphere interaction 
[F(3,113) = 0.08, p = 0.97].  The addition of demographic (Figure 6-6) and clinical 
covariates did not change the results, the PD-MCI group continued to exhibit higher MD 
values than PD-N (p = 0.02) with a further increase in PD-D relative to PD-MCI (p = 
0.03).   
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F(3,110)=1.10, p = 0.35
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Figure 6-6: Volume, and diffusion measures of thalamic integrity 
Thalamic volume and integrity differences between groups.  L: = Left; R: = Right, lines represent standard 
error bars.  Mean diffusivity was the most sensitive measure to cognitive dysfunction and showed a 
progressive increase in value while thalamic volume was only significant lower in the dementia group.   
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a) Thalamic changes in unimpaired PD relative to control subjects 
 
       
b) Thalamic changes in unimpaired PD relative to mild cognitive impairment 
 
       
c) Thalamic changes in unimpaired PD relative to dementia 
 
       
d) Thalamic changes in mild cognitive impairment relative to dementia 
 
       
Figure 6-7:  Thalamic changes in PD patients with cognitive impairment  
Horizontal sections are displayed using radiological convention, the left side of the image corresponds to the right side of the brain.  Slices are presented from the most dorsal 
slice to the most ventral slice where the thalamus is visible.  Rows a) – d) show thalamic mean diffusivity (green) and volumetric (red) changes after accounting for co-
variates.  There were no instances where there was significant volume loss without a significant increase in MD.  Image is 4D image with MNI space co-ordinates Z: 30-24
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6.7.5 The relationship between the thalamus and cognition 
6.7.5.1 Correlation Results 
In the first instance simple Pearson correlations were used to determine if the thalamus had 
an association with cognition.  In the case of a relationship the association was then further 
examined using regression modeling.  For each correlation the bilateral thalamus variables 
(volume, FA and MD) were independently examined for their relationship with each 
cognitive domain (attention, executive function, learning and memory, 
visuospatial/visuoperception and aggregate global score).  Correlations were conducted 
separately for the control and patient groups following the recommendations of Little, et 
al., (2010) in order to counteract the possibility of a false association by virtue of the 
patients consistently exhibiting a greater variance in cognitive scores.  The assumptions of 
normality, of a linear relationship between the two variables, of minimum outliers and 
homoscedasticity – where the variance along the line of best fit remained similar, held for 
all variables.   
In healthy control subjects  
In the healthy control subjects there was no association between any thalamic measures 
with any areas of cognition.   
In Parkinson’s disease  
The same correlation matrices were applied to the patient group.  Volumetric measures of 
the thalamus yielded a relationship with attention (r = 0.21, p = 0.05) and aggregate global 
Z score (r = 0.21, p = 0.05).  Not surprisingly, there was no association between the 
thalamus and cognition when FA was used as the integrity measure.  Conversely, MD 
showed an association with all cognitive domains: learning and memory, (r = -0.40, p < 
0.001); executive function, (r =-0.36, p < 0.001); attention (r =-0.37, p < 0.001); 
visuospatial/perception (r =-0.36, p < 0.001) and global Z score, (r =-0.41, p < 0.001).   
6.7.6 The influence of covariates  
For those domains that had a significant correlation with the thalamus, the relationship 
between thalamic structure, integrity and cognition was then examined using multiple 
regression to determine the thalamic influence after accounting for covariates.  Each 
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cognitive domain was examined using a separate model where that variable was entered as 
the dependent variable and either volume or MD was entered as the independent variable 
along with the covariates age, education, depression, and disease duration.   
The assumption of normality in arrays held, each group was normally distributed 
around the criterion variable (predicted score – observed score).  The residuals of each 
criterion variable were also normally distributed.  The assumption of multi-colinearity did 
not hold for the UPDRS III and disease duration variables (r = 0.44, p < 0.05) or for left 
and right thalamus (Vol r = 0.91, p < 0.001; MD r = 0.79, p < 0.01) so the UPDRS III 
variable was excluded and only the average bilateral thalamus variables were used in the 
analysis.  The assumption of linearity held in that the relationship between each criterion 
variable and each predictor variable was linear.  Homogeneity of variance in arrays - that 
for any set of predictor variables the corresponding variance of criterion variable will be 
the same also held.  The control participants were excluded for all models due to the fact 
there was no association between the thalamus and cognition in this group.   
Multiple regression statistics are reported in Table 6-5.  After accounting for the 
influence of covariates, there was no longer an association between thalamic volume and 
cognition.  Mean diffusivity measures of the thalamus survived the inclusion of co-variates 
however and remained a predictor of all cognitive domains and the aggregate Z score.  In 
every case the overall model accounted for a significant proportion of the variance in the 
respective cognitive domain with the thalamus contributing between 3-6% of the unique 
variance.   
Table 6-5: Multiple Regression Analysis: Relationship between thalamic variables and cognitive 
domains adjusted for covariates (controls excluded) 
   
Proportion of variance accounted for (R
2
) 
     
 Beta p Whole model Thalamic measure 
Volume     
Global Z score  -0.02 0.87 40%, p<0.001 -0.0002, p=0.87 
Attention/wm/processing -0.02 0.83 37%, p<0.001 -0.0003, p=0.83 
     
Mean Diffusivity      
Global Z score  -0.25 >0.01 45%, p<0.001 5%, p<0.01 
Attention/wm/processing speed -0.19 0.05 40%, p<0.001 3%, p=0.05 
Executive function -0.19 0.04 47%, p<0.001 3%, p=0.04 
Learning and memory -0.27 >0.01 33%, p<0.001 6%, p<0.01 
Visuospatial/perception -0.25 0.02 31%, p<0.001 5%, p=0.02 
Thalamic volume and mean diffusivity were entered in multiple regression analysis as predictors of cognitive 
domain scores along with the covariates age, education, depression, disease duration.  The UPDRS III was 
excluded due to co-linearity with disease duration.   
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Thalamic MD values were then used to predict cognitive function using the 
following regression equation:   
Cognitive domain score = constant – (intercept * MD). 
These results are presented graphically in Figure 6-8 and show a clear difference in group 
distribution.  The PD-D patients (red), clustered around the lower ends of the graphs show 
high diffusivity and low cognitive function.  This group also has the largest variance in 
scores.  The control (blue) and PD-N (green) groups are clustered around the upper ends of 
the graphs, showing low diffusivity and high cognitive scores with the PD-N group 
showing higher variance than the controls.  The PD-MCI (yellow) group represents an 
intermediate stage, exhibiting cognitive scores corresponding to a medium level of 
thalamic degeneration.  The groups all show significant overlap, especially in regards to 
PD-N and PD-MCI, suggesting that they will not be easily distinguishable by thalamic MD 
alone.   
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Figure 6-8: The association between thalamic mean diffusivity and cognition  
Thalamic mean diffusivity is a unique predictor of each cognitive domain and the regression equation can be 
applied to show the predicted level of cognitive function for each individual.   
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6.7.7 Using thalamic measures to aid in group discrimination 
Receiver operating characteristics were conducted to determine the measure most sensitive 
to cognitive dysfunction in the PD groups.  In each case, analyses were only conducted 
using MD and volume measures and FA was not included as there was no indication this 
measure of thalamic integrity had an effect on cognition in this sample.  Optimal 
diagnostic values are reported in Table 6-6 where specificity (the probability of true 
negatives) is >80% and positive predictive values (the probability of an accurate positive 
test) are >80% when available.  The following pair-wise comparisons were examined: PD-
D from control, PD-N and PD-MCI; PD-MCI from control and PD-N and, to determine the 
effect of Parkinson’s disease alone PD-N from control.  The assumption that all groups 
were normally distributed was upheld.   
6.7.7.1 Prediction of the patient group  
Thalamic volume was not sensitive to cognition in this sample, and generally did not result 
in successful identification of those groups who were exhibiting any level of cognitive 
impairment.  The only exception was in regards to the PD-D group which showed a 
significant area under the curve (AUC) compared to the control and PD-N groups, enabling 
correct identification of dementia 65% and 53% of the time respectively.   
Mean diffusivity, on the other hand was more sensitive to cognitive dysfunction, 
showing significant AUC statistics for all pairwise comparisons except between the control 
subjects and PD-N.  Not surprisingly, the further removed the cognitive groups were from 
each other on the spectrum of cognitive dysfunction, the easier it was to differentiate 
between them.  Identification of the dementia group was more successful when the control 
group, rather than the PD-N group was the comparison sample for example, although both 
were achieved with high success.  Similarly, identification of PD-MCI was also easier 
when the comparison group was the control rather than PD-N group.  Together, dementia 
was successfully identified approximately 80% of the time while PD-MCI was identified 
approximately 70% of the time.   
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Table 6-6: Separation of cognitive groups using thalamic integrity measures, RoC results 
 Predicting PD  Predicting mild cognitive impairment  Predicting dementia 
Control  C vs PD-MCI PD-N vs PD-MCI  C vs PD-D PD-N vs PD-D 
Thalamic Volume  
AUC 
(95% CI) 
0.50 ns (0.39-0.62)  0.5ns (0.35-0.66) 0.50ns (0.34-0.61)  0.70
c
 (0.54-0.83) 0.70
b
 (0.58-0.80) 
Sensitivity 32.1  36.8 14.3  64.7 53.0 
Specificity 80.0  80.0 84.2  80.0 80.4 
        
Thalamic Mean diffusivity  
AUC 
(95% CI) 
0.53ns (0.41-0.64)  0.70
b
 (0.54-0.83) 0.68
c
 (0.56-0.78)  0.84
a
 (0.69-0.94) 0.82
a
 (0.71-0.90) 
Sensitivity 32.1  57.9 47.4  76.5 70.6 
Specificity 80.0  80.0 80.4  80.0 84.0 
 
 
 
  
 
  
AUC: area under the receiver operating curve (chance = 0.5; perfect separation = 1.0).  Superscript numbers indicate level at which the comparison is significant, a: p < 0.001; 
b: p < 0.01; c: p < 0.05.   
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6.8 Discussion 
6.8.1 Summary of the results 
The study in this chapter used a cross-sectional design to investigate the thalamus as a 
potential biomarker for cognitive impairment in Parkinson’s disease.  We expected that 
thalamic integrity and volume would be reflective of cognitive dysfunction in PD.  The 
thalamus was identified a priori as an area for investigation due to its many cortical 
connections with areas that are known to be implicated in cognitive dysfunction in PD 
(Taber, et al., 2004).  Volume, fractional anisotropy and mean diffusivity of the whole 
thalamus were all examined for a relationship with cognition from structural images in 
native subject space.  Thalamic volume had a relationship with various cognitive domains 
but this did not hold once co-variates were accounted for.  Fractional anisotropy did not 
have any relationship with cognition.  Mean diffusivity on the other hand was significantly 
associated with multiple facets of cognition and resulted in an overall group difference, an 
independent relationship between thalamus and cognition and the ability to differentiate 
between the similar cognitive groups within Parkinson’s disease.   
6.8.2 Thalamic volume reduction  
In terms of thalamic volume, the hypothesis was supported but significant volume 
reduction was only evident in the dementia group.  In the PD-MCI group, volume loss was 
only at trend level.  In the PD group who had no cognitive impairment there were no 
volume changes compared to control subjects.  Together, results indicate that thalamic 
volume is related to severe cognitive dysfunction, is not sensitive to mild cognitive decline 
and not reflective of other Parkinson symptoms.  Because thalamic atrophy has been 
shown to decline with age (Sullivan, Rosenbloom, Serventi, & Pfefferbaum, 2004) our 
results are reported after accounting for age effects in ANCOVA models and after each PD 
patient in our group was age matched to one of our healthy control participants.   
The thalamic atrophy in the PD-D group that was identified in this study has not 
previously been investigated in native subject space.  Thalamic atrophy in PD-D has 
previously been identified in standardised space (Burton, et al., 2004; Summerfield, et al., 
2005) however and supports our findings, showing a significant reduction relative to 
control subjects.  The comparison between our findings and those of others in standard 
space will be more thoroughly explored in the subsequent chapter (Section 7.3.2).  The 
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ventricles that surround the thalamus have previously shown significant dilation 
(Camicioli, et al., 2011) in PD-D, identified in native subject space.  This previous study 
supports our findings as an increase in ventricles is thought to relate to the atrophy of the 
surrounding structures, including the thalamus (Gaser, et al., 2004).   
In regards to the trend level atrophy in the PD-MCI group, only one study (Dalaker, 
et al., 2011) has previously examined the thalamus in PD-MCI and report’s findings 
similar to our own, there was no atrophy in the thalamus of this group compared to control 
subjects.  The criteria used to categorise PD-MCI in Dalaker and colleagues sample was 
less stringent than our own and only required patients to exhibit impairment in one 
cognitive domain rather than two (Aarsland, et al., 2010).  It is therefore, somewhat 
surprising that our own sample who is exhibiting impairment closer to PD-D than PD-N 
shows no thalamic atrophy.   
More research has been conducted on PD patients without dementia.  Generally, 
only basic criteria has been used to exclude dementia in these patients so sub-threshold 
cognitive impairment is still possible.  Nevertheless, three previous research groups 
(McKeown, et al., 2008; Messina, et al., 2011; Peran, et al., 2010) support our findings of 
no thalamic atrophy in PD compared to normal control subjects and two (Lee, et al.; 
Lisanby, et al., 1993) contradict our findings, showing significant levels of atrophy in the 
thalamus.  The most obvious reason for the contrast in findings is that cognitive 
dysfunction was only examined using the MMSE in the Lee, et al., (2011a) sample and not 
at all in the Lisanby, et al., (1993) sample.  Thus, it is highly likely that instead of being PD 
patients with no disenable cognitive impairment; the patients were in fact exhibiting 
significant levels of impairment which was reflected in the degree of thalamic atrophy.  
Given the insensitivity of the MMSE, and that the Lee et al., PD patients had a score of 
27.4 (SD 1.8) cognitive impairment not being detected is a likely scenario.   
We have used a large sample of PD patients, extensive neuropsychological testing 
and robust statistical analysis and although our findings are in contrast to some previous 
studies, they are not in contrast to those studies that have also used more extensive 
neuropsychological examination and statistical analysis.  We have also shown that level of 
thalamic atrophy was useful in discriminating between PD-D and all other PD groups, as 
reflected in our RoC analysis.  Thalamic volume could effectively discriminate between 
the dementia group and: the control; PD-N and PD-MCI groups.  It is especially relevant 
that the subtle difference between PD-MCI and PD-D, but not the difference between PD-
N and PD-MCI was able to be detected in our sample.  Due to the controversy currently 
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surrounding the diagnosis of PD-MCI (Dalrymple-Alford, et al., 2011) we propose that 
thalamic volume could effectively be employed as a tool to aid in discrimination between 
PD-MCI and PD-D.   
6.8.3 Thalamic cellular disruption  
Mean diffusivity changes are assumed to reflect increases in the extracellular space as a 
result of cellular degeneration and fractional anisotropy measures are assumed to relate to 
the disruption in white matter fiber tracts (Kantarci, et al., 2001).  We expected significant 
cellular alterations in our PD groups without dementia as cellular disruptions such as these 
occur prior to gross levels of atrophy (Peran, et al., 2010).  Our results show that, although 
thalamic volume reduction was not evident in our PD-MCI group, mean diffusivity of the 
thalamus was significantly altered relative to the PD-N group.  This only partly supports 
our hypothesis as we also expected fractional anisotropy measures to show significant 
alterations but FA remained at the same levels across all groups.   
 The significant disruption in diffusion in the absence of volumetric changes 
supports the findings of Peran, et al., (2010) who is the only other group to have examined 
both the micro and macro structure of the thalamus in PD.  In their sample, microstructural 
alteration of the thalamus was identified using both FA and MD measures and occurred in 
the absence of any greater volume changes.   
6.8.3.1 Fractional anisotropy differences 
Fractional anisotropy values of the thalamus did not support the hypothesis, there was no 
group effect nor a trend for change in any of the PD groups compared to controls.  This is 
in contrast to Peran, et al., (2009) who reported significant FA reduction in the thalamus of 
PD relative to controls.  Significantly lower FA has also been reported in Alzheimer’s 
disease - a disorder characterised by its cognitive dysfunction, (Canu, et al., 2010).  
Unfortunately neuropsychological testing was not conducted in the Canu, et al., (2010) 
sample but given that AD had been diagnosed, patients were probably exhibiting similar 
levels of cognitive impairment seen in our own PD-D group.  The  most likely reason for 
the discrepancy between their findings and our own is that the profile of cognitive 
impairment in PD is different to that of the more common dementia of the Alzheimer’s 
type.  Given that both disorders are neurological in origin, the different manifestation of 
symptoms could be due to pathology in different cortical regions; differentially affecting 
the thalamus.  In PD-D for example, the overall cognitive profile is of severely reduced 
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visuospatial function followed by impairment in memory and then attention and executive 
function (Emre, 2010).  Visuospatial deficits are particularly impaired in PD-D compared 
to AD as patients have difficulty with the visual perception of objects and visual 
discrimination between objects (Mosimann, et al., 2004).  Visuospatial function is not 
typically attributed to the thalamus and is more the domain of the posterior cingulate and 
medial temporal – frontal lobe circuitry (Kravitz, Saleem, Baker, & Mishkin, 2011).   
The biggest contrast between the two disorders is the level of memory dysfunction, 
the thalamus has strong connections with the limbic system which mediates memory 
processes (Aggleton & Brown, 1999) and this could lead to a significant relationship 
between the thalamus and cognitive dysfunction in Alzheimer’s but not Parkinson’s 
disease.  Memory deficits are the hallmark of AD but attention and executive function are 
most affected in PD-D (Bronnick, et al., 2007) and a memory deficit is not specifically 
required for diagnosis of PD-D (Emre, et al., 2007).  Some patients do experience 
significant trouble with working memory (Emre, 2003) and mainly struggle with keeping 
information ‘in mind.’  For example, when asked to repeat back a sequence of numbers – 
either in the order given to them, or in reverse order, patients will not be able to remember 
which numbers, beyond a few that were presented to them (Woods & Troster, 2003b).   
An extensive meta-analysis undertaken by Emre, (2010) shows that verbal memory 
is deficient in PD-D compared to control subjects, but it still remains better than AD 
patients.  Patients will generally experience episodic memory deficits where the memory 
content of past events is not able to be consciously accessed (Baddeley, 2002).  It is 
interesting that in a phenomenon specific only to PD, patients are able to recognise stimuli 
when it is presented to them, but may not be able to verbally recall the information on 
request (Dubois & Pillon, 1997).  In the California Verbal Learning Test, for example, a 
series of words are presented to a patient and he is asked to recall these at a later time.  For 
patients with dementia the recall is very difficult and they typically cannot provide more 
than a few words.  Conversely, when these same words are presented visually and the 
patient is asked to confirm whether they were part of the original test sample, performance 
rate is significantly higher (Breen, 1993).   
 Another possibility is that the white matter that runs through the thalamus was not 
large enough to reflect FA changes in our sample.  This has been demonstrated in 
Parkinson’s disease before  when the tracts of the basal ganglia were examined (Nilsson, et 
al., 2007).  The authors found that although there were increased MD and decreased FA 
values in the region of the nigrostratial tract it was not possible to track the white matter 
THE THALAMUS IN PARKINSON’S DISEASE:  
A multimodal investigation of thalamic involvement in cognitive impairment 
Chapter 6 | 160 
tract through this region as they were only of a minor magnitude.  The integrity of the 
thlamic-cortico tracts may be better measured using tractography as this has been 
successfully applied to examine basal ganglia-thalamocortical circuit connectivity in PD 
before (Hamasaki, Yamada, Hirai, & Kuratsu, 2010).  After stimulation of sub-thalamic 
nucleus, those patients who had greater white matter volumes showed greater improvement 
in symptoms, thought to be due to the better connectivity in the thalamocortical circuit.  
These results indicate that although the tracts within the thalamus of our PD patients may 
not have been detected using diffusion imaging in this instance, they could potentially be 
large enough to be examined successfully using a tractography approach – a hypothesis 
which is examined in Chapter 9.   
6.8.3.2 Mean Diffusivity Differences 
Mean diffusivity measures of the thalamus did support the hypothesis, the groups with 
higher cognitive impairment have higher MD values.  In our sample, the dementia group 
shows the most cellular alterations, with thalamic MD values significantly higher than both 
the control and unimpaired group.  After excluding the control participants in order to 
control for clinical co-variates, MD values are higher than both the unimpaired and MCI 
group.  To the best of our knowledge this is the first study to find increased diffusivity in 
the thalamus of PD patients which has a relationship with cognition and also show 
significant comparisons between the dementia group and other PD groups without 
dementia.  This indicates that thalamic changes cannot be solely due to the motor 
symptoms of PD.   
Diffusion values of the thalamus have been examined in PD before and confirm our 
results.  Nicoletti et al., (2006) reports trend level increases in PD compared to control 
subjects who did not meet criteria for dementia.  Peran (2010) also reports higher 
diffusivity in PD without dementia compared to control subjects, at a significant level.  
Increased diffusivity in these samples could be reflective of cognitive dysfunction as there 
is no increases in diffusivity between patients with PD and those with other parkinsonism 
disorders of a highly motor phenotype.  In the Rizzo, et al., (2008) sample for example PD, 
PSP and CBDS patients were all examined using DTI.  Diffusivity differences were only 
approaching significance between control subjects and all patient groups, indicating the 
motor dysfunction and disease duration evident in these groups was not reflected in 
thalamic disruption.  Cognition was not examined but all subjects Hoehn and Yahr and 
UPDRS scores reflect examination in the off state, indicating motor dysfunction was at a 
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level worse than normally reported in motor disorders and there were still no cellular 
changes in thalamus.   
We have also shown that thalamic diffusivity is a reliable biomarker that can 
discriminate between the different cognitive subtypes of Parkinson’s disease.  Mean 
diffusivity values show a significant area under the curve in RoC analysis for comparisons 
between the unimpaired and MCI and dementia groups.  Raw mean diffusivity values 
cannot distinguish between the similar PD-MCI and PD-D groups however.  Interestingly, 
after adjusting for co-variates including age, disease duration, depression and motor score 
the adjusted MD is able to distinguish between these two groups.   
Other attempts have been made at identifying biomarkers for Parkinson’s disease 
but, as yet there is currently no well established biomarker for the distinct cognitive levels 
within PD (Breen, Michell, & Barker, 2011).  Because deficits in executive function, 
visuospatial function and memory are present even in the very early stages and indicate 
higher chance of a later progression to dementia (Janvin, et al., 2006), it is important that 
these symptoms are identified as early as possible.   
Other attempts have been made to investigate the earliest biomarkers of cognitive 
dysfunction in PD but are applied with limited success.  Amyloid B concentrations in 
newly diagnosed PD patients, for example, had a significant linear relationship with 
memory, but are not useful for examination with visuospatial and executive dysfunction 
(Alves, et al., 2010).  The level of cortical plaques can be directly measured by looking at 
the amount of amyloid beta in the cerebral spinal fluid as there is an inverse relationship 
between B-Amyloid and plaques (Strozyk, Blennow, White, & Launer, 2003).  Another 
study (Compta, et al., 2009) showed that amyloid B levels in CSF are higher in control 
subjects, intermediate in PD patients without dementia and lowest in PD-D patients, and 
could prove to be an early marker for cognitive dysfunction.  There is a strong association 
between this measure and semantic fluency – an executive function measure, known to be 
impaired in the early stages.  In this study the PDND patients had lower scores in memory, 
executive function and visuospatial functioning than controls, indicating that most 
individuals were exhibiting some degree of mild cognitive impairment but as this was not 
specifically diagnosed according to any criteria it is difficult to establish to what degree 
cognition was impaired in this group.   
The sensitivity of MD to the different levels of cognitive dysfunction in our PD 
groups has also been reported in other neurodegenerative studies.  In Alzheimer’s disease 
for example, when cognitive impairment is advanced the thalamus shows both structural 
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degeneration and a significant disruption in diffusivity (Zarei, et al., 2009) but in pre 
Alzheimer’s mild cognitive impairment there is no structural difference in the volume of 
the thalamus between AD-MCI and AD, although there is a significant increase in 
diffusivity between the two groups (Cherubini, et al., 2010).   
In contrast to the majority of research that has examined PD-MCI we have 
diagnosed MCI within the PD group according to criteria that has proven to be valid when 
compared against other criteria (Dalrymple-Alford, et al., 2011; Litvan, et al., 2012).  This 
makes diffusivity a stronger biomarker in PD as varying levels of cognitive impairment, 
not just dementia, can be identified.   
6.8.4 Thalamic influence on cognition  
The relationship between the above level of thalamic disruption is inferred to be reflective 
of cognitive dysfunction due to the higher levels of cognitive impairment evident in those 
groups who exhibit greater thalamic disruption.  Robust statistical analyses further 
examined the relationship in order to control for extraneous variables.  Mean diffusivity 
measures of the thalamus had the strongest relationship with cognitive dysfunction in this 
cohort.  For the first time, this research found a strong relationship between MD and 
multiple cognitive domains.  It was the only measure of thalamic integrity that was an 
independent predictor of: attention/working memory/processing speed; executive function; 
visuospatial/visuoperception and learning and memory as well as global Z score.  After 
adjusting for demographic and clinical co-variates MD still had a strong independent 
relationship with the cognitive variables and could be practical in estimating the level of 
thalamic integrity disruption once their global Z score is known.   
Thalamic diffusivity has clearly shown a relationship with cognitive domains in 
multiple disorders (de Jong, et al., 2008; Houtchens, et al., 2007) but no other disorders 
have been examined with such extensive neuropsychological testing, making this research 
the first to show thalamic diffusion measures have a strong independent relationship with 
multiple areas of cognition as measured by several different tests.   
In other neurodegenerative disorders, the results between thalamic diffusion values 
and cognition are varied and difficult to examine due to the different methods used to 
quantify cognitive function.  Thalamic MD has shown an independent relationship with 
cognition in Schizophrenia (Spoletini, et al., 2009).  There was a clear disease effect, 
thalamic diffusivity was higher in patients compared to controls and there was a correlation 
between the right thalamus of the schizophrenic group and working memory.  In temporal 
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lobe epilepsy (Wang, et al., 2010) there was a strong relationship between diffusion values 
of the right thalamus and a category fluency task (a measure of executive function).  In 
Multiple Sclerosis, mean diffusivity of the thalamus is increased in patients compared to 
controls, and has a strong relationship with the paced auditory serial addition task with is a 
measure of information processing and attention (Tovar-Moll, et al., 2009).  In 
Alzheimer’s disease (Canu, et al., 2010), patients were diagnosed as having moderate to 
severe AD and showed increased diffusion in multiple subcortical regions, including in the 
thalamus bilaterally.  When grey and white matter volume loss were included as co-
variates, only the effect in the right thalamus remained significant. 
From results of other disease samples it is unlikely that FA is related to cognition, a 
result that also supports our findings.  In the temporal lobe epilepsy example, reduced FA 
was seen in bilateral thalamus of patients compared to controls.  FA showed a direct 
relationship with epilepsy specific characteristics such as age of seizure onset and duration 
of epilepsy but did not show any relationship with cognitive measures (Wang, et al., 2010).   
6.9 Summary  
Here, we have applied comprehensive cognitive testing to a large sample of Parkinson’s 
disease patients of varying cognitive state.  We have used advanced medical imaging and 
analysis techniques to examine the differences between subject groups and report results 
that have taken the motor confounds of Parkinson’s disease into account.  We report that 
the microstructural integrity of the thalamus is compromised in Parkinson’s disease, even 
when thalamic volume is maintained.  This subtle abnormality shows a strong relationship 
with multiple areas of cognition and can be used to discriminate between the cognitive 
subtypes of PD.  The practical applications of these results are widespread.  Cognitive level 
of a patient can already be identified within Parkinson’s disease using neuropsychological 
tests and accepted criteria for diagnosis.  Although the criteria for PD-D is widely used, 
controversy still surrounds the PD-MCI criteria, and in some cases a patient is identified as 
unimpaired when other criteria would diagnose them with MCI (Dalrymple-Alford, et al., 
2011).  An incorrect diagnosis is distressing for patient and family and we hope, by 
exhibiting that the thalamus can be used as a biomarker for cognitive impairment we have 
gone some way in aiding the detection of MCI in PD.  
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Chapter 7. Study Two: THE THALAMUS IN STANDARD 
SPACE  
7.1 Objectives  
The objective of this chapter was to compare our findings of thalamic atrophy and cellular 
disruption, identified in native space in the previous chapter (Chapter 6), to standard space 
analysis of the same groups.  As the thalamus has been examined more frequently in 
standard, rather than native space, a secondary objective was to compare previous findings 
with our findings.  Previous studies have typically applied whole brain analysis instead of 
region of the region of interest approach applied in our study so comparison between these 
two methodologies will also explored.  Similar to the analyses conducted in the previous 
chapter, the relationship between thalamic integrity and cognitive function in Parkinson’s 
disease will be examined and compared with that of the healthy control group.  This 
chapter begins with a literature review which covers brain changes that have already been 
identified in Parkinson’s disease using VBM.  Again, the literature review is not restricted 
to changes only within the thalamus and will also address wider brain changes due to the 
influence the thalamus has on the wider neocortex.   
7.2 Voxel Based Morphometry 
Voxel based morphometry (VBM) is an automated imaging method which allows for 
comparison of all image voxels within any part of the brain.  The whole brain can be 
examined without arbitrary definition of regions of interest or reliance on user consistency 
(Burton, et al., 2004) and without the requirement of a prior hypothesis about the areas of 
interest (Ashburner & Friston, 2000).  Essentially, the VBM process involves segmenting 
individual MR images into grey, white and cerebral spinal fluid.  The integrity of the grey 
and white matter tissue reflects the integrity of underlying neurons and synapses.  Grey 
matter, for example is made up of neuronal cell bodies, dendrites, axon terminals and glial 
cells - although it is impossible to tell to what degree each component is represented.  
White matter volumes mainly consist of the mylenated axons which connect neuronal 
bodies (Kanai & Rees, 2011).  The tissue to be studied – typically only the grey and white 
matter, is transformed to standardised space and each groups’ images are averaged to a 
template.  The voxel within each image is then able to be compared and any areas of 
difference between groups is able to be identified (Good, et al., 2001).  VBM is 
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advantageous in that the whole brain volume can be extracted from other non brain matter 
such as the skull or sinus tissue and grey and white matter volumes can also be extracted 
and compared independently (Bozzali, Cercignani, & Caltagirone, 2008).   
7.3 VBM in Parkinson’s disease 
In PD, there are grey matter changes in both cortical (Camicioli, et al., 2009; Cordato, 
Duggins, Halliday, Morris, & Pantelis, 2005; Pereira, et al., 2009) and subcortical 
(Brenneis, et al., 2003) areas.  In PD patients who also have dementia, grey matter density 
occurs to a greater degree and in wider regions than those that are implicated in PD (Lee, et 
al., Ibarretxe-Bilbao, Tolosa, Junque, & Marti, 2009; 2010).  In the thalamus, grey matter 
density is only reduced in PD dementia patients, (Beyer, Larsen, et al., 2007; Burton, et al., 
2004; Nagano-Saito, et al., 2005b; Summerfield, et al., 2005), showing no change in PD 
without dementia (Burton, et al., 2004; Nagano-Saito, et al., 2005b; Summerfield, et al., 
2005).  The protocols applied to VBM methodology can vary widely, add to this the 
inevitable variation between patient samples and controversy surrounding the details of 
grey matter loss in PD remains.  Some studies report no change in PD (Price, et al., 2004) 
or PD-D (Sanchez-Castaneda, et al., 2009) compared to healthy control subjects.   
7.3.1 Grey Matter Changes in Parkinson’s disease without dementia 
In PD patients without dementia grey matter decreases are evident in both cortical and 
subcortical regions.  The degree and distribution of integrity changes described are widely 
variable however, mostly due to the criteria that is used in the diagnosis of dementia.  In 
some cases the DSM-IV criteria (2000) is applied, but generally neuropsychological testing 
is limited.   
 Only the caudate nucleus (Brenneis, et al., 2003) and the area surrounding the left 
intraparietal sulcus (Cordato, et al., 2005) have been implicated in PD patients without 
dementia, showing significant volume loss compared to healthy control subjects.   
When more advanced neuropsychological testing has been applied, the relationship 
between grey matter changes and cognition is further supported.  Camicioli, et al., (2009) 
used several neuropsychological tests (DRS, CDR and MMSE) to examine cognition and 
exclude dementia in an older PD group.  Grey matter loss was only evident in the bilateral 
cerebellum, an area that is normally involved in motor function but also plays a role in 
some cognitive functions (Gordon, 2007).  Despite no changes in the Camicioli, et al., 
study, the integrity of several structures including the temporal gyrus, temporal lobe and 
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putamen did have a significant correlation with the long delay free recall component of the 
California Verbal Learning Test.  This structure-function relationship was independent of 
any age effects.  The caudate nucleus and the temporal lobe also correlated with a 
composite measure of executive function - derived from several tests including the Stroop, 
the Trail Making Test and the Digit Ordering Test, suggesting that in this sample at least, 
slight grey matter changes in some areas have a relationship with cognition in PD.   
Along with memory and executive function, visuoperception also has a relationship 
with grey matter deficits in both cortical and subcortical structures in PD.  In a sample of 
PD patients without dementia (Pereira, et al., 2009), for example, visuoperceptual function 
was significantly worse in the PD patients compared to control subjects.  Visuoperception 
ability in this instance was an aggregate of tests of facial recognition, recognition memory 
and visual discrimination.  Grey matter integrity of the parietal, occipital and frontal 
regions, as well as the fusiform gyrus in the temporal lobe had a significant correlation 
with the facial recognition task.  Subcortically, the parahippocampus was also correlated 
with the facial recognition task.   
In contrast to the above results, Price, et al., (2004) reported no areas of grey matter 
changes between PD and control subjects after examining the whole brain using VBM.  
The protocol that was applied to both the Camicioli, et al.,  and Price, et al., studies 
originated from the same group and has been validated in some large samples (Ashburner 
& Friston, 2000; Good, et al., 2001) indicating this discrepency between results is likley 
due to variation in a different aspect of the methodology that was applied in each study.   
7.3.2 Grey Matter Changes in Parkinson’s disease with dementia 
In PD patients with dementia there are multiple cortical and subcortical regions of the brain 
that show distinct patterns of grey matter loss.  Compared to a control sample, grey matter 
loss has been identified in the bilateral prefrontal, temporal, occipital and right parietal 
areas of PD-D patients (Lee, et al., 2010).  Subcortically, grey matter loss is primarily 
evident in areas that are known targets of Lewy body inclusions (Braak, et al., 2003) 
including the hippocampus and cingulate gyrus (Ibarretxe-Bilbao, et al., 2009).   
The location and degree of grey matter loss in PD still remains controversial 
however, even in PD dementia.  Neither of the above studies adjusted for covariates, 
indicating that the grey matter loss in this instance may be due to effects of age or disease 
duration, rather than dementia.  When years of education and the severity and duration of 
PD has been controlled for in PD-D (Sanchez-Castaneda, et al., 2009), no areas of grey 
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matter change were identified.  In this same sample, the left parietal cortex and right 
occipital lobe did show reduced grey matter prior to adjustment for covariates, suggesting 
that patient characteristics other than their cognitive function are influencing results.  In the 
Sanchez-Castaneda, et al., (2009) sample, although cognition was examined there was no 
relationship between grey matter density and measures of attention, memory or 
construction abilities, further supporting the idea of grey matter degeneration being 
influenced by factors other than cognitive dysfunction.   
7.3.3 White matter changes in Parkinson’s disease and Parkinson’s disease 
with dementia 
Some PD samples also show distinct patterns of integrity reduction in white matter which 
appears to occur in the absence of grey matter changes.  In very early stage PD patients 
(disease duration = 3 years) for example, there was a significant reduction in white matter 
of the right fusiform gyrus and temporal gyrus compared to control subjects (Martin, 
Wieler, Gee, & Camicioli, 2009).  Although these areas are commonly implicated later in 
PD (Beyer & Aarsland, 2008), at the time of examination patients were not showing any 
atrophy.  Similarly, in another group of early PD patients (Disease duration = 6.33 years) 
without dementia there was a small cluster of white matter reduction in the brainstem of 
the PD group compared to the control group.  This result was independent of age, disease 
duration and severity and also occurred in the absence of grey matter changes (Jubault, et 
al., 2009).   
Increases in white matter density have also been observed in early-mid stage 
(disease duration 5.5 years) PD patients without dementia (Focke, et al., 2011).  There was 
a small cluster of increased white matter volume in the right superior longitudinal 
fasciculus but this did not remain significant after whole brain correction.  White matter 
changes may occur prior to grey matter changes in the early stages of PD, but when 
dementia has developed grey matter, rather than white matter changes predominate.  In the 
Lee, et al., (2010) sample mentioned earlier, for example, areas of white matter reduction 
are less widespread than grey matter reduction and localised to the left temporal, occipital 
and prefrontal areas while grey matter reductions were evident in bilateral dorsolateral 
prefrontal, temporal, occipital, posterior cingular and right parietal cortical areas.   
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7.3.4 The progression from PD to PD-D as measured by VBM 
The comparison between PD and PD-D and control subjects shows a distinct pattern of 
cortical and subcortical changes different to that of DLB (Lee, et al., 2010) or AD 
(Almeida, et al., 2003) indicating that it is pathology specific to PD that underlies these 
changes.  Within PD, cortical changes are more evident in PD-D than in PD.   
A recent cross sectional study (Nisho, et al., 2010) has shown that in PD patients 
with no cognitive impairment there is still large areas of change in the frontal, temporal 
and occipital cortices compared to the control group.  In the PD-D group of this same study 
further grey matter decreases were evident in the same areas that were implicated in the PD 
group and also in the parietal cortex and cerebellum when compared with the PD-N group.  
All contrasts in this study were independent of movement impairment confounds (UPDRS-
III) suggesting frontal, temporal and occipital grey matter reduction contributes to 
dementia in PD.   
Some longitudinal studies have isolated regions most involved in the progression 
from PD to PD-D.  Longitudinal studies follow patient groups for the duration of the 
disease and, as such, allow for greater interpretation of grey matter correlations with the 
cognitive symptoms of PD.  Burton, et al., (2004) employed both cross-sectional and 
longitudinal methods to show the progression of grey mater changes.  Compared to the 
control subjects, only the frontal lobes were reduced in PD-N.  In PD-D, grey matter loss 
extended to the frontal, temporal, occipital and parietal lobes as well as subcortical 
structures within the limbic system.  At one year follow up (Burton, McKeith, Burn, & 
O'Brien, 2005) in a small subset of the original cohort atrophy was significantly increased 
in these same areas in PD-D compared to both the PD and the control group.  Total grey 
matter density was significantly associated with cognition, directly highlighting the 
influence of grey matter degeneration in the development of dementia.   
The progressive nature of grey matter reduction in PD was also explored by 
Ramirez-Ruiz, et al., (2005).  PD patients with and without dementia were initially 
examined and re-examined at two year follow up.  In the PD patients without dementia, 
grey matter loss was primarily restricted to the subcortical limbic regions; the 
hypothalamus, nucleus accumbens and left hippocampus all showed some degree of grey 
matter reduction.  In PD-D patients, grey matter loss was mainly in cortical regions.  At 
follow up the limbic and wider temporal regions all showed further reduction in the PD 
patients.  In the PD-D groups there was widespread grey matter loss in the temporal 
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regions.  Cognitive function was measured using several neuropsychological tests, all of 
which concentrated on learning and memory.  When co-varied against the degree of grey 
matter loss, the grey matter differences between pre and post MRI lost significance, 
supporting the idea that grey matter loss in PD is significantly related to cognitive decline.   
7.3.5 Identifying grey matter changes in PD-MCI as a precursor to dementia 
The degree of grey matter atrophy in PD also appears to be related to the time of dementia 
onset.  Those with a shorter duration of PD prior to dementia (<8 years) show greater 
absolute and subcortical atrophy than those who develop dementia later in disease stage 
(Beyer & Aarsland, 2008).  The first study to examine PD patients who also had MCI 
(Beyer, Janvin, et al., 2007) suggested that the degree of grey matter atrophy reflects the 
progression of cognitive impairment in PD.  Beyer et al., (2007) showed that although 
there were no grey matter changes in PD patients who did not have MCI compared to 
healthy control subjects, in those that did have PD-MCI, the frontal gyrus and small areas 
within the bilateral temporal lobes were all significantly reduced.  This result did not 
survive correction for multiple comparisons and was no longer significant when age was 
included as a co-variate in the ANCOVA analysis which renders the results questionable 
however.  In contrast, the PD-D patients had areas of significantly reduced grey matter 
within the bilateral frontal, limbic, parietal and temporal lobes which survived corrections 
for the effect of age, suggesting changes are more robust in advanced stages of the disease.   
Dalaker et al., (2010) also reports no change in grey matter density in any brain 
regions between PD-MCI and PD without MCI.  Despite there being no obvious changes 
between groups there were some significant correlations between the association areas of 
the cortex within the frontal and temporal gyrus and reduced performance on a composite 
measure of attention/executive function.  These were lost once the co-variates age, motor 
severity (UPDRS III) and intracranial volume were included in a regression analysis 
however.   
The progressive nature of cortical changes in PD was also examined by Song and 
colleagues (2011).  This research included comparisons between PD-MCI and PD-D but 
did not include a control group for comparison.  Their results largely confirm that of the 
Beyer (2007) study with the exception that all grey matter differences remained significant 
after the inclusion of age, education, total GM volume and disease duration in ANCOVA.  
Some caution must still be applied when interpreting these results as no correction was 
made for multiple comparisons.  Results showed that grey matter atrophy increased with 
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cognitive dysfunction, the PD-MCI group had decreased grey matter in the right frontal 
area compared to the PD-N group.  In the PD-D group there were areas of decreased grey 
matter in bilateral temporal and left prefrontal areas compared to the PD-MCI group.  The 
authors conclude that the location and degree of GM atrophy of PD-MCI appears to 
represent an intermediate stage between PD-N and PD-D, implying that PD-MCI is the 
initial stages of PD-D and this is reflected in cortical atrophy levels.   
Recent work from our own lab Melzer et al., (2011b) was the first to fully 
investigate the progressive nature of PD, including comparisons between PD-N, PD-MCI, 
PD-D and a healthy control group in a cross-sectional design.  The sample included 104 
PD patients and 39 control participants matched for age, sex and education level, making it 
the largest PD sample of this nature to date.  There was no grey matter atrophy evident in 
the PD-N group compared to controls, but density loss was clearly evident throughout the 
PD group as cognitive impairment worsened.  In the PD-MCI patients, there was only 
moderate loss in temporal and frontal areas in comparison to control subjects.  In PD-D 
there was more extensive loss in these same regions and other regions such as the 
prefrontal regions and, subcortically in the parahippocampus and the caudate nucleus.   
As the cortical changes associated with cognitive dysfunction were a primary focus 
here, the PD-MCI and PD-D groups were further compared against the PD-N group and 
the UPDRS III score added as a covariate to control for any grey matter changes that may 
have mainly been influenced by the movement, rather than cognitive dysfunction within 
the PD groups.  The intermediate nature of the MCI stage is immediately evident within 
these comparisons.  Between PD-MCI and PD-N, grey matter reductions are slight 
compared to the loss that is evident in the PD-D group when compared to PD-N.  There is 
also no further loss between the PD-MCI and PD-D group, indicating the grey matter 
changes detected in PD-MCI are subtle reductions and that only select cortical regions 
need to be affected before cognitive impairment is evident.  There were no areas of change 
between PD-N and the control group, highlighting that the integrity changes throughout 
this cohort cannot be attributed to the motor dysfunction of PD alone.  
Extensive neuropsychological testing was conducted in the Melzer, et al., (2011b) 
study – the same testing has been applied to a different sample in the course of this 
research (see Chapter 5).  Regression analysis using an amalgamation of these 
neuropsychological measures showed a relationship between global cognitive score and 
areas of the: posterior cingulate cortex, parietal, occipital, frontal and temporal cortices as 
well as temporal subcortical regions including the hippocampus and medial thalamus. This 
THE THALAMUS IN PARKINSON’S DISEASE:  
A multimodal investigation of thalamic involvement in cognitive impairment 
Chapter 7 | 172 
relationship persists after correcting for multiple comparisons and is unlikely to be due 
solely to motor deficits as there is only a small area of the frontal gyrus that had a 
relationship with UPDRS III score when cognitive score was co-varied for.   
7.3.6 VBM and the thalamus  
Grey matter loss in the thalamus has only been identified in PD-D.  There is a significant 
bilateral (Burton, et al., 2004) and left (Summerfield, et al., 2005) grey matter reduction in 
PD-D compared to control subjects.  Although both these studies also included a PD group 
without dementia for comparison, there were no significant grey matter changes between 
PD and PD-D.   
A further research group (Nagano-Saito, et al., 2005a) and a later study by Beyer et 
al., (2007) has implicated thalamic degeneration in the cognitive, rather than motor 
symptoms of PD.  The bilateral (Nagano-Saito, et al., 2005b) thalamus was reduced in a 
PD-D group compared to a PD group and, in the later study, the right pulvinar was also 
implicated in PD-D compared to a PDND.  In this case, the PDND group also included 
some PD-MCI subjects which suggests the pulvinar is most implicated when cognitive 
impairment is advanced and is unlikely to show change when cognitive impairment is not 
evident (Beyer, Janvin, et al., 2007).   
Not surprisingly, grey matter reduction in the thalamus has also been implicated in 
relation to movement dysfunction of PD.  In patients with unilateral resting tremor the 
thalamus shows a significant grey matter increase contralateral to the tremor side, a 
phenomenon not evident in control subjects (Kassubek, et al., 2002). 
VBM is advantageous over native space analysis in that it allows for identification 
of individual voxels that change within an area of interest.  Each voxel that shows a change 
can be identified with provision also made for change to be shown if only large 
aggregations of adjacent voxels are also changed.  In the thalamus, large clusters of voxels 
that have changed normally approximate a thalamic nucleus.  This has been demonstrated 
in the PD-D group examined by Beyer & Janvin, et al., (2007) who reported grey matter 
reduction in a cluster of voxels in the pulvinar region in the absence of the wider thalamus.  
The mediodorsal nucleus of the thalamus has also been implicated in this way in PD 
patients with depression (Cardoso, et al., 2009), discussed in Section 4.5.1.4.  In both 
studies VBM has allowed for identification of areas of change that would have been 
missed using native space analysis as, in both cases changes were only focal and the whole 
thalamus did not show any atrophy.   
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7.3.7 Diffusion and VBM 
Four studies so far have also applied the voxel based method to diffusion tensor images.  
This combination of methodology enables detection of the subtle cellular changes that DTI 
is sensitive to, but in standardised space.  The frontal and temporal degeneration typically 
identifiable in PD using traditional VBM methods (Beyer, Larsen, et al., 2007; Song, et al., 
2011) is able to be detected much earlier on in the disease stage using diffusion VBM.  
Significantly decreased fibre directionality (a measure of axonal integrity) is evident in the 
frontal and temporal regions of non demented PD patients with short (6 years) disease 
duration (Kendi, et al., 2008).  Axonal integrity is likley the first step of degeneration as no 
grey, or white matter loss was evident in any region of these patients.  Diffusion changes 
within the frontal lobes were greatest in the supplementary motor area, prefrontal areas and 
the anterior cingulate.  Although the PD patients were reported as having ‘no cognitive 
impairment’ this was only measured using the MMSE and, on average patients were 
scoring lower than the optimal 30 points (28.2) so could have had some slight cognitive 
impairment that went undetected, and this could be associated with the subtle changes 
detected.  The idea that the fibre changes are influencing cognition is supported by the fact 
that, with exception to the motor area of the cortex, all other regions that showed change 
have previously been implicated in other studies of cognitive impairment.  The anterior 
cingulate and prefrontal areas (Nagano-Saito, et al., 2005b) are commonly involved in 
executive function and memory deficits (Aarsland, Bronnick, Larsen, Tysnes, & Alves, 
2009) in early and late stage Parkinson’s disease.  Lewy body density in the anterior 
cingulate has also been shown to be predictive of later cognitive deficits in Parkinson’s 
disease (Kovari, et al., 2003).   
Prior to the development of motor symptoms or cognitive impairment, early 
olfactory changes are considered to be some of the earliest symptoms of PD (Doty, Stern, 
Pfeiffer, Gollomp, & Hurtig, 1992).  Combination DTI and VBM has been used to detect 
the neurocorrelates of olfactory deficits in early PD.  The first study (Ibarretxe-Bilbao, et 
al., 2010) to identify disruption in the olfactory system using this method showed a 
significant decrease in fibre directionality (FA) and cellular integrity (MD) of the 
cerebeller and orbifrontal cortex of PD compared to control subjects.  Disease duration of 
this patient group was on average, 3 years and motor dysfunction was at Hoehn and Yahr 
stage I and II so patients would not have been exhibiting a great degree of motor 
symptoms.  Olfactory changes may therefore be evident prior to even the earliest clinical 
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presentation of motor dysfunction in some cases.  Change in the rest of the olfactory 
system were later confirmed by Zhang, et al., (2011) who established that decreases in the 
fibre directionality within the cerebeller and orbifrontal cortex of PD patients corresponds 
to clinical measures of olfactory dysfunction.  The degree to which these areas change can 
also be used as early biomarkers of PD and are able to correctly identify PD from control 
subjects in 94.1% of cases (Scherfler, et al., 2006).   
7.4 Summary  
Voxel based morphometry methodology allows for the automated examination of the 
whole brain without reliance on controlling for variance between users or the need for a 
prior hypothesis (Ashburner, et al., 2003).  VBM has been applied in various PD samples, 
identifying changes in large areas of cortex and some subcortical regions.  Implicated areas 
include frontal, temporal and occipital regions (Lee, et al., 2010) and, subcortically the 
regions within the temporal lobe (Ibarretxe-Bilbao, et al., 2009).  Changes are more 
extreme and evident in larger areas in PD groups who also have dementia (Beyer, Janvin, 
et al., 2007), and degeneration co-varies with cognitive decline in longitudinal studies of 
PD cohorts (Burton, et al., 2005).  Typically, grey matter degeneration is the most common 
finding in PD and in PD-D, but in some cases white matter degeneration has also been 
identified and is a reliable biomarker olfactory dysfunction (Scherfler, et al., 2006).  Grey 
matter degeneration has also been found in the thalamus in some PD samples and is most 
extreme in those cohorts who have advanced cognitive decline (Burton, et al., 2004; 
Summerfield, et al., 2005).  In contrast to what is able to be achieved in native space, VBM 
enables detection of sub regions of change within wider regions of interest.  This allows for 
the identification of change that is not able to be measured from the gross volume analysis 
available in native space.  Voxel based methodology can also be applied to diffusion 
images to detect the most subtle of cellular changes.  Few studies have applied this method 
to PD cohorts, but in those that have, diffusion measures reveal significant cellular 
disruption in regions that later show significant white or grey matter degeneration 
(Karagulle Kendi, et al., 2008).  Despite this methodology being able to detect early, subtle 
changes that covary with some of the earliest symptoms of PD this method has not yet 
been applied in the thalamus of PD patients in relation to cognitive dysfunction.   
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7.5 Hypothesis 
 That results in standard space will reflect those identified in native subject space 
and the integrity of the thalamus will reflect cognitive dysfunction in Parkinson’s 
disease  
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7.6 Method 
7.6.1 Participant information  
All participants (Section 5.2) were included in this analysis, the final sample consisted of 
images from 92 Parkinson’s patients, of these 17 were classified as PD-D, 19 as PD-MCI 
and 56 as PD-N.  All 25 control subjects were also included.  
7.6.2 Imaging pre-processing 
The structural (T1) and diffusion (MD and FA) images were used for the voxel based 
analysis.  All VBM processing was completed using SPM 5 (Friston, 2005) in Matlab 
R2008a (Massachusetts, USA: The Math Works, INC) using the following steps. 
7.6.3 Image analysis 
7.6.3.1 Standardised elderly template 
Due to the age of our participants a probabilistic template (Lemaître, et al., 2005) based on 
an elderly sample of 331 males and 331 females (age 65-72) was used for the segmentation 
procedure to reduce age bias and ensure more accurate segmentation and normalisation. 
7.6.3.2 Segmentation 
Unified segmentation (SPM 5) was used to segment images.  The segmentation process 
classifies brain tissue into three tissue types: grey matter, white matter or cerebral spinal 
fluid (Figure 7-1) based on the prior probability of any voxel in a subject’s image 
belonging to any of the tissue classes.  This is able to be achieved irrespective of tissue 
intensity.  The standard probability maps are generated by registering a large number of 
subjects together, assigning all voxels to the different tissue types and averaging the tissue 
classes over subjects.   
 
The Thalamus in Standard Space 
Chapter 7 | 177 
a) 
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Figure 7-1: Segmented whole brain images  
a) grey matter, b) white matter, c) cerebral spinal fluid segmentation.  
7.6.3.3 Normalisation 
The normalisation procedure involves assigning images stereotactically to standard space – 
in this instance subject images were normalised to the elderly template during the 
segmentation procedure.  The primary function of this procedure is to enable inter-subject 
averaging and characterisation of anatomy as all individual subject regions are assigned to 
the same location in space as each other.  Normalisation involves matching the study 
images to the template image using a series of algorithms.  Normalisation begins with 
registration.  The whole of the head is first matched to the template then only the cortex is 
matched together – using appropriate weighting of the voxels of the template.  This 
procedure is automated and accounts for the confounding effects of skull and scalp 
differences, searching for the solution that maximises the probability of the registration 
being correct.   
a) 
 
b) 
 
c) 
 
Figure 7-2: Normalised whole brain images  
a) Grey matter , b) Normalised and modulated, c) Normalised, modulated and smoothed. 
7.6.3.4 Modulation 
The segmented and normalised images were modulated to compensate for the effect of 
normalisation, as when a series of images are warped to match a template, volumetric 
differences are introduced into the warped images.  Modulation of the grey matter images 
preserves the volume of tissue within each voxel (Burton, et al., 2004).  The procedure 
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involves adjustment of the signal proportional to the amount of warping by simply 
multiplying the relative volume of the normalised images before and after the warping 
procedure.  The total amount of grey matter signal is now preserved in the resulting images 
irrespective of any volume changes that may have occurred in the previous steps.   
7.6.3.5 Smoothing  
The template and source images should have approximately the same smoothness in order 
for the data to be normally distributed and allow for statistical analysis to be applied 
(Ashburner & Friston, 2000).  The elderly template has been smoothed by 8mm so the 
segmented, normalised and modulated images were smoothed using a 8mm FWHM 
isotropic Gaussian kernel to improve the signal to noise ratio.   
7.6.4 Creation of the thalamus template  
In order to restrict analysis to only the thalamus, a study specific template was created by 
averaging 20 previously defined thalamus images (n = 5 from each group).  
   
Figure 7-3: The thalamus template 
A study specific thalamus mask was created and VBM analysis restricted to this area only.  The template is 
seen here overlayed on the standardised elderly template.   
7.6.5 Statistical Analysis 
Statistical analysis for participant characteristics are described earlier (Section 3.3.1).  
Smoothed images from the pre-processing steps were analysed using SPM 5 (Friston, 
2005).  SPM is based on the general linear model and identifies regions of tissue with 
increased or decreased density or concentration that is significantly related to the effects 
being studied (Ashburner & Friston, 2000).  The following voxel-based analysis (VBA) of 
grey and white matter, mean diffusivity and fractional anisotropy were performed using 
this analysis.   
Differences between groups were assessed using between and within analysis of 
variance (ANOVA).  Additional analysis of co-variance were also performed where age, 
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education and depression were included as co-variates in the first instance before excluding 
control subjects in order to focus on the changes within Parkinson’s disease.  Analyses 
restricted to Parkinson’s disease patients co-varied for the disease specific variables 
disease duration and UPDRS III in addition to the original variables.   
Multiple regression analyses examined the relationship between grey matter 
concentration and multiple measures of cognition using the general linear modelling 
feature of SPM5 which allows for all study images to be entered into the analysis along 
with the desired co-variates.  The relationship between the intensity of each voxel and the 
cognitive measures were examined accounting for the following co-variates: age, 
education, depression, disease duration.  The same model was applied to examine the 
relationship between cognition and white matter, mean diffusivity and fractional 
anisotropy voxel values.  The cognitive domains examined were the same as those 
previously: attention/working memory/processing speed; executive function; 
visuospatial/visuoperception and learning and memory.  Global Z Score, an aggregate 
measure of the above scores was also included.  All results are presented at the voxel level.  
The co-ordinates for the anatomic location with maximal gray matter loss within each 
significant cluster are reported in MNI space.   
To examine the influence of pre-processing steps, grey and white matter volumes 
of the thalamus in native space were extracted for each individual using Matlab 2008 
(Massachusetts, USA: The Math Works, INC).  ANOVA, ANCOVA and regression 
analysis were conducted in Statistica 2001 (Tulsa, USA: StatSoft, INC) following the same 
models with the same co-variates as above.  In addition, Medcalc (Schoonjans, 1993) was 
used to create receiver operating characteristics of the grey and white matter measures to 
determine the discriminatory nature of the variables.  
In all analyses only the thalamus was examined.  Significance levels were set at     
p < 0.05 and corrected for multiple comparisons using the family wise error rate.  
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7.7 Results  
7.7.1 Participant information 
As all participants were included in this analysis demographic characteristics are identical 
to those reported in Table 6-2.  In brief, the four groups were well matched in terms of 
education, depressive symptoms and the group distribution of sex and handedness.  The 
PD-MCI and PD-D groups were older and had lower levels of premorbid IQ than the PD-N 
and control groups however.  As expected, there was progressive worsening of clinical 
characteristics from PD-N to PD-MCI to PD-D.  Cognitive characteristics are identical to 
those reported in Table 6-3, as before, the dementia group exhibited the lowest levels of 
cognitive function, the PD-N group a level within the range of that of healthy control 
subjects and the PD-MCI group a level that was generally intermediatery between the PD-
N and PD-D groups.   
7.7.2 Cross sectional changes in thalamic concentration  
The grey matter and white matter concentration levels of the thalamus were compared 
between the two groups.  To examine the similarity between the thalamus in native space 
and standardised space, mean diffusivity and fractional ainsotropy of the thalamus was also 
compared between groups.  Grey and white matter values were extracted from the 
standardised images and examined using general linear modelling in Statistica.  The mean 
diffusivity and fractional ainsotropy values were examined using voxel based analysis in 
Matlab.   
7.7.2.1 Grey and white matter concentration  
Mean grey and white matter concentration levels are shown in Table 7-1 with mean values 
after inclusion of demographic covariates presented in Figure 7-4.  With the exception of 
total grey matter volume in the dementia group which was slightly positively skewed (SW-
W = 0.89, p = 0.05) all variables met the assumption of normality and the Levene’s test for 
homogeneity of variance.  There was no group or hemisphere effect for the level of grey 
matter concentration.  Adding age, education and level of depressive symptoms did not 
change results [F(3,110) = 0.29, p = 0.84] nor did excluding control subjects and adding 
the clinical covariates disease duration and UPDRS [F(2,84) = 0.10, p = 0.90].   
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Table 7-1: Mean (SD) group differences in thalamic grey and white matter integrity  
 Control 
(n = 25) 
Unimpaired 
(n = 56) 
MCI      
(n = 19) 
Dementia 
(n = 17) 
 Group 
Effect 
 Hemisphere 
Effect 
  F p  F p 
Grey Matter 8272.97 
(1363.15) 
8653.94 
(1185.21) 
8326.76 
(836.04) 
8469.62 
(1449.63) 
 0.72 0.54  0.68 0.41 
Left 4158.26 
(675.18) 
4331.15 
(618.86) 
4133.68 
(424.22) 
4287.27 
(748.48) 
      
Right 4114.80 
(697.66) 
4322.85 
(616.95) 
4193.07 
(443.04) 
4182.34 
(720.42) 
      
White 
Matter 
4994.83 
(970.13) 
5251.78 
(1276.95) 
4802.56 
(1343.54) 
4865.08 
(1070.18) 
 0.94 0.42  52.77 <0.001 
Left 2581.52 
(474.73) 
2770.01 
(702.12) 
2521.36 
(716.77) 
2552.67 
(548.13) 
      
Right 2413.32 
(545.20) 
2481.78 
(621.30) 
2281.23 
(645.41) 
2312.39 
(539.37) 
      
Grey and white matter concentration is reported mean (SD) in mm
3
.  There was no group effect and no 
hemisphere x group interactions for either measure.   
There was also no group effect for white matter concentration in the thalamus, 
although there was a main effect of hemisphere in the left > right direction.  There was no 
group x hemisphere interaction; the hemisphere effect was consistent for all groups.  
Adding covariates did not result in a group effect [F(3,110) = 0.49, p = 0.69] and reduced 
the hemisphere effect so that it was no longer significant [F(1,110) = 0.01, p = 0.92].  
Results did not change with the addition of clinical covariates [F(2,84) = 0.48, p = 0.62].  
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Figure 7-4: Grey and white matter concentration after controlling for covariates 
There was no group difference in mean grey (a) and white (b) matter concentration values.  Lines represent 
standard error bars.   
7.7.2.1 Diffusion integrity changes  
Mean diffusivity measures have previously been shown to be sensitive to cognitive group 
when the thalamus was examined in native space (Section 6.7.4).  To investigate whether 
this result held when the thalamus was examined in standard space several pairwise 
comparisons were made using VBM analysis for all groups on both FA and MD measures 
(Figure 7-5).  Results were consistent with the native space results.  Mean diffusivity was 
again sensitive to group at the voxel level, the PD-D group exhibited increased diffusivity 
in several thalamic areas relative to all other groups.   
 L  
 R 
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Figure 7-5: Pariwise comparison of control and PD-D group.  
Areas of significantly increased mean diffusivity (p < 0.01) are overlayed on the mean brain T1 template in 
saggital, coronal and axial view.   The blue crosshair is positioned onto ventral posterior lateral thalamus 
(MNI co-ordinates 16, -20, 2). 
The size and coordinates of each area are reported in (Table 7-2).  The ventral regions of 
the thalamus were particularly susceptible; the largest areas of thalamic change were 
between the PD-D and the control and PD-N groups.  A smaller thalamic area also showed 
increased mean diffusivity in the PD-D group relative to the PD-MCI group.  Fractional 
ainsotropy was not reduced in any group.    
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Table 7-2: Areas of significant difference in MD within the thalamus  
       
MNI coordinates  Area  T value  FWE Corrected (p<0.05) 
x y z       
    
C vs PD-D    
8 -12 0  Ventral Anterior  5.18  <0.001 
-12 -22 -6  Ventral Lateral  5.16  <0.001 
-16 -22 4  Centromedian/Parafascicular  5.06  0.001 
-8 -10 -2  Centromedian/Parafascicular  4.64  0.003 
16 -20 2  Ventral posterior lateral  4.36  0.007 
20 -24 6  Ventral posterior lateral  4.10  0.017 
20 -26 -2  Ventral posterior lateral  3.78  0.045 
         
PD-N vs PD-D    
8 -12 0  Ventral Anterior  4.46  0.005 
5 -12 4  Centromedian/Parafascicular  4.41  0.005 
-5 -10 -6  Ventral Anterior  4.29  0.009 
-2 -12 5  Mediodorsal  3.91  0.030 
18 -24 5  Ventral Lateral  3.85  0.037 
14 -24 4  Centromedian/Parafascicular  3.82  0.040 
20 -28 -2  Ventral posterior lateral  3.68  0.059 
         
PD-MCI vs PD-D    
16 -20 2  Ventral Lateral  3.79  0.042 
-14 -22 -4  Centromedian/Parafascicular  3.75  0.048 
The regions of the thalamus that show significantly increased mean diffusivity.  FWE: family wise error  
7.7.3 The association between the integrity of the standardised thalamus and 
cognition 
The relationship between thalamic measures and cognition was examined in Matlab with 
multiple regression analyses.  The relationship between each thalamic measure and 
cognitive domain was examined separately for control participants and PD patients.  In the 
models for the control subjects age, education and depression were included as covariates.  
There was no relationship between any measures of the thalamus and cognition within the 
control group (Table 7-3).  The additional covariate disease duration was added when 
multiple regressions were restricted to patients only.  Similar to the regression results for 
the thalamus in native space (Section 6.7.5) mean diffusivity measures of the thalamus 
were more sensitive to cognition than the other diffusion or integrity measures.  Mean 
diffusivity measures in large areas of the thalamus had a strong correlation with overall 
global cognition and all individual cognitive domains except the learning and memory 
domain (Table 7-3).  White matter concentration and fractional ainsotropy did not have an 
association with any cognitive subset.   
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Table 7-3: Size (mm
3
) of thalamic clusters which have a significant relationship with cognition 
 Global Z Score  Attention/WM/ 
Processing Speed 
 Executive Function  Visuoperception/ 
Visuospatial 
 Learning and 
Memory 
 Size T (p value)  Size T (p value)  Size T (p value)  Size T (p value)  Size T (p value) 
Control Subjects 
Grey Matter 0  0  0  0  0 
White Matter 0  0  0  0  0 
Mean Diffusivity 0  0  0  0  0 
Fractional Anisotropy 0  0  0  0  0 
          
PD Patients 
Grey Matter 0  0  0  0  0 
White Matter 0  0  0  0  0 
Mean Diffusivity 256  4.23, (0.02)  112 4.03 (0.03)  552 4.32 (0.03)  96 3.97 (0.03)  0 
MNI co-ordinates 6 -14 2  6 -14 0  6 -14 0  8 -22 2   
Area CM/Pf  CM/Pf  CM/Pf  CM/Pf   
Fractional Anisotropy 0  0  0  0  0 
The relationship between thalamic measures and cognition.  Size of the area of the thalamus (mm
3
) which has an association with each measure after accounting for the co-
variates: age, education and depression in the case of control subjects with disease duration an additional covariate added for the PD patients models.  P values are reported 
after family wise error correction.  MNI: Montreal Neurological Institute; CM/Pf: Centromedian/Parafascicular region.  
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7.8 Discussion 
7.8.1 Summary of the results  
We expected the standard space examination to reflect the results of the native space study 
in that thalamic degeneration would reflect cognitive dysfunction in Parkinson’s disease.  
This hypothesis was only partly supported.  When mapped to standard space, the thalamus 
does not show any reduction in integrity across the cognitive spectrum of Parkinson’s 
disease despite the results of the native space analysis indicating a volume reduction in PD-
D.  Diffusion tensor image results, on the other hand are more sensitive to cognitive 
impairment and reflect native space results, there is a significant disruption in cellular 
integrity in the PD-D group compared to healthy control subjects and the PD patients 
without cognitive impairment.  VBA allows for the identification of regions of change 
within the thalamus instead of only detecting thalamic change if it induces atrophy of the 
whole structure.  Along with the motor regions of the thalamus, the ventral posterior, 
centromedian and mediodorsal regions all showed significant cellular disruption.  The non-
specific centromedian/parafascicular region had the greatest degree of change, and after 
accounting for covariates was heavily implicated in all aspects of cognition except learning 
and memory.  The centromedian/parafascicular region was the only region that was 
implicated in cognition however, no other regions had an association with any cognitive 
domains.   
7.8.2 Standard space results compared to native space results  
Comparisons between the methodology used in this chapter and the one previous yielded 
different results, the level of change detected in the thalamus in standard space is not as 
great as when the thalamus is examined in native subject space.  The thalamus shows no 
change in white or grey matter integrity between any groups in this study.  The lack of 
thalamic change is consistent with previous VBM results reported from our own group 
(Melzer, et al., 2011b) but in contrast to previous results which do show a reduction in PD-
D relative to control subjects in the bilateral (Burton, et al., 2004) and left (Summerfield, et 
al., 2005) thalamus and a reduction in PD dementia relative to those PD without dementia 
in the bilateral (Nagano-Saito, et al., 2005b) and right pulvinar region of the thalamus 
(Beyer, Janvin, et al., 2007).  Our results are mostly consistent with Peran, et al., (2010) 
who is the only other study to apply both standard VBM and native space analysis to the 
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thalamus of the same PD sample.  In the Peran, et al., cohort, the authors determined that 
the regions were accurately assessed in all instances and the subcortical structures created 
on the VBM map did not show any noteworthy variations between subjects compared to 
manually defined regions.  Results were mostly the same as seen in our cohort; mean 
diffusivity of the thalamus was significantly increased in PD relative to controls, when 
examined in both standard and native space.  Fractional anisotropy results were in contrast 
to ours however, FA was reduced in the left thalamus in both VB and native space analyses 
but was only showed reduction in the right thalamus in native space.   
The reason for the discrepancy between our results and those of previous studies is 
unlikely to be due to methodological differences as the protocol used here is the optimised 
VBM protocol created by (Good, et al., 2001) which was also applied in all the above 
studies except the one conducted by (Nagano-Saito, et al., 2005b).   
The results here reflect examination of the thalamus only, rather than the whole 
brain approach which was used in all previous studies, which could account for 
discrepencies.  After the normal image analysis processing we created a template of the 
thalamus using a subset of patients from each cognitive group and restricted statistical 
analysis to this area only.  A similar method was used in Summerfield, et al., (2005) where 
volumetric analysis was restricted to the wider temporal lobe area (caudate, lentiform 
nuclei, cingulate gyrus, anterior cingulate, thalami, insula, extranuclear region, amygdala, 
hippocampi, and the parahippocampus gyri).  When comparing the results of these two 
studies the whole brain approach appears to be best for detecting gross regions of atrophy 
such as in the cortex of the temporal or frontal lobes.  It is only when these areas are 
excluded from the analysis that further changes in smaller regions are evident.   
When the wider cortex of the temporal lobe was excluded in the (Summerfield, et 
al., 2005) analysis for example, further subcortical changes that had not been previously 
identified were evident.  Larger areas of the hippocampus and the putamen, accumbens, 
hypothalamus and thalamus also showed significant grey matter reduction.   
In relation to our own whole brain VBM analyses, there is no thalamic change 
(Melzer, et al., 2011b).  This is despite the sample size of patients being more than 
adequate and patients of a similar level of impairment as the previous studies.  The patients 
included in the Melzer, et al., (2011b) study are also very similar to the ones that have been 
examined in this thesis, indicating the similarity between our results and the dissimilarity 
with others may, in fact be due to the patient sample.  As, in both studies from our group 
the patients were of lower cognitive state, had a higher Hoehn and Yahr score and were 
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older than the others it is unlikely they were not showing significant levels of impairment 
however.   
 VBM of the whole brain has been compared directly with a region of interest 
approach, using both an automated and manual method in standardised space (Kennedy, et 
al., 2009).  Manual tracing methods are considered to be the gold standard in 
neuroanatomy analyses, and compared to manual tracing, whole brain VBM produced 
stronger differences between subject groups and a different spatial distribution of changes 
compared to manual measures.  This suggests that the whole brain VBM approach has a 
high propensity for Type II error.  When VBM was restricted to previously defined 
anatomical regions however, the gross differences between VBM and manual methodology 
disappeared suggesting that it is not the VBM methodology itself that is prone to error, 
rather, spurious results are likely when a large area is examined for change.   
The Kennedy, et al., (2009) study was conducted on a large cross-sectional sample 
of healthy non demented adults to examine the relationship between age and cortical grey 
matter reductions.  The optimised VBM protocol of Good, et al., (2001) was applied for 
the whole brain VBM analysis.  Study specific masks for subcortical structures were 
manually drawn on the T1 coronal image of one patient and then registered to standard 
space, a method similar to the one applied in this thesis.  Unfortunately the thalamus was 
not included in the masking procedure and cortical regions of interest were restricted to the 
anterior cingulate gyrus, dorsolateral prefrontal cortex, temporal and parietal regions.  
Subcortically, only the hippocampus and parahippocampal gyrus were included.   
VBM whole brain results showed a widespread and less differential pattern of age 
differences than the manual volumetric method.  Furthermore, a direct comparison 
between manual tracing and VBM derived masks of subcortical structures revealed that, 
for some regions the whole brain VBM actually produced isolated outliers that enhanced 
the association with age.  This elevated sensitivity of whole brain VBM suggests that the 
positive findings of regions of change for VBM results should not be taken at face value.  
The reason for the occurrence of spurious results is thought to be due to the spatial 
smoothing of an image.  When an image is spatially smoothed the resolution of that image 
is consequently reduced, serving to average smaller structures in such a way that small 
differences are amplified (Allen, Bruss, Brown, & Damasio, 2005).   
When just the hippocampus and parahippocampal gyrus were compared using the 
previously defined masks in the above study however, the discrepancy between whole 
brain and manual methods disappeared.  VBM, therefore does seem to provide realistic 
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estimates of differences in regional grey matter, but only when applied to masked regions 
rather than whole brain regions.  The authors recommend that whole brain VBM analysis 
be used as a hypotheses-generating method.  Any areas of difference that are identified 
should then be explored further using masking or manual tracing methods.  In relation to 
our results, the contrast between our report of no grey matter reduction in the thalamus and 
the grey matter reduction that others have identified could be due to the fact that the whole 
brain VBM approach has lead to misleading results.   
One study does show a similarity between whole brain and masked VBM 
approaches, with the sensitivity of the masked VBM approach increased in the thalamus.  
In patients with chronic pain the thalamus shows a similar level of grey matter atrophy in 
both a whole brain and masking VBM approach (Gwilym, Filippini, Douaud, Carr, & 
Tracey).  Initially, the authors conducted a whole brain VBM analysis to examine 
neurocorrelates of pain in patients with osteoarthritis of the hip.  The thalamus was one of 
the regions implicated in this initial analysis but the significance of the comparison 
between pain patients and healthy controls disappeared after provision for multiple 
comparisons were made.  The thalamus was then isolated using a masking approach.  
Results were similar between the two methods, when masked from the whole image the 
thalamus showed a significant reduction in the pain patients and the result remained 
significant as multiple comparisons did not need to be taken into consideration.  In both 
cases the change was isolated to the bilateral medial thalamus which has been implicated in 
pain processing in only a few cases before (Apkarian, et al., 2004).   
Our discrepancy between manual and VBM masked results is therefore most likely 
due to the differences in the underlying tissue that is measured using the two methods.  
VBM is restricted to measuring one tissue type at a time (Good, et al., 2001).  Voxel based 
measures in standard space only take into account white and grey matter where white 
matter tissue primarily consists of the axons of a cell body and grey matter is the cell 
bodies themselves, along with dendrites and other extracellular and intracellular structures 
that form the total cell structure (Kanai & Rees, 2011).  Volumetric measures of atrophy on 
the other hand take into account all cellular structures and all tissue types.  The fact that we 
found no grey matter, or white matter reductions in the thalamus in this sample could 
suggest that the overall atrophy levels found in the manual tracing sample are reflective of 
the cumulative degeneration of total neurons – structures which are reflected in both grey 
and white matter.  Although degree of neuronal degeneration does normally correspond 
with the degree of volume loss observed in the thalamus of PD patients, this is only true for 
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some of the thalamic nuclei (Halliday, 2009; Henderson, et al., 2000a).  The lack of grey 
matter reduction identified in our sample therefore could indicate that neuronal loss alone 
is not occurring to a degree that is great enough to be detected by VBM.  The volume loss 
identified in native space study could be reflective of the degeneration of extracellular 
structures alongside neuronal loss and could account for the differences in results between 
the two methodologies.  This idea is supported by the fact that diffusion tensor analysis 
was more sensitive to cognitive dysfunction in PD than grey matter analysis in this sample, 
in line with results seen in our native space study (Section 6.7.4).  Although there were no 
grey or white matter changes between any of the PD groups, mean diffusivity images 
showed significant differences between PD-D and all other groups.   
 One VBM study has also applied region of interest guided VBM of white matter 
maps of the thalamus in Parkinson’s disease with the objective of comparing patients with 
and without co-morbid depression (Li, et al., 2010).  Decreased FA was evident bilaterally 
in the patients with depression and PD compared to those PD patients without depression.  
The region most implicated was the mediodorsal region of the thalamus.  This result is in 
contrast to our VBM analysis where no differences were found in the white matter of the 
thalamus – most likely due to the fact the patients in the (Li, et al., 2010) sample were of 
normal cognition and the patients in our sample were not showing any depressive 
symptoms.   
 No other studies have examined the thalamus in standard space in PD.  Our results 
that diffusion measures are disrupted in the absence of any integrity measures are 
somewhat supported by previous research in other cortical regions of PD however.  Fiber 
integrity in temporal and frontal regions is disrupted in early PD (Karagulle Kendi, et al., 
2008) and regions of the olfactory system also show significant diffusion changes in PD in 
the absence of any integrity changes (Ibarretxe-Bilbao, et al., 2010; Scherfler, et al., 2006; 
Zhang, et al., 2011).  Analysis of diffusion tensor images allows for the earlier detection of 
change than grey or white matter integrity in standard space.   
In line with the discrepancy between volume and integrity measures of the 
thalamus, DTI results in standard space are not as sensitive to cognition as DTI results in 
native space.  Although fractional anisotropy measures showed no change between groups 
in either case, mean diffusivity showed progressive increases across the cognitive spectrum 
of PD in the native, but not standard space analysis.  Diffusivity in the PD-MCI group was 
increased relative to PD-N in native space for example, and a further increase was shown 
in the PD-D group relative to PD-MCI.  In contrast, the standard space results only 
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revealed a change in diffusivity once cognitive impairment was extreme, showing an 
increase in PD-D relative to PD-MCI but not in PD-MCI relative to PD-N.  The 
discrepancy between the two studies is likely an artifact of the VBM methodology as 
several other studies also report less sensitivity when interpreting small structures using 
VBM (Brookstein, 2001; Davatzikos, 2004; Kennedy, et al., 2009).   
7.8.3 The influence of the thalamus on cognition from standard space 
examination  
Grey matter changes did not support the hypothesis, there no areas of grey matter change 
in the thalamus and no association between grey matter volume and any aspect of 
cognition in our sample.  It is difficult to draw conclusions about this in PD as previous 
studies have either not conduced analysis (Beyer, Larsen, et al., 2007; Burton, et al., 2004; 
Summerfield, et al., 2005) or report no relationship (Dalaker, et al., 2010; Nagano-Saito, et 
al., 2005b) between thalamic grey matter and cognition.  The above studies have 
implicated the thalamus in PD-D relative to control subjects and in PD-D relative to PD-N 
however, so by virtue of the fact that the thalamus shows a reduction in the group with 
cognitive dysfunction our results could be considered to be in contrast to this.   
As the bilateral thalamus has also been implicated in mild cognitive impairment of 
the Alzheimer’s type (Pennanen, et al., 2005; Teipel, et al., 2010), this suggests that there 
could be some association with the thalamus in PD patients with cognitive impairment.  In 
the Pennanen, (2005) sample the thalamus was significantly reduced relative to control 
subjects.  No statistical analysis was conducted to determine the influence this had on 
cognition but it could be assumed that the thalamus was at least partially influential on the 
development of AD symptoms.  In the Teipel, (2010) study the influence on grey matter 
atrophy in the thalamus was additionally examined in patients who converted to AD at 
follow up and MCI patients who had not converted to AD at follow up.  The thalamus was 
one of the only regions of subcortical atrophy identified in the MCI subjects who later 
converted to AD.  The thalamus was also implicated in another AD study (Chetelat, et al., 
2005) and showed a significant level of grey matter reduction in the patients that converted 
from MCI to AD.   
The contrast between findings of thalamic involvement in PD and AD could be due 
to confounds of the motor dysfunction of PD as one study (Kassubek, et al., 2002) reports 
an increase in the grey matter of the thalamus in PD as a result of motor dysfunction.  The 
grey matter increase was reported in the hemisphere contralateral to the side PD movement 
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symptoms originated in, suggesting this was due to compensatory mechanisms.  If grey 
matter increases reflect movement dysfunction it can only be assumed that, when analysed 
with VBM this serves to ‘cancel out’ any grey matter decreases that may be occurring as a 
function of cognitive dysfunction.   
In terms of the mean diffusivity changes in the thalamus in PD, the second 
hypothesis was supported.  We have shown for the first time that areas of change were 
restricted to only some regions of the thalamus and were mainly isolated to the motor 
ventral anterior and lateral nuclei and to the association mediodorsal nucleus and the non-
specific centromedian/parfascicular area.  Diffusivity was significantly increased in these 
areas of PD-D relative to all other groups.   
Our VBM study did not allow for analysis of the relationship between each 
thalamic region and cognition and, overall, results only partially suggest a domain-specific 
influence on cognition.  In total, mean diffusivity measures of the thalamus show an 
association with executive function, attention, visuospatial/visuoperception function and 
the aggregate global Z score.  The only cognitive domain not implicated was learning and 
memory.  The relationship between diffusion measures of the thalamus and executive 
function is somewhat in accordance with the results of (Rose, McMahon, et al., 2006) who 
report that diffusion measures of the right thalamus are significantly correlated with 
measures of executive function in participants with MCI of the Alzheimer’s type.  In 
contrast to our mean diffusivity results however, the diffusion measure used in the Rose, 
McMahon, et al., (2006) sample was fractional anisotropy rather than mean diffusivity and 
our sample shows no change in fractional anisotropy measures.   
In regards to the regions within the thalamus, the mediodorsal nucleus has 
previously been extensively implicated in performance on attention, memory and executive 
function tasks in Schizophrenia (Kemether, et al., 2003) and it is therefore somewhat 
surprising that no relationship with memory is evident in our sample.  It is also surprising 
that the ventral anterior and ventral lateral nuclei are both implicated in cognition here, as 
traditionally they are considered to be pure motor influences (Jones, 2007a) and analyses 
was conducted here independently of disease duration effects which may have otherwise 
accounted for this result.   
 The centromedian/parafascicular association with cognition was the only expected 
result.  This region has traditionally been considered ‘non-specific’ (Jones, 2007a) but has 
also been implicated in some of the frontal symptoms of Schizophrenia, including 
executive function deficits (Kemether, et al., 2003).   
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 The fact that learning and memory components of cognition are not implicated here 
could be due to the fact that this is commonly considered to be an anterior dominant 
(Aggleton & Brown, 1999) function and the anterior region of the thalamus showed no 
changes in diffusivity.   
Other regions of the cortex that are known to be involved in cognition have been 
implicated using VBM however, suggesting that the lack of thalamic findings here are 
most likely due to the difficulty that arises when examining small structures in VBM 
(Kennedy, et al., 2009) – not due to a lack of cortical change in our PD sample.   
7.8.4 Limitations of the study methodology  
Limitations inherent to whole brain VBM studies include confounds that arise from 
warping structures and cortices to the same space; a high risk of reporting false positive 
findings and difficulty in interpreting the results of small structures (Bookstein, 2001; 
Crum, Griffin, Hill, & Hawkes, 2003).  Registration to standard space has also been shown 
to work least well in groups where there are large differences in structures (Kennedy, et al., 
2009) – particularly around the ventricles.  As Parkinson’s disease patients typically have 
enlarged ventricles (Dalaker, et al., 2011) it was especially important to take this into 
consideration when conducting voxel based methods on this sample.  We hoped to 
overcome the majority of difficulties that typically arise during the whole brain VBM 
approach by masking out the thalamus from the standard space image and using a region of 
interest approach.   
Here, the region of interest approach shows no grey matter reduction of the 
thalamus in Parkinson’s disease; although this has been identified in previous research.  
There are two possibilities for this.  Firstly, that previous studies are reporting false 
positives or secondly, that the region of interest approach is not sensitive to thalamic 
destruction in Parkinson’s disease.  Due to the fact our group has previously used the 
optimised protocol (Good, et al., 2001) in a similar PD cohort and also found no thalamic 
changes (Melzer, et al., 2011b) the second hypothesis is unlikely.  Some previous studies 
have attempted a direct comparison between a region of interest approach and whole brain 
analysis.  One study found an increase in false positives when the whole brain approach 
was applied (Kennedy, et al., 2009) and the other, no difference between the two methods 
(Gwilym, et al.).  We conclude, therefore that the masked region of interest approach is 
comparable, if not better to the whole brain VBM approach.  As mean diffusivity results 
are similar to those we report in native space (Section 6.7.4) this provides further evidence 
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that the region of interest approach is more sensitive to ‘real’ thalamic degeneration and 
less prone to Type II error than the whole brain approach.  That is, grey matter density 
changes may not have been identified here as thalamic disruption may not have been to a 
degree great enough across the board of the thalamus to be reflected in an examination of 
the whole thalamus, a hypothesis that will be explored further in the subsequent chapter.   
7.8.5 Summary  
The thalamus was examined in standard space using a region of interest approach.  No grey 
matter reduction was found in the thalamus, a result that is in contrast to previous reports 
of thalamic reduction that has been identified using a whole brain approach (Beyer & 
Aarsland, 2008; Summerfield, et al., 2005).  Our own group, however has reported no 
thalamic changes using a whole brain approach in a similar sample (Melzer, et al., 2011b).  
We suggest that the discrepancy between the findings of our own group and others is due 
to methodological, and patient cohort differences.  Although the criteria of Good, et al., 
(2001) was applied across the board of studies we have segmented the thalamus from the 
whole brain and only applied the VBM methodology to this masked image rather than the 
whole image.  This method has been applied previously in other samples and found to 
reduce false positive findings (Kennedy, et al., 2009) or show no difference between this 
and the whole brain approach (Gwilym, et al., 2010).   
We conclude, therefore that the lack of grey matter reduction seen here in the 
thalamus, although in contrast to our own native space results (Figure 6-6) is a more likely 
finding than that that has been reported in pervious studies. As grey matter integrity 
reflects the neuronal body density and does not take into account the axonal white matter 
or other extracellular structures, we propose that neuronal density is not the only factor to 
take into consideration when examining native atrophy results.  The atrophy that is evident 
in native space is likely to be reflective of all other cellular components as well as neuron 
bodies.   
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Chapter 8. Study Three: THE THALAMIC NUCLEI IN NATIVE 
SPACE  
8.1 Objectives 
The individual nuclei that comprise the thalamus are addressed in this chapter.  The aim of 
this study is to examine the gross volumetric as well as the subtle cellular changes in 
clusters of the thalamus that are assumed to represent the main thalamic nuclei.  Thalamic 
nuclei changes that have already been identified in PD or in patients with other types of 
cognitive decline are briefly reviewed here from a variety of research methods including 
post mortem neuro-histology and in vivo magnetic resonance imaging (MRI).  The 
breakdown in cortico-thalamic connectivity will be addressed in the subsequent chapter 
(Chapter 9).   
8.2 Nuclei involvement in PD, dementia and cognitive dysfunction  
The cognitive symptoms of Parkinson’s disease are heterogeneous, pointing to the 
involvement of several cortical areas.  The structure – function relationship does not 
operate in isolation however and it is the interaction between cortical areas that is most 
important in Parkinson’s disease.  Braak (2003) suggests that the progression of Lewy 
pathology from preclinical, to symptomatic, to advanced disease spreads along axonal 
pathways that interconnect vulnerable brain regions.  The multifaceted symptoms of PD 
likely arise from this cortical wide disruption in connectivity and communication, affecting 
normal function and behaviour to a greater degree than the sum of degeneration in isolated 
areas could.  As the thalamic nuclei each show reciprocal connectivity with key areas of 
the cortex these subcortical structures are regions that are likely to reflect, or give rise to 
the degeneration that may be occurring in the wider cortex.   
8.2.1 Parkinson’s disease 
The midline and intralaminar nuclei have been frequently examined in PD due to their 
connectivity with the striatum and areas of the motor cortex (Jones, 2007a), areas heavily 
involved in PD motor dysfunction (Brooks & Halliday, 2009).  Degeneration in these 
regions is easily identified using both neuro-histology and in vivo MR methodology as this 
region of the thalamus can be visually identified from structural MR images with some 
success (Kemether, et al., 2003).  There are several subdivisions within both the midline 
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and intralaminar nuclei which have been individually implicated in distinct subtypes of 
motor symptoms in PD.  The midline nucleus consists of the patatenial nucleus (Pt) and the 
paraventricular (Pv) nucleus and lies dorsal to the larger intralaminar complex.  The 
intralaminar complex is an aggregation of several smaller nuclei and lies in the ventral 
region of the thalamus and is easily distinguished from the surrounding thalamus due to the 
border of the internal medullary lamina.  The intralaminar complex can be further 
distinguished into caudal and rostal components.  Larger in size, the caudal region includes 
the CM/ while the rostal region is comprised of the smaller central dorsal, central lateral 
(Cl) and central medial (CeM) nuclei (Figure 8-1).   
Figure 8-1:  Location of the components of the midline and intralaminar nuclei  
Coronal sections of the thalamus demonstrate the architecture of the midline (a) and intralaminar nuclei at the 
anterior (b) and posterior (c) ends of the thalamus.  Image modified from (Brooks & Halliday 2009).  AP: 
anterior principal; AD: anterior dorsal; Cu: cucullar; Pt: Paratenial; CL: central lateral; MD: mediodorsal; 
Pv: paraventricular; CeM: central medial; CM/Pf: centromedian/parafascicular.   
To date, only one MR study (McKeown, et al., 2008) has identified degeneration in 
the intralaminar region of PD patients compared to control subjects.  Although the volume 
of the whole thalamus was examined the only area of significant change was in the CM/Pf.  
The lack of total thalamic volume loss is consistent with other studies who report no 
overall thalamic volume reduction in PD patients (Peran, et al., 2010; Rizzo, et al., 2008), 
suggesting degeneration may only occur in select areas that are undetectable when 
measuring gross thalamic atrophy in PD patients without dementia.  Although cell loss was 
not specifically investigated in the McKeown, et al., sample thalamic degeneration was 
hypothesised to be due to the loss of neuronal and glial cells.   
Lewy pathology is in fact the likely cause of cell loss as cellular loss has been 
confirmed to occur as a function of the accumulation of the alpha synuclein (α-SN) protein 
a) Midline  Intralaminar  
   b)       Rostal c) Caudal  
 Pt and Pv  Cu, Cl and CeM  CM and Pf  
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which is the primary component of Lewy body (LB) and Lewy neurites (LN) (Volpicelli-
Daley, et al., 2011).  These pathological hallmarks of Parkinson’s disease (Baba, et al., 
1998) differentially target specific thalamic nuclei and could result in cell loss in some 
regions only.   
Several neuro-histological studies have identified heavy Lewy burden in some 
nuclei whilst others remain relatively spared.  Lewy pathology heavily infiltrates the CM, 
and to a lesser degree the Pf nuclei in PD (Rub, Del Tredici, Schultz, et al., 2002) for 
example, occurring in the early stages of the disease and increasing significantly in those 
groups with cognitive impairment (Braak, Rub, et al., 2006).   
Pathology is significantly related to the level of neuronal loss in PD.  In an 
aggregation of PD patients (Halliday, 2009) from several different autopsy studies (n = 37) 
who had a long (13 years) disease duration but no dementia, neuronal and volume loss was 
associated with pathology levels in some thalamic regions.  Components of the limbic loop 
(CL, CeM, Pt and Pv nuclei), an integral system for learning, memory and attention 
process, for example were heavy targets for PD-related pathology while the motor nuclei 
belonging to the striatal loop (CM, VA) were only lightly involved.  Nuclei in the 
cerebellar (VL) loop – which connects the premotor and primary motor fields (Braak, et 
al., 2000) and the medial region of the sensory (VP) nuclei were only infiltrated by a few 
LB’s or LN’s.  Not surprisingly, those regions that were heavily targeted by pathology also 
showed the greatest degree of neuronal loss.  Neuronal reduction was evident in the Pv and 
Pt nucleus, and was so severe in the Pt nucleus that gross atrophy was also visible 
(Henderson, et al., 2000b).  The posterior (VLp) and anterior (VLa) subdivisions of the VL 
nucleus and the VA nucleus, on the other hand did not exhibit any reduction in neurons, 
despite being critical components of the motor loop (Halliday, 2009).  The VL nucleus has 
shown neuronal loss at trend level in another PD sample (Xuereb, et al., 1991) however. 
The mediodorsal and anterior nuclei that primarily connect to the prefrontal and 
limbic cortices and the anterior cingulate cortex, respectively, were also included in the 
above works but did not show either neuron or volume loss (Halliday, 2009), although the 
AP nuclei was also implicated in the earlier work (Xuereb, et al., 1991) and reported to 
have an 80% reduction in neurons.   
There is a strong relationship between α-synuclein deposits, neurodegeneration and 
the appearance of clinical (motor, autonomic and neuropsychiatric) symptoms in PD 
(Hawkes 2010).  Total LB density is also significantly associated with the rate of annual 
decline in MMSE score (Aarsland, Perry, Brown, Larsen, & Ballard, 2005) and LB density 
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in frontal, temporal and associated subcortical (amygdala, hippocampus) regions correlates 
with a global deterioration scale of cognitive impairment, independently of Alzheimer’s 
neuropathology (plaques and tangles) (Mattila, et al., 2000).   
DTI images can be thought to be representative of underlying cellular integrity and 
density (Kinoshita, et al., 2008) and have confirmed that cell loss does not occur 
throughout the thalamus uniformly.  In the only DTI study to date that has examined the 
regions of the thalamus in PD patients, differential loss was found in PD patients with co-
morbid depression compared to those without (Li, et al., 2010).  The mediodorsal nucleus 
(MDn) had significantly higher mean diffusivity in patients with co-morbid depression 
with no corresponding changes in any other regions of the thalamus.   
8.2.2 Dementia 
Several thalamic nuclei are implicated in Parkinson’s disease dementia.  The post-mortem 
work by Brooks & Halliday (2009) in Lewy body diseases shows that the intralaminar Pv, 
CU and CL nucleus are all implicated in dementia as all three nuclei show increased levels 
of α-sync and trend level volume reduction in PD dementia (PD-D) compared to PD 
patients without dementia.  When analyses were collapsed across the other Lewy body 
disease patients who had either PD-D or DLB, the CL nucleus showed the strongest 
relationship with dementia as more volume loss was evident in this region in the PD-D and 
DLB groups compared to the non-dementing PD group.  The CL nucleus primarily projects 
to the anterior cingulate and prefrontal cortices (Van der werf, et al., 2002) suggesting that 
the attention and memory deficits of dementia may be, in part due to pathology in this 
region.   
 The intralaminar nuclei have also been implicated in Alzheimer’s disease.  LB 
pathology burden progressively affects the intralaminar nuclei while wider cortical 
pathology is still evolving and a significant linear relationship exists between the degree of 
LB burden and cortical stage of degeneration (Rub, Del Tredici, Del Turco, et al., 2002).   
 In vivo techniques have also identified select thalamic nuclei loss in dementia.  In 
PD dementia for example, whole brain voxel based morphometry (VBM) identified 
significant changes that co-varied with cognitive decline in the pulvinar (Pu) nucleus.  In 
PD-D patients there was also significant grey matter loss in frontal, limbic, parietal and 
temporal lobes bilaterally compared to non-dementing PD patients but the only subcortical 
region implicated was the Pu which had significantly reduced grey matter density on the 
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right side.  Robust statistical analyses were conducted on this sample and the reduction 
remained significant after inclusion of age, sex and disease duration covariates (Beyer, 
Larsen, et al., 2007).   
In Alzheimer’s disease, diffusion tensor imaging (DTI) techniques have identified 
significant cellular disruption in the limbic AP and association MDn nuclei (Chen, Kang, 
Hu, Hu, & Zou, 2007).  The dementia cohort in this instance was an AD group who also 
had cerebrovascular lesions (ADv).  Both limbic nuclei had disrupted cellular integrity – 
shown by an increase in mean diffusivity (MD), relative to AD patients without lesions.  It 
is impossible to determine whether this increase was due to higher levels of cognitive 
dysfunction in the ADv group however as only the MMSE was used to evaluate cognitive 
status of patient groups.  Also, as the relationship between MMSE and brain changes was 
restricted to changes in only the hippocampus, no insight into the thalamic influence on 
cognition can be provided.   
8.3 The identification of thalamic nuclei 
As cell size, density and the distribution of cells varies considerably between nuclei, the 
differentiation of individual thalamic regions is easily achieved under a microscope 
(Henderson, et al., 2000b).  Histological studies are limited to cross-sectional design as 
these characteristics are only able to be visualised post-mortem (Vernon, et al., 2010) and 
the in vivo visualisation of individual thalamic components has historically been more 
difficult as structural MR images remain normal in PD (Stoessl, 2011).  Although not 
easily visualised (Magnotta, Gold, Andreasen, Ehrhardt, & Yuh, 2000), it is possible to 
identify some of the larger thalamic nuclei by mapping the intensity changes between T1 
and T2 relaxation times in thalamic regions.  The intensity difference is assumed to be 
reflective of the variations in fibre size, density and myelination which comprise each 
nucleus (Deoni, Josseau, Rutt, & Peters 2005) but this method does not allow for 
quantification of cellular changes between regions.   
Recently, nuclear imaging has advanced and the longitudinal examination of 
thalamic nuclei changes in neurodegenerative disease may be possible.  New methodology 
must first be validated however and we seek to do this using a cross-sectional design here 
where the between group changes are assumed to represent disease progression and allow 
for the identification of areas that are most likely to degenerate through the course of 
disease.   
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Diffusion tensor imaging is a modern method of nuclear medicine that is sensitive 
to the microstructural architecture of cells and provides measures of water distribution 
thought to be reflective of underlying cellular structure and integrity (Watts, 2008).  DTI 
methods may be able to detect the changes that occur as a result of neuro-pathology, as 
these inclusions typically lead to neuronal cell loss and sometimes volume loss in the 
infiltrated regions (Henderson, et al., 2000a).  DTI also allows for the non-invasive in vivo 
visualisation of regional structures and can be used to differentiate between cellular 
aggregations that are assumed to represent individual thalamic nuclei.  The segmentation 
of thalamic nuclei is achieved through the grouping of similarly orientated axonal fibre 
tracts that traverse the thalamic region as they travel throughout the cortex, inter 
connecting multiple subcortical and cortical regions.  For the fibres that originate in the 
thalamus, the principal orientation of every fibre will vary depending on the cortical region 
of primary connectivity (Niemann, Mennicken, Jeanmonod, & Morel, 2000).  Within a 
nucleus, neuronal axons or fibres will primarily project to the same cortical region and thus 
will tend to orientate in the same direction (Figure 8-2).  The segmentation of nuclei 
therefore, is achieved through the grouping of fibres of the same principal direction by way 
of algorithms which examine the diffusion images.  
 
e) 
 
Figure 8-2: Identifying thalamic nuclei using diffusion tensor imaging  
Diffusion (represented by an ellipsoid, e) is strongest in the direction of prominent fibre orientation, Image 
from Watts, (2008).  Thalamic nuclei (b, c, d) have primary connectivity with distinct areas of the cortex (a) 
dictating that fibres within each nuclei will orientate in a similar direction.  Image from Behrens, et al., 
(2003).  Fibres of similar orientation can thus be grouped into clusters of thalamic nuclei.   
Successful segmentation of thalamic nuclei has been achieved in young, healthy control 
subjects (Wiegell, et al., 2003) but this method has not yet been validated in a disease 
sample.   
Behrens, et al., 2003 
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8.4 Summary 
The thalamus is topographically organised and each region preferentially connects to a 
distinct area of the cortex.  The thalamic nuclei are thus involved in cognitive processes 
specific to these regions and these regions are known to be affected in PD, indicating that 
thalamic nuclei are likely to also be affected.  Indeed, histological studies indicate that 
thalamic nuclei are differentially targeted by Lewy body pathology in PD and this 
corresponds to neuronal loss.  Measurement of cell loss in thalamic nuclei in vivo using 
advanced nuclear imaging techniques could be a sensitive measure of thalamic nuclei 
integrity.  Given the specificity of each region, degeneration of a specific nucleus is 
expected to correspond to decline in a related domain of cognition.  Integrity measures of 
thalamic nuclei could therefore provide neurocorrelates of cognitive dysfunction across the 
spectrum of PD.  Executive function deficits are particularly relevant, as this is an area of 
frontal dysfunction that is often the first cognitive symptom a PD patient will present and 
is one of the strongest contributing factors to later dementia development (Aarsland, et al., 
2003).   
The intralaminar CM/Pf complex is the only region of the thalamus that has been 
identified as showing volume loss in PD using MR imaging to date (McKeown, et al., 
2008).  Although the more sensitive DT imaging technique has previously been applied in 
PD, this has only identified cellular disruption in the mediodorsal region of the thalamus in 
PD patients with depression compared to those without (Li, et al., 2010).  As yet, imaging 
methodology has not been applied in a disease sample to all thalamic nuclei and compared 
to a healthy control group.  This study will therefore address a significant gap in the 
literature and examine the whole thalamic region, aggregated into specific nuclei regions in 
order to determine the value of diffusion tensor imaging as a neurocorrelate of cognitive 
dysfunction in Parkinson’s disease.   
8.5 Hypothesis 
 That individual regions of the thalamus will be differentially involved in 
Parkinson’s disease and reflect cognitive dysfunction  
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8.6 Method 
8.6.1 Participants 
The identification of the thalamic nuclei depended on judgments of size and location so in 
instances where the k-means clustering procedure produced unusually large clusters or 
when more than one nucleus (such as the VA and VL) was included in a single cluster this 
resulted in the exclusion of that subject.  Eight patients (PD-N = 5, PD-MCI = 1, PD-D = 
2) and one control participant from the original sample (Section 6.7.1) were excluded.  The 
final sample of participants for which thalamic nuclei were defined included 51 PD-N, 18 
PD-MCI, 15 PD-D patients and 24 control participants.  Exclusion of these participants did 
not result in any major discrepancy of clinical or cognitive characteristics between these 
groups and those in the previous chapters.   
8.6.2 K-means Clustering 
The thalamic nuclei were clustered separately for each hemisphere using a k-means 
clustering algorithm which was created specifically for this study.  The algorithm was 
based on an implementation by Wiegell et al., (2003) and was further developed using the 
specific study parameters for this research by Dr. Tracy Melzer and Dr. Richard Watts of 
the New Zealand Brain Research Institute.  The algorithm requires the definition of four 
specifications prior to implementation: number of clusters; initialisation of the cluster 
centroids; distance metric; and a convergence criterion and results in the creation of several 
clusters of similar voxels.  Each cluster is then able to be designated a primary label based 
on its size, location in the thalamus and approximation to adjacent clusters.  While 
recognising that each cluster is only an approximation of individual thalamic nuclei, they 
are henceforth labelled by their atlas name.  
8.6.2.1 Number of Clusters 
To determine the optimal number of clusters to be created for each thalamus the k-means 
clustering algorithm was applied to one image several times using a number of different 
clusters per hemisphere (n = 14, n = 16, n = 18, n = 20, n = 22, n = 24).  The trade-off 
between too few and too many clusters was optimised at 20 clusters (Figure 8-3) as 
similarly orientated nuclei such as the ventral nuclei combined to form one larger nucleus 
when k-means was set to find less than 20 clusters and small and meaningless clusters were 
created when the algorithm was set to find any more than 20 clusters.   
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b) 
 
c) 
 
Figure 8-3: Segmented nuclei after the k-means clustering procedure 
MNI co-ordinates are given in parentheses.  The a) saggital (Z: 26), b) coronal (Y: 63) and c) horizontal (X: 
68) sections of left and right thalamus (in radiological space) enable simultaneous visualisation of thalamic 
clusters.  
8.6.2.2 Initialisation of the cluster centroids 
The centroid is defined as the centre of the nucleus and is first generated based solely on 
spatial location and is thus uniformly distributed.  The first centroid was simply placed at 
the centre of the thalamus with each subsequent centroid then placed at a maximum 
distance from all other centroids.  The first centroid, for example would be located in the 
centre of the thalamus, with the second placed on the furtherest voxel from this location.  
The third centroid is then placed on the voxel furtherest from both the first and second 
centroid and so forth.  This process continues until all centroids are allocated a spatial 
location.   
8.6.2.3 Distance Metric 
The distance between voxels was defined using both spatial and tensor parameters to 
ensure the relationship between distance and direction was optimised.  Initial centroids 
were regenerated so similarly orientated voxels at a maximum distance from all others 
were combined to form a cluster.  For example, if the centroid 1 and the centroid 13 were 
similarly orientated, they would be combined into one centroid.  Specifically, the position-
diffusion tensor distance Ejk between a voxel j and a centroid k was taken as a linear 
combination of the voxel position distance and the diffusion tensor distance, i.e.:  
 
where χj is the location of voxel j,  is the mean voxel location for cluster k, Wk is the covariance matrix for 
the voxels in cluster k, y is a weighting factor to control the trade-off between the diffusion tensor distance 
and the voxel distance, Dj is the diffusion tensor for voxel j, and  is the mean diffusion tensor for cluster k. 
(Bishop, 1997; Hartigan & Wong, 1979; Wiegell, et al., 2003). 
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8.6.2.4 Convergence Criterion 
The clustering procedure continued through as many iterations as necessary until no voxels 
within a cluster were changed.  There was no restraint on the number of possible iterations 
although the process was manually disrupted in the event there were more than 1000 
iterations, as this indicated the algorithm had become circular.  In the majority of cases 20-
50 iterations were required before the clusters were defined.   
8.6.3 Nuclei Labelling 
Following multiple anatomical guidelines (Duvernoy, 1991; Jones, 2007b; Morel, Magnin, 
& Jeanmonod, 1997) the 20 clusters were assigned to 9 nuclei (MDn, LP, Pu, AP, LD, VA, 
VL, VP and CM/Pf).  Individual nuclei were labelled manually by one observer (N.B.) 
after reference to all three anatomical planes and consideration of location, size and the 
proximity to other nuclei.  Typically, multiple clusters made up structures such as the 
mediodorsal nucleus (Figure 8-4 b) which has several subdivisions while the lateral nuclei 
were comprised of one or two clusters (Figure 8-4 c).   
a) 
 
b) 
 
 c) 
 
Figure 8-4:  Combining clusters to form nuclei  
The clusters can be visually inspected and combined to form assumed sub-divisions of the thalamus 
according to anatomical guidelines, (Morel, et al., 1997) (a).  In the mediodorsal sub-division (b) several 
clusters are combined: Magnocellular (MDmc) - yellow; parvocellular (MDpc) - green, light blue, purple and 
paralamellar (MDpl) – dark blue. In the lateral sub-divisions (c) only one or two clusters are combined: VA - 
red; VL - blue, green and VP - purple.  All panels are presented in the axial plane.   
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Table 8-1: Aggregated thalamic clusters that approximate anatomical guidelines for thalamic nuclei  
Section and nuclei  Morel (1997) Guidelines Identified Nuclei 
Saggital 
MDn (red) 
LP (green) 
Pu (yellow) 
CM/Pf (blue) 
VA (yellow) 
VL (purple) 
VP (blue) 
 
 
Coronal  
AP (green)  
VA (yellow) 
VL (purple) 
 
  
Horizontal – Dorsal sections  
AP (green) 
LD (yellow - medial)  
MDn (red)  
CM/PF (blue) 
VP (light blue) 
LP (green) 
Pu (yellow) 
 
  
 
  
Horizontal - Ventral section 
AP (green) 
VA (yellow) 
VL (purple) 
VP (blue) 
LP (green) 
Pu (yellow) 
CM/Pf (blue) 
 
  
 
  
Coronal 
LP (green) 
Pu (yellow) 
CM/Pf (blue) 
 
  
The view that the nuclei is best visualised in is presented.  Images are in MNI standard space and are referred 
to using radiological convention, where the left side of the image is the right side of the brain.   
The anatomical guidelines used to identify nuclei are shown in Figure 8-4, with 
complete sections presented in Appendix 12.1.  Cluster aggregations were always viewed 
simultaneously in three planes.  The primary view was dependent on which nucleus was to 
be defined.  The LD, MDn and CM/Pf were identified first, and are best visualised in the 
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saggital plane.  The AP is best distinguished from the VA using the coronal plane, while 
the lateral nuclei are best identified using horizontal sections, beginning in the most dorsal 
slice and following continuous slices until the most ventral slice is reached.  Finally, the 
LP and Pu are easily identified in the coronal section, where the LP is immediately dorsal 
to the Pu, although these structures are also easily identified in the horizontal section where 
the LP is immediately anterior to the Pu.   
8.6.4 Statistical Analysis 
Between group differences were examined using a between and within groups analysis of 
variance (RM ANOVA) where the dependent variable was the measure of an individual 
thalamic nucleus (either volume, FA or MD), the independent variable was group (healthy 
controls, PD-N, PD-MCI and PD-D) and the within groups factor was hemisphere (left and 
right).  Only significant interactions are reported.  In the case of a significant group effect 
Newman-Keuls post-hoc comparisons were conducted.  In the case of a group x 
hemisphere interaction, follow up one-way ANOVA’s were conducted to examine the 
group effect independently of the hemisphere effect.  Kruskal-Wallis ANOVA was 
employed when non-parametric analyses were required.  To control for the confounding 
variables: age, education and level of depressive symptoms these were added to the 
statistical model in an analysis of covariance (ANCOVA).  To focus on the changes 
specific to Parkinson’s disease the control subjects were also excluded and the clinical 
covariates (disease duration and UPDRS III) additionally included in a similar ANCOVA 
model.   
In the first instance the relationship between nuclei and cognition was examined 
using Pearson simple correlations to determine if the relationship between the two was 
linear, as required to meet the assumptions for multiple regression.  All measures (vol, FA, 
MD) of all nuclei were included.  Subsequently, those nuclei showing a significant 
association with cognition were included in a series of backward elimination stepwise 
regressions where two models were used following the methodology of Stewart, et al., 
(2009).  To examine the proportion of unique variance in each of the cognitive domains 
(attention, learning and memory, executive function, visuospatial function) attributable to 
thalamic nuclei measures, a block of thalamic nuclei were entered as predictor variables.  
The unique proportion of variance attributable to each thalamic nucleus was determined by 
proceeding through several backward elimination steps where the nucleus that contributed 
the least variance was removed, followed by the next least variance and so forth until the 
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final model only included those nuclei that contributed a significant proportion of the 
variance in that cognitive domain.  A second block of predictors was then entered for each 
model to examine the effect of covariates.  Covariates (age, education, disease duration and 
depression) were entered alongside all nuclei that were originally entered in Model One.  
The change in the R
2
 coefficient from the first block of predictors to the second block 
represented the percentage of unique variance in a given cognitive measure attributable to 
that combination of nuclei.  The individual contribution of each nucleus was also 
determined from each final model using the Beta values.  The bilateral, as opposed to 
separate left and right measures were used for these analyses in order to prevent violation 
of the multi-colinearity assumption.   
Finally, the predictive validity of each nucleus ROI was examined using receiver 
operating characteristics curves (ROC).  Several pairwise comparisons were conducted for 
levels of cognitive impairment where each group was compared to both the control group 
and the PD-N group.  AUC statistics and the corresponding sensitivity levels are reported 
at least 80% specificity.   
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8.7 Results 
8.7.1 Participant information 
The demographic and clinical measures of participants for whom clustering of thalamic 
nuclei were determined are shown in (Table 8-2).  This sample is similar to that of the 
previous chapter (Section 6.6.1), only eight patients (PD-N = 5, PD-MCI = 1, PD-D = 2) 
and one control participant have been excluded from the following analyses.  As before, 
the characteristics of the groups remained the same in terms of education, depressive 
symptoms, and the distribution of sex and handedness between groups and all four groups 
were well matched on these variables.  In terms of age, the PD-N group remained younger 
than the PD-D group but was now well matched to the PD-MCI group.  As before, all 
clinical variables showed a steady increase from PD-N to PD-MCI to PD-D.   
Global cognitive, cognitive domain scores and individual neuropsychological test 
scores are shown in Table 8-3.  The overall distribution of results mirrored that found 
previously.  The control and PD-N groups had significantly superior performance on all 
cognitive measures except the digit span and RCFT immediate recall and the PD-MCI 
group on all measures except the map search when compared to the PD-D group.  
Neuropsychological performance of the control and the PD-N group was generally above 
the standardised mean score for most tests and the two groups comparable on all tests.  The 
aggregated domain scores were all significantly higher in the control group in all areas of 
cognition except in the area of visuospatial/visuoperceptual function.  Cognition in the 
mild cognitive impairment group was generally of an intermediate nature and mostly 
significantly different to both the PD-D and the PD-N group.   
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Table 8-2: Mean (SD) of demographic and clinical data for all groups 
 
Control  
(n = 24) 
PD-N  
(n = 51) 
PD-MCI 
(n =18) 
PD-D  
(n = 15) 
Statistic p Adjacent pairwise 
comparisons 
Demographic        
Age   67.42 (9.8)   64.61 (8.5)   70.50 (8.6)   73.20 (7.1) F=    4.8  <0.01 C = N = MCI= D 
Education   13.88 (2.8)   13.59 (3.1)   12.56 (2.9)   12.60 (2.3) F=    1.2 =0.33 C = N = MCI = D 
Depression (GDS) [median (range)]     0.04 (0.2)     1.10 (2.1)     1.33 (2.9)     3.20 (3.3) H= 14.4  <0.01 C = N = MCI = D 
Sex (M/F)   16/8   33/18   12/6   13/2 χ2 =  2.7  =0.44  
Handedness (R/L)   19/4   49/2   16/2   14/1 χ2 =  4.0 =0.26  
Premorbid IQ (WTAR) 118.3 (9.8) 114.5 (8.5) 107.0 (12.8) 108.5 (9.4) H= 15.6 =0.01 C > N > MCI = D 
Clinical        
Hoehn + Yahr [median (range)]      2.00 (1 -  3)     2.50 (1.5- 4)     4.0 (2 - 4) F=  22.4  >0.01        N > MCI > D  
UPDRS III (max=88)    24.00 (0 -70)   30.50 (9 - 69)   52 (18 - 81) n=14 F=  20.4  >0.01        N > MCI > D 
Disease Duration      4.11 (3.5) 7.86 (5.2)  12.68 (9.1) H= 18.3  >0.01        N > MCI > D 
Although 9 subjects were lost in this subset due to imaging constraints the same general pattern emerges for demographic and clinical variables.  The groups are well matched 
in terms of age, education and sex and handedness distributions.  As expected, there is progressive worsening of clinical motor scores from the PD-N group to the PD-MCI 
group with the worst scores evident in the PD-D group.  GDS: Geriatric depression scale; WTAR: Weschler test of adult reading; UPDRS III: Unified Parkinson’s disease 
rating scale.  All participants completed all tests unless otherwise indicated by n value.  F: ANOVA F ratio; H: Kruskall-Wallis statistic; χ2: chi-square analysis.   
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Table 8-3: Mean (SD) of average cognitive domain and individual neuropsychological test Z-scores for all participants 
 
Control (n = 24) PD-N (n = 51) PD-MCI (n = 18) PD-D (n = 15) Statistic p Adjacent pairwise 
comparisons 
Global Cognitive        
MMSE (max=30) 28.71 (1.5) 28.47 (1.5) 26.22 (2.4)  23.27 (3.3) H= 43.3 <0.01 C = N > MCI > D 
MoCA (max=30)  27.75 (1.5) n=48 26.77 (2.2) 22.56 (2.4)  17.07 (3.6) H= 64.0  <0.01 C = N > MCI > D 
Attention and working memory+   0.39 (0.4)   -0.02 (0.5)  -0.88 (0.5)   -1.84 (0.5) F=  83.5  <.001 C > N > MCI > D 
Digits Forward/Backwards 1.1 (1.1) 0.4 (0.8) -0.0 (0.9) -0.7 (1.0) F=  11.9  <.001 C > N = MCI > D 
Digit Ordering   -0.4 (0.9)   -0.5 (1.0) -1.7 (0.7) -2.2 (0.6) F=  21.3  <.001 C = N > MCI = D 
Map Search  0.7 (1.0) n=46   -0.2 (0.9) -1.7 (0.8) -2.2 (0.8) F=  43.3  <.001 C > N > MCI = D 
Stroop Colour Trial  0.2 (0.8) n=50    0.1 (0.9) -0.5 (0.8) -1.9 (0.9) F=  23.1  <.001 C = N > MCI > D 
Stroop Word Trial  0.4 (0.6)n=50    0.1 (0.6) -0.5 (0.8) -1.5 (1.2) H= 32.3  <.001 C = N > MCI > D 
Trail Making Test A 0.3 (0.9)    -0.1 (0.7) n=17 -0.8 (1.0) -2.6 (0.5) F=  53.3  <.001 C = N > MCI > D 
Executive Function+   0.88 (0.5) 0.43 (0.6) -0.73 (0.8)   -1.98 (0.5) F=  84.1  <.001 C > N > MCI > D 
Letter Fluency 1.1 (1.2) 0.8 (1.2) -0.2 (1.1) -1.4 (0.9) F=  18.8  <.001 C = N > MCI > D 
Action Fluency 0.7 (1.0) 0.3 (1.3) -0.9 (1.0) -1.6 (0.6) H= 40.5  <.001 C = N > MCI > D 
Category Fluency 1.2 (0.9) 0.9 (1.2) -0.4 (1.0) -1.4 (0.8) F=  27.8  <.001 C = N > MCI > D 
Category Switching 1.1 (0.9) 0.2 (0.9) -0.7 (0.8) -2.0 (0.9) F=  46.0  <.001 C > N > MCI > D 
Trail Making Test B  0.6 (0.5)   -0.1 (0.9) n=17 -0.9 (1.2) -2.9 (0.1) H= 49.8  <.001 C > N > MCI > D 
Stroop Interference 0.6 (0.5) n=50 0.4 (0.7) -1.2 (1.5) -2.5 (0.8) H= 49.7  <.001 C = N > MCI > D 
Learning and Memory+   0.92 (0.8) 0.35 (0.8) -0.74 (0.5)   -1.60 (0.7) F=  46.1  <.001 C > N > MCI > D 
CVLT Free Recall 1.0 (0.9) 0.5 (0.9) -0.9 (0.9) -1.8 (1.0) F=  39.6  <.001 C = N > MCI > D 
CVLT Short Delay (30s) 1.1 (1.3) 0.4 (1.1) -0.7 (1.0) -1.7 (0.8) H= 43.4  <.001 C = N > MCI > D 
CVLT Long Delay (10min) 0.8 (0.8) 0.4 (0.9) -0.5 (0.8) -0.9 (0.7) F=  18.6  <.001 C = N > MCI = D 
RCFT Immediate (3 min) 1.0 (1.3) 0.2 (1.4) -0.6 (1.3) -1.8 (0.9) F=  15.2  <.001 C > N = MCI > D 
RCFT Delayed (30 min) 0.8 (1.5) n=22         -0.3 (1.5) n=24 -1.2 (1.2) n=13 -1.9 (1.1) F=  12.1  <.001 C > N > MCI > D 
Visuospatial/Perception function+   0.58 (0.6) 0.47 (0.4) -0.40 (0.6)   -1.26 (0.8) H= 53.7  <.001 C = N > MCI > D 
RCFT Copy 0.3 (0.9) 0.1 (0.8) -1.0 (1.3) -2.1 (1.3) F=  24.3  <.001 C = N > MCI > D 
JOL 0.7 (0.6) 0.6 (0.5) -0.2 (0.9) -0.8 (1.1) F=  21.6  <.001 C = N > MCI > D 
VOSP Fragmented Letters  0.8 (0.8) n=23 0.7 (0.5) -0.0 (1.1) -0.9 (1.1) H= 25.4 <.001 C = N > MCI > D 
Global Z+   0.69 (0.4) 0.32 (0.4) -0.69 (0.4)   -1.67 (0.5) F=138.9  <.001 C > N > MCI > D 
As expected worse performance was evident in the PD-D group.  In most cases the PD-N group performed at a level similar to that of the control group while the PD-MCI 
group was consistently performing at an intermediary level.  + age adjusted Z score. Global Z score is an aggregate mean score of the mean value in each cognitive domain.  
MMSE: Mini mental state examination; MoCA: Montreal cognitive assessment.  CVLT: California verbal learning test; RCFT: Rey complex figure test; JOL: Judgement 
of line orientation; VOSP: Visual object space perception battery.  All participants completed all tests unless otherwise indicated by n.   
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8.7.2 Volumetric changes of thalamic nuclei  
Nucleus volume was first computed relative to the individuals intracranial volume (nucleus 
divided by ICV for each subject) to adjust for head size.  Between – within ANOVA 
examined group differences for each nucleus with co-variates age, education and 
depression and then disease duration and UPDRS III additionally added in subsequent 
models.  Mean values of thalamic nuclei ROI’s and ICV are shown in Table 8-4.  There 
were no group differences of mean ICV and thalamic nuclei volumes relative to ICV 
except in the AP nucleus.  This may be an unreliable finding however as Newman-Keulis 
post-hoc results show the effect to be due to trend level volume reduction in the PD-N 
group only.  The group effect remained when the demographic covariates (age, education 
and depression) were added to the model [F(3,101) = 3.73, p = 0.01] but not [F(2,76) = 
1.39, p = 0.26] after inclusion of the clinical covariates (disease duration and UPDRS III).  
Regions of the association (MDn), limbic (LD) motor (VA) and non-specific CM/Pf 
thalamic nuclei also showed a trend for volume loss, with the PD-D group consistently 
showing the lowest volumes for all comparisons.  A main effect of hemisphere was evident 
in the left > right direction for the MDn and LP nuclei but this was consistent for all 
groups; there were no group x hemisphere interactions.   
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Table 8-4: Comparison of nuclei volumes (corrected for ICV) between PD groups and control subjects 
 Control  
(n = 24) 
PD-N  
(n = 51) 
PD-MCI  
(n = 18) 
PD-D  
(n = 15) 
Group Effect Hemisphere 
Effect 
     F p F p 
Association Nuclei     
MDn 1.86 (0.4) 1.82 (0.3) 1.83 (0.4) 1.70 (0.3) 0.47 0.70 13.01 <0.001 
Left 1.0 (0.3) 1.0 (0.2) 1.0 (0.2) 0.9 (0.2)     
Right 0.8 (0.2) 0.9 (0.2) 0.9 (0.3) 0.8 (0.2)     
LP 0.55 (0.1) 0.57 (0.1) 0.53 (0.2) 0.55 (0.2) 0.43 0.73 4.51 0.04 
Left 0.3 (0.1) 0.3 (0.1) 0.3 (0.1) 0.3 (0.1)     
Right 0.3 (0.1) 0.3 (0.1) 0.2 (0.1) 0.3 (0.2)     
Pu 0.93 (0.2) 0.94 (0.2) 0.99 (0.2) 0.94 (0.2) 0.37 0.78 0.82 0.37 
Left 0.5 (0.1) 0.5 (0.1) 0.5 (0.1) 0.5 (0.1)     
Right 0.4 (0.1) 0.5 (0.1) 0.5 (0.2) 0.5 (0.1)     
         
Limbic Nuclei     
AP 0.51 (0.1) 0.41 (0.2) 0.48 (0.2) 0.50 (0.1) 3.12 0.03 1.43 0.24 
Left 0.3 (0.1) 0.2 (0.1) 0.2 (0.1) 0.2 (0.1)     
Right 0.3 (0.1) 0.2 (0.1) 0.3 (0.1) 0.3 (0.1)     
LD 0.44 (0.2) 0.43 (0.2) 0.44 (0.1) 0.42 (0.1) 0.09 0.96 2.13 0.15 
Left 0.2 (0.1) 0.2 (0.1) 0.2 (0.0) 0.2 (0.1)     
Right 0.2 (0.1) 0.2 (0.1) 0.3 (0.1) 0.2 (0.1)     
         
Sensory Nucleus     
VP 0.74 (0.2) 0.79 (0.3) 0.83 (0.2) 0.76 (0.24) 0.51 0.68 0.64 0.43 
Left 0.4 (0.2) 0.4 (0.2) 0.4 (0.2) 0.4 (0.2)     
Right 0.4 (0.2) 0.4 (0.2) 0.4 (0.1) 0.4 (0.2)     
         
Motor Nuclei     
VA 0.82 (0.2) 0.83 (0.3) 0.74 (0.2) 0.73 (0.3) 0.95 0.42 1.16 0.28 
Left 0.4 (0.2) 0.5 (0.2) 0.4 (0.2) 0.4 (0.2)     
Right 0.4 (0.2) 0.4 (0.2) 0.4 (0.1) 0.4 (0.2)     
VL 0.74 (0.3) 0.76 (0.2) 0.79 (0.2) 0.78 (0.2) 0.22 0.88 0.03 0.88 
Left 0.4 (0.2) 0.4 (0.1) 0.4 (0.1) 0.4 (0.1)     
Right 0.3 (0.2) 0.4 (0.2) 0.4 (0.2) 0.4 (0.1)     
         
Non-Specific Nucleus     
CM/Pf 1.72 (0.4) 1.72 (0.4) 1.73 (0.3) 1.58 (0.3) 0.93 0.43 3.40 0.07 
Left 0.9 (0.2) 0.9 (0.2) 0.9 (0.3) 0.8 (0.2)     
Right 0.8 (0.3) 0.8 (0.2) 0.8 (0.2) 0.8 (0.2)     
         
ICV (cm
3
) 1495.6 
(151.1) 
1545.5 
(169.1) 
1478.0 
(100.2) 
1608.5 
(183.1) 
2.42 0.07   
ICV corrected nuclei volumes are reported mean (SD) in mm
3
 x10
-3
.  Repeated measures ANOVA was used 
to examine group and hemisphere effect in the first instance (indicated in bold face).  No follow up analyses 
were needed as there was no group x hemisphere interaction in any nucleus.  The AP nucleus was the only 
region to show a group effect, there were no significant post-hoc comparisons.  The hemisphere effect in the 
MDn and LP nuclei was in the left > right direction.   
8.7.2.1 Relative to thalamic volume  
Nucleus volume was also calculated relative to thalamic volume (nucleus in each 
hemisphere divided by whole thalamic volume of that hemisphere x 100) and expressed as 
a proportion of total thalamic volume (Figure 8-5) to correct for the variation in overall 
thalamic degeneration between groups.  In accordance with anatomical guidelines 
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(Duvernoy, 1991; Morel, et al., 1997) the largest aggregations were the MDn and CM/Pf 
nuclei and the smallest the anterior principal and lateral dorsal aggregates.  Results were 
similar when ROI’s were corrected for thalamic volume as they were when corrected for 
ICV, there were again no between group differences of nuclei volume except for the AP 
nucleus [F(3,104) = 4.1, p < 0.01].  This effect remained when demographic variables and 
depressive scores were included in the model [F(3,101) = 4.2, p = 0.04] but not when the 
additional clinical covariates were included [F(2,76) = 1.06, p = 0.35] suggesting 
significant influence of motor dysfunction on this finding.  There was again a significant 
hemisphere effect (left > right) in the MDn nucleus [F(1,104) = 6.09, p = 0.02] and no 
interactions between group and hemisphere.   
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 Figure 8-5:  Volume of nuclei relative to whole thalamus  
Group mean nuclei volume differences are presented for each nucleus.  Lines represent standard error bars.  
Repeated measures ANOVA examined between group differences, results were similar as when thalamus 
was examined relative to ICV.  The AP nucleus was the only region to show a significant effect of group but 
post-hoc results did not reach significance.   
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8.7.3 Fractional anisotropy changes of thalamic nuclei  
Mean fractional anisotropy values for each thalamic nucleus were compared in the same 
way as they were for volume except that a weighted average was calculated for each region 
to account for the variation in size between nuclei.  The FA values across thalamic nuclei 
aggregations for each group are shown in Figure 8-6.  FA did not differ between groups 
except in the lateral dorsal nucleus.  Post-hoc results showed integrity was significantly 
reduced in PD-D as well as in PD-MCI compared to the control group and in PD-D 
compared to PD-N.  The group effect and post-hoc comparisons remained when 
demographic covariates were added to the model [F(3,101) = 2.95, p = 0.04] but were no 
longer significant when control subjects were excluded and clinical covariates added 
[F(2,76) = 1.76, p = 0.18], suggesting directionality integrity co-varies with motor 
dysfunction in this area.  There was a significant hemisphere effect (left > right) in the AP 
[F(1,104) = 13.09, p = 0.001]; VA [F(1,104) = 20.91, p < 0.001]; VP [F(1,104) = 19.56, p 
< 0.001]; and Pu [F(1,104) = 4.24, p = 0.04] nuclei and an interaction between group and 
hemisphere in the MDn nucleus [F(3,104) = 4.80, p < 0.01].  For the MDn nucleus the 
hemisphere effect (left > right) was only evident in the control group, suggesting that the 
left hemisphere is sensitive to cognitive dysfunction in PD, irrespective of cognitive status.  
Follow up ANOVA on the group effect of integrity in the left MDn only showed trend 
level reduction in FA [F(3,104) = 2.44, p = 0.07].   
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 Figure 8-6: FA values of thalamic nuclei  
Mean FA values for each ROI, lines represent standard error bars. p indicates significant post hoc 
comparisons between groups (collapsing left and right), italic = comparison between dementia group, bold = 
comparison between MCI group. The LD is the only nucleus to show reduction in FA between groups.  
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8.7.4 Mean diffusivity changes of thalamic nuclei  
Mean MD values across the thalamic nuclei clusters are shown in Figure 8-7 and were also 
computed using the weighted average formula.  In contrast to volume results, there was a 
significant group effect in all nuclei except the AP.  The AP results could again be an 
unreliable finding due to the significant group x hemisphere interaction [F(3,104) = 3.36, p 
= 0.02] which resulted in an effect of group only in the right [F(3,104) = 5.66, p < 0.001] 
hemisphere.  For all other regions post-hoc results showed diffusivity to be higher in those 
groups with worse cognitive dysfunction; MD was higher in the PD-D group compared to 
control subjects and the PD-N group in all regions except the AP; and higher in PD-MCI 
compared to control subjects in the MDn, LD and Pu and in the LD and MDn compared to 
PD-N.  In contrast to the volume and FA results, there was only an effect of hemisphere in 
the VP [F(1,104) = 12.20, p < 0.001] which was in the left > right direction.   
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 Figure 8-7: MD Values of thalamic nuclei.   
Mean MD values for each ROI, lines represent standard error bars.  p indicates significant post hoc 
comparisons between groups (collapsing left and right), italic = comparison between dementia group, bold = 
comparison between MCI group.   
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There were few changes once demographic and clinical covariates were accounted 
for.  Figure 8-8 shows which nuclei are most affected in PD-MCI and PD-D relative to 
healthy control and PD-N groups with the corresponding group effect for each nucleus 
presented in Table 8-5.  In PD-D relative to control subjects all nuclei (including the 
previously not changed AP nucleus) had significantly higher MD levels.  In PD-D relative 
to PD-N where clinical covariates were also accounted for all nuclei except the AP, VA or 
VL nuclei had higher MD values.  As the VA and VL are motor nuclei and were 
implicated prior to the inclusion of clinical covariates in the model this demonstrates the 
adequate control of motor symptoms identified using disease duration and UPDRS III 
measures.  In PD-MCI relative to control subjects only the MDn, LD and Pu continued to 
show higher diffusivity after inclusion of demographic covariates.  The MDn and LD 
continued to show higher diffusivity relative to PD-N, indicating findings were not due to 
the symptoms of Parkinson’s disease alone.  MD measures of nuclei appear to primarily 
reflect cognitive status.  As cognitive decline increases in the PD-D group relative to the 
PD-MCI group so does diffusivity in the MDn, CM/Pf and VP nuclei.  In the cognitively 
similar PD-N and control groups there were no differences in mean diffusivity for any 
nuclei.   
After the inclusion of demographic covariates there was an additional hemisphere 
effect [F(1,101) = 4.17, p = 0.04] in the VL nucleus (left > right).  The hemisphere effect in 
the VP nucleus prior to the inclusion of covariates was no longer significant.  In the AP, 
the group x hemisphere interaction [F(3,101) = 3.16, p = 0.03] remained due to there again 
being a significant group effect in the right hemisphere only [F(3,104) = 5.66, p < 0.01].    
The hemisphere effect in the VL nucleus remained after the inclusion of clinical 
covariates [F(1,75) = 4.10, p = 0.05] but the group x hemisphere interaction in the AP 
nucleus was no longer significant.   
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a) All thalamic nuclei 
 
       b) Regions of the thalamus that change in unimpaired PD relative to control subjects 
 
       c) Regions of the thalamus that change in mild cognitive impairment and dementia relative to unimpaired patients in PD 
 
       d) Regions of the thalamus that change between mild cognitive impairment and dementia in PD 
 
       
Figure 8-8: The changes in mean diffusivity between groups  
Horizontal sections (dorsal – ventral) are presented using radiological convention, the left side of the image corresponds to the right side of the brain.  Row a) shows all 
thalamic nuclei where AP is green, MDn red, LD yellow, VP light blue, CM/Pf blue, VA yellow, VL violet.  The LP and Pu, visible only in ventral slices are also represented 
in green and yellow respectively.  Row b) – d) shows regions of change in PD-N (green), PD-MCI (yellow) and PD-D (red) relative to control subjects (b), patients without 
cognitive impairment (c) and in PD-D relative to PD-MCI (d).  Image is the 4D image of a PD-N patient, MNI co-ordinates Z: 30-24.  
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Table 8-5: Between group comparisons of MD values after the inclusion of covariates 
  
Covariates 
     
  Demographic  Clinical 
  Age, education, depression  Disease duration, UPDRS III 
     
Nuclei  Group Effect  Group Effect 
        
  F(3,101) p Adjacent pairwise  F(2,75) p Adjacent pairwise 
Association Nuclei  
MDn  4.87 0.003 C=N<MCI<D  2.67 0.08 N<MCI<D 
LP  1.65 0.18 C=N<D  0.51 0.60 N<D 
Pu  5.85 0.001 C=N<D  1.40 0.25 N<D 
         
Limbic Nuclei  
AP  1.49 0.22 C<D∆  0.48 0.62 N=MCI=D 
LD  3.99 0.01 C=N<MCI=D  4.24 0.02 N<MCI=D 
         
Sensory Nucleus 
VP  5.15 0.002 C=N=MCI<D  2.46 0.09 N=MCI<D 
         
Motor Nucleus  
VA  1.49 0.22 C<D  0.37 0.69 N=MCI=D 
VL  1.65 0.18 C<D  1.35 0.27 N=MCI=D 
         
Non-specific nucleus 
CM/Pf  4.91 0.003 C=N=MCI<D  6.37 0.003 N=MCI<D 
The group effect and adjacent pairwise comparisons for each nucleus after inclusion of demographic and 
clinical covariates is presented.  F: RM ANCOVA F ratio; p: p value; ∆ denotes a significant group x 
hemisphere interaction; MDn: mediodorsal; LP: lateral posterior; Pu: Pulvinar: AP: anterior principal; LD: 
lateral dorsal; VP: ventral posterior; VA: ventral anterior; VL: ventral lateral; CM/Pf: 
centromedian/parafascicular thalamic nuclei; C: control participants; N: patients with intact cognition; MCI: 
patients with mild cognitive impairment; D: patients with dementia.   
8.7.5 The association between the integrity of thalamic nuclei and cognition 
8.7.5.1 Correlation results  
Simple Pearson correlations were used in the first instance to determine which nuclei had 
an association with cognition so these could be later included in a regression model.  
Similar to the analyses conducted in Chapter 6 where the whole thalamus was examined, 
volume and both diffusion measures of integrity (FA and MD) were examined for their 
relationship with cognition.  Correlations were conducted for the control and patient 
groups in the manner of Little, et al., (2010) in order to avoid biasing the results due to the 
fact the patient groups have lower volume and FA and higher MD than control subjects.   
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Healthy controls 
Thalamic mean diffusivity was the measure most sensitive to cognitive changes and had a 
moderate to strong correlation with the most areas of cognition.  The AP was correlated 
with learning and memory (r = -0.46, p = 0.02), the MDn (r = -0.50, p = 0.01) and VP (r = 
-0.55, p = 0.01) with executive function, and the VP with attention (r = -0.42, p = 0.04) and 
the aggregate global score (r = -0.41, p = 0.05).  The motor VL motor nuclei was also 
negatively correlated with learning and memory (r = -0.45, p < 0.03) and global Z score (r 
= -0.48, p = 0.02).   
Thalamic fractional anisotropy was only sensitive to visuospatial/perception and 
had a strong positive correlation (r = 0.42, p = 0.04) with the VP nucleus.   
Only the VP nucleus had a significant association with cognition when volume 
measures were examined, showing a significant positive correlation with the visuospatial (r 
= 0.49, p = 0.02) and learning and memory (r = 0.50, p = 0.01) domains as well as with 
global Z score (r = 0.48, p = 0.02).   
Parkinson’s disease 
Pearson correlation results for the patient group are reported in Table 8-6.  Mean 
diffusivity measures of the thalamic nuclei are associated with cognition.  The correlation 
coefficient was generally smaller than that seen in the control group, but there was a 
moderate relationship between the majority of the cognitive domains and all nuclei except 
the motor nuclei.  All limbic (AP, LD), association (MDn, Pu, LP, VP) and the diffuse 
non-specific CM/Pf nuclei were associated with the executive function, visuospatial, 
learning and memory and aggregate global Z score.  For attention and working memory 
only one of the limbic (LD), some of the association (MDn, and Pu), the sensory VP and 
the CM/Pf nuclei showed a positive relationship with this domain score.   
Fractional anisotropy measures were also associated with cognition in the patient 
group.  As in the control subjects, FA of the VP was associated with the visuospatial 
domain and in addition to this, FA measures of the LD nucleus had a moderate to strong 
positive relationship with all cognitive domains and global Z score.   
In contrast to the control subjects, only the AP nucleus was implicated in cognition 
using volume measures, showing a moderate negative relationship with learning and 
memory.   
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Table 8-6: Relationship between thalamic nuclei measures and cognition  
 Attention Executive 
Function 
Visuospatial Learning and 
Memory 
Global Z Score 
 
Fractional Anisotropy 
Association Nuclei 
MDn 0.03 0.01 0.01 0.09 0.03 
LP 0.05 0.06 0.05 0.03 0.05 
Pu 004 -0.00 0.00 0.06 0.04 
Limbic Nuclei 
AP 0.13 0.07 0.08 0.18 0.12 
LD 0.31** 0.29** 0.26* 0.24* 0.30** 
Sensory Nucleus 
VP 0.16 0.14 0.28* 0.14 0.19 
Motor nuclei 
VA -0.05 -0.03 0.09 0.05 0.01 
VL 0.12 0.16 0.11 0.08 0.13 
Non-specific nuclei 
CM/Pf -0.07 -0.06 0.01 -0.09 -0.05 
 
Volume Total – ICV corrected 
Association 
MDn 0.09 0.04 -0.01 0.03 0.04 
LP 0.01 -0.00 0.02 -0.07 -0.01 
Pu 0.05 0.04 0.09 0.07 0.06 
Limbic 
AP -0.15 -0.20 -0.14 -0.24* -0.21 
LD 0.08 0.04 0.13 0.10 0.08 
Sensory 
VP 0.01 0.04 0.02 0.02 0.02 
Motor 
VA 0.16 0.16 0.12 0.11 0.15 
VL -0.10 -0.08 0.04 -0.13 -0.07 
Non-specific 
CM/Pf 0.10 0.15 0.15 0.10 0.14 
Pearson correlations (r) between thalamic nuclei measures and cognition in PD patients.  Significant 
correlations are indicated as follows: *p < 0.05; **p < 0.01; *** p < 0.001. 
 
Mean Diffusivity 
Association nuclei 
MDn -0.35** -0.38*** -0.38*** -0.44*** -0.44*** 
LP -0.17 -0.23* -0.31** -0.22* -0.25* 
Pu -0.34** -0.30** -0.28** 0.28** -0.34** 
Limbic nuclei 
AP -0.20 -0.24** -0.22* -0.23** -0.26** 
LD -0.38** -0.28** -0.39*** -0.29** -0.37** 
Sensory nucleus 
VP -0.32** -0.36** -0.37*** -0.39*** -0.40*** 
Motor nuclei 
VA -0.13 -0.20 -0.18 -0.14 -0.18 
VL -0.03 -0.13 -0.11 -0.15 -0.12 
Non-specific 
CM/Pf -0.32** -0.31** -0.35** -0.31** -0.37** 
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8.7.5.2 Regression modelling results 
Mean diffusivity measures of the thalamic nuclei were considered to be the most sensitive 
to cognitive changes within the PD groups and were further examined using multiple 
regression analyses.  Individual nuclei were highly intercorrelated on this measure (Table 
8-7) so a series of stepwise linear regressions were applied to the nuclei data with cognitive 
domain as the dependent variable to establish the independent association between each 
thalamic nucleus and each cognitive domain.   
Table 8-7: The association between thalamic nuclei (MD measure) 
 Association  Limbic  Sensory  Motor  Non-
specific 
 LP Pu  AP LD  VP  VA VL  CM/Pf 
Association            
MDn 0.41*** 0.31**  0.46*** 0.18  0.51  0.45*** 0.38***  0.43*** 
LP  0.19  0.39*** 0.11  0.42***  0.36*** 0.21  0.31 
Pu    0.17 0.09  0.40***  0.31** 0.21  0.17 
Limbic             
AP     0.23*  0.43***  0.37*** 0.24*  0.19 
LD       0.02  0.05 0.03  0.07 
Sensory             
VP         0.58*** 0.60***  0.44 
Motor             
VA          0.77***  0.19 
VL            0.31 
Pearson correlations (r) between thalamic nuclei in PD patients.  Significant correlations are indicated: *p < 
0.05; **p < 0.01 ; ***p < 0.001. 
For each cognitive domain two models were created.  In the first backward 
stepwise regression the nuclei that had an association with that cognitive domain (Table 
8-6) were entered as independent variables.  In the second model the covariates: age, 
education, depression and disease duration were added.  The proportion of variance (R
2
) in 
cognitive domain was calculated for Model 1 to determine the cumulative effect of nuclei 
and for Model 2 to determine if the relationship between the thalamic nuclei and cognitive 
domain survived the inclusion of covariates.  Each model also provided the unique 
proportion of variance each nucleus contributed to the cognitive domain score.  The motor 
nuclei (VA and VL) were excluded from these analyses as they did not have an association 
with any of the cognitive domains.  Results are presented in Table 8-8.  In the first MD 
model attention score was the dependent variable and all nuclei except the AP and LP and 
the motor nuclei (MDn, CM/Pf, LD, VP and Pu) were entered.  This model accounted for a 
significant proportion of the variance in domain scores and the LD, CM/Pf and Pu were all 
an independent influence on the attention scores (Beta values are presented in parentheses).   
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This same strategy was applied to the executive function, learning and memory, 
visuospatial/visuoperception and to the aggregate global score where all the thalamic 
nuclei except the motor nuclei (AP, MDn, CM/Pf, LD, VP, LP, Pu) were entered into the 
model.  Each model accounted for a significant proportion of the variance in domain scores 
and had at least two nuclei which were independent predictors of domain score.  The LD 
and CM/Pf nuclei were the most common predictors of cognition, the LD was involved in 
all cognitive domains and the CM/Pf in attention and visuospatial domains and with global 
Z score.   
When covariates were added into the second model additional variance was 
accounted for in each domain, although this increase was only significant for the executive 
function domain and the overall global Z score.  Within the attention, learning and memory 
and visuospatial domains all nuclei that were previously implicated continued to predict 
cognitive score.  Within the executive function domain the LD was no longer a predictor 
after the inclusion of covariates and for global Z score the only remaining nucleus was the 
LD.   
Some FA and volume measures of nuclei also had an association with cognitive 
domain so the same multiple regression analyses were applied in order to determine their 
individual influence on cognition.  For FA values, although the white matter integrity of 
the LD nucleus had a significant association with all cognitive domains and the aggregate 
global domain when examined using Pearson correlations, this result was not upheld in the 
regression models.  In regards to the visuospatial/perception domain Model One accounted 
for 7% of the variance in domain score, [F(2,105) = 3.9, p = 0.02].  Within this model, only 
the LD nucleus was a unique predictor, accounting for 5% of the unique variance (p = 
0.02).  When covariates were added in the second model, an additional 20% (p < 0.001) of 
the variance (R
2
 = 30%, p < 0.001) was accounted for by the covariates but LD was no 
longer an independent predictor of domain score.  For the other cognitive domains, Model 
One was not computed as LD was the only nucleus that was associated with these domains, 
making this an unnecessary step.  When LD was included alongside the covariates in 
Model Two LD was no longer a unique predictor for the attention, learning and memory, 
executive function domains, or for the aggregate global score.   
The AP was the only nucleus to show a volumetric association with cognition so 
the first model was not computed.  In the second model where AP was entered alongside 
the covariates the overall model was not significant and AP was not a unique predictor of 
attention, [R
2
 = 0.02, p = 0.74].   
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Table 8-8: Backward stepwise linear regression results for MD measures of nuclei  
Entered variables 
Model 1  Model 2 
Nuclei that have a correlation with domain  Nuclei and covariates  
   
% of variance accounted for by unique predictors 
Attention† 
R
2
 = 32%, F(5,78) = 7.31, p<0.01  R
2
 = 44%, F(9,74) = 6.45, p<0.01 
CM/Pf (β = 
-
0.17) 6 (<0.01)  CM/Pf (β = 
-
0.15) 8 (<0.01) 
LD (β = -0.33***) 15 (<0.01)  LD (β = -0.25**) 9 (<0.01) 
Pu (β = -0.20) 9 (<0.01)  Pu (β = -0.18)  5 (0.01) 
   Disease duration (β = -0.25*) 16 
   Depression (β = -0.20*) 3 
Executive Function   
R
2
 = 27%, F(7,76) = 3.94, p<0.01  R
2
 = 48%,F(11,72) = 6.1, p<0.01 
LD (β = -0.23*) 6 (<0.01)  VP (β = -0.18) 4 (p<0.01) 
VP (β = -0.16) 15 (<0.01)  Age (β = -0.14) 3 (0.03) 
   Education (β = -0.15) 3 (0.04) 
   Disease Duration (β = -
0.34***) 
4 (<0.01) 
   Depression (β = -0.29**) 8 (<0.001) 
Learning and Memory     
R
2
= 30%, F(7,76) = 4.7, p<0.01  R
2
 = 38%, F(11,72) = 3.95,p<0.001 
MDn (β = -0.25*) 19 (<0.001)  MDn (β = -0.18) 4 (0.03) 
LD (β = -0.24*) 5 (0.03)  LD (β = -0.20*) 8 (<0.01) 
VP (β = -0.20) 4 (0.03)  VP (β = -0.23) 15 (<0.001) 
   Depression (β = -0.24*)  
Visuospatial/Visuoperception 
R
2 
= 35%, F(7,76) = 5.80, p<0.001  R
2
 = 42%, F(11,72) = 4.7, p<0.001 
CM/Pf (β = -0.16) 4 (0.04)  CM/Pf (β = -0.16) 4 (0.03) 
LD (β = -0.34***) 1 (<0.001)  LD (β = -0.32**) 8 (<0.001) 
   Disease Duration (β = -0.23*) 5 (0.01) 
Global Z Score 
R
2
 = 38%, F(7,76) = 6.5, p<0.001  R
2
 = 51%, F(11,72) = 6.8, p<0.001 
MDn (β = -0.18) 19 (<0.001)  LD (β = -0.25**) 5 (<0.01) 
CM/Pf (β = -0.17) 4 (0.04)  Depression (β = -0.23**) 7 (<0.01) 
LD (β = -0.32**) 9 (<0.01)  Disease Duration (β = -0.27**) 8 (<0.01) 
Pu (β = -0.16) 4 (0.03)    
Two linear models were used to gauge the proportion of variance accounted for in each cognitive domain.   
† All nuclei except the motor nuclei were included in each model except for in the attention domain where 
neither the AP nor the LP nucleus had a correlation with attention scores so were not included.  R
2 
= 
proportion of variance accounted for.  Only some nuclei in each domain were independent predictors of 
cognition.  Significant beta values are denoted: *p < 0.05; **p < 0.01; *** p < 0.001. 
8.7.6 Using thalamic measures to discriminate between groups  
Receiver operating characteristics were conducted using both integrity (FA, MD) and 
volume measures of all nuclei in order to determine the most sensitive region for the 
separation of the dementia patients (from the control, unimpaired and mild cognitive 
impaired patients) and of the mild cognitive impairment patients (from control and 
unimpaired patients).  In order to determine the effects of Parkinson’s disease alone RoC 
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analysis was also conducted between the control subjects and PD patient group with no 
impairment.  Results are presented in Table 8-9.   
8.7.6.1 Identification of the patient group 
The Parkinson’s disease group without cognitive impairment had very similar thalamic 
characteristics to the healthy control group.  Although volume measures of the AP had a 
significant area under the curve, separation of the two groups was only achieved with 
58.8% accuracy (specificity = 83.33%).  MD of the Pu also had a significant AUC, but this 
only resulted in accurate identification of the patient group 39.2% of the time (specificity = 
83.33%).   
8.7.6.2 Identification of dementia 
Relative to healthy control subjects 
For all nuclei, mean diffusivity measures were the best thalamic variable to predict the 
dementia patients.  All regions had a significant AUC and were accompanied by high 
sensitivity levels in most cases - the following sensitivity levels are reported at 80% 
specificity.  MD of the CM/Pf nucleus approached near perfect separation, correctly 
classifying the dementia patients 93% of the time.  Two of the association nuclei (MDn, 
Pu) also had high AUC values, enabling correct classification of dementia in 86.7% and 
80% of cases respectively.  The sensory (VP: 66.7%) and motor (VA: 53.3%; VL: 60%) 
nuclei displayed sensitivity for dementia above chance levels but regions of the limbic 
(AP: 40%; LD: 46.7%) and association (LP: 33.33%) nuclei displayed poor sensitivity for 
the dementia group.   
Relative to patients with no cognitive impairment (PD-N)  
Prediction of the PD-D group relative to the PD-N group was examined to determine the 
degree to which the groups could be separated when motor symptoms were not a 
confounding factor.  In the majority of cases this was best achieved using MD measures of 
nuclei.  Volume of AP was the only exception, showing a higher AUC than either FA or 
MD.  Despite this, the volume of the AP was not sensitive to dementia, only correctly 
identifying 20% of cases.   
Similar to prediction of PD-D relative to controls MD of the CM/Pf region had the 
highest AUC values when predicting PD-D relative to PD-N in this model.  Despite this, 
correct identification of the dementia group was only achieved 40% of the time.  Between 
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patient groups, the effect of motor confounds that is seen in the comparison with the 
control subjects are reduced and the association nuclei (MDn: 60%; Pu: 66.7%) are better 
predictors of dementia than either the VL (60%) or the VA (46.7%) nuclei.  No other 
region could correctly identify dementia much more than half the time (VP; 53.33% LP: 
33.3%; LD: 53.3%).   
Relative to patients with mild cognitive impairment  
Prediction of the PD-D group relative to PD-MCI was not highly accurate.  Only three 
regions showed a significant area under the curve, and all only when measured with mean 
diffusivity.  The CM/Pf, (AUC: 0.81, p < 0.001) could only accurately identify PD-D 40% 
of the time, the VP (AUC: 0.71, p = 0.02) 46.7% of the time with the VL (AUC: 0.74, p = 
0.01) the worst region at 26.7% sensitivity.   
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Table 8-9: Group separation by integrity measures of nuclei, RoC results  
 PD motor  Mild cognitive impairment  Dementia 
 C vs PD-N  C vs PD-MCI PD-N vs PD-MCI  C vs PD-D PD-N vs PD-D PD-MCI vs PD-D 
Association nuclei 
MDn         
Vol 0.51ns (0.39–0.62)  0.52ns (0.36–0.68) 0.51ns (0.38–0.63)  0.57ns (0.40–0.73) 0.57ns (0.45–0.70) 0.60ns (0.41–0.76) 
FA 0.57ns (0.45-0.68)  0.57ns (0.41–0.72) 0.51ns (0.39–0.64)  0.56ns (0.3–0.72) 0.53ns (0.40–0.67) 0.55ns (0.37–0.73) 
MD 0.54ns (0.42–0.65)  0.73b (0.58-0.86) 0.69b (0.57-0.80)  0.86c (0.72-0.95) 0.83c (0.71-0.91) 0.68ns (0.50 – 0.83) 
Pu         
Vol 0.52ns (0.40–0.64)  0.59ns (0.42–0.74) 0.58ns (0.46 – 0.70)  0.51ns (0.35–0.67) 0.54ns (0.41–0.66) 0.60ns (0.42–0.77) 
FA 0.60ns (0.48-0.71)  0.54ns (0.38–0.69) 0.60 ns (0.48-0.72)  0.54ns (0.38–0.70) 0.56ns (0.43–0.68) 0.52ns (0.34–0.69) 
MD 0.70
b
 (0.58-0.80)  0.75
b
 (0.59-0.87) 0.59ns (0.47 – 0.71)  0.80b (0.64-0.91) 0.72a (0.60-0.82) 0.63ns (0.45 – 0.79) 
LP         
Vol 0.53ns (0.42–0.65)  0.60ns (0.44–0.75) 0.64 ns (0.52-0.75)  0.56ns (0.39–0.71) 0.60ns (0.48–0.72) 0.56ns (0.38-0.73) 
FA 0.57ns (0.45–0.69)  0.56ns (0.40–0.71) 0.53ns (0.40–0.65)  0.61ns (0.44–0.76) 0.56ns (0.43–0.68) 0.56ns (0.38–0.73) 
MD 0.57 ns (0.45-0.69)  0.62 ns (0.46-0.77) 0.62ns (0.49–0.73)  0.71a (0.54-0.84) 0.70b (0.58-0.81) 0.60ns (0.42 – 0.77) 
Limbic nuclei 
AP         
Vol 0.71
c
 (0.59-0.81)  0.59ns (0.43-0.74) 0.68
c
 (0.55-0.79)  0.53ns (0.37-0.69) 0.68
a
 (0.55-0.79) 0.57ns (0.39-0.74) 
FA 0.52ns (0.40-0.63)  0.60ns (0.44-0.75) 0.57ns (0.44-0.69)  0.58ns (0.41-0.74) 0.57ns (0.44-0.69) 0.54ns (0.36-0.72) 
MD 0.59ns (0.47–0.70)  0.61ns (0.45-0.76) 0.62ns (0.49-0.73)  0.68a (0.51-0.82) 0.62ns (0.49-0.73) 0.57ns (0.38-0.74) 
LD         
Vol 0.53ns (0.41-0.64)  0.51ns (0.35-0.67) 0.51ns (0.38-0.63)  0.53ns (0.36-0.69) 0.51ns (0.38-0.63) 0.54ns (0.36-0.71) 
FA 0.55 ns (0.43-0.66)  0.73
b
 (0.57-0.86) 0.69
c
 (0.57-0.80)  0.70
a
 (0.53-0.84) 0.69
b
 (0.57-0.80) 0.52ns (0.34-0.69) 
MD 0.51ns (0.39-0.62)  0.73
b
 (0.58-0.86) 0.72
b
 (0.60-0.82)  0.79
c
(0.63-0.90) 0.80
c
 (0.68-0.89) 0.52ns (0.34-0.70) 
Sensory nucleus 
VP         
Vol 0.54ns (0.42-0.66)  0.60ns (0.44-0.75) 0.56ns (0.43-0.68)  0.52ns (0.35-0.68) 0.54ns (0.41-0.66) 0.59ns (0.41-0.76) 
FA 0.63 ns (0.51-0.74)  0.56ns (0.39-0.71) 0.55ns (0.43-0.67)  0.51ns (0.35-0.68) 0.60ns (0.47-0.72) 0.53ns (0.35-0.71) 
MD 0.55ns (0.43-0.67)  0.62 ns (0.46-0.77) 0.58 ns (0.46-0.70)  0.84
c
 (0.69-0.94) 0.80
c
 (0.68-0.88) 0.71
a
 (0.52-0.85) 
Non-specific nucleus 
CM/Pf         
Vol 0.53ns (0.41-0.65)  0.54ns (0.37-0.69) 0.51ns (0.38-0.63)  0.59ns (0.42-0.74) 0.62ns (0.49-0.74) 0.64ns (0.46-0.80) 
FA 0.52ns (0.40-0.63)  0.53ns (0.37-0.69) 0.52 ns (0.40-0.65)  0.53ns (0.36-0.69) 0.60ns (0.47-0.72) 0.51ns (0.33-0.69) 
MD 0.61 ns (0.49-0.72  0.62 ns (0.46-0.76) 0.51ns (0.39-0.63)  0.92
c
 (0.79-0.98) 0.83
c
 (0.72-0.91) 0.81
c
 (0.64-0.93) 
 
THE THALAMUS IN PARKINSON’S DISEASE:  
A multimodal investigation of thalamic involvement in cognitive impairment 
Chapter 8 | 230 
 PD motor  Mild cognitive impairment  Dementia 
 C vs PD-N  C vs PD-MCI PD-N vs PD-MCI  C vs PD-D PD-N vs PD-D PD-MCI vs PD-D 
Motor nuclei 
VA         
Vol 0.50ns (0.39-0.62)  0.62ns (0.46-0.77) 0.62ns (0.49-0.73)  0.63ns (0.46-0.78) 0.62ns (0.49-0.74) 0.54ns (0.36-0.72) 
FA 0.62 ns (0.50-0.73)  0.55ns (0.39-0.70) 0.56ns (0.43-0.68)  0.59ns (0.42-0.74) 0.56ns (0.44-0.69) 0.52ns (0.34-0.70) 
MD 0.58ns (0.47-0.70)  0.74
b
 (0.58-0.86) 0.66
a
 (0.54-0.77)  0.74
b
 (0.57-0.87) 0.68
a
 (0.55-0.79) 0.52ns (0.34-0.69) 
VL         
Vol 0.55ns (0.43-0.67)  0.58ns (0.42-0.73) 0.54ns (0.42-0.66)  0.59ns (0.42-0.74) 0.55ns (0.42-0.67) 0.50ns (0.33-0.68) 
FA 0.54ns (0.42-0.66)  0.57ns (0.40-0.72) 0.60 ns (0.47-0.72)  0.58ns (0.41-0.73) 0.65
a
 (0.52-0.76) 0.52ns (0.34-0.70) 
MD 0.59 ns (0.47-0.70)  0.63ns (0.47-0.78) 0.56ns (0.43-0.68)  0.87
c
 (0.72-0.95) 0.79
c
 (0.68-0.88) 0.74
b
 (0.56-0.88) 
AUC: area under the receiver operating curve (chance = 0.5; perfect separation = 1.0).  Superscript numbers indicate level at which the comparison is significant: a p < 0.05; b 
p < 0.01; c p < 0.001.   
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8.7.6.3 Identification of PD mild cognitive impairment  
Relative to healthy control subjects 
MD remained the best variable to predict cognitive impairment.  The lower level of motor 
impairment in the PD-MCI group resulted in even the motor nuclei being unable to 
separate the two groups (VA: 50%; VL: 33.3%).  The cognitive nuclei were also of limited 
value, with only the association nuclei (MDn, Pu) able to correctly identify cognitive 
decline more often than chance (55.6% for both regions).  For every other nucleus AUC 
levels were either not significant (AP, LP, CM/Pf, VP) or sensitivity level was only 50% 
(LD).   
Relative to patients with no cognitive impairment 
Arguably the most important comparison, that of the unimpaired patients and those with 
mild cognitive impairment was best achieved using diffusivity measures in the majority of 
cases.  The only exception which reached significance was again in the AP nucleus where 
volume had a higher AUC (33.3%) than MD or FA.  For the first time, the LD nucleus was 
the best discriminatory ROI here, although this only resulted in correct identification of 
PD-MCI in 55.6% of cases.  None of the other regions associated with cognition had a 
significant AUC (CM/Pf, VP, LP, Pu), or could not predict PD-MCI at higher than chance 
levels (MDn).  Not surprisingly, the motor nuclei (VA: 44.4%; VL: 38.9%) could also not 
discriminate between groups at higher than chance levels. 
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8.8 Discussion 
8.8.1 Summary of the results  
The preceding chapter addressed the idea that the regions of the thalamus are not affected 
in unison and instead exhibit differential involvement in the symptoms of PD.  In line with 
the results of a prior study into thalamic integrity in PD (Peran, et al., 2010), we have 
shown that examining the structural integrity of the thalamic nuclei using diffusion 
parameters provides a better reflection of thalamic disruption than measures of gross 
structural atrophy in PD does.  In addition, we have confirmed the relationship between all 
thalamic nuclei and multiple domains of cognition in a single sample for the first time.  
Our results support two previous studies that have reported a relationship between 
cognition and some thalamic regions in a Schizophrenia (Hazlett, et al., 1999) and 
Alzheimer’s (Qiu, Fennema-Notestine, et al., 2009) sample and one where the anterior and 
medio-dorsal nuclei were independently segmented from the rest of the thalamus shown to 
have a strong relationship with related cognitive domains (Gilbert, et al., 2001).  Finally, 
we have shown that the thalamic nuclei are differentially targeted and begin showing 
degeneration according to the vulnerability of the cortical regions they have primary 
connectivity with.  The limbic nuclei, reciprocally connected with the frontal lobes (Jones, 
2007a) are the most affected and show the signs of subtle degeneration at the cellular level 
in PD patients with no detectable cognitive impairment before exhibiting gross levels of 
atrophy in those with dementia.  These results confirm what our group (Melzer, et al., 
2011a), and others (Beyer, Janvin, et al., 2007; Burton, et al., 2005) have found in regards 
to frontal lobe disruption occurring in the early stages of PD.  We have shown that the 
association nuclei and the centromedian/parafascicular complex, previously heavily 
implicated in PD (Henderson, et al., 2000a, 2000b) and PD-D (Brooks & Halliday, 2009) 
at autopsy show disruption in those patients with only mild cognitive impairment and have 
a strong association with multiple cognitive domains in this sample.  The sensory and 
motor nuclei are only involved in those patients with dementia, in line with histology 
studies that show minimal pathology in these regions in PD (Braak, et al., 2003).   
Mean diffusivity, fractional anisotropy and volume of the thalamic nuclei were 
examined to give a detailed impression of nuclei degeneration in PD.  In most instances the 
mean diffusivity measures of thalamic nuclei were more reflective of the cognitive state of 
the PD patients, showed a greater association with domains of cognition and allowed for 
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markedly better discrimination between cognitive groups than either volume or fractional 
anisotropy measures.  These results confirm those reported in Chapter 7 where diffusivity 
measures of the whole thalamus showed significant change between cognitive groups with 
only mild cognitive dysfunction and dementia, prior to evidence of gross atrophy in the 
PD-D group.  The only exception was in the LD nucleus where FA was a better predictor 
of cognition.  In all other nuclei except the motor nuclei, increased diffusivity was 
observed in the PD-D group, and in the case of the MDn and LD nuclei, also in the PD-
MCI group relative to PD-N patients in the absence of volume loss.   
 Increased MD is the result of disruption in neurons, axons or supporting glial cell 
structures (Assaf & Pasternak, 2008) within the thalamic nuclei and is most likely caused 
by neuronal death or LB pathology (Brooks & Halliday 2009).  LB pathology especially 
plays an important part in the development of dementia in PD (Aarsland, et al., 2005; 
Hurtig, et al., 2000) and is thought to be one of the main contributions to the MD results 
within this study.   
  In the thalamic nuclei that are associated with cognitive function mean diffusivity 
measures of degeneration are increased in those areas known to be infiltrated with LB 
pathology.  The association (MDn, LP and Pu) nuclei show medium level infiltration 
(Braak & Braak, 2000; Rub, Del Tredici, Schultz, et al., 2002), with the LP the worst 
affected.  The CM/Pf complex is undoubtedly the most affected by pathology and has 
heavy infiltration levels in the CM and only slightly less in the Pf.  This appears to 
contribute to cellular degeneration as both regions also exhibit a great degree of neuronal 
loss and the Pf, gross volume loss (Henderson, et al., 2000a).  It is interesting to note then, 
that in our study these regions also show the greatest change in mean diffusivity between 
cognitive groups.  The MDn nucleus is the only region to show a significant progressive 
increase in diffusivity from PD-N to PD-MCI to PD-D and, along with the VP – the CM/Pf 
one of the only regions to show a MD increase from PD-MCI to PD-D.  As histology has 
not been carried out on the VP nucleus of PD patients to date, we can only assume that LB 
pathology is also present in this region.  MD levels in the pulvinar also show an association 
with cognition in our sample, there is a significant increase in MD in both the PD-D and 
PD-MCI group relative to control subjects, as well as in the PD-D group relative to PD-N.  
In the LP, a similar result is seen with a significant MD increase in PD-D relative to 
controls and PD-N.   
The VA and VL motor nuclei reportedly show light LB pathology (Braak & Braak, 
2000), and in this sample also show a significant increase in diffusivity between the PD-D 
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group and control subjects.  No changes are observed in comparison between any other PD 
groups, indicative of the fact the VA and VL have no association with cognition.  The AP 
nucleus reportedly shows no LB pathology, neuronal or volume loss (Braak & Braak, 
2000), and not surprisingly also shows no bilateral MD changes within the PD cognitive 
groups in this sample.  In the right hemisphere however the AP has significant cellular 
disruption in PD-N patients, perhaps suggesting differential LB infiltration between 
hemispheres although this is a difficult issue to explore as to date, no histological studies 
have provided a comparison between hemispheres of neuronal count.  Peran, (2009) has 
previously reported a significant effect of lateralisation in the thalamus however, where the 
right thalamic volume was larger than the left in an ageing cohort and this could indicate 
degeneration occurs in one hemisphere prior to the other.   
8.8.2 The relationship between thalamic nuclei and cognition  
Using robust statistical analyses we confirmed the association between thalamic nuclei and 
specific areas of cognition in some cases, but did not find an association where expected in 
others.  We did successfully extrapolate cognitive influence from the contaminant of motor 
dysfunction in PD better than has been attempted previously however.  All nuclei showed a 
strong association with at least one area of cognition, with the combined effect of several 
nuclei showing a markedly increased contribution to specific areas of cognitive function.   
Although volume of the AP nucleus and FA of the LD and VP nuclei had a 
correlation with some areas of cognition, mean diffusivity was the best independent 
predictor of cognitive function in all cases.  When covariates were controlled for using 
multiple regression analysis the relationship between volume and FA measures of nuclei 
did not survive.  Mean diffusivity measures of the individual thalamic nuclei on the other 
hand showed an independent contribution to specific domains of cognition while the 
combined effect of groups of thalamic nuclei further increased contribution in most cases.  
One recent DTI study has reported decreased FA of the MDn nucleus as a neurocorrelate 
of depression (Li, et al., 2010), but diffusivity measures of thalamic nuclei have not 
previously been examined in relation to cognition in PD.   
The notion that cellular disruption in thalamic nuclei causes cognitive dysfunction 
is somewhat supported by the above autopsy examinations of LB pathology (Braak, et al., 
2000; Henderson, et al., 2000a; Rub, Del Tredici, Del Turco, et al., 2002).  In all three 
samples any patients that were exhibiting dementia prior to death were excluded from the 
investigation.  This could perhaps explain the lack of abundant pathology in wider thalamic 
The Thalamic Nuclei in Native Space  
Chapter 8 | 235 
regions.  Prior to the development of dementia, it is now well established that most PD 
patients will exhibit lower levels of cognitive dysfunction, even in the early stages 
(Aarsland, et al., 2009).  There is no guarantee that patients in any of the above samples 
were not exhibiting some degree of cognitive impairment as none of the studies report 
conducting extensive neuropsychological tests.  This hypothesis is somewhat supported by 
the fact the Henderson, et al., (2000a) sample reports an average disease duration of 7.2 
years and the Rub, et al., (2002) sample an average Hoehn and Yahr stage of 4-5.  MCI has 
been previously diagnosed in a PD sample with average Hoehn and Yahr stage of 2.6 
(Beyer, Janvin, et al., 2007) with reduced mini mental status is evident in a sample of PD 
patients from the same group who had a disease duration of 6 years (Beyer & Aarsland, 
2008).  Data from our own cohort also supports the possibility of MCI at this length of 
disease duration and Hoehn and Yahr staging.  In one of our cohorts, MCI was diagnosed 
in a group with average disease duration of 7.3 years and a Hoehn and Yahr stage of 2.6 
(Dalrymple-Alford, et al., 2010).  The degree of LB pathology in these samples therefore is 
a likely correlate of early cognitive dysfunction, and can be reflected in the cellular 
disruption that is shown by mean diffusivity levels.   
MD parameters of thalamic nuclei show an association with multiple domains of 
cognition, although this is primarily domain-specific with each region influencing the 
cognitive subtype that is moderated by those areas of the cortex that they show the greatest 
reciprocal connectivity with.  This domain-specific association confirms a recent study 
(Sasson, Doniger, Pasternak, Tarrasch, & Assaf) which used combined DTI and VBM 
analysis of the whole brain to examine the relationship between cognition and specific 
cortical regions in healthy control subjects.  Participants were healthy, aged 25-82.  
Cognition, separated into domains of executive function, information processing speed and 
memory was examined using a computerised neuropsychological test battery.  Results are 
similar to our own, where our nuclei that have frontal connectivity correlate with executive 
function and attention, the Sasson et al., (2012) study showed partial correlations between 
executive function score and diffusion parameters in the left inferior frontal gyrus.  
Similarly, in our nuclei that have temporal connectivity we demonstrated a correlation with 
memory, and Sasson, et al., a relationship between memory and temporal and frontal 
regions including the right inferior frontal gyrus, medial frontal gyrus and superior 
longitudinal fasciculus – the white matter tract which links the parietal and temporal lobes 
to the frontal lobes.  This study lends significant support to the idea that the microstructural 
integrity of the cortex is heavily associated with cognition.   
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8.8.2.1 Attention 
The limbic AP (Aggleton & Brown, 1999) and LD (Edelstyn, et al., 2006) thalamic nuclei 
are considered to be primarily influential over the learning and memory domains of 
cognition.  It was also expected that the AP would play a significant role in the cognitive 
domain of attention due to its largely prefrontal afferent connectivity (Aggleton & Brown, 
1999).  The role of the anterior nuclei complex in attention is supported by the fact that this 
complex shows increased activation in patients suffering from prepulse inhibition – a 
neurological phenomenon which manifests in the inability to filter out unnecessary 
information, or, pay attention to target information (Hazlett, et al., 2001).   
Our results show that the LD was involved in the attention domain but the AP was 
not.  Attention was mainly predicted by the LD, but it was the combined influence of the 
AP, CM/Pf and Pu nuclei that accounted for the greatest proportion of variance in attention 
domain score.   
The CM/Pf complex accounted for only slightly less of the variance in attention 
domain scores than the LD nucleus.  Although the CM/Pf has traditionally been considered 
non-specific due to the diffusivity of its connectivity (Jones, 2007b), this result confirms 
those of Kinomura, et al., (1996) who showed that in healthy control subjects the CM/Pf 
complex was the only thalamic region to show increased blood flow during the 
performance of an attention task.  Our results also implicate the Pu on attention tasks.  
These results were not unexpected as the Pu is primarily involved in visuospatial function.  
As all attention tasks in our neuropsychological test battery (Section 5.3) required visual 
interpretation we can assume Pu disruption would manifest as a deficit on these tests, a 
result that is in line with previous research showing Pu involvement when a participant is 
required to only attend to a stimulus and not perform any other tasks (Kastner, et al., 2004; 
LaBerge & Buchsbaum, 1990).   
8.8.2.2 Executive function 
We expected a significant association between the MDn nucleus and the executive function 
domain, a result that was not upheld here.  Surprisingly, the VP nucleus was the only 
independent predictor of this domain, although the LD nucleus was also involved before 
the influence of covariates was considered.  The connectivity between the VP and the 
secondary somatosensory cortex may account for this result.  Terminations of the VP 
include regions of the secondary somatosensory cortex (Bhatnagar, 2002) and this region 
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has previously shown activation during tasks of executive function in healthy control 
participants (Kircher, Nagels, Kirner-Veselinovic, & Krach, 2011).   
The neuropsychological tests applied here to measure executive function included 
measures of fluency - specifically category, letter and action fluency (See Section 5.3.4.2) 
where participants were given a letter or category and asked to name as many objects 
beginning with that letter or within the category as quickly as possible.  The relationship 
between executive function and the VP was primarily driven by the letter fluency task 
where participants were required to name as many words as they could think of beginning 
with a certain letter.  Follow up analysis of each test independently indicated that this task 
was the only neuropsychological test to show a relationship (r = 0.25, p = 0.02) with the 
VP nucleus, and that the VP also remained a significant independent predictor of the letter 
fluency task after the inclusion of covariates (r
2 
= 6%, p = 0.02).  In the healthy control 
study (Kircher, et al., 2011), although the cerebellum, frontal and temporal lobes were all 
activated during the performance of any verbal fluency task, letter fluency was shown to be 
the specific domain of the parietal lobe.  We have therefore concluded that the association 
between VP and letter fluency in this sample is due to the connectivity between the VP and 
several areas within the secondary somatosensory cortex, specifically areas within the 
parietal lobe.   
8.8.2.3 Learning and Memory 
As expected, the MDn and LD influenced the learning and memory domain, although 
somewhat counterintuitively, the VP nucleus was the biggest contributing factor here.  The 
influence of the MDn and LD over learning and memory confirms results from several 
previous studies.  In regards to the MDn, this region has been consistently implicated in 
Schizophrenia (Qiu, Zhong, et al., 2009) and in healthy control subjects (Johansen-Berg, et 
al., 2005), showing a strong relationship with executive function and working memory 
tasks in both studies.  Similarly, the LD has been previously implicated in recall memory 
(Edelstyn, et al., 2006) in a single subject with LD lesions.  In addition, the LD nucleus has 
reciprocal connectivity with the limbic cortex and the cortices surrounding the 
hippocampus and is part of the extended hippocampal pathway which mediates learning 
and memory processes (Edelstyn, et al., 2006) confirming that degeneration in this area 
will correspond to deficits in memory processes.   
In regards to the VP, due to axons primarily terminating in the somotosensory 
cortices, (Bhatnagar, 2002) we expected this region to show an association with sensory 
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deficits.  The somatosensory cortex has previously been implicated in a PD sample (Brefel-
Courbon, et al., 2005), where higher somatosensory cortex activation and lower pain 
threshold was evident in PD patients compared to controls during the administration of 
painful stimuli.  Surprisingly, we could not confirm this association.  Although there was a 
significant association between VP and UPDRS III score (r = 0.30, p = 0.01) in our cohort, 
there was no association between the sensory subset of UPDRS (r = -0.07, p = 0.54) and 
the VP.   
Follow up analysis was again employed to examine the specific subsets of learning 
and memory to examine which specific test accounted for the strong influence of the VP 
within this domain.  Individually, none of the cognitive tests had an association with the 
VP despite the overall significant relationship between the VP and the aggregate learning 
and memory score.  This lack of association suggests that the VP influence over learning 
and memory is greater than the sum of the influence of individual tasks.  Another factor is 
likley mitigating the effect of the VP in this cognitive domain. This could be other thalamic 
nuclei that have connectivity with the VP, or it might be that the connectivity between the 
VP and other regions is disrupted, preventing adequate performance of these tasks.  
Our own fibre tracking results which will be explored in depth in the subsequent 
chapter, indicate that connectivity of the VP does primarily terminate in the somatosensory 
cortices. Prior to reaching this destination however, fibres appear to be concentrated in 
regions of the medial temporal lobe, with dense projections cumulating in the hippocampal 
region.  As the main function of the hippocampus is memory consolidation (Alvarez & 
Squire, 1994) it is possible that disruption within these axonal tracks has affected the 
normal function of the hippocampus in this sample, which has lead to the observed deficits 
in learning and memory and the contribution of the VP nucleus to this domain.   
8.8.2.4 Visuospatial/Visuoperception 
Interestingly neither the LP nor Pu were involved in visuospatial or perception ability as 
expected, with the CM/Pf appearing to be primarily responsible for this.  This result is in 
contrast to the findings of (Ricker & Millis, 1996) who showed significant LP and Pu 
involvement in visuospatial/perception in patients with posterior thalamic lesions.  As this 
group only examined these posterior nuclei and did not contrast results with changes in any 
other regions of the thalamus it is difficult to conclude that visuospatial function is solely 
the domain of the LP and Pu however.   
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The combined involvement of the CM/Pf and LD suggests that frontal disruption is 
the primary cause of visuospatial and perception dysfunction in PD.  The CM/Pf complex 
and the LD nuclei were the only regions to show an independent association with this 
cognitive domain.  The primary projections of the CM/Pf are to the striatum but diffuse 
connectivity is also evident throughout the cortex, and in PD, degeneration of a small 
nucleus surrounding this region is associated with dementia (Brooks & Halliday 2009). 
Visuoperception is impaired in in some PD-D patients (Janvin, et al., 2003) and is a likely 
mitigating factor underlying other cognitive domains as visual interpretation is required for 
nearly all neuropsychological tests.    
The LD nucleus has similar prefrontal and frontal connectivity as the AP and can 
also be considered as part of the limbic system extended hippocampal pathway (Edelstyn, 
et al., 2006).  As a deficit in visual perception corresponds to activation of the medial 
temporal lobe (Holt, et al., 2006) the disruption in the LD could be hypothesised to cause 
the visual spatial/perception deficits observed here due to a breakdown in communication 
with the temporal lobe.   
 The visuospatial/perception domain encompassed examination of spatial awareness 
and stimuli perception, functions that were able to be independently examined in most 
cases.  In regards to the visuospatial deficits, the judgement of line orientation test (JOL) 
primarily examined spatial awareness.  LD was not an independent predictor of the JOL 
test after inclusion of covariates.  CM/Pf on the other hand, remained a unique predictor of 
JOL, accounting for 10% (p < 0.001) of the variance in the test score.  Our results are 
supported by work with primates, where the CM/Pf is involved in the interpretation of the 
spatial location of visual stimuli (Minamimoto & Kimura, 2002).  In monkeys, the reaction 
time required to detect a target was decreased if the presentation of the target was preceded 
by a warning stimulus in the same spatial location, compared to in an opposite location of 
the target.  During presentation of the warning stimulus the neurons in the CM/Pf complex 
showed strong activation.  Lesioning of the CM/Pf complex rendered the monkeys 
completely unable to interpret the visual stimuli.  The generalisation of this result to human 
subjects is somewhat limited by results from a single subject who had experienced a left 
thalamic haemorrhage which caused damage to the CM/Pf and VL nuclei.  Although the 
patient experienced significant motor dysfunction, no spatial neglect was evident when he 
was asked to copy a three dimensional structure or draw a picture of a clock or a room 
(Manabe, Kashihara, Ota, Shohmori, & Abe, 1999).   
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Visual perception was examined using the visual objects and space perception 
(VOSP) fragmented letters test.  Both the LD (r
2
 = 4%, p = 0.04) and CM/Pf (r
2
 = 5%, p = 
0.03) nuclei were influential over this domain, with a significant proportion of the variance 
in test scores accounted for by these regions after the inclusion of covariates in the multiple 
regression.  Similarly, both the LD (r
2 
= 15%, p < 0.001) and CM/Pf (r
2
 = 7%, p = 0.01) 
contributed to the copy subset of the Rey Complex Figure Test (RCFT), a test 
encompassing both spatial and visual perception.  The fact that both nuclei were influential 
in these domains suggests that the influence over visual perception is mediated by frontal 
connectivity as both the LD and CM/Pf have extensive frontal connectivity, but do not 
generally share connectivity with any other cortical regions.   
8.8.2.5 Global Z score 
Finally, in regards to the aggregate measure of global functioning, the LD nucleus was the 
only region that had an independent association with this score.  Prior to inclusion of the 
covariates however, the association (MDn, Pu) and CM/Pf nuclei were also heavily 
involved.  This suggests the aggregate score is largely reflective of frontal dysfunction as 
all these regions, except the Pu (Highley, et al., 2003) have demonstrated primarily frontal 
connectivity (Jones, 2007a).  In this case, either the CM/Pf or LD, sometimes in 
conjunction, primarily influenced the level of global cognitive, rather than specific 
domains of dysfunction in this cohort.  If the mini mental status exam can be considered to 
be representative of global function, the idea of frontal disruption influencing global 
cognitive status has been confirmed from previous studies.  The Burton et al., (2004) 
cohort showed that grey matter atrophy was restricted to the frontal lobes in PD patients 
relative to controls.  The PD patient group excluded those with dementia but, on average 
the group demonstrated a lower MMSE score (26.4) compared to the control group (28.1) 
so this could indicate that frontal dysfunction in this instance is largely reflective of early 
cognitive decline.  Similarly, a later PD cohort that was examined by the same group 
(Beyer, Larsen, et al., 2007) showed largely frontal, but also some temporal trend level 
grey matter loss in PD-MCI relative to healthy control subjects.  Using more extensive 
neuropsychological testing, our own group (Melzer, et al., 2011b) has also demonstrated 
that frontal lobe disruption is the biggest correlate of global function, showing grey matter 
loss in largely frontal, but also some temporal regions in PD-MCI compared to controls, 
worsening in PD-D.  An association between aggregate global Z score and extensive 
regions of the frontal and few regions of the temporal cortex was observed in our sample 
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and the association between the aggregate global measure and MMSE and MoCA was 
supported, with the patient group exhibiting progressively lower MMSE and MoCA scores 
from PD-MCI to PD-D.   
8.8.3 Nuclei involvement at different levels of cognitive impairment in PD  
After examination of all nuclei it is clear that each become involved in the cognitive or 
motor symptoms of Parkinson’s disease at different stages and the limbic nuclei are 
especially vulnerable.  The AP nucleus is disrupted in the very early stages of PD, 
indicated by the fact celluar disruption is evident in this region in patients without 
cognitive impairment.  This is not to say that each influences a specific behaviour with no 
interconnection however.  Rather, what appears to be happening is the differential 
pathological infiltration of the thalamic nuclei primarily affects those cortical regions with 
preferential connectivity, with the influence of degeneration in surrounding, and connected 
areas involved to a lesser degree.  Thus, we should see nuclei degeneration in accordance 
with LB pathology levels at each stage of PD.   
This study measured the level of nuclei degeneration at each cross-sectional stage 
of PD, with changes in volume, diffusivity or anisotropy assumed to represent the 
accumulation in disruption that occurs after the previous stage.  In the early stages of PD 
not all nuclei are affected, but most show heavy degeneration in those patients that have 
dementia in the final stages.  The following section of this chapter addresses the changes in 
thalamic nuclei at each cognitive stage of PD and compares results with evidence gained 
from other studies.   
8.8.3.1 In PD without cognitive impairment 
The limbic nuclei are the first to show degeneration in PD.  Increased diffusivity is 
apparent in the AP (right side only) of PD-N subjects relative to controls, with further 
increases occurring as cognition worsens in PD-MCI and PD-D.  AP degeneration is also 
hypothesised to occur in the early stages of AD, and along with the MDn, is one of the 
thalamic regions showing the greatest level of cellular disruption in AD (Chen, et al., 
2007).  Given the level of degeneration, the authors of the Chen et al., (2007) study 
hypothesised that disruption occurs in the AP earlier and to a greater degree than it does in 
other thalamic regions.   
Degeneration in the AP nucleus was assumed to cause wider communication 
disruption and be representative of further degeneration in the limbic loop (Braak & Braak, 
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2000) but despite the early involvement of the AP nucleus in cognitive dysfunction, 
examination of this region did not aid in discrimination of PD cognitive groups.  Although 
the anterior principal nucleus has not been investigated in PD before, the connectivity of its 
axons has been investigated by our own group using DTI methods (Melzer, et al., 2011a).  
In our PD-N group, reduced MD was evident in several fibre tracts, including in the 
anterior thalamic radiation – the white matter tract which connects the anterior regions of 
the thalamus to the prefrontal cortex.  This suggests that the subtle degeneration observed 
in the AP in this study is a consequence of, or a contributing factor to the reduced integrity 
of the white matter tract into the frontal lobes.   
Support for this hypothesis comes from a single sample of PD patients.  When grey 
and white matter density, FA and MD were examined in a PD cohort (Kendi, et al., 2008) 
and compared to healthy controls no decrease in grey or white matter volumes were 
observed in the patient group.  Conversely, a significant decrease in FA was reported for 
extensive regions of the frontal lobes in patients, in the absence of wider cortical changes.  
As there was no corresponding change in MD this suggests the axonal integrity is primarily 
disrupted here, and that other cellular integrity largley remained intact (Watts, 2008).  
Although the patients in the Kendi, et al., sample did not have dementia, their level of 
neuropsychological functioning was not examined any further than what was required to 
exclude dementia.  This leads to difficulties in interpretation of their level of cognitive 
dysfunction.  It can be assumed they were not showing significant levels of impairment 
however as their Hoehn and Yahr score was only 1.8 and disease duration only 5.8 years, 
clinical characteristics that are very similar to those seen in our own (Dalrymple-Alford, et 
al., 2010) PD-N sample [H+Y = 1.9 (0.7), DD = 4.6 (3.9)].   
8.8.3.2 In PD with mild cognitive impairment 
The LD and MDn thalamic nuclei become disrupted in patients with PD-MCI.  In the LD, 
reduced fractional anisotropy and increased mean diffusivity was evident in the PD-MCI 
group relative to controls but neither variable aided in distinguishing PD-MCI from PD-N.  
Degeneration of the MDn was slight, only detected by changes in mean diffusivity.  The 
MDn showed an increase in diffusivity relative to both the control and PD-N groups but 
there was significant overlap between the PD-MCI and PD-N groups.  PD-MCI could 
successfully be identified relative to the control subject’s using this variable however.   
 Little is known about the neuroanatomical substrates of MCI in PD and although 
we (Melzer, et al., 2011a) have previously implicated the AP in PD-MCI no other thalamic 
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nuclei have been specifically examined in PD or AD MCI.  With their combined prefrontal 
connectivity however, the LD and MDn disruption can be assumed to represent further 
frontal lobe degeneration, an idea confirmed by several groups that have used various 
imaging modalities to investigate MCI in PD.  In the Beyer, Janvin, et al., (2007) sample 
trend level frontal lobe grey matter loss is evident in PD-MCI relative to patients with 
intact cognition.  In our own (Melzer, et al., 2011b) cohort, changes in PD-MCI were 
examined relative to healthy controls, showing a significant reduction in grey matter 
throughout the frontal lobes.  Similar to the Beyer, et al., (2007) sample, when changes 
were examined relative to PD-N, grey matter reduction levels did not remain significant.  
In contrast, a small region of the middle frontal gyrus shows degeneration in the (Song, et 
al., 2011) PD-MCI group relative to PD with intact cognition.   
Frontal atrophy is not a contaminant of Parkinson’s disease MCI alone, as it has 
also been identified in those with neurodegenerative (n-MCI), vascular (v-MCI) and 
Parkinson’s Lewy body MCI (plb-MCI) relative to control subjects (Meyer, Huang, & 
Chowdhury, 2007).  One very interesting study (Lee, et al. 2010b) has also compared 
single domain amnesic MCI patients (aMCI: diagnosed according to Petersen, et al., 
(1997) criteria) with and without PD.  Frontal lobe degeneration is again heavily 
implicated in cognitive dysfunction here, as relative to control subjects grey matter loss is 
evident in the middle frontal and precentral gyrus in PD-MCI.  The difference in pre AD 
and pre PD-D groups in regards to memory impairment was highlighted, as the pre AD 
aMCI group had more severe impairment on the neuropsychological tests of memory than 
the pre PD-D aMCI group had.  This was reflected in the difference in cortical changes, as 
the aMCI group without PD showed significant temporal degeneration while these regions 
were largely spared in the aMCI group with PD.   
 The MDn also has some connectivity with temporal, parietal and occipital regions 
of the cortex (Buchsbaum, Buchsbaum, et al., 2006).  A comparison with a-MCI with and 
without PD reports significant perfusion decreases in temporal, parietal and occipital lobes 
in those with PD compared to those without, and a healthy control group (Nobili, et al., 
2009).  The temporal lobes especially are implicated in MCI suggesting MDn degeneration 
is also reflective of degeneration in the wider temporal cortex.  In the above samples 
superior and inferior temporal lobes (Beyer, Larsen, et al., 2007), Heschl’s gyri, planum 
temporale and right insula along with the superior and inferior temporal lobes (Melzer, et 
al., 2011b), the bilateral temporal horn of those with neurodegenerative MCI and in the 
wider temporal cortex in those with n-MCI, v-MCI and plb-MCI all exhibited significant 
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grey matter atrophy relative to control subjects (Meyer, et al., 2007).  Temporal 
degeneration is reflective of multiple domain mild cognitive impairment in PD.  In a group 
with multiple domain mild cognitive impairment, cortical atrophy was more extensive and 
included further regions in the temporal as well as the frontal lobes than were implicated in 
single domain cognitive impairment (Lee, et al., 2010a).   
As mentioned previously, the anterior thalamic radiation shows significant 
disruption in PD-N relative to controls.  Not surprisingly, the integrity of this tract further 
worsens in PD-MCI (Melzer, et al., 2011a).  In one of the few other studies to apply 
diffusion tensor imaging to PD-MCI (Hattori, et al., 2011) several other white matter tracts 
were also found to be disrupted in PD-MCI relative to controls, including the inferior 
fronto-occipital fasciculus which is a white matter tract connecting the frontal lobe to the 
occipital and temporal lobes (Wanaka, Jiang, Nagae-Poetscher, van Zijl, & Mori, 2004).  
Interestingly, in this PD sample no grey matter atrophy was identified in PD-MCI in any 
regions, and the changes in diffusivity of the white matter tract did not remain when 
examined relative to PD-N, suggesting that degeneration is subtle and occurs as a pre-
cursor to grey matter reduction.   
 The notion of disruption localised to the frontal and temporal lobes in the early 
stages of cognitive dysfunction is not a new one.  Before the concept of PD-MCI was well 
established Braak, et al., (2003) demonstrated that LB and LN pathology exists in the 
temporal mesocortex as early as stage 3, worsening in stage 4 and spreading to prefrontal 
and other regions of the neocortex in stage 5.  Later, this group (Braak, Rub, et al., 2006) 
showed that cognition (MMSE) is impaired as early as stage 3 in some patients, with a 
significantly greater number of patients showing mildly impaired (MMSE 21-24), 
moderately impaired (MMSE 11-20) and severely impaired (MMSE 0-10) cognition from 
stages 4-6.   
8.8.3.3 In PD with dementia  
The CM/Pf, Pu, LP and VP nuclei all only begin showing significant levels of degeneration 
once cognitive dysfunction is advanced in PD-D, and were all best measured by MD, 
indicating disruption is not yet severe enough to be reflected in gross atrophy of these 
regions.  The bilateral diffusivity changes in the CM/Pf is in line with the histology studies 
conducted by Brooks et al., (2009) who showed degeneration of regions within the 
intralaminar nuclei exhibit markedly reduced volume in PD-D relative to PD and a strong 
relationship with cognition in the CL nucleus.  In our cohort, RoC statistics show near 
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perfect separation of the PD-D group from the control subjects using MD measures of the 
CM/Pf.  Between the PD-D and PD-N groups however, there is slightly more overlap, 
confirming the involvement of the CM/Pf in the motor (Henderson, et al., 2000b) as well 
as cognitive dysfunction of PD. 
The mean diffusivity of the pulvinar nucleus was an even better discriminatory 
variable, separating the PD-D group from PD-N.  This is in line with the grey matter loss 
identified in the Pu by (Beyer, Larsen, et al., 2007) and our own group (Melzer, et al., 
2011b) which both showed significantly greater grey matter loss in PD-D group relative to 
PD-N and independent of the demographic and disease contaminants of PD.   
The pulvinar may be more involved in specific subsets of dementia.  In subcortical 
ischemic dementia patients the Pu shows reduced blood flow and a significant association 
with the executive function and memory subsets of cognitive dysfunction (Kato, et al., 
2008).  Research from a schizophrenia cohort also supports this idea, as Pu degeneration 
(Harms, et al., 2007) and activation (Andrews, et al., 2006) shows a strong association with 
tests of working memory.   
The lateral posterior nucleus is also an area of significant disruption in PD-D, 
showing increased diffusivity relative to PD-N and healthy control subjects.  Despite this, 
the LP nucleus showed a significant degree of overlap between PD-D and control patients 
and could not be considered a useful tool for identifying dementia in this cohort.  This did 
not come as a surprise as the LP does not show extensive pathology in PD, only showing 
isolated LB’s and LN’s (Rub, Del Tredici, Schultz, et al., 2002).   
The VP nucleus shows a significant increase in diffusivity in PD-D relative to 
control subjects and PD-N patients.  The VP nucleus was also able to identify the PD-D 
group from the control subjects as well as from the PD-N group with some success.  The 
VP nucleus has not previously been implicated in PD, although there is some evidence to 
suggest significant disruption of the primary projection site – the somatosensory cortex in 
PD patients who experience pain associated with dystonic symptoms (Defazio, et al., 
2008).  There is no evidence to suggest VP involvement in the cognitive symptoms of 
dementia.  As the motor symptoms are more advanced in the PD-D group compared to the 
others in this sample however it can be assumed that VP disruption once dementia is 
present is in fact primarily reflective of the accompanying advance in motor dysfunction.   
As expected, the motor nuclei were not influential across the cognitive changes of 
PD.  Only the left VL nucleus shows any change from PD-N to PD-D, with increased 
diffusivity not evident until PD-D.  Both the VA and VL separated the PD-D group from 
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controls and PD-N with some success however, but again this can be assumed to relate to 
the increased motor dysfunction in PD-D relative to the other PD groups.   
8.8.4 Justification of the study methodology  
For the first time, we have examined the nuclei of the thalamus simultaneously and 
identified dissociation between nuclei and specific domains of cognition in PD.  The 
method used to segment the thalamic nuclei here was adapted from that of Wiegell, et al., 
(2003) with the application of similar methods in healthy control subjects gaining 
momentum in recent years.  Several studies (Deoni, Rutt, Parrent, & Peters, 2007; Devlin, 
et al., 2006; Duan, Li, & Xi, 2007; Johansen-Berg, et al., 2005; Jonasson, et al., 2007; 
Rittner, Lotufo, Campbell, & Pike, 2010) have incorporated the original theory and 
moderated aspects of the technique in their own healthy cohorts.  It is somewhat surprising 
therefore that this is the first time this method has been applied in Parkinson’s disease, or 
in any neurodegenerative disorder.   
 The comparison between our results and those produced by Wiegell, et al., (2003) 
and after reference to the anatomical guidelines of several neurological atlases (Duvernoy, 
1991; Niemann, et al., 2000; Nolte & Angevine, 2007) indicates that the procedure applied 
here has produced accurate segmentation of the thalamus for this cohort.  Furthermore, 
given the association between specific thalamic regions and subsets of cognitive function 
that we have demonstrated, we believe the thalamus has undergone successful 
segmentation.   
8.8.5 Summary  
We propose that we have identified a new method to aid in the classification of cognitive 
dysfunction in PD.  Careful monitoring of thalamic nuclei changes in PD patients will aid 
in identification of cognitive impairment, and could also provide neurocorrelates of 
cognitive dysfunction that can be monitored longitudinally.   
 We have confirmed the association between the LD nuclei and attention and also 
found an association between the CM/Pf and Pu with attention which is somewhat 
supported by research in other areas (Kemether, et al., 2003).  We showed a previously 
unreported association between the VP and executive function but did not find the 
expected relationship with MDn and this area.  In regards to learning and memory, the 
expected relationship between the LD and MDn was upheld but the VP produced an 
unexpected relationship with this domain.  We expected the posterior thalamic nuclei (LP 
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and Pu) to be involved in visuospatial and perception but this was not upheld, and instead, 
the CM/Pf and LD were heavy influences here.  
 As hypothesised we reported that the limbic nuclei would be the first to show 
degeneration in PD, with the association and CM/Pf nuclei implicated soon after in PD-
MCI.  In accordance with other studies that studied the whole brain (Beyer & Aarsland, 
2008; Summerfield, et al., 2005), the order of vulnerability follows the pattern of frontal, 
temporal and parietal involvement.   
The thalamic nuclei have previously been examined in some neurodegenerative 
disease samples including in Schizophrenia (Byne, et al., 2001) and Alzheimer’s disease 
(Braak & Braak, 1991).  No studies have yet examined all thalamic nuclei simultaneously 
in a disease sample however.  Previously, cognitive function has been associated with 
individual thalamic nuclei volume loss (Byne, et al., 2002), activation decreases (Andrews, 
et al., 2006; Buchsbaum, et al., 2006) or changes in diffusivity (Li, et al., 2010) in both 
disease and healthy samples but we believe we have provided extensive 
neuropsychological examination of a PD cohort to fully investigate cognitive function 
using robust statistical analysis for the first time.  
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Chapter 9. Study Four: THE CORTICAL CONNECTIVITY OF THE 
THALAMUS AND THALAMIC NUCLEI  
9.1 Objectives  
The white matter pathways that have been delineated from thalamic seed points are 
addressed in this chapter.  These white matter tracts are assumed to represent the cortico-
thalamic fiber network.  The aim of this study was to determine the level of integrity 
disruption in the fiber tracts in PD and the corresponding influence of each on cognitive 
dysfunction.  We also examined the combined influence of the thalamic tracts and the 
thalamic nuclei which were identified in the previous chapter.  Tractography, the method 
used to identify fiber tracts is a new development arising from diffusion tensor imaging 
and has mainly only been applied in healthy samples to validate the technique.  All reports 
which have applied tractography, in the whole brain or from individual regions are 
reviewed here.   
9.2 Diffusion tensor fiber tracking 
Just as the relationship between brain structure and function is fundamental to 
neuroscience (Behrens & Johansen-Berg, 2005), the relationship between brain function 
and connectional architecture is a fundamental principal underlying the circuits of the 
brain.  The relationship between circuitry and function has only recently begun to be tested 
in vivo using advanced diffusion tensor methodology.  Utilising the diffusion tensor image 
for fiber tracking is a simple principle.  Just as water moves more freely through a cell 
unrestricted by barriers, water moves faster in tissue with a high degree of organisation.  In 
the white matter of the brain for example, water diffusion is restricted in those voxels 
where the major axis of a fiber is orientated in a perpendicular, rather than parallel 
direction.  The fiber orientation in one voxel can be systematically mapped to a colour 
pathway, where each colour represents the orientation of the fiber in that voxel.  A path of 
smooth transition in colour is then able to be followed from one voxel to the next.  The 
colour pathway can be considered to represent the trajectory of the major underlying white 
matter pathway (Jones, 2008).   
As the principal direction of diffusion is able to be computed at each voxel, the 
underlying properties of fiber direction are able to be inferred based on the quantification 
of water movement.  Using this information, large white matter tracts are able to be traced 
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by computing the main direction of movement in one voxel and then computing the main 
direction of movement in all adjacent voxels, essentially ‘following’ the main direction of 
diffusion from voxel to voxel to quantify the direction of the underlying main white matter 
pathways (Behrens & Johansen-Berg, 2005). 
There is considerable evidence to suggest that subcortical degeneration in 
Parkinson’s disease occurs as a result of disruption in network connectivity (Braak & del 
Tredici, 2008).  Connectivity arising from the thalamus is particularly important as, not 
only is a better understanding of the connectivity pattern between the cortex and thalamus 
crucial for neuroscience in general (Lin, Lu, Liang, Hua, & Muzik, 2008) but it is 
particularly important in Parkinson’s disease as the thalamico-cortico system mediates 
numerous symptoms of the disorder.   
The thalamic white matter fiber tracts have not been explicitly examined in a 
Parkinson’s disease cohort using a controlled study.  Here, we have applied methodology 
modified from Behrens, et al., (2003) to investigate fiber tracts originating in each region 
of the thalamus.  A probabilistic tractography approach is applied whereby the main 
direction of each voxel is determined based on several samples of the diffusion parameters 
at each voxel.   
9.2.1 Whole brain fiber tracts  
As with any new technique, fiber tracking was first applied in normal healthy control 
subjects.  One of the first studies (Eluvathingal, Hasan, Kramer, Fletcher, & Ewing-Cobbs, 
2007) applied tractography in normally developing children and adolescents to explore the 
normal effects of age, sex and lateralisation on cortical networks.  Several tracts were 
isolated for analysis, mainly those connected with the frontal lobe: arcuate fasciculus (AF); 
inferior longitudinal fasciculus, inferior fronto-occipital fasciculus (IFOF), uncinate 
fasciculus (UF), corticospinal tract (CST) and the somatosensory pathway (SS).  The main 
findings varied for each tract: there was a significant decrease in MD values of white 
matter pathways with age in the IFOF; a significant decrease in MD, but not FA with age 
for the left CST and no changes in either diffusivity measure due to age in the SS.  The left 
hemisphere was less affected in most instances, showing higher FA values in the majority 
of tracts (AF, UF and CST) and lower FA only in the case of the AF.  
In older samples there is a significant correlation between fiber tract integrity and 
cognition.  Zahr (2009) investigated the fiber tracts of the corpus callosum, association 
cortices (cingulate, inferior longitudinal fasciculus and the uncinate) along with the fornix 
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in an older sample and compared the integrity with that of a younger sample.  In the elderly 
sample, cellular disruption (lower FA and higher MD) was most prominent in the anterior 
tracts, especially in the genu, fornix and uncinate fibers.  There was a relationship between 
these tracts and measures of problem solving, working memory and motor function, 
supporting the hypothesis that degeneration of white matter tracts in the elderly 
significantly contributes to age related decline.   
Only one study to date has examined the integrity of the fiber tracts longitudinally.  
White matter tract degeneration appears to occur as a function of aging and the frontal 
tracts are implicated in the cognitive decline associated with Alzheimer’s disease.  Teipel 
(2010) studied 11 healthy elderly subjects and 14 subjects with amnesic MCI, performing 
follow up analysis at 13-16 months.  The frontal white matter tracts were again heavily 
implicated, the superior longitudinal fasciculus, uncinate fasciculus, inferior fronto-
occipital fasciculus and the cingulate bundle all exhibited decreased FA at follow up.  In 
the MCI subjects, FA reduction was predominantly concentrated in the anterior corpus 
callosum.  Total grey and white matter atrophy agreed with the pattern of fiber tract 
changes in the MCI subjects and was concentrated to prefrontal, cingulate and parietal lobe 
areas.  Over time, the changes in fiber tracts agreed with the wider pattern of degeneration 
in MCI and were related to aging as well as the early stages of AD neurodegeneration in 
this sample.   
Just as the integrity of grey matter structures has a relationship with cognition in 
neurodegenerative disease, the white matter tracts also strongly contribute to cognitive 
impairment in some samples.  In Alzheimer’s disease for example (Zhou, Bai, & 
Dougherty, 2009), the fiber pathway between the dorsal caudate area and the 
parahippocampal gyrus is significantly disrupted in early stage AD patients compared to 
control subjects.  As this pathway mediates the process by which new information is 
integrated this suggests significant impairment in learning ability in these patients – a 
phenomenon known to occur in the early stages of AD (Germano & Kinsella, 2005) and 
underlie short term memory dysfunction.   
Another AD sample (Nakata, et al., 2008) which examined the fiber integrity of the 
fiber tracts originating from the posterior cingulate area found significant disruption in 
both the direction of the fiber (FA) and the integrity of the cells (MD) within the tract.  
This abnormal disruption was considered to indicate a loss of barriers to diffusion and was 
consistent with reports of neuropathological data which showed partial loss of myelin, 
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axons and oligodendrial cells in the white matter of AD brains.  MD and FA values in this 
fiber tract reflected the progression of AD related changes in the posterior cingulate tract 
and was considered to represent a biomarker for disease progression.   
Fiber tracking techniques have also been applied in Schizophrenia (Zalesky, et al., 
2010) indicating network disruption could underlie some of the behavioural symptoms 
such as delusions, hallucinations and disordered thoughts that are evident in this disorder.  
The entire cortical network was examined in these patients and significant connectivity 
impairment particularly evident in the medial frontal, parietal, occipital and left temporal 
lobe, cumulating in a 20% less efficient network in patients compared to control subjects.  
There was no implication for cognitive performance from this finding, although the intact 
network in the control subjects correlated with IQ measures.   
9.2.2 Thalamic fiber tracts  
Given the extensive connectivity of the thalamus with the cortex it is not surprising that the 
thalmic-cortico connections have also been examined in various disease samples to 
determine their association with dysfunction.  The fronto-striatal circuit is of particular 
interest here due to its influence on motor dysfunction.  Leh (2007) used DTI tractography 
and reconstructed the neural connections between the frontal cortex and the caudate 
nucleus and putamen in a small sample of young healthy control subjects.  Results 
reflected what is known from animal studies, in the human brain, strong white matter 
pathways are evident between the caudate nucleus and the prefrontal cortex, inferior and 
middle temporal gyrus, frontal eye fields, cerebellum and the thalamus.  The putamen is 
interconnected with the prefrontal, primary, supplementary and pre motor areas, the 
somatosensory cortex, cerebellum and the thalamus.   
Lo (2011) also examined the fronto-striato-thalamic white matter tracts in healthy 
subjects.  The main objective of this study was to determine gender and handedness 
differences in different white matter tracts.  Three main tracts were isolated for 
investigation, the bilateral cingulum bundles, fornices and the anterior thalamic radiation 
as these are the main connections of the frontal lobe, limbic system and thalamus and 
mediate functions of emotion, memory and decision making.  Handedness was implicated 
in the cingulum and anterior thalamic radiation tracts where the right tract was more 
impaired than the left.  Gender was also a factor, showing an effect of lateralisation in male 
but not female subjects in the fornix tract.  The authors suggested that the lateralisation by 
gender interaction could have been due to an increased number or greater density of axons 
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or myelination of the fornix in the left hemisphere that may have only been evident in the 
male subjects.   
In bipolar disorder (Mahon, et al., 2009), tractography suggests that the thalamic 
radiation fibers are involved in the underlying pathology of symptoms.  FA values of tracts 
originating from several seed points within the frontal lobes were investigated in a large 
sample of patients and control subjects.  Tract integrity was significantly reduced in the 
patient group, particularly in regards to the white matter bundles that comprised the 
corticopontine and corticospinal tracts, pontine crossing tract and thalamic radiation fibers.  
The mood deregulation in bipolar disorder, could therefore, arise from deficits in 
cerebellar-striatal-prefrontal connectivity which encompasses structures involved in 
emotion generation (Green, Cahill, & Malhi, 2007).  Bipolar mania is characterised by 
reduced frontal inhibition and could also arise due to network disruption in the frontal 
lobes (Foland, et al., 2008).   
Fibre tracts originating from individual thalamic nuclei have been examined in few 
cases.  Jakab (2012) was one of the first to recognise the differential influence of thalamic 
nuclei and segmented the mediodorsal nucleus from the rest of the thalamus using 
tractography and a k means clustering algorithm.  The fibre tracts originating in the lateral 
portion of the MDn cluster merged with the anterior thalamic radiation and terminated in 
the superior and middle frontal gyri.  From the medial MDn nucleus, pathways mainly 
joined the fronto-occipital fasciculus and the inferior longitudinal fasciculus and 
terminated in the frontal and temporal cortex.  Although the authors reported that the MDn 
cluster was correlated with cognitive performance and that this was due to the fibre 
connectivity of the MDn to the cortex, unfortunately they did not also quantitatively 
examine the association between tract integrity and cognition.   
Eckert and colleagues (2012) are the most recent group to publish results of 
thalamic fibre tracking.  Fibre tracts originating from the mediodorsal and centromedian 
nuclei were delineated to aid in understanding of the differential connectivity of the two 
thalamic regions.  The nuclei were preferentially associated to distinct networks, the MDn 
to prefrontal and limbic regions and the CM to subcortical regions.  Tractography was 
achieved in normal healthy subjects but no examination with the correlates of cognition 
were carried out.   
Only our own group (Melzer, et al., 2011a) has applied tractography in PD to 
examine the influence on cognition.  A tract based spatial statistical analysis of the primary 
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fibre tracts across the whole brain was conducted.  This study identified that the tracts 
arising from anterior regions of the thalamus influenced cognition.  The anterior thalamic 
radiation, the white matter tract which connects the anterior thalamus to the frontal lobes 
showed significantly increased diffusivity in all three PD cognitive groups relative to 
control subjects, with higher values evident in the PD-D and PD-MCI groups.  When 
analysis was limited to PD groups only however, there was no change in the anterior 
thalamic radiation in the PD-MCI group compared to the PD-N group, suggesting 
disruption in this region is not the sole influence over cognitive dysfunction in PD-MCI.  
Rather the anterior thalamic radiation may be a moderator of both motor and cognitive 
symptoms frontal symptoms in PD.    
9.2.3 Fibre tracts and motor dysfunction in PD  
As with other aspects of this study, the association between cortical changes and motor 
dysfunction cannot be discounted.  In PD, some pathways have been examined specifically 
due to their hypothesised influence on motor dysfunction.  The nigrostriatal and 
mesolimbic pathways were isolated in a small sample of patients with dopamine 
responsive PD (Gupta, et al., 2000).  Although there was a significant reduction in fiber 
density of both tracts in PD patients, this was not investigated in relation to motor 
dysfunction scores.  The study does highlight that diffusion measures of defined 
dopaminergic tracts could aid in the early diagnosis of PD and be applied as a measure of 
disease progression however.   
The connections of the basal ganglia were also identified as a region of interest in a 
PD study (Nilsson, et al., 2007).  Unfortunately the delineation of fiber tracts from this 
region was found to be impossible due to the low spatial resolution of the diffusion images.  
Although diffusion was measured in 32 directions, as it was in this thesis, image 
acquisition was achieved in the Nilsson, (2007) on a scanner of only 1.5 Telsa, rather than 
the 3 Telsa that was applied in our own studies.  This is the most likely reason for the 
inability to detect the basal ganglia fiber tracts and highlights the importance of adequate 
spatial resolution in diffusion imaging.   
9.3 Summary  
Tractography has mainly been applied in healthy samples to date (Eluvathingal, et al., 
2007; Teipel, et al., 2010; Zahr, et al., 2009) but there is significant evidence to suggest 
investigation into the integrity of network connectivity in PD is warranted.  Previous 
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studies in PD point to significant degeneration in cortical areas associated with the 
thalamus (Beyer & Aarsland, 2008) and it is reasonable to expect that, alongside thalamic 
degeneration in corresponding areas, the white matter tracts connecting them will also be 
affected.  Previous tractography studies in PD have focused on the integrity of the motor 
network and found significant degeneration in key components which influence movement 
symptoms (Leh, et al., 2007; Lo, et al., 2011).  To date, only the tracts of the MDn and 
CM/Pf thalamic nuclei have been investigated using this method, and only in healthy 
samples (Eckert, et al., 2012; Jakab, et al., 2012).  This study will be the first of its kind to 
address connections of major thalamic nuclei simultaneously in a Parkinson’s disease 
sample.   
9.4 Hypothesis  
 That cortical connectivity between the thalamus and the cortex will be disrupted in 
PD and contribute to cognitive symptoms  
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9.5 Method 
9.5.1 Participants 
Participant characteristics are identical to those reported in Section 8.6.1 as fibre tracking 
was achieved successfully in all participants.   
9.5.2 Fibre Tracking 
White matter fibre tracking was carried out on the 4D brain using the FMRIB Diffusion 
Toolbox (FDT: version 4.9.1) which is a software tool for the analysis of diffusion 
weighted images.  FDT samples from the distributions of voxel-wise principal diffusion 
directions and computes a sample from the distribution on the location of the true direction 
of the sample.  This process is repeated until there are many samples and the connectivity 
distribution is modelled.  Within the toolbox, we ran two programmes.  The first, Bayesian 
Estimation of Diffusion Parameters Obtained using Sampling Techniques (bedpostx) 
modelled the local diffusion parameters, building a distribution of diffusion parameters at 
each voxel.  Bedpostx creates all the files that are necessary to run probabilistic 
tractography.  The required inputs to the bedpostx programme is the 4D brain, the 3D brain 
with no diffusion weighting (nodiff_brain_mask) and the bvecs and bvalues files which 
contain the list of gradient directions that were applied during diffusion weighting of 
volumes and for the volumes with no diffusion weighting respectively.  After bedpostx was 
applied it was possible to run the probtrackx programme.  Probtrackx was used for 
tractography and connectivity based segmentation and gives an estimation of the most 
probable location of a pathway from a seed point using Bayesian techniques.  The 
previously defined thalamic clusters were used to create a seed mask for the thalamic 
nuclei of each individual.  For each nucleus the clusters that make up that nucleus were all 
able to be entered as seed points.  Probabilistic tractography was then run from every voxel 
with a value different from 0 in this mask.  The default parameters of the probtrackx 
algorithm were applied as follows.   
9.5.2.1 Number of samples 
Number of samples is the number of individual pathways that are drawn through the 
probability distribution.  The optimum number of samples is 5000 as convergence is 
reached without compromising on a reasonable amount of processing time.   
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9.5.2.2 Steplength  
Steplength determines the length of each step, where a step is the distance travelled before 
the direction of diffusion is re-examined.  Default steplength is 0.5mm and is 
recommended unless the sample is of unusually small sized brains such as in the case of 
infants.  Adjustment to steplength was not necessary as the brains in this sample are 
considered to be within the average range.  The maximum number of steps is 2000 by 
default, samples were terminated when they travelled 2000 steps, corresponding to a 
distance of 1m at step length of 0.5mm.   
9.5.2.3 Curvature threshold  
Curvature threshold was 0.2, corresponding to a minimum angle of approximately ± 80 
degrees.  This threshold limits how sharply pathways can turn which excludes implausible 
pathways.   
9.5.2.4 Thresholding  
Once a fibre tract was constructed, the entire trajectory was verified on a slice-by-slice 
basis to ensure consistency with established anatomical atlases.  Displayed results are 
original and have not been thresholded.   
9.5.3 Statistical Analysis 
Group differences and the relationship between tracts and cognition were examined in the 
same way as for the previous chapter (Section 8.6.4).  We also wanted to examine the 
combined effect of nuclei and tracts in this study however so the following additional 
analyses were performed in Statistica version 6.0.  The relationship between each thalamic 
nucleus and the tracts arising from the thalamic nuclei were examined first using Pearson 
correlation, and then using backward stepwise regression where the influence of a thalamic 
nucleus between every thalamic tract was determined.  It was expected that the nuclei 
would each influence the thalamic tract that originated from that nucleus but also would 
have an influence on other associated tracts.  Nuclei and tracts were then examined 
together using logistic regression analysis to aid in discrimination between the patient 
groups.   
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9.6 Results 
9.6.1 Participant Information  
The fibre tracking procedure was performed successfully for all participants, thus 
demographic, clinical and cognitive characteristics of the groups are identical to those 
reported in Section 6.6.1 for the whole thalamus tracts and in Section 8.6.1 for the thalamic 
nuclei tracts.   
9.6.2 Integrity changes in thalamic tracts  
Fibre tracts were first computed using every voxel within the thalamus as a seed point 
(whole thalamus tracts) to determine overall connectivity.  Between – within ANOVA 
examined the group differences in the same way as for previous chapters.  The ANCOVA 
models made additional provision for thalamic size due to the fact thalamic tracts varied 
according to the size of the thalamic nucleus.  Total thalamic volume (uncorrected in mm
3
) 
was therefore the first co-variate added to the ANCOVA model, followed by demographic 
and clinical co-variates in subsequent models in the same way as before.  Group mean 
values of DTI parameters for whole thalamus tracts are presented in Table 9-1 and adjacent 
pair wise comparisons after accounting for co-variates in Figure 9-1.  Unexpectedly, there 
was no group effect for FA values of thalamic tracts.  There was a hemisphere effect in the 
left > right direction but this did not result in a group x hemisphere interaction.  Results did 
not change after the addition of thalamic volume, [F(3,112) = 1.83, p = 0.32]; 
demographic, [F(3,109) = 1.32, p = 0.27] or clinical [F(2,84) = 1.44, p = 0.24] covariates.   
MD of thalamic tracts was more sensitive to the changes between cognitive groups.  
There was a significant effect of group where MD was higher in the PD-D group relative to 
all other groups.  The group effect was consistent for both the left and the right tracts; there 
was no effect of hemisphere or higher order interactions.  The group effect remained when 
total thalamic volume was included in the model [F(3,112) = 8.17, p < 0.01].  Once 
thalamic size was accounted for, the additional post hoc contrast between PD-MCI and the 
control group was also significant in the expected direction.  This contrast, and the overall 
group effect remained after the addition of demographic [F(3,109) = 5.74, p < 0.01] but not 
clinical covariates [F(2,84) = 2.13, p = 0.13].   
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Table 9-1:  Diffusion parameters of averaged bilateral thalamo – cortical fiber tracts  
 C (n = 25) PD-N (n = 56) PD-MCI (n = 19) PD-D (n = 17)  Group Effect  Hemisphere Effect 
      F p N-K  F p 
            
Fractional Anisotropy 
(range 0-1) 
0.41 (0.02) 0.41 (0.02) 0.40 (0.02) 0.40 (0.04)  1.43 0.24 C=N=MCI=D  4.02 0.05 
Left 0.41 (0.02) 0.41 (0.03) 0.40 (0.02) 0.41 (0.03)  1.23 0.30     
Right 0.41 (0.02) 0.41 (0.03) 0.40 (0.02) 0.40 (0.03)  1.46 0.23     
            
Mean Diffusivity  
(mm
2
 per sec x 10
-3
) 
0.57 (0.28) 0.66 (0.28) 0.79 (0.31) 0.98 (0.24)  8.35 <.001 C=N=MCI<D  0.77 0.38 
Left 0.57 (0.27) 0.66 (0.28) 0.79 (0.31) 0.98 (0.25)  8.23 <.001 C=N=MCI<D    
Right 0.57 (0.28) 0.66 (0.29) 0.80 (0.31) 0.98 (0.23)  8.36 <.001 C=N=MCI<D    
Fractional anisotropy and mean diffusivity values for each group are reported mean (SD).  Fiber tracking was able to be performed on all participants where the thalamus 
was able to be defined, so sample size here reflects that of Section 6.7.1.  Between-within ANOVA where group was the between effect and hemisphere the within effect 
shows the group and hemisphere effect for FA and MD measure of bilateral thalamus (bold face).  The hemisphere effect for FA is in the left > right direction.  There were 
no higher order interactions.  N-K = Newman-Keulis post-hoc test.  
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 In PD with normal cognition (relative to healthy control subjects)  
 after the inclusion of thalamic size, age, education and depression  
 Fractional Anisotropy  Mean Diffusivity  
 28 25 23  28 25 23  
a) 
   
b) 
   
 
         
 Within Parkinson’s disease (excluding control subjects)  
 after the additional inclusion of thalamic size, disease duration and UPDRS III   
 Fractional Anisotropy  Mean Diffusivity  
 28 25 23  28 25 23  
         
 In PD with normal cognition relative to PD with mild cognitive impairment   
c) 
   
d) 
   
 
 In PD with normal cognition relative to PD with dementia   
e) 
   
f) 
   
 
 In PD with mild cognitive impairment relative to PD with dementia  
g) 
   
h) 
   
 
Figure 9-1: The progressive changes in whole thalamus tracts   
Horizontal sections of the furtherest dorsal (Z = 28), medial (Z = 25) and furtherest ventral (Z = 23) slice 
where the thalamus is visible are presented.  The fibre tracts have been generated from all thalamus voxels.  
Progressive FA (left) and MD (right) changes in whole thalamus tracts are presented from control subjects to 
PD-N, from PD-N to PD-MCI (p < 0.001) and from PD-MCI to PD-D (p = 0.03).  The additional comparison 
where the PD-N group is used as a control group to establish changes in the PD-D group is also presented in 
the middle row.   
Fibre tracts were then examined independently for each thalamic nucleus (nuclei 
tracts) to determine the integrity of differential connectivity.  For FA measures of integrity 
(Table 9-2), there was clear differential involvement of the thalamic nuclei; only the limbic 
nuclei tracts were sensitive to cognition.  In both the AP and LD nuclei tracts there was an 
overall significant group effect and a significant post hoc effect where the PD-D group 
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showed reduced FA compared to both the control and PD-N groups.  There was also a 
significant group by hemisphere interaction [F(3,104) = 4.74, p < 0.01] in the AP nucleus 
which warranted follow up analyses.  One way ANOVA’s (indented), conduced 
independently for left and right hemisphere of the AP tract revealed the group effect to be 
driven by the left hemisphere, the PD-N group had lower FA than the control group (p < 
0.01) and the PD-D group had lower FA than the PD-N group (p < 0.01) but only in the 
right hemisphere did the PD-D group show reduced FA in comparison to the control group 
(p = 0.04).   
Including AP size [F(3,103) = 7.23, p < 0.01] and demographic [F(3,100) = 4.63, p 
< 0.01] covariates did not change the overall group effect although the post-hoc results 
changed, the PD-D group only had reduced FA compared to the PD-N group (p < 0.01) but 
not the control group (p = 0.05).  As the interaction between hemisphere and group 
[F(3,100) = 3.56, p = 0.02] remained when AP size was included along with demographic 
covariates, independent follow up analyses were again conducted for left and right AP.  
The group effect again only held in the left, [F(3,100) = 7.38, p < 0.01] but not the right, 
[F(3,100) = 2.21, p = 0.09] AP.  After the addition of clinical covariates the overall group 
effect remained [F(2,75) = 3.97, p = 0.02] and the interaction between group and 
hemisphere [F(2,75) = 1.03, p = 0.36] was no longer significant.   
 In the LD nucleus tract FA was decreased in PD-D relative to all other groups.  
Although there was an effect of hemisphere, where the left tract showed higher FA than the 
right, this was consistent for all groups and there was not a higher order interaction 
between group and hemisphere.  Adding LD size [F(3,100) = 3.16, p = 0.03] and 
demographic [F(3,101) = 3.11, p = 0.03] covariates did not change results but the group 
effect was no longer significant when clinical covariates were added [F(2,75) = 2.31, p = 
0.11].   
 
The Cortical Connectivity of the Thalamus and Thalamic Nuclei 
Chapter 9 | 261 
Table 9-2: FA (range 0-1) values for each thalamic nuclei – cortical fiber tract  
 C (n=24) PD-N (n=51) PD-MCI (n=18) PD-D (n=15) Group  Hemisphere 
     F p N-K  F p 
Association Nuclei            
MDn 0.37 (0.03) 0.38 (0.03) 0.37 (0.02) 0.36 (0.04) 1.59 0.20   7.35 <0.01 
Left 0.38 (0.04) 0.38 (0.03) 0.38 (0.03) 0.37 (0.05) 0.43 0.73     
Right 0.36 (0.03) 0.37 (0.04) 0.36 (0.03) 0.35 (0.05) 1.53 0.21     
LP 0.42 (0.04) 0.42 (0.04) 0.41 (0.04) 0.42 (0.05) 0.60 0.62   4.67 0.03 
Left 0.43 (0.04) 0.43 (0.05) 0.41 (0.05) 0.43 (0.05) 0.50 0.68     
Right 0.42 (0.06) 0.41 (0.05) 0.40 (0.04) 0.41 (0.07) 0.61 0.61     
Pu 0.41 (0.04) 0.42 (0.04) 0.40 (0.03) 0.40 (0.04) 1.66 0.18   0.06 0.81 
Left 0.42 (0.05) 0.42 (0.05) 0.39 (0.05) 0.39 (0.04) 2.57 0.06     
Right 0.40 (0.05) 0.42 (0.05) 0.41 (0.06) 0.41 (0.06) 0.85 0.42     
Limbic Nuclei            
AP 0.36 (0.03) 0.37 (0.03) 0.35 (0.03) 0.34 (0.03) 5.18 <0.01 C=N>D  5.25 0.02
Ϊ 
Left 0.35 (0.03) 0.38 (0.03) 0.36 (0.03) 0.34 (0.03) 8.85 <0.01 C>N=MCI=D    
Right 0.36 (0.03) 0.36 (0.04) 0.34 (0.04) 0.33 (0.04) 2.74 0.05 C>D    
LD 0.34 (0.04) 0.35 (0.04) 0.33 (0.04) 0.31 (0.03) 5.12 <0.01 C=N=MCI>D  23.07 <0.001 
Left 0.36 (0.06) 0.36 (0.06) 0.35 (0.06) 0.33 (0.06) 1.13 0.34     
Right 0.32 (0.04) 0.34 (0.05) 0.32 (0.06) 0.28 (0.04) 5.67 <0.01     
Sensory Nucleus           
VP 0.45 (0.04) 0.45 (0.03) 0.45 (0.03) 0.45 (0.03) 0.42 0.74   0.82 0.37 
Left 0.45 (0.04) 0.45 (0.04) 0.45 (0.03) 0.46 (0.03) 0.38 0.77     
Right 0.45 (0.04) 0.45 (0.03) 0.44 (0.03) 0.44 (0.04) 0.81 0.49     
Motor Nuclei            
VA 0.42 (0.04) 0.43 (0.03) 0.41 (0.03) 0.41 (0.04) 2.90 0.04   7.13 <0.01 
Left 0.42 (0.04) 0.44 (0.04) 0.42 (0.04) 0.41 (0.04) 3.07 0.03     
Right 0.41 (0.04) 0.42 (0.03) 0.41 (0.04) 0.40 (0.05) 1.54 0.21     
VL 0.44 (0.04) 0.44 (0.03) 0.43 (0.03) 0.43 (0.03) 0.17 0.92   0.63 0.43 
Left 0.43 (0.04) 0.44 (0.04) 0.43 (0.03) 0.44 (0.03) 0.41 0.75     
Right 0.44 (0.04) 0.43 (0.03) 0.43 (0.03) 0.43 (0.03) 0.16 0.93     
Non-Specific Nucleus            
CM/Pf 0.40 (0.04) 0.40 (0.04) 0.39 (0.04) 0.40 (0.04) 0.23 0.87   0.82 0.37 
Left 0.41 (0.05) 0.40 (0.05) 0.39 (0.05) 0.40 (0.04) 0.22 0.88     
Right  0.39 (0.04) 0.40 (0.06) 0.39 (0.04) 0.40 (0.06) 0.20 0.90     
Fractional anisotropy values for each thalamic nucleus are reported mean (SD).  Repeated measures ANOVA (bold face) shows the group and hemisphere effect for each 
nucleus.  All hemisphere effects were in the L>R direction.  Ϊ
 
Denotes an interaction between group and hemisphere, follow up one way ANOVA’s (indented) show the 
group effect independently of hemisphere.  All significant post-hoc group comparisons are reported, not only adjacent comparisons.  N-K = Newman-Keulis.  
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MD measures of thalamic tracts were more sensitive to the changes between 
cognitive groups than FA measures (Table 9-3).  All nuclei tracts except those originating 
from the CM/Pf, LP and Pu nuclei showed a main effect of group.  Post hoc comparisons 
showed a significant increase in the PD-D group compared to the control group in the AP 
(p < 0.01); MDn (p < 0.01); VA (p < 0.001); VL (p = 0.016); VP (p = 0.03) nuclei tracts 
and, compared to the PD-N group in the AP (p < 0.001); MDn (p < 0.01); LD (p < 0.01); 
VA (p < 0.001); VL (p = 0.01) and VP (p = 0.01) nuclei tracts.  In the MDn (p < 0.01); AP 
(p < 0.01); and VA (p = 0.03) tracts there was an additional significant increase in PD-D 
compared to the PD-MCI group.  The VA (p = 0.05) was the only region to show a 
significant increase from PD-N to PD-MCI.   
Although there was not a hemisphere effect in the thalamic tract that was delineated 
from the whole thalamus, all individual nuclei tracts had higher MD values in the left tract 
compared to the right.  There was a significant group by hemisphere interaction in the tract 
of the AP nucleus [F(3,104) = 4.50, p < 0.01] which suggested the need for further 
analyses independent of hemisphere.  Follow up one way ANOVA’s for the AP tract 
(indented) showed that it was again the left hemisphere that was more sensitive to lower 
levels of cognitive dysfunction.  Although there was an overall significant group effect in 
both hemispheres and a significant post hoc comparison between PD-D and both the 
control (left p < 0.01; right p < 0.01) and the PD-N (left p < 0.001; right p = 0.03), only the 
left hemisphere showed an increase in diffusivity from PD-MCI to PD-D (p < 0.001).   
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Table 9-3: MD (mm
2
 per sec x10
-3
) values of each thalamic nucleus – cortical fiber tract  
 C (n=23) PD-N (n=51) PD-MCI (n=18) PD-D (n=15)  Group  Hemisphere 
      F p N-K  F p 
Association Nuclei            
MDn 0.93 (0.07) 0.95 (0.11) 0.95 (0.08) 1.04 (0.09)  4.12 <0.01 C=N=MCI<D  0.13 <0.01 
Left 0.93 (0.08) 0.95 (0.13) 0.96 (0.10) 1.01 (0.11)  1.60 0.19     
Right 0.93 (0.08) 0.94 (0.12) 0.95 (0.10) 1.06 (0.09)  5.27 <0.01 C=N=MCI<D    
LP 0.92 (0.07) 0.93 (0.11) 0.96 (0.08) 0.96 (0.08)  0.75 0.53 C=N<D  0.04 0.85 
Left 0.95 (0.09) 0.93 (0.13) 0.96 (0.13) 0.95 (0.04)  0.51 0.68     
Right 0.91 (0.10) 0.94 (0.14) 0.95 (0.07) 0.98 (0.14)  1.12 0.34     
Pu 0.96 (0.09) 0.93 (0.11) 1.00 (0.10) 1.01 (0.07)  3.67 0.01   0.05 0.82 
Left 0.95 (0.10) 0.93 (0.13) 1.00 (0.13) 1.03 (0.08)  3.90 0.01 C=N<D    
Right 0.98 (0.12) 0.93 (0.13) 1.00 (0.14) 0.99 (0.10)  1.76 0.16     
Limbic Nuclei             
AP 0.98 (0.08) 0.97 (0.12) 0.99 (0.09) 1.10 (0.09)  5.75 <0.01 C=N=MCI<D  0.01 0.92Ϊ 
Left 1.00 (0.09) 0.95 (0.14) 0.97 (0.08) 1.11 (0.10)  7.04 <.001 C=N=MCI<D    
Right 1.00 (0.09) 0.99 (0.15) 1.02 (0.16) 1.09 (0.10)  3.82 0.01 C=N>D    
LD  1.14 (0.16) 1.09 (0.19) 1.18 (0.17) 1.27 (0.12)  4.75 <0.01 C=N<MCI=D  8.73 <0.01 
Left 1.10 (0.03) 1.06 (0.24) 1.15 (0.21) 1.16 (0.17)  1.17 0.33     
Right K-W ANOVA 1.19 (0.19) 1.11 (0.23) 1.21 (0.34) 1.37 (0.21)  12.3 <0.01 C=N<D    
Sensory Nucleus            
VP 0.83 (0.03) 0.84 (0.07) 0.87 (0.06) 0.89 (0.05)  3.81 0.01 C=N<D  1.65 0.20 
Left 0.84 (0.03) 0.84 (0.13) 0.88 (0.06) 0.88 (0.04)  4.20 <0.01 C=N<MCI=D    
Right 0.83 (0.04) 0.83 (0.09) 0.85 (0.05) 0.88 (0.06)  2.79 0.04 C=N<D    
Motor Nuclei             
VA 0.84 (0.06) 0.83 (0.08) 0.88 (0.08) 0.93 (0.06)  8.73 <.001 C=N<MCI<D  10.56 <0.01 
Left 0.84 (0.06) 0.81 (0.07) 0.87 (0.08) 0.91 (0.06)  7.83 <.001 C=N<MCI=D    
Right 0.84 (0.05) 0.84 (0.09) 0.88 (0.08) 0.94 (0.08)  8.08 <.001 C=N=MCI<D    
VL 0.82 (0.04) 0.82 (0.08) 0.85 (0.05) 0.88 (0.05)  3.98 <0.01 C=N<D  3.98 <0.01 
Left 0.83 (0.04) 0.83 (0.09) 0.86 (0.06) 0.88 (0.05)  2.57 0.06     
Right 0.82 (0.05) 0.82 (0.07) 0.85 (0.05) 0.88 (0.04)  4.81 <0.01 C=N<D    
Non-Specific Nucleus             
CM/Pf 0.88 (0.06) 0.88 (0.10) 0.91 (0.08) 0.94 (0.05)  2.31 0.08   0.27 0.61 
Left 0.88 (0.08) 0.87 (0.10) 0.90 (0.09) 0.94 (0.06)  2.75 0.05 C=N<D    
Right  0.88 (0.07) 0.89 (0.13) 0.91 (0.08) 0.94 (0.07)  1.01 0.39     
Mean diffusivity values for each thalamic nucleus are reported mean (SD).  Repeated measures ANOVA (bold face) shows the group and hemisphere effect for each 
nucleus.  All hemisphere effects were in the L>R direction.  Ϊ
 
Denotes an interaction between group and hemisphere, follow up one way ANOVA’s (indented) show the 
group effect independently of hemisphere.  All significant post-hoc group comparisons are reported, not only adjacent comparisons.  N-K = Newman-Keulis 
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After the inclusion of nuclei size and demographic covariates (Table 9-4).  There was no 
longer a group effect of MD in any thalamic nuclei tract except the VA.  This did not 
change when control participants were excluded and clinical covariates included.  The 
interaction between hemisphere and group remained in the AP nucleus after inclusion of 
demographic covariates [F(3,100) = 3.69, p = 0.01], and as the overall group effect was 
approaching significance follow up analyses were conducted for this region.  The left 
hemisphere was again the most sensitive, only MD measures of the left thalamic nuclei 
tract had a group effect, there was no effect of cognition in the right AP tract.   
Table 9-4: MD ANCOVA results after inclusion of demographic and clinical covariates  
  Demographic (All participants)  Clinical (Patients only) 
  Nuclei size, age, education, depression  adds disease duration, UPDRS III 
     
  Group Effect  Group Effect 
  F(3,100) p Adjacent pairwise  F(2,75) p Adjacent pairwise 
         
Association Nuclei  
MDn  1.55 0.21      
LP  0.11 0.96      
Limbic Nuclei  
AP  2.68 0.05      
Left  3.96 0.01 C=N=MCI<D  4.36 0.02 N<MCI<D 
Right   1.88 0.14   0.43 0.65  
LD  1.99 0.12      
Sensory Nucleus 
VP  0.82 0.49      
Motor Nucleus  
VA  3.26 0.02 C=N<MCI<D  5.17 0.02 N<MCI<D 
VL  1.23 0.30      
Nuclei tracts that previously indicated a group effect of mean diffusivity were examined using ANCOVA’s 
where nuclei size along with demographic and clinical covariates were added.  After inclusion of 
demographic and clinical covariates the overall group effect only remained significant in the VA tract.  As 
there was an interaction between group and hemisphere in the AP tract, independent one way ANOVA’s 
were also conducted on the left and right tract (indented).   
Post-hoc pairwise comparisons after the inclusion of covariates are shown in Figure 9-2 
for both FA and MD measures of thalamic nuclei tracts.  Tracts were examined separately 
within each hemisphere as the left hemisphere has consistently demonstrated more 
sensitivity to cognitive dysfunction in this cohort.   
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In PD with normal cognition (relative to healthy control subjects) 
 
 after the inclusion of nuclei size, age, education and depression  
 
Fractional Anisotropy  Mean Diffusivity 
 
 28 25 23  28 25 23  
a) 
   
b) 
   
 
         
 Within Parkinson’s disease (excluding control subjects)  
 after the additional inclusion of nuclei size, disease duration and UPDRS III   
 
Fractional Anisotropy  Mean Diffusivity 
 
 28 25 23  28 25 23  
 In PD with normal cognition relative to PD with mild cognitive impairment  
c) 
   
d) 
   
 
   
 In PD with normal cognition relative to PD with dementia  
g) 
   
h) 
   
 
     
 In PD with mild cognitive impairment relative to PD with dementia  
e) 
   
f) 
   
 
Figure 9-2: Adjacent pairwise comparisons in nuclei tracts   
Horizontal sections of the furtherest dorsal (Z = 28), medial (Z = 25) and furtherest ventral (Z = 23) slice 
where the thalamus is visible are presented.  The fibre tracts have been generated from nuclei voxels only.  
Progressive FA (left) and MD (right) changes are presented from control subjects to PD-N, from PD-N to 
PD-MCI and from PD-MCI to PD-D.  The additional comparison where the PD-N group is used as a control 
group to establish changes in the PD-D group is also presented.  Statistics are reported within the text.  Fiber 
tracts originating from the motor nuclei (VA) are shown in yellow, limbic nuclei (AP, LD) in green and 
association (MDn) nuclei in red.   
After controlling for co-variates, fractional ainsotropy measures were only sensitive 
to tract degeneration in the AP tract of the left hemisphere [F(3,100) = 7.13, p < 0.001].  
FA reduction was evident in PD-N relative to the healthy control group (p < 0.01) and also 
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significantly disrupted in PD-D relative to PD-N (p < 0.01) and PD-MCI (p = 0.03), 
suggesting a significant association with cognitive dysfunction.   
 Mean diffusivity measures of thalamic nuclei tracts also implicated the left AP 
[F(2,75) = 4.36, p = 0.02] in PD-D relative to PD-N (p < 0.001) and PD-MCI (left p < 
0.001) but not in PD-N relative to controls, suggesting primary involvement in cognitive, 
rather than motor dysfunction.  The other limbic nucleus, the LD also showed significant 
cellular disruption in the PD groups with worse cognition [F(2,75) = 3.90, p = 0.02].  This 
was localised to the right hemisphere and MD was increased in PD-D relative to PD-N (p < 
0.01), and PD-MCI (p = 0.04).  The only other tract known to associate with cognition that 
was implicated was the association MDn nucleus tract which showed significant MD 
increase in the right hemisphere [F(2,75) = 4.85, p = 0.01] in PD-D relative to PD-N (p < 
0.01) and PD-MCI (p = 0.001).  The motor VA nucleus tract also showed significant 
degeneration, in PD-MCI relative to PD-N on the left [F(2,75) = 4.82, p = 0.02], in PD-D 
relative to PD-N bilaterally (left p < 0.001; right p < 0.001) and in PD-D relative to PD-
MCI on the right (p < 0.01) which suggested motor symptoms needed to be accounted for 
when examining the association with cognition.   
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9.6.3 The association between the integrity of thalamic tracts and cognition 
9.6.3.1 Correlation results 
A simple Pearson correlation was used to ascertain the relationship between the integrity 
measures of thalamic tracts and cognition.  In all cases left and right tracts were averaged 
and the new average variable entered against all cognitive domain scores (attention, 
executive function, visuospatial/visuoperception, learning and memory and global Z 
score).   
In healthy controls 
In healthy control subjects there was no association between the integrity measures of 
whole thalamus tracts and cognition.  When the integrity of tracts was examined from each 
thalamic nucleus however there was an association with some individual nuclei tracts.  
Irrespective of the measure of integrity (FA or MD), only the association nuclei had a 
significant relationship with cognition.  FA measures showed a relationship between the 
MDn nucleus and: attention (r = 0.43, p = 0.04); executive function (r = 0.43, p = 0.04) 
and between the LP nucleus and attention (r = 0.42, p = 0.04).  When measured with MD, 
results were similar; the MDn nucleus was correlated with learning and memory (r = -0.41, 
p = 0.04) and the LP was correlated with attention (r = -0.42, p = 0.04).   
In Parkinson’s disease  
Correlation results for Parkinson’s disease patients are presented in Table 9-5.  There was 
no relationship between FA measures of whole thalamic tracts and any cognitive domain.  
Mean diffusivity measures were more sensitive to cognitive dysfunction and showed a 
relationship with all cognitive domains.  When examined by specific thalamic nuclei the 
MDn and LP association nuclei and the AP limbic nucleus had a relationship with all 
cognitive domains.  The limbic LD nucleus was also heavily involved in cognition, 
showing a relationship with all domains except the visuospatial/perception domain.  
Unexpectedly, the motor nuclei also had an association with multiple cognitive domains.   
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Table 9-5:  Pearson correlations (r) between thalamic nuclei tracts and cognition in PD patients  
 Attention Executive Function Visuospatial Learning and Memory Global Z Score 
 
Fractional Anisotropy 
Whole thalamus 
Average  -0.03 -0.05 -0.56 -0.03 -0.04 
Association nuclei 
MDn 0.18 0.16 0.14 0.25* 0.21 
LP 0.04 0.03 0.06 -0.03 0.03 
Pu 0.18 0.16 0.16 0.07 0.16 
Limbic nuclei 
AP 0.33* 0.28** 0.17 0.26* 0.30** 
LD 0.42*** 0.36*** 0.32** 0.19 0.36*** 
Sensory nucleus 
VP 0.01 -0.03 0.05 0.11 0.06 
Motor nuclei 
VA 0.26* 0.24* 0.20 0.16 0.24* 
VL 0.04 0.01 -0.05 0.02 0.13 
Non-specific nuclei 
CM/Pf -0.18 -0.08 -0.12 -0.10 -0.06 
 
Mean Diffusivity 
Whole thalamus 
Average -0.32** -0.31** -0.27* -0.28** -0.33** 
Association nuclei 
MDn -0.30** -0.27* -0.29*** -0.28** -0.33** 
LP -0.12 -0.12 -0.13 -0.07 -0.12 
Pu -0.36*** -0.34*** -0.34*** -0.27* -0.34*** 
Limbic nuclei 
AP -0.31* -0.30** -0.21 -0.26* -0.31** 
LD -0.39*** -0.34** -0.31** -0.23* -0.36*** 
Sensory nucleus 
VP -0.32*** -0.30*** -0.24* -0.26* -0.31*** 
Motor nuclei 
VA -0.45*** -0.41*** -0.34*** -0.39*** -0.44*** 
VL -0.34* -0.30*** -0.19 -0.26* -0.30** 
Non-specific 
CM/Pf -0.22* -0.16 -0.13 -0.20 -0.20 
The relationship between FA and MD measures of thalamic nuclei tracts and each cognitive domain were 
performed for PD patients only.  Significant correlations are indicated as follows: *** p < 0.001; **p < 0.01; 
*p < 0.05.   
9.6.3.2 Regression modelling results  
Regression analysis were conducted to determine the independent influence of the thalamic 
tracts over cognition.  In order to adhere to the assumptions of multiple regression, only 
those tracts which showed a significant correlation with cognitive domain (Table 9-5) were 
included.  Control subjects were also excluded from the analysis in order for the clinical 
covariates to be included.  Due to violation of the multicolinearity assumption the UPDRS 
III score was excluded and only disease duration remained in the model as a measure of 
clinical severity of motor symptoms.  Two backward stepwise models were performed.  
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The first examined the independent effect of thalamic nuclei tracts on each cognitive 
domain.  The second repeated the parameters of the first model but additionally included 
demographic and clinical covariates in order to determine the influence of tracts over and 
above the demographic and clinical factors.   
Fractional anisotropy 
Results for fractional anisotropy measures of thalamic nuclei tracts are presented in Table 
9-6.  The first model for each cognitive domain was significant, indicating that combined, 
FA measures of integrity made a significant contribution to cognitive score in each 
domain.  Within each of these models, the limbic nuclei were the only unique predictors 
that were involved in every cognitive domain, which indicated they were the only regions 
to independently contribute to all aspects of cognition.  When the covariates were added in 
Model 2 the proportion of variance accounted for in each cognitive domain increased.  
Neither of the limbic nuclei independently contributed to the variance in the learning and 
memory or global Z score domain in these models but continued to contribute to the 
variance in attention, executive function and visuospatial/perception.   
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Table 9-6:  Backward stepwise linear regression results for FA of nuclei tracts 
% of variance accounted for by unique predictors  R2 change 
     
Model 1  Model 2   
Nuclei tracts (specified for each model)  Nuclei tracts and covariates   
   age, education, depression, disease duration   
       
Attention    
Entered tracts: AP, LD, VA     
R
2
 = 20%, F(3,80) = 6.37, p<0.001  R
2
 = 44%, F(7,76) = 8.36, p<0.001  ↑ 19% (p<0.01) 
LD (β = 0.32*) 5% (0.04)  LD (β = 0.23*) 3% (0.04)   
   Age (β = -0.21*) 4% (0.03)   
   Depression (β = -0.22*) 4% (0.04)   
   Disease duration (β = -0.23*) 4% (0.02)   
       
Executive Function      
Entered tracts: AP, LD, VA      
R
2
 = 14%, F(3,80) = 4.36, p<0.001  R
2
 = 44%, F(7,76) = 8.36, p<0.001  ↑ 29% (p<0.01) 
LD (β = 0.27*)   LD (β = 0.17) 3% (0.04)   
   Age (β = -0.20*) 6% (<0.01)   
   Education (β = 0.22*) 4% (0.02)   
   Depression (β = -0.30***) 8% (<0.01)   
   Disease duration (β = -0.32***) 8% (<0.01)   
       
Visuospatial / Perception      
Entered tracts: LD      
R
2
 = 10%, F(1,82) = 9.12, p<0.01  R
2
 = 25%, F(5,78) = 5.32, p<0.01  ↑ 15% (p<0.01) 
LD (β = 0.32**) 10% (<0.01)  LD (β = 0.19) 5% (0.03)   
   Disease Duration (β=-0.32*) 6% (0.01)   
       
Learning and Memory      
Entered tracts: AP, MD     
R
2
 = 9%, F(2,81) = 4.08, p=0.02  R
2
 = 27%, F(6,77) = 4.65, p<0.01  ↑ 17% (p<0.01) 
AP (β = 0.19) 7% (0.02)  Age (β = -0.22*) 9 (<0.01)   
   Depression (β=-0.28**) 9 (<0.01)   
       
Global Z score       
Entered tracts: AP, LD, VA     
R
2
 = 15%, F(3,80) = 4.56, p<0.01  R
2
 = 39%, F(7,76) = 6.94, p<0.01  ↑ 24% (p<0.01) 
LD (β = 0.26*) 4% (0.04)  Age (β = -0.22*) 8% (<0.01)   
   Education (β = 0.57*) 4% (0.04)   
   Depression (β = -0.26**) 6% (0.01)   
   Disease duration (β=-0.27**) 6 (<0.01)   
Two linear models were used to gauge the proportion of variance accounted for by FA measures of thalamic 
nuclei tracts in each cognitive domain.  Only those nuclei that had a significant correlation with the cognitive 
domain were entered into the model.  Only the limbic nuclei tracts were independent predictors of cognition.  
R
2 
= proportion of variance accounted for.  Significant Beta values are indicated as follows: *** p < 0.001; 
**p < 0.01; *p < 0.05. 
Mean diffusivity  
Results for mean diffusivity measures of thalamic nuclei tracts are presented in Table 9-7.  
All of the first Model 1 analyses were significant, indicating that combined, the effect of 
the nuclei tracts that were entered into the model accounted for a significant proportion of 
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the variance in cognitive domain scores, for all cognitive domains.  Within Model 1, the 
only independent predictor of any cognitive domain was the motor VA nucleus which 
accounted for a significant independent proportion of the variance in attention, executive 
function, learning and memory and global Z score.  As expected, after the inclusion of 
covariates in Model 2, there was an increase in the proportion of variance accounted for in 
all cognitive domain scores.  Within Model 2, the VA nucleus remained an independent 
predictor of the attention and global Z score domains and became an independent predictor 
of the visuospatial domain.   
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Table 9-7:  Backward stepwise linear regression results for MD of nuclei tracts  
% of variance accounted for by unique predictors  R2 change 
     
Model 1  Model 2   
Nuclei tracts (specified for each model)  Nuclei tracts and covariates   
  age, education, depression, disease duration   
     
Attention   
Entered tracts: AP, MDn, CM/Pf, LD, VA, VL, VP, Pu 
R
2
 = 27%, F(8,75) = 3.45, p<0.01  R
2
 = 43%, F(12,71) = 4.49, p<0.001  ↑16% 
(p<0.001) VA (β = -0.67**) 7% (<0.01)  VA (β = -0.54*) 4% (0.03)  
   Disease Duration (β=-0.30**) 8 (<0.01)  
Executive Function 
Entered tracts: AP, MDn, LD, VA, VL, VP, Pu   
R
2
 = 20%, F(7,76) = 2.72, p<0.01  R
2
 = 48%,F(11,72) = 6.0, p<0.001  ↑28% 
(p<0.001) VA (β = -0.53*) 4% (0.04)  Education (β = 0.24*) 4% (0.02)  
   Depression (β = -0.29**) 7 % (<0.01) 
   Disease Duration (β = -0.37†) 12% (<0.001) 
Learning and Memory  
Entered tracts: AP, MDn, LD, VA, VL, VP, Pu   
R
2
 = 17%, F(7,76) = 2.21, p=0.04  R
2
 = 30%, F(11,72) = 2.82, p<0.01  ↑13 
(p=0.01) VA (β= -0.64*) 6% (0.02)  Depression (β = -0.25*) 6% (0.02)  
   Disease Duration (β= -0.20) 5% (0.03)  
Visuospatial/Visuoperception    
Entered tracts: MDn, LD, VA, VP, Pu    
R
2
 = 16%, F(5,78) = 2.82, p<0.02  R
2
 = 28%, F(9,74) = 3.28, p<0.01  ↑13% 
(p=0.01) none   VA (β = -0.26) 8% (0.01)  
   Disease Duration (β=-0.30*) 8% (<0.01)  
Global Z Score  
Entered tracts: AP, MDn, LD, VA, VL, VP, Pu   
R
2
 = 24%, F(7,76) = 3.41, p<0.01  R
2
 = 44%, F(11,72) = 5.15, p<0.001  ↑ 20% 
(p<0.001) VA (β= -0.62*) 6 % (0.02)  VA (β = -0.48*) 3% (0.05)  
   Education (β = 0.20*) 4% (0.03)  
   Depression (β = -0.24*) 5% (0.01)  
   Disease Duration (β=-0.32***) 9% (<0.001) 
Two linear models were used to analyse the proportion of variance accounted for by MD measures of 
thalamic nuclei tracts in each cognitive domain.  Only those nuclei that had a significant correlation with the 
cognitive domain were entered into the model.  Only the motor nuclei tract was an independent predictor of 
cognition.  R
2 
= proportion of variance accounted for.  Significant Beta values are indicated as follows: *** p 
< 0.001; **p < 0.01; *p < 0.05.  
9.6.4 Fibre tracts as a tool for group discrimination 
Receiver operating curve (RoC) statistics were generated independently from FA and MD 
measures of tract integrity to calculate the predictive validity of each thalamic nuclei tract 
and are reported in Table 9-8.  Several pairwise comparisons were conducted to first 
separate the patient group with no cognitive impairment from healthy control participants 
and then to separate mild cognitive impairment and dementia from both the healthy 
controls and the unimpaired PD-N group.   
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9.6.4.1 Identification of the patient group 
The PD-N group could not be separated from the healthy controls; in every case the AUC 
of each thalamic nuclei tract was not significant.  
9.6.4.2 Identification of dementia 
Identification of the PD-D group relative to the other groups was not achieved as easily as 
it was using diffusion measures of the nuclei in the previous chapter.  The comparison 
between PD-D and controls and the PD-N group was best achieved using sensory and 
motor nuclei tracts whilst the discrimination between PD-D and PD-MCI was best 
achieved using the association tracts and the limbic AP tract.  Relative to the control 
subjects the best discriminatory variable was the sensory VP nucleus, but this only allowed 
for identification of PD-D 66.7% of the time.  Identification of PD-D was achieved with 
higher success when discriminating from the PD-N group, MD of the VA identified PD-D 
patients 86.7% of the time.  Not surprisingly, separating the PD-D group from the PD-MCI 
group proved more difficult.  MD values of tracts gave higher AUC than FA in most cases, 
but for the LP and LD nuclei tracts FA was the better diffusion measure.  In terms of the 
accuracy of the separation, only MD measures of the limbic AP tract allowed for correct 
identification of the PD-D group at a level greater than chance (66.67%).  
9.6.4.3 Identification of mild cognitive impairment  
Separating the PD-MCI group from the controls was not successful, there were no thalamic 
nuclei tracts that gave a significant area under the curve.  Although MD measures of the 
association (Pu), limbic (LD) and motor (VA) nuclei tracts all had a significant AUC, none 
of these regions enabled successful discrimination between the two groups with a great 
degree of accuracy, all showed sensitivity less than 50%.   
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Table 9-8: Predicting PD and PD cognitive impairment using DTI measures of nuclei tracts 
   Fractional Anisotropy  Mean Diffusivity 
   AUC (p level) Cutoff Sensitivity Specificity  AUC (p level) Cutoff Sensitivity Specificity 
Association Nuclei  
Mediodorsal C vs PD-N 0.57 (0.35) >0.3847 37.25 83.33  0.49 (0.88) <0.0009 27.45 83.33 
  PD-MCI 0.50 (0.96) <0.3466 11.11 83.33  0.56 (0.56) >0.001 22.22 83.33 
  PD-D 0.60 (0.32) <0.3464 40.00 83.33  0.78 (<0.01) >0.001 53.33 83.33 
 PD-N vs PD-MCI 0.57 (0.37) <0.3542 22.22 80.39  0.53 (0.71) >0.0011 27.78 80.39 
  PD-D 0.65 (0.11) <0.3524 40.00 80.39  0.77 (<0.01) >0.001 60.00 80.39 
 PD-MCI vs PD-D 0.61 (0.32) <0.3505 40.00 83.33  0.74 (<0.01) >0.001 46.67 83.33 
Lateral Posterior C vs PD-N 0.55 (0.49) <0.3888 27.45 83.33  0.54 (0.59) >0.001 15.69 83.33 
  PD-MCI 0.61 (0.22) <0.3874 38.89 83.33  0.60 (0.28) >0.001 27.78 83.33 
  PD-D 0.50 (0.98) <0.3836 33.33 83.33  0.62 (0.20) >0.001 20.00 83.33 
 PD-N vs PD-MCI 0.57 (0.41) <0.3823 27.78 80.39  0.55 (0.47) >0.01 16.67 80.39 
  PD-D 0.53 (0.75) >0.4537 33.33 80.39  0.57 (0.39) >0.001 13.33 80.39 
 PD-MCI vs PD-D 0.59 (0.39) >0.454 33.33 83.33  0.52 (0.89) >0.001 13.33 83.33 
Pulvinar C vs PD-N 0.60 (0.19) >0.444 21.57 83.33  0.59 (0.21) <0.0009 31.37 83.33 
  PD-MCI 0.55 (0.62) <0.3756 33.33 83.33  0.58 (0.37) >0.0011 22.22 83.33 
  PD-D 0.55 (0.63) <0.3719 33.33 83.33  0.64 (0.11) >0.0011 33.33 83.33 
 PD-N vs PD-MCI 0.63 (0.09) <0.3863 38.89 80.39  0.67 (0.03) >0.001 38.89 80.39 
  PD-D 0.62 (0.16) <0.3863 40.00 80.39  0.77(<0.01) >0.001 60.00 80.39 
 PD-MCI vs PD-D 0.50 (0.97) <0.3558 13.33 83.33  0.58 (0.43) >0.0011 6.67 83.33 
Limbic Nuclei  
Anterior 
Principal 
C vs PD-N 0.62 (0.09) >0.3766 41.18 83.33  0.53 (0.65) <0.0009 25.49 83.33 
 PD-MCI 0.48 (0.86) >0.3766 27.78 83.33  0.53 (0.73) >0.0011 16.67 83.33 
 PD-D 0.68 (0.04) <0.3292 40.00 83.33  0.81 (<0.01) >0.0011 60.00 83.33 
 PD-N vs  PD-MCI 0.64 (0.05) <0.3412 33.33 80.39  0.56 (0.40) >0.0011 16.67 80.39 
  PD-D 0.78 (<0.01) <0.3401 53.33 80.39  0.81 (<0.01) >0.0011 60.00 80.39 
 PD-MCI vs PD-D 0.68 (0.06) <0.3254 40.00 83.33  0.82 (<0.01) >0.0011 66.67 83.33 
Lateral Dorsal  C vs PD-N 0.56 (0.41) >0.3798 25.49 83.33  0.60 (0.15) <0.001 35.29 83.33 
  PD-MCI 0.57 (0.41) <0.297 16.67 83.33  0.56 (0.51) >0.0013 22.22 83.33 
  PD-D 0.77 (<0.01) <0.3011 46.67 83.33  0.74 (<0.01) >0.0013 60.00 83.33 
 PD-N vs PD-MCI 0.63 (0.08) <0.3228 38.89 80.39  0.66 (0.03) >0.0012 33.33 80.39 
  PD-D 0.80 (<0.01) <0.3211 80.00 80.39  0.80 (<0.01) >0.0012 66.67 80.39 
 PD-MCI vs PD-D 0.73 (0.01) <0.3011 46.67 83.33  0.68 (0.06) >0.0013 53.33 83.33 
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Table 10-8 Continued  
   
Fractional Anisotropy  Mean Diffusivity 
   
AUC (p level) Cutoff Sensitivity Specificity 
 
AUC (p level) Cutoff Sensitivity Specificity 
Sensory Nucleus           
Ventral 
Posterior  
C vs PD-N 0.49 (0.87) <0.4194 9.80 83.33  0.50 (0.99) <0.0008 15.69 83.33 
 PD-MCI 0.55 (0.56) <0.4181 16.67 83.33  0.66 (0.09) >0.0009 50.00 83.33 
  PD-D 0.49 (0.87) <0.4194 9.80 83.33  0.79 (<0.01) >0.0009 66.67 83.33 
 PD-N PD-MCI 0.56 (0.44) <0.4283 22.22 80.39  0.64 (0.11) >0.0009 44.44 80.39 
  PD-D 0.52 (0.82) <0.4296 33.33 80.39  0.79 (<0.01) >0.0009 60.00 80.39 
 PD-MCI PD-D 0.54 (0.69) >0.4561 46.67 83.33  0.62 (0.25) >0.0009 26.67 83.33 
            
Motor Nuclei            
Ventral Anterior  C vs PD-N 0.57 (0.38) >0.4537 19.61 83.33  0.54 (0.59) <0.0008 13.73 83.33 
  PD-MCI 0.56 (0.52) <0.3816 22.22 83.33  0.62 (0.17) >0.0009 27.78 83.33 
  PD-D 0.64 (0.15) <0.3818 40.00 83.33  0.84 (<0.01) >0.0009 60.00 83.33 
 PD-N PD-MCI 0.63 (0.13) <0.4047 38.89 80.39  0.67 (0.03) >0.0009 44.44 80.39 
  PD-D 0.73 (<0.01) <0.4047 53.33 80.39  0.87 (<0.01) >0.0009 86.67 80.39 
 PD-MCI PD-D 0.60 (0.34) <0.3814 33.33 83.33  0.70 (0.04) >0.001 33.33 83.33 
Ventral Lateral  C vs PD-N 0.50 (0.97) <0.41 15.69 83.33  0.52 (0.77) >0.0009 21.57 83.33 
  PD-MCI 0.57 (0.44) <0.4079 22.22 83.33  0.62 (0.18) >0.0009 33.33 83.33 
  PD-D 0.51 (0.91) <0.4099 20.00 83.33  0.78 (<0.01) >0.0009 53.33 83.33 
 PD-N PD-MCI 0.55 (0.54) <0.4165 33.33 80.39  0.61 (0.14) >0.0009 33.33 80.39 
  PD-D 0.51 (0.92) >0.4534 26.67 80.39  0.78 (<0.01) >0.0009 53.33 80.39 
 PD-MCI PD-D 0.57 (0.53) >0.453 26.67 83.33  0.66 (0.11) >0.0009 20.00 83.33 
Non-Specific Nucleus           
Centromedian/ 
Parafascicular 
C vs PD-N 0.50 (0.99) <0.3685 23.53 83.33  0.50 (0.99) >0.0009 11.76 83.33 
 PD-MCI 0.57 (0.45) <0.3694 33.33 83.33  0.56 (0.51) >0.0009 27.78 83.33 
  PD-D 0.49 (0.93) >0.4419 13.33 83.33  0.76 (<0.01) >0.0009 53.33 83.33 
 PD-N PD-MCI 0.55 (0.57) <0.3579 22.22 80.39  0.56 (0.45) >0.0009 33.33 80.39 
  PD-D 0.50 (0.96) <0.3564 13.33 80.39  0.75 (<0.01) >0.0009 60.00 80.39 
 PD-MCI PD-D 0.57 (0.52) >0.4189 33.33 83.33  0.70 (0.03) >0.001 46.67 83.33 
AUC: area under the receiver operating curve (chance = 0.5; perfect separation = 1.0)   
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9.6.5 The combined contribution of nuclei and nuclei tract integrity in cognitive 
dysfunction  
To further aid in discrimination of the cognitively impaired PD patients from the 
unimpaired PD patients and healthy control subjects the diffusion parameters of both the 
thalamic nuclei and the associated nuclei tracts were analysed together.  We have 
previously established the contribution that each thalamic nucleus makes to cognitive 
domain (Table 8-6) and here have determined that the tracts arising from these nuclei make 
little contribution to cognition.  This final analysis examines the combined effect of 
thalamic nuclei and their associated tracts over cognitive dysfunction.  In order to 
determine the combined effect of nuclei and their tracts on cognitive dysfunction we first 
had to determine the association between the thalamic nuclei and their tracts.  Results are 
presented in Table 9-9. 
9.6.5.1 Fractional ainsotropy 
We first conducted a series of Pearson correlations to determine the association between 
each nuclei tract and the nuclei themselves.  Results (light grey) were as expected, each 
thalamic nuclei tract showed an association with the nuclei it originated from.  For each 
tract, the strongest correlation was with the nucleus it was seeded from (white).  A series of 
multiple regression analyses were then conducted for each tract.  All nuclei that had an 
association with that tract were entered to determine if the nuclei was an independent 
predictor of its associated tract, or if there were underlying effects of surrounding nuclei 
contributing to this association.  Multiple regression results (dark grey) were mostly as 
expected.  For the association MDn, LP and Pu, the limbic LD, sensory VP, motor VL and 
non-specific CM/Pf nuclei tracts the strongest independent predictor of FA values of that 
tract was the FA values of the associated nucleus.  In some cases, other surrounding 
thalamic nuclei also strongly contributed to a nuclei tract other than the one seeded from it.  
In the case of the MDn and LP tracts the Pu was also a unique predictor, in the case of the 
VP tract the VL nucleus was an additional unique predictor and in the case of the CM/Pf 
tract the LP nucleus was a unique predictor, suggesting a significant amount of shared 
variance between these nuclei.  For the limbic AP, and motor VA tracts, nuclei other than 
the one where the tract originated from were the strongest unique predictors of FA tract 
values.  For the AP tract the other limbic LD nuclei was the strongest unique predictor and 
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for the VA the other motor VL nucleus was the strongest predictor, indicating that these 
nuclei have shared connectivity arising from their functional roles.   
9.6.5.2 Mean diffusivity  
With exception to the motor VA and VL nuclei, in terms of correlation analysis each nuclei 
showed the strongest relationship with its associated tract when measured with MD.  The 
VA tract had stronger associations with the MDn and VP nuclei while the VL tract had 
stronger associations with the LD, VP, VA and CM/Pf nuclei.  When entered into the 
multiple regression model results were as expected, every tract was uniquely predicted by 
its associated nucleus.  There were no cases where a stronger unique predictor was found.  
There were two instances where there was an additional nucleus which uniquely predicted 
some of the variance in MD values of tracts however.  The first was the VA tract where the 
MDn was also a unique predictor and the second was the CM/Pf where the VA was also a 
unique predictor.   
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Table 9-9:  Association between thalamic nuclei and corresponding thalamic nuclei tracts  
Nuclei tracts Statistic MDn LP Pu AP LD VP VA VL CM/Pf 
 
Fractional Anisotropy 
Association Nuclei  
MDn r 0.36*** 0.10 0.07 0.19 0.16 0.20* 0.20* 0.16 0.23* 
 β 0.23*     0.17 -0.01  0.12 
LP r 0.34*** 0.35*** 0.21* 0.22* 0.10 0.10 0.18 0.07 0.26** 
 β 0.19 0.21*  0.10     0.18* 
Pu r 0.35*** 0.33† 0.26*** 0.27** 0.17 0.07 0.11 0.10 0.09 
 β 0.20* 0.21* 0.20* 0.13      
Limbic Nuclei  
AP r 0.22* 0.00 0.21* 0.39*** 0.24* 0.10 0.22* 0.11 0.17 
 β 0.02   0.25** 0.10  0.11   
LD r 0.09 -0.02 0.13 0.39*** 0.63*** 0.04 0.16 0.14 0.12 
 β    0.29*** 0.61***     
Sensory Nucleus  
VP r 0.10 0.23* 0.21* -0.01 0.10 0.40*** 0.24* 0.23* 0.11 
 β  0.14    0.34*** 0.11 0.13  
Motor nuclei  
VA r 0.11 0.11 -0.02 0.03 0.03 0.19 0.36*** 0.20* 0.11 
 β       0.14 0.05  
VL r 0.18 0.24* 0.06 0.13 0.10 0.32** 0.44*** 0.43*** 0.12 
 β  0.16    0.23* 0.38*** 0.38***  
Non-specific nucleus 
CM/Pf r 0.34*** 0.11 -0.03 0.30** 0.14 0.07 0.24* 0.13 0.34*** 
 β 0.18   0.14   0.20*  0.26** 
Pearson correlations (r) and Beta values (β) of the association between thalamic nuclei (column 1) and the tracts that are seeded from them (column 2).  All participants were 
included.  Significant associations are denoted: *** p < 0.001; **p < 0.01; *p < 0.05, Beta values are only reported for those comparisons that have a significant correlation.  
White: relationship between nucleus and its associated tract; Light grey: correlation results; dark grey: multiple regression results.   
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Table 9-9 Continued 
Nuclei tracts Statistic MDn LP Pu AP LD VP VA VL CM/Pf 
 
Mean Diffusivity 
Association Nuclei 
MDn r 0.51† 0.22* 0.24* 0.35† 0.18 0.30** 0.53† 0.24* 0.27** 
 β 0.34** -0.02 0.01 0.09  0.01 0.23* -0.04 0.03 
LP r 0.21* 0.33† 0.17 0.11 0.03 0.17 0.30** 0.12 0.15 
 β -0.05 0.20  -0.17   0.00  - 
Pu r 0.26** 0.09 0.39† 0.21 0.15 0.23 0.36† 0.16 0.18 
 β 0.06  0.29** 0.06   0.10   
Limbic Nuclei  
AP r 0.38† 0.27** 0.26** 0.47† 0.29** 0.30† 0.43† 0.24* 0.20* 
 β 0.16 0.15 0.12 0.40† 0.13 0.09 0.15 0.07 0.07 
LD r 0.15 0.18 0.23* 0.21* 0.69† 0.22* 0.27** 0.26** 0.16 
 β   0.15 0.09 0.66† 0.17 0.15 0.22*  
Sensory Nucleus  
VP r 0.43† 0.25** 0.27** 0.31** 0.11 0.44† 0.48† 0.35† 0.31† 
 β 0.17 -0.04 0.04 0.03  0.35** 0.12 0.22 0.10 
Motor nuclei  
VA r 0.31** 0.30 0.24† 0.24* -0.01 0.32† 0.47† 0.26† 0.26** 
 β -0.07 0.11 0.08 0.04  0.16 0.27* 0.09 0.17 
VL r 0.32** 0.29** 0.19* 0.23* 0.07 0.25** 0.36† 0.25** 0.23* 
 β 0.10 0.10 -0.01 0.02  -0.14 -0.11 -0.01 -0.09 
Non-specific nuclei 
CM/Pf r 0.25** 0.21* 0.18 0.27** 0.21* 0.25* 0.31** 0.26** 0.36† 
 β -0.01 0.08  0.17 0.14 0.06 0.07 0.13 0.29** 
Pearson correlations (r) and Beta values (β) of the association between thalamic nuclei (column 1) and the tracts that are seeded from them (column 2).  All participants were 
included.  Significant associations are denoted: *** p < 0.001; **p < 0.01; *p < 0.05, Beta values are only reported for those comparisons that have a significant correlation.  
White: relationship between nucleus and its associated tract; Light grey: correlation results; dark grey: multiple regression results.   
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Once it was determined that tractography values are mostly uniquely predicted by 
their associated nuclei, we examined the influence the combination of each of these has on 
cognition by performing a series of backward stepwise linear regressions in a manner 
similar to that described previously in this thesis (Section 8.7.5.2).  Briefly, all nuclei that 
showed an association with a cognitive domain were entered into a backward stepwise 
regression to firstly ascertain the total amount of variance accounted for in that cognitive 
domain (R
2
 for model) and also to determine the contribution each nucleus made to this (R
2
 
change).  Following this, a second model was created whereby all associated thalamic 
nuclei tracts were entered to determine if this increased the variance accounted for in each 
cognitive domain, and the individual contribution each thalamic nuclei tract made to this.  
Ten models were created, two for each cognitive domain.  Only MD measures of thalamic 
nuclei and tracts were used in this instance as they showed a stronger association with 
cognition than FA measures.  Results are presented in Table 9-10.   
For each nucleus, adding the MD measures of its associated nuclei tract increased 
the variance accounted for in cognition.  This increase was only significant for the 
association and limbic thalamic nuclei however, and mainly in the domains of attention 
and executive function.  For the attention domain adding the nuclei tract arising from the 
Pu increased the variance accounted for in attention scores.  For the executive function 
domain adding the MDn, Pu and AP tracts gave a significant increase.  For the 
visuospatial/visuoperception domain adding thalamic nuclei tracts did not increase the 
overall proportion of variance accounted for, nor the variance accounted for by each 
individual nuclei.  The same is true for the learning and memory domain.  In the global 
domain, the MDn is again implicated, with a significant increase in the proportion of 
variance accounted for in scores once the nuclei tract is added.   
The Cortical Connectivity of the Thalamus and Thalamic Nuclei 
Chapter 9 | 281 
Table 9-10:  The variance in cognition accounted for by the combined MD measures of thalamic nuclei 
and tracts  
 Model 1 
Nuclei associated with 
cognition 
 Model 2 
Adds tracts of those nuclei 
 Model 1 vs  
Model 2 
 Beta p R
2
 p  Beta p R
2
 p  R
2 
change p 
Attention 
Models  R
2
 = 32%, F(5,78) = 7.31, p<0.01 R
2
 = 34%, F(10,73) = 3.82, p<0.01 2% 0.75 
MDn -0.27 0.03 12% <0.01  -0.17 0.16 14% <0.01  2% 0.16 
Pu -0.21 0.07 11% <0.01  -0.27 0.02 17 <0.01  6% 0.02 
LD -0.22 0.13 15% <0.01  -0.24 0.10 17% <0.01  3% 0.10 
VP -0.22 0.07 10% <0.01  -0.21 0.08 14% <0.01  3% 0.08 
CM/Pf -0.28 0.02 10% <0.01  -0.11 0.36 11% <0.01  1% 0.36 
Executive Function 
Models R
2 
= 27%, F(7,76) = 3.93, p<0.01 R
2
 = 34%, F(14,69) = 2.51, p<0.01 0.7% 0.40 
MDn -0.33 <0.01 14% <0.01  -0.11 0.38 0.8% 0.38  15% <0.01 
LP -0.22 0.07 5% =0.10  -0.04 0.74 5% 0.10  0.01% 0.10 
Pu -0.18 0.12 9% <0.01  -0.25 0.03 14% 0.01  5% 0.03 
AP -0.13 0.28 6% 0.03  -0.25 0.04 10% 0.01  5% 0.04 
LD -0.10 0.51 8% <0.01  -0.27 0.07 12% <0.01  4% 0.07 
VP -0.28 0.02 13% <0.01  -0.17 0.16 15% <0.01  2% 0.16 
CM/Pf -0.30 <0.01 10% <0.01  -0.04 0.74 10% 0.01  0.01% 0.74 
Visuospatial/Visuoperception 
Models R
2
 = 35%, F(7,76) = 5.80, p<0.01 R
2 
= 38%, F(14,69) = 3.05, p<0.01 3% 0.80 
MDn -0.32 <0.01 15% <0.01  -0.14 0.25 16% <0.01  1% 0.25 
LP -0.31 <0.01 10% <0.01  -0.03 0.79 10% 0.02  0.01% 0.79 
Pu -0.22 0.07 8% <0.01  -0.14 0.25 10% 0.02  0.02% 0.25 
AP -0.16 0.20 5% 0.04  -0.14 0.25 7% 0.06  2% 0.25 
LD -0.33 0.02 15% <0.01  -0.33 0.02 15% <0.01  0.01% 0.57 
VP -0.33 <0.01 14% <0.01  -0.08 0.51 14% <0.01  0.01% 0.51 
CM/Pf -0.36 <0.01 13% <0.01  0.01 0.90 13% <0.01  0.01% 0.90 
Learning and Memory  
Models  R
2
 = 30%, F(7,76) = 4.68, p<0.01 R
2
 = 33%, F(14,69) = 2.40, p = 0.01 3% 0.91 
MDn -0.40 <0.01 20% <0.01  -0.08 <0.01 20% <0.01  0.01% 0.51 
LP -0.23 0.05 5% 0.04  0.02 0.89 5% 0.13  0.01% 0.88 
Pu -0.20 0.09 8% <0.01  -0.18 0.14 10% 0.01  2% 0.14 
AP -0.19 0.13 5% 0.03  -0.19 0.13 8% 0.03  3% 0.13 
LD -0.25 0.09 9% <0.01  -0.06 0.69 9% 0.02  0.01% 0.69 
VP -0.34 <0.01 15% <0.01  -0.09 0.43 16% <0.01  1% 0.43 
CM/Pf -0.28 0.02 10% <0.01  -0.80 0.49 10% 0.01  0.01% 0.49 
Global Z Score  
Models R
2
 = 38%, F(7,76) = 6.53, p<0.01 R
2 
= 42%, F(14,69) = 3.56, p<0.01 4% 0.64 
MDn -0.36 <0.01 19% <0.01  -0.15 0.20 21% <0.01  2% 0.01 
LP -0.23 0.05 6% 0.02  -0.03 0.79 6% 0.08  0.01% 0.79 
Pu -0.23 0.05 11% <0.01  -0.23 0.05 16% <0.01  5% 0.05 
AP -0.15 0.22 7% 0.02  -0.24 0.04 11% <0.01  5% 0.04 
LD -0.24 0.10 14% <0.01  -0.19 0.18 16% <0.01  2% 0.18 
VP -0.33 <0.01 16% <0.01  -0.15 0.20 18% <0.01  2% 0.20 
CM/Pf -0.35 <0.01 13% <0.01  -0.05 0.64 14% <0.01  0.2% 0.64 
Model 1 shows the combined contribution of thalamic nuclei to each cognitive domain.  Model 2 shows the 
increased contribution gained after adding associated nuclei tracts.  In most instances adding tracts does not 
increase the proportion of variance that is accounted for in cognitive scores by a significant amount.  Beta 
values for each nucleus and tract are also provided to give an indication of each individual contribution to 
cognition and reflect the values given in the individual models of nuclei and tracts, not in the overall model – 
significant beta values for the overall model have previously been reported (Table 9-7 ).  The thalamic nuclei 
independently influence cognition more than the nuclei tracts do.  Only PD patients have been included in 
analysis.   
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As expected, including covariates in Model 2 increased the proportion of variance 
accounted for in each cognitive domain.  In the attention domain R
2
 increased to 45% 
[F(14,69) = 4.08, p < 0.01] and none of the nuclei or tracts were independent predictors.  In 
the executive function domain R
2 
increased to 52% [F(18,65) = 3.89, p < 0.01] and again 
no nuclei or tracts were independent predictors of executive function.  In the visuospatial 
domain however the LD nucleus remained an independent predictor of domain score after 
the inclusion of covariates.  R
2
 increased to 44% in this model [F(18,65) = 2.89, p < 0.01].  
In the learning and memory domain R
2
 increased to 39%, [F(18,65) = 2.35, p < 0.01] and 
there were no regions which independently predicted this cognitive domain after the 
inclusion of covariates.  Finally, in the overall measure of global cognition R
2
 increased to 
53% after the inclusion of covariates [F(18,65) = 4.04, p < 0.001] but no regions were 
independent predictors.   
9.6.6 Using combined thalamic nuclei and tracts to aid in group discrimination 
Logistic regression analyses were applied to determine the degree to which groups could 
be separated when taking into account both diffusion parameters of thalamic nuclei and 
thalamic nuclei tracts.  For each pairwise comparison Beta values for each measure (FA 
and MD) of each thalamic nuclei and each thalamic nuclei tract are reported in Appendix 
B: Logistic regression results.  The total model was tested for significance using Wald’s 
chi-square.  The success rates for identification of cognitive decline within the patient 
group and for identification of PD from the healthy control group are reported in Figure 
9-3. 
9.6.6.1 Identification of the patient group 
The best nuclei and tracts to predict PD-N from healthy normal controls was the Pu.  
Within this model the best independent predictor of PD-N was MD measures of the Pu 
nuclei followed by FA measures of the Pu tract.   
9.6.6.2 Identification of dementia  
Successful identification of the PD-D group from the healthy control group was achieved 
with high success (71.79 - 87.18) and from the PD-N group to a similar degree (74.24 – 
86.36).  The best region to aid in discrimination of the PD-D group from the healthy 
controls was again the Pu, with FA measures of the Pu tract the strongest independent 
predictor, and MD measures of the Pu nucleus a close second.  Surprisingly, identifying 
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PD-D from the PD-N sample was best achieved by the VA motor nucleus where the best 
independent predictor was the FA measure of the VA tract, followed by the MD measure 
of the VA nucleus.  Separation of PD-D and PD-MCI was again one of the most difficult 
pairwise comparisons where only the AP, CM/Pf and VA regions had an overall model 
which was significant.  Of these three regions the AP region showed the highest level of 
correct identifications.  Within this model MD of the AP thalamic nuclei tract was a very 
slightly better independent predictor of dementia than FA of the AP thalamic nuclei tract.   
9.6.6.3 Identification of mild cognitive impairment  
Identification of PD-MCI was achieved 50% - 74.43% of the time from the healthy control 
group with higher accuracy (71.01% - 76.81%) than was possible when separating PD-
MCI from the PD-N group.  The Pu nucleus was again implicated, giving the highest 
degree of success rate in both comparisons.  Within the models MD of the Pu was the 
strongest independent predictor followed by FA of the Pu tract when using the healthy 
control group as a comparison with the reverse true for the comparison with the PD-N 
group (FA of the Pu tract was the strongest predictor followed by MD of the Pu nucleus).   
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Figure 9-3:  Identification of cognitive declining Parkinson’s disease groups 
Separation of the PD groups is possible using diffusion parameters of the thalamus and associated tracts 
(top).  The success rate increases when analysis is restricted to individual thalamic regions, with the 
association and limbic nuclei regions particularly useful here.  Separation of PD from normal healthy controls 
is also able to be achieved with some success (bottom).   
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9.7 Discussion  
9.7.1 Summary of the results  
The fibre network in Parkinson’s disease is significantly disrupted, with the anterior tracts 
arising from the limbic thalamic nuclei most affected.  Degeneration within the fibre 
network is generally only identifiable in the group with Parkinson’s disease dementia and 
not evident in the groups exhibiting milder forms of cognitive dysfunction.  Although 
others have previously examined individual thalamic tracts in neurodegenerative or 
psychological disease we are the first to isolate all fibre tracts originating from the 
thalamus and classify them by region.  Very few have quantitatively examined the 
influence of thalamic fibre tracts on dysfunction, although some have determined 
degeneration of the cortico-spinal tract contributes to motor dysfunction in PD.  We have 
gone one step further and examined the influence of the thalamic nuclei and each of the 
thalamic nuclei tracts in conjunction with each other, and independently to determine their 
association with cognitive dysfunction in Parkinson’s disease.  Only FA measures of the 
LD tract and MD measures of the VA tract had an independent influence on cognition.  
The LD was an independent predictor of attention, executive function and visuospatial 
cognitive domain scores and the VA an independent predictor of the attention and 
visuospatial cognitive domain scores.  The influence of the fibre tracts was not as great as 
the influence of the thalamic nuclei and alone, diffusion measures of the fibre tracts did not 
adequately discriminate between the different cognitive subtypes of PD.  In conjunction 
with the thalamic nuclei however successful identification of PD-D and PD-MCI was 
possible at higher levels than possible using diffusion measures of the thalamic nuclei only.   
9.7.2 Tract disruption  
The integrity of the whole thalamus tracts did show significant disruption in relation to the 
levels of cognitive dysfunction.  Reflective of mean diffusivity results in the whole 
thalamus (Section 6.7.4), there was a significant increase in the PD-D group relative to all 
other groups.  These results confirm previous reports from our own group (Melzer, et al., 
2011a).  The anterior thalamic radiation, of which the tracts arising from the whole 
thalamus can be assumed to join, shows significant disruption in PD.  In contrast to our 
results which demonstrated increases in PD-D relative to both control subjects and to PD-
N, increased diffusivity was evident in all PD (PD-D; PD-MCI; PD-N) groups relative to 
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controls in the Melzer, et al., (2011a) sample but not in PD-D or PD-MCI relative to PD-N.  
We have perhaps therefore demonstrated here that integrity disruption in PD-D is an 
artifact of dementia rather than motor symptoms in PD for the first time.   
 The tracts arising from the individual thalamic nuclei are more sensitive to 
cognitive dysfunction than the whole thalamus tracts.  Alongside the MDn, the AP tract is 
the only other tract to show a significant increase in diffusivity in PD-D relative to PD-
MCI and the LD the only tract to show a significant increase in PD-MCI relative to PD-N.  
The LD nucleus is involved in the episodic memory pathway (Aggleton & Brown, 1999; 
Cipolotti, et al., 2008) and also mediates executive function (van der Werf, 2003) so fiber 
disruption here could be reflective of the two earliest symptoms of cognitive dysfunction in 
PD (Janvin, et al., 2006).  The nuclei involved in this pathway (both AP and LD) appear to 
be relatively spared by LB pathology in PD (Halliday, 2009), suggesting the 
communication breakdown between these subcortical regions and the cortex is an artifact 
of network disruption.  Results from our previous chapter support this idea, the AP is the 
only region to show no mean diffusivity changes in any of the PD groups (Section 8.7.4), 
although the fiber tract shows significant MD changes in PD-D relative to all other groups.   
 Degeneration of cortical tracts is thought to be due to the loss of cells in connecting 
regions (Hulshoff Pol, et al., 2000) and, as the anterior thalamic radiation is one of the 
major fiber tracts connecting the thalamus to the cortex it could reflect degeneration in 
multiple other areas of the thalamus which also project to the frontal lobes and mediate 
frontal symptoms such as the MDn (Kemether, et al., 2003).  Indeed, the tract specifically 
delineated from the MDn shows significant disruption in PD-D relative to all other groups 
in this sample.   
 The influence of the anterior thalamic radiation, or the tract arising from the AP in 
this case has to be considered carefully in our sample as there was a significant group x 
hemisphere interaction here, even after controlling for co-variates.  Follow up analyses 
indicated a significant group effect in the left tract, but not the right.  Previous chapters 
also report that the left whole thalamus is larger and has higher FA than the right.  In 
regards to the thalamic nuclei, the MDn was larger and had higher FA in the left, the LD 
was larger in the left hemisphere, the AP, VA, VP and Pu had higher FA in the left and the 
VP had lower MD in the left hemisphere.  The greater integrity in the left doesn’t appear to 
have unduly influenced results however.  The right hemisphere can be loosely described as 
influencing non-verbal material whilst the left mediates verbal tasks but the cognitive 
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profile of our cohort includes deficits of both verbal and visual memory.  Cipolotti, (2008) 
is one of the few studies to have previously examined the lateralisation effect in regards to 
cognition in PD and reports that the left hemisphere was more affected than the right in the 
patients, a result that is in direct contrast to ours.  Although Cipolotti only examined the 
mammillothalamic tract in PD patients, FA reduction was localised to the left tract.  
Despite this, the cognitive profile of the patients was similar to our own as they exhibited 
equal involvement of verbal and visual dysfunction.  Given the myriad of connectivity 
between the left and right thalamus it is not unreasonable to assume that although our 
results indicate degeneration appears to be worse in the right hemisphere, connectivity 
disruption between the left and right thalamus dictates that this will manifest as both verbal 
and visual dysfunction.  The few previous studies that have reported differential 
hemisphere influence on cognition in regards to the thalamus support this idea.  Peran 
(2009) showed significant cellular disruption bilaterally which aided in discrimination 
between PD and controls and although Summerfield (2005) reports that only the left 
thalamus was degenerated in PD, this had a significant association with the presence of 
dementia.   
 Across the spectrum of PD in this sample the tracts of the motor nuclei (VA, VL) 
are also significantly disrupted in PD-D relative to PD-N (VL) and the VA is the only tract 
to show progressive disruption from PD-N to PD-MCI through to PD-D.  These results 
confirm a previous study (Gupta, 2012) of the motor pathway in PD which showed 
significant degeneration of the nigrostriatal and mesolimbic tracts – reflected in both 
decreased FA and increased MD in PD relative to healthy controls.  The authors did not 
discriminate between the level of cognitive impairment in their sample but suggest that 
diffusion disruptions reflect loss of dopaminergic neurons in the early stages of the disease 
and that this could be used as an early biomarker.  The influence of our VA tract on 
cognition is most likely a result of the fact that the mean diffusivity measure of the VA 
tract is strongly associated with the MDn nucleus.  As the VA and the MDn both project 
from the thalamus to the frontal region (Mori, Oishi, & Faria, 2009) it is possible the tracts 
of these nuclei merged into the anterior thalamic tract and reflect the function of this white 
matter pathway, rather than the differential function of the motor or limbic pathway as 
intended.   
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9.7.3 The relationship with cognition  
Similar to the results of the previous chapter there was a significant association between 
fiber tracts and the function of the region they terminated in.  Frontal lobe dysfunction such 
as attention and executive function for example, was significantly associated with the 
limbic nuclei which project to this region.  The frontal fiber network has previously been 
implicated in regards to dysfunction in the working memory and executive function 
domains in Schizophrenia (Mamah, et al., 2010).  Although fractional anisotropy, not mean 
diffusivity was the integrity measure of choice there was significant cellular disruption in 
Schizophrenia patients compared to control subjects which correlated with these measures 
of cognition.   
 The influence of cortical connectivity on mild cognitive dysfunction has previously 
only been examined by ourselves (Melzer, et al., 2011a) and in Alzheimer’s disease 
(Mielke, et al., 2009).  Tractography was not applied in the Alzheimer’s disease sample, 
instead regions of interest within major fiber tracts were examined.  Results showed that in 
anterior regions; the anterior cingulum bundle and the fornix AD patients had significantly 
lower FA compared to control subjects.  Compared to MCI patients, these regions along 
with the selenium were also significantly disrupted and had a significant association with a 
range of cognitive scores.  Alongside our current results which also show significant 
cellular disruptions in some white matter tracts between PD-MCI and PD-D this could 
indicate that network connectivity is one of the major changes that contribute to the 
development of dementia in neurodegenerative diseases.  Indeed, we have also shown that 
tracts implicated between PD-MCI and PD-D in our sample (MDn, AP) influence the areas 
of cognition most involved in the progression to dementia, the frontal and temporal regions 
(Beyer & Aarsland, 2008).   
 The progression to dementia is the likely result of multifaceted, rather than single 
region disruption.  This thesis also extensively examined the combined and independent 
influence of the nuclei and associated tracts and found that in conjunction, the nuclei and 
their connections heavily influence cognitive dysfunction in PD but the tracts alone do not 
provide much added influence.  The thalamic nuclei and connections have not previously 
been examined but, rather than influencing cognition themselves could lead to 
degeneration in connected areas rather than directly influencing cognition.  In temporal 
lobe epilepsy for example (Wang, et al., 2010) patients exhibited decreased FA and 
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increased MD in bilateral thalamus and the white matter of connected frontal and occipital 
regions.  DT changes were associated with impairment of tasks of executive function.   
The idea of relative axonal integrity in PD is further supported by Braak (2004) 
who suggests that nerve cells with long robust axons that are insulated by myelin are 
actually protected against LN and LB formation throughout the entire course of PD.  The 
principles of diffusion tensor imaging in relation to tractography depend on the direction of 
diffusion, as dictated by the integrity of the white matter axons (Watts, Liston, Niogi, & 
Ulug, 2003).  As our FA results barley change across PD groups and the limbic tracts are 
the only ones to show significant degeneration, in PD-D relative to: PD-N in the case of 
the AP; and to PD-MCI, PD-N and control groups in the case of the LD this could be why.  
Furthermore, despite being one of the main influences on the DTI signal, myelin integrity 
does not appear to influence DTI results.  Assaf & Pasternak (2008) address this directly in 
a review of white matter mapping and agree with this hypothesis.  Experiments on 
myelinated and non myelinated axons also show that anisotropy values are similar 
(Beaulieu & Allen, 1994).  The most compelling evidence comes from a multiple sclerosis 
sample which showed limited FA disruption in areas of white matter where demyelination 
is known to occur (Assaf, et al., 2002; Bammer, et al., 2000; Filippi, Cercignani, Inglese, 
Horsfield, & Comi, 2001).  The authors of the review conclude that myelin is only partially 
reflected in DTI measures of FA.  If the sheaths are protected against Lewy formation there 
is no reason for the cells to show degeneration.  The discrepancy between FA and MD 
results is easily explained by the fact that MD is a measure of cellular integrity and more 
reflective of degeneration within the axon rather than the overall degeneration of direction.  
FA is more reflective of increases in cellular space and DTI studies in stroke patients 
(Sotak, 2002) show a marked reduction of FA at the lesion site.  Lesion sites typically 
show neuronal death (and an increase in extracellular space).   
The protection against LB pathology could also explain the low association 
between fiber tracts and cognition in this sample.  Although the influence of the thalamic 
tracts cannot be ignored as they do add to the model of cognition, this could just be due to 
their association with the main area of the cortex they are connected with.  It is not 
surprising, for example that the tracts originating from the anterior nuclei and the 
mediodorsal nucleus have an association with executive function and memory.  These 
regions preferentially connect to the frontal lobes by way of the anterior thalamic radiation 
and disruption in this tract could just reflect long term cellular degeneration of the grey 
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matter structures of the nuclei.  A theory heavily supported by the fact the tracts do not 
show degeneration until cognitive dysfunction is well advanced in PD-D in our sample.   
9.7.4 Justification of the study methodology 
Although very few groups have completed tractography from the thalamus, our 
tractography results appear to converge with those that have.  The anterior thalamic 
radiation has been specifically targeted for examination in two cases (Lo, et al., 2011; 
Mahon, et al., 2009) for example and shows connectivity between the frontal lobe and 
thalamus, completing the fronto-striato-thalamic circuit by penetrating the thalamus and 
proceeding to other cortical regions, the brainstem and cerebellum.  In our sample we used 
the anterior principal nucleus as a seed point and created a strong fibre tract which 
projected from here to the prefrontal cortex and which can be assumed to represent the 
anterior thalamic tract as this tract is associated with anterior and mediodorsal thalamic 
regions (Wanaka, et al., 2004).   
 The mediodorsal and centromedian/parafascicular thalamic nuclei are the only 
other two regions to be targeted for tractography investigation (Eckert, et al., 2012).  
Results in healthy subjects confirm the pattern of connectivity we have shown in our 
patient sample.  The MDn connected with the dorsolateral prefrontal cortex, and regions of 
the anterior cingulate cortex.  The CM/Pf showed a different pattern, connecting with the 
frontal cortex and not continuing into prefrontal regions.  This study also allowed for 
examination of subcortical connections and results converge with previous functional and 
animal studies.  The MDn forms part of the relay system between the basal ganglia and 
cortex; part of the dorsolateral-prefrontal loop between the caudate nucleus and the cortex; 
and part of the limbic network between the cingulate cortex and MDn, systems 
fundamental to cognitive, motivation and movement processing (Haber & Mcfarland, 
2001).  The CM/Pf had strong connectivity with the pallidum, putamen, hippocampus and 
amygdala.  We did not allow for examination of the degree of connectivity between 
structures as Eckert, (2012) did so are restricted to visual examination of connectivity only.  
This does not lead to easy identification of connectivity between thalamic regions and 
surrounding subcortical structures but our CM/Pf tracts do appear to agree with those of 
Eckert and colleagues, passing through the region of the basal ganglia and limbic system, 
whilst the MDn bypasses the basal ganglia, instead projecting through the cingulate to the 
cortex.   
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 Unfortunately DTI does not allow for anterograde and retrograde connections to be 
differentiated (Leh, et al., 2007).  We cannot, therefore establish whether the fibre tracts 
are travelling to or from the thalamic nuclei.  Despite this limitation, DTI still offers a 
valuable contribution in understanding the organisation of thalamic network connectivity, 
and the disruption which is evident in PD.   
9.7.5 Summary  
Our tractography study provides, for the first time, an evaluation of all major fiber 
pathways between the thalamus and the cortex.  We have shown there is a significant 
disruption in network connectivity in PD-D, and that this is mainly confined to those tracts 
originating from anterior thalamic regions, assumed to represent the anterior thalamic 
radiation.  In conjunction with the integrity of the thalamic nuclei it is possible to use 
measures of integrity of tracts to discriminate between those PD patients with no cognitive 
impairment, and those with mild cognitive impairment.  The integrity of the fiber tracts 
alone does not allow for much discrimination between groups however as, generally 
degeneration is only evident in the PD-D group and not prior to this in the PD-MCI group.  
Although few studies have applied tractography to investigate the connectivity of the 
thalamus (Leh, et al., 2008; Lo, et al., 2011; Mahon, et al., 2009) our findings are in 
accordance with anatomical guidelines of white matter fiber tract based atlases (Wanaka, et 
al., 2004) and agree with the two studies that have delineated tracts from the AP, MD and 
CM/Pf thalamic nuclei (Eckert, et al., 2012; Jakab, et al., 2012).  Examination of network 
integrity in Parkinson’s disease alongside examination of cellular integrity in the thalamus 
could allow for detailed examination of disease progression and efficacy of interventions 
longitudinally.   
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Chapter 10. SUMMARY, LIMITATIONS AND RECOMMENDATIONS 
10.1 Summary 
This thesis applied multiple imaging techniques in a large sample of Parkinson’s disease 
patients stratified by stage of cognitive decline.  We have shown that thalamic 
degeneration is a significant factor in the cognitive symptoms of this disorder.  Traditional 
structural based imaging methods showed significant levels of whole thalamic atrophy in 
Parkinson’s disease with dementia and a significant relationship with multiple facets of 
cognition across the whole sample.  This component of the thesis also examined the 
microstructural integrity of the whole thalamus and showed cellular disruption, as 
evidenced by increased mean diffusivity in the thalamus in Parkinson’s disease with mild 
cognitive impairment.  Mean diffusivity measures of integrity were more sensitive to 
cognition and, overall had a stronger relationship within multiple cognitive domains.  In 
contrast to previous reports (Peran, et al., 2009) this study did not identify any relationship 
between fractional anisotropy measures of thalamic integrity and Parkinson’s disease.   
In an effort to compare two commonly applied methodologies in the same sample, 
the whole thalamus was also examined using a region of interest approach in standard 
space.  In contrast to other studies that have used a whole brain approach (Burton, et al., 
2005; Summerfield, et al., 2005) our standard space results did not show any regions of 
thalamic reduction in any of the Parkinson’s disease groups.  This result does confirm a 
previous study generated by our own group however who examined the whole brain in a 
similar sample of PD patients and report no areas of thalamic change (Melzer, et al., 
2011b).  The relationship between mean diffusivity measures of the thalamus and 
cognition remained in standard space with the greatest changes concentrated to ventral and 
centromedian/parafascicular regions.  These results supported what has previously been 
identified in vivo in one Parkinson’s sample (McKeown, et al., 2008) and what has 
previously been identified from histology studies at autopsy (Halliday, 2009; Henderson, et 
al., 2000a).   
For the first time in a neurodegenerative sample, we applied a k means clustering 
technique (Behrens, et al., 2003) to the diffusion tensor images and segmented the 
thalamus into several clusters where each cluster was assumed to represent the major 
subdivisions of the thalamus.  These thalamic nuclei showed different levels of cellular, 
and volumetric disruption according to their anatomical location.  As in the whole 
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thalamus, mean diffusivity measures were more sensitive to cognitive dysfunction, 
showing significant disruption in some areas in the PD-N group, worsening and affecting 
further regions in the PD-MCI group and eventually showing disruption at a higher level in 
all nuclei in PD-D.  Most regions had a significant association with expected domains of 
cognition, although there were some unexpected findings which suggested the nuclei work 
in unison to moderate behaviour rather than operating as independent units, an idea 
supported by the extensive research that has been conducted by Braak (2008).   
This thesis also identified the major fiber pathways that originated from each 
thalamic nucleus to explore the differential involvement of nuclei in Parkinson’s disease.  
This is the first time this has been conduced in PD using all of the thalamic nuclei as seed 
points, although our group has previously applied a whole brain tractography approach and 
shown that the anterior tracts are most affected in groups with worse cognitive dysfunction 
in PD (Melzer, et al., 2011a).  We found that the fiber tracts were significantly 
degenerated.  The tracts that originated in the limbic and association nuclei exhibited the 
worst levels of disruption and the strongest association with cognition.  The integrity of the 
fiber tracts alone was not sufficient to discriminate between the differeing levels of 
cognitive dysfunction in the PD samples however, it was only when the integrity of the 
thalmic nuclei was also considered that a high accuracy of identification of cognitive 
dysfunction was possible.  We showed that PD-D especially, could be identified from PD-
N with 74 - 86% accuracy.  More importantly however, PD-MCI could be identified from 
PD-N with 71 - 77% accuracy.  This is especially relevant in the current medical climate as 
several different recommendations for the clinical criteria for PD-MCI have been made 
(Aarsland, et al., 2010; Litvan, et al., 2011; Petersen, et al., 1999), and our group has 
shown some of these to be more lenient than others (Dalrymple-Alford, et al., 2011).  The 
current thesis could go some way in aiding understanding of the progression from PD-MCI 
to PD-D and aid in identification of the neuropsychological criteria best applied to identify 
this.  Although ~ 70 – 85% accuracy may not be as high as desired it should be noted that 
the predictive strength of mammograms for detecting breast cancer in the general 
population is also within this range, at 76% and this method is the current gold standard for 
breast cancer detection and monitoring (National Collaborating Centre for Cancer, 2009).   
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10.2 Limitations 
As with any long term research, limitiations arose during the course of this thesis.  We 
hoped that by applying a region of interest approach that some of the common pitfalls of 
neuroimaging such as spurious results or insensitivity to changes in small regions could be 
avoided.  We feel this has mostly been achieved, and our structural T1 volume changes, 
especially are in accordance with other studies.  The structural and diffusion imaging 
methods have been validated in an AD sample (de Jong, et al., 2008) and were carefully 
checked in order to ensure coherence with anatomical guidelines (Duvernoy, 1991; 
Nieuwenhuys, et al., 2008a).  Our region of interest VBM approach has only been applied 
once before in PD (Summerfield, et al., 2005), using slightly different methodology and 
results here are not consistent as our sample reports no grey or white matter changes in PD.  
The lack of grey matter changes in the thalamus has previously been reported by our own 
group who applied a whole brain approach to a similar patient cohort (Melzer, et al., 
2011b) so we feel that the region of interest approach has not resulted in grey matter 
change being ‘missed’ in this sample.   
Diffusion tensor imaging is a relatively new technique, and despite multiple groups 
(Assaf & Pasternak, 2008; Chan, et al., 2007; Watts, 2008) reporting that increased mean 
diffusivity is the result of an increase in extracellular space due to the degeneration of 
neurons and supporting structures (Assaf & Pasternak, 2008), to the best of our knowledge 
this has not been verified by histology.  Given that the cellular density and distribution of 
each thalamic nucleus is inherently variable (See Chapter 4) it could be argued that the 
variation in MD between nuclei is merely reflective of variations in cell density.  The 
MDn, for example is made up of both widely dispersed cell bodies (anterior division) and 
smaller, packed cells (lateral division), and has a neuronal ratio (number of 
neurons/volume) 10 times that of the AP or CM/Pf nucleus (Henderson, et al., 2000b).  In 
our sample, the MDn is one of the only regions to show a progressive increase in the PD 
group while the AP nucleus shows limited changes.  We have included a control group for 
comparison; the MD increase in groups with greater cognitive dysfunction does represent a 
decline in cellular integrity and does not render results invalid.  It cannot be overlooked 
however, that if a nucleus such as the MDn has a greater ratio of neurons to begin with 
then changes will be most evident here, regardless of underlying cause and may not 
indicate that the MDn is a target of degeneration, or is more affected than any other region.   
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It is also uncertain what FA values are actually representative of, with suggestions 
that myelin is not wholly reflected in this DTI measure.  Reduced FA, instead may be the 
result of increases in extracellular space or, the increase in cellular water concentration 
(Assaf & Pasternak, 2008).  Currently, it is difficult to explore this further as the DTI 
images are constrained by their large voxel size (in comparison to T1 images) and a 
2.5mm
3 
voxel most likely contains tens of thousands of axons and glial cells.  A single 
diffusion tensor could not represent all these components.  Averaging cellular components 
presents with additional problems as areas of partial tissue volume, such as where grey 
matter and white matter are present in the same voxel will not be represented adequately 
by the DTI model (Jansons & Alexander, 2003; Papadakis, et al., 1999; Tuch, et al., 2002).   
The main limitation centres on the fiber tracking approach.  We used similar 
methodology to that that has been applied previously but as the majority of previous 
research has been conducted in a normal healthy sample it is difficult to establish what the 
effect of neurodegeneration would have had on the algorithm.  Visual inspection of the 
images confirm what is known from previous animal studies and from what is suspected 
from fMRI and PET imaging studies, and is also in accordance with some of our own work 
(Melzer, et al., 2011a).  We still do not know the direction of any of the fiber tracts 
however, as this is not yet a possibility using this DTI method (Leh, et al., 2007).  
Although the seed points originated subcortically and the tract was delinated outwards 
from here, the main white matter fibers could have been in any direction.  Also, due to the 
abundance of white matter fibers within the thalamus, it is possible the algorithm picked up 
some tracts that in fact would have normally originated from another nucleus.  This could 
potentially account for the frontal involvement seen here as the anterior thalamic radiation 
is a strong white matter pathway that could be dominating results.  From the centromedian 
nucleus for example it is possible that instead of following white matter tracts that we 
would expect to diffuse in multiple directions it is possible the algorithm merley picked up 
the voxels in the strongest direction and followed the path from here, taping into the 
anterior thalamic radiation.   
10.3 Recommendations 
The thalamus is an intregral component of multiple neurological functions which mediate 
several facets of behavior.  It is recommended that further research be carried out on a 
similar cohort to this one and followed longitudinally to validate the cross-sectional 
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findings of this thesis.  Longitudinal investigation into these patients would allow for 
comparisions to be made between thalamic integrity in the early stages of the disorder 
when patients are still exhibiting cognitive function within the normal range and the 
assumed decline in integrity in those that progress to PD-MCI and finally to PD-D.  Follow 
up analysis on this cohort may also provide a strong neurocorrelate of cognitive 
dysfunction which may aid in the earliest identification of cognitive decline in PD.  
Thalamic degeneration, especially in select areas could also be used to monitor any new 
pharmalogical or behavioural interventions that may aid in the treatment of cognitive 
impairment in PD in the future.   
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Chapter 12. Appendices  
12.1 Appendix A: Nuclei Identification  
Table 12-1: Coronal Slices  
Right Left Nuclei 
  
AP (green) 
VA (yellow) 
 
  
AP (green) 
VA (yellow) 
 
  
AP (green) 
VA (yellow) 
VL (violet) 
  
AP (green) 
VA (yellow) 
VL (violet) 
  
AP (green) 
VA (yellow) 
VL (violet) 
CMPf (blue) 
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Table 12-1 Continued 
  
VA (yellow) 
VL (violet) 
CMPf (blue) 
MD (red) 
 
  
VA (yellow) 
VL (violet) 
CMPf (blue) 
MD (red) 
 
  
VL (violet) 
CMPf (blue) 
MD (red) 
 
  
VL (violet) 
CMPf (blue) 
MD (red) 
LD (yellow) 
VPL (light blue) 
 
 
  
VL (violet) 
CMPf (blue) 
MD (red) 
LD (yellow) 
VPL (light blue) 
 
  
VL (violet) 
CMPf (blue) 
MD (red) 
LD (yellow) 
VPL (light blue) 
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Table 12-1 Continued 
  
VL (violet) 
CMPf (blue) 
MD (red) 
VPL (light blue) 
LD (yellow) 
  
CMPf (blue) 
MD (red) 
VPL (light blue) 
LD (yellow) 
LP (green) 
  
CMPf (blue) 
VPL (light blue) 
LP (green) 
Pulvinar (yellow) 
  
CMPf (blue) 
LP (green) 
Pulvinar (yellow) 
 
  
CMPf (blue) 
LP (green) 
Pulvinar (yellow) 
  
LP (Green) 
Pulvinar (yellow) 
 
 Pulvinar (yellow) 
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Table 12-2: Saggital slices  
Right Left Nuclei 
  
LD (yellow) 
CMPf (blue) 
AP (green) 
  
LD (yellow) 
CMPf (blue) 
AP (green) 
VPL (light blue) 
VL (violet) 
  
LD (yellow) 
CMPf (blue) 
AP (green) 
VPL (light blue) 
VL (violet) 
MD (red) 
  
CMPf (blue) 
VPL (light blue) 
VL (violet) 
MD (red) 
VA (yellow) 
LP (green) 
Pulvinar (yellow) 
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Table 12-2 Continued 
  
CMPf (blue) 
VPL (light blue) 
VL (violet) 
MD (red) 
VA (yellow) 
LP (green) 
Pulvinar (yellow) 
  
CMPf (blue) 
VPL (light blue) 
VL (violet) 
MD (red) 
VA (yellow) 
LP (green) 
Pulvinar (yellow) 
  
CMPf (blue) 
VPL (light blue) 
VL (violet) 
MD (red) 
VA (yellow) 
LP (green) 
Pulvinar (yellow) 
  
CMPf (blue) 
VPL (light blue) 
VL (violet) 
MD (red) 
VA (yellow) 
LP (green) 
Pulvinar (yellow) 
  
CMPf (blue) 
VPL (light blue) 
VL (violet) 
MD (red) 
LP (green) 
Pulvinar (yellow) 
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Table 12-2 Continued  
  
VPL (light blue) 
VL (violet) 
LP (green) 
Pulvinar (yellow) 
 
 
VPL (light blue) 
LP (green) 
Pulvinar (yellow) 
 
 
VPL (light blue) 
LP (green) 
Pulvinar (yellow) 
 
 
LP (green) 
Pulvinar (yellow) 
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Table 12-3: Horizontal slices  
Right Left Nuclei 
  
AP (green) 
LD (yellow – medial) 
MD (red) 
VA (yellow – lateral) 
VPL (light blue) 
  
AP (green) 
LD (yellow – medial) 
MD (red) 
VA (yellow – lateral) 
VL (violet) 
VPL (light blue) 
CMPf (blue) 
  
AP (green - anterior) 
LD (yellow – medial) 
MD (red) 
VA (yellow – lateral) 
VL (violet) 
VPL (light blue) 
CMPf (blue) 
LP (green – posterior) 
Pu (yellow – posterior) 
  
AP (green - anterior) 
VA (yellow – lateral) 
VL (violet) 
VPL (light blue) 
CMPf (blue) 
LP (green – posterior) 
Pu (yellow – posterior) 
  
AP (green - anterior) 
VA (yellow – lateral) 
VL (violet) 
VPL (light blue) 
CMPf (blue) 
LP (green – posterior) 
Pu (yellow – posterior) 
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Table 12-3 Continued 
  
AP (green - anterior) 
VA (yellow – lateral) 
VL (violet) 
VPL (light blue) 
CMPf (blue) 
Pu (yellow – posterior) 
  
VL (violet) 
VPL (light blue) 
CMPf (blue) 
Pu (yellow – posterior) 
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12.2 Appendix B: Logistic regression results 
Table 12-4:  Combined effect of tracts and nuclei using FA and MD Logistic regression results, predicting PD 
 Association  Limbic  Sensory  Non-Specific  Motor  Whole Thalamus 
 MDn LP Pu  AP LD  VP  CM/Pf  VA VL  Left Right Average 
C vs PD-N 
ROI                  
FA -0.14  -0.34 -0.27  -0.25  -0.33  -0.28  -0.66  -0.09a -0.17  -0.47 -0.32 -0.40 
MD -0.74  -0.60 -0.71  -0.64  -0.26  -0.72  -0.68  -0.70 -0.76  -0.81 -0.78 -0.81 
Tract                  
FA -0.66  -0.45 -0.54  -0.68  -0.65  -0.40  -0.28  -0.66a -0.43  -0.40 -0.49 -0.41 
MD -0.25 -0.37 -0.28  -0.38  -0.62  -0.16  -0.45  -0.12 -0.20  0.15 0.13 -0.16 
Model                  
chi2 (df=4) 5.11 0.90 14.54  6.37 4.50  4.39  2.66  11.87 4.47  2.91 2.17 2.49 
p 0.28 0.92 0.01  0.17 0.34  0.36  0.62  0.02 0.35  0.57 0.70 0.65 
% correct 69.33 68.00 76.00  66.67 64.00  68.00  69.33  73.33 68.00  69.14 69.14 69.14 
C vs PD-MCI 
ROI                  
FA -0.13 -0.26 -0.30  -0.19 -0.03  -0.36  -0.38  -0.30 -0.12  -0.66 -0.59 -0.62 
MD -0.39a -0.45 -0.63a  -0.33 -0.02  -0.63  -0.63  -0.76a -0.65  -0.82 -0.86 -0.85 
Tract                  
FA -0.71 -0.53 -0.59  -0.73 -0.80  -0.34  -0.46  -0.70 -0.51  -0.45 -0.47 -0.47 
MD -0.67 -0.52 -0.30  -0.68 -0.67  -0.27  -0.42  -0.21 -0.35  0.37 0.23 0.33 
Model                  
chi2 (df=4) 8.28 3.09 9.22  2.15 9.06  3.33  2.28  8.36 3.58  9.02 7.89 8.57 
p 0.08 0.54 0.06  0.71 0.06  0.50  0.69  0.08 0.47  0.61 0.10 0.07 
% correct 66.67 59.52 74.43  59.52 50.00  66.67  59.52  71.42 59.52  68.18 63.63 65.91 
C vs PD-D 
ROI                  
FA -0.25 -0.12 -0.35  -0.58 -0.20  -0.04  -0.41  -0.37 -0.11  -0.59a -0.47 -0.53 
MD -0.78 -0.66 -0.69  -0.24a -0.28  -0.76a  -0.85  -0.64 -0.83a  -0.83 -0.86a -0.84a 
Tract                  
FA -0.66 -0.63 -0.71  -0.58 -0.62  -0.43  -0.70  -0.56 -0.08  -0.30 -0.40 -0.33 
MD -0.56 -0.51 -0.26  -0.77a -0.59  -0.51  -0.82  -0.30a -0.45  -0.05a -0.26a -0.16b 
Model                  
chi2 (df=4) 19.59 6.72 16.35  15.17 9.98  18.03  24.27  15.64 19.25  23.83 25.60 25.10 
p >0.01 0.15 >0.01  >0.01 0.04  >0.01  >0.001  >0.01 >0.001  >0.001 >0.001 >0.001 
% correct  84.62 71.79 87.18  76.92 66.67  82.05  84.62  76.92 74.36  82.05 82.05 82.05 
ROI = region of interest (either nucleus or whole thalamus).  Superscript numbers denote significance at the following levels: a: p < 0.05; b: p < 0.01; c: p < 0.001.   
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Table 12-5:  Combined effect of tracts and nuclei using FA and MD Logistic regression results, predicting cognitive impairment  
 Association  Limbic  Sensory  Non-Specific  Motor  Whole Thal 
 MDn LP Pu  AP LD  VP  CM/Pf  VA VL  Left Right Average 
PD-N vs PD-MCI  
ROI                  
FA -0.30 -0.37 -0.36  -0.12 -0.37  -0.37  -0.55  0.06 0.07  -0.40 -0.28 -0.34 
MD -0.73 -0.57 -0.52  -0.43 -0.18  -0.59  -0.55  -0.50 -0.48  -0.71 -0.78 -0.76 
Tract                  
FA -0.55 -0.52 -0.64  -0.67 -0.72  -0.41  -0.48  -0.76 -0.65  -0.42 -0.53 -0.45 
MD -0.09 -0.33 -0.36  -0.51 -0.68  -0.16  -0.37  -0.44 -0.43  0.16 0.13 0.18 
Model                  
chi2 (df=4) 7.85 2.97 7.59  4.02 9.72  4.35  1.97  10.82 6.61  9.36 7.09 8.53 
p 0.97 0.56 0.11  0.40 0.05  0.36  0.74  0.03 0.16  0.05 0.13 0.07 
% correct 72.46 73.91 76.81  71.01 72.46  73.91  73.91  76.81 75.36  77.33 77.33 77.33 
PD-N vs PD-D 
ROI                  
FA -0.30 -0.37 -0.32  -0.11 -0.41  -0.16  -0.37  0.05 0.20a  -0.37 -0.20 -0.31 
MD -0.62a -0.68b -0.48  -0.14 -0.22  -0.58  -0.49  -0.52 -0.39  -0.73a -0.80a -0.77b 
Tract                  
FA -0.54 -0.60 -0.66  -0.74 -0.56  -0.46  -0.74  -0.72 -0.64  -0.41 -0.50 -0.42 
MD -0.35 -0.36 -0.53  -0.71 -0.74  -0.43  -0.74  -0.10c -0.75b  -0.14a -0.01a -0.06a 
Model                  
chi2 (df=4) 20.53 20.53 12.98  17.41 18.10  14.22  20.65  28.78 18.44  23.98 24.31 25.09 
p >0.01 >0.001 0.01  >0.01 >0.01  >0.01  >0.01  >0.001 >0.01  >0.001 >0.001 >0.001 
% correct  80.30 74.24 80.30  78.79 75.76  80.30  80.30  86.36 83.33  84.93 82.19 84.93 
PD-MCI vs PD-D 
ROI                  
FA -0.20 -0.35 -0.45  -0.19 -0.16  -0.38  -0.16  -0.17 0.14  -0.67 -0.72 -0.70 
MD -0.44 -0.56 -0.40  -0.07 -0.24  -0.41  -0.75a  -0.49a -0.48  -0.71 -0.84 -0.79 
Tract                  
FA -0.62 -0.73 -0.71  -0.83 -0.82  -0.37  -0.80  -0.68 -0.55  -0.28 -0.44 -0.35 
MD -0.51 -0.48 -0.46  -0.84 -0.79  -0.41  -0.42  -0.07 -0.29  0.12 -0.03 0.11 
Model                  
chi2 (df=4) 8.44 5.13 3.08  12.31 7.22  5.86  17.26  12.15 5.61  4.66 7.60 5.73 
p 0.08 0.27 0.54  0.02 0.12  0.21  0.002  0.02 0.23  0.32 0.11 0.22 
% correct  75.76 66.67 66.67  72.72 66.67  66.67  69.70  66.67 66.67  66.67 63.89 66.67 
ROI = region of interest (either nucleus or whole thalamus).  Superscript numbers denote significance at the following levels: a: p < 0.05; b: p < 0.01; c: p < 0.001.   
 
  
 
